gene,original_gene,diseases
BRCA1,BRCA1,"Gallbladder Adenocarcinoma;Malignant peripheral nerve sheath tumor;Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation;head and neck squamous cell carcinoma;non-small cell lung carcinoma;Extramammary Paget Disease;Small Intestinal Diffuse Large B-Cell Lymphoma;bladder transitional cell carcinoma;Lung Inflammatory Myofibroblastic Tumor;Atypical Meningioma;Carcinoma;cutaneous melanoma;Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant;amelanotic skin melanoma;BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1;T-cell acute lymphoblastic leukemia;cervical squamous cell carcinoma;Fanconi anemia;breast ductal adenocarcinoma;Glioma;squamous cell lung carcinoma;pharyngeal squamous cell carcinoma;kidney neoplasm;ovarian serous adenocarcinoma;embryonal rhabdomyosarcoma;gastric adenocarcinoma;Pleural Epithelioid Mesothelioma;cervical adenocarcinoma;Transitional Meningioma;leiomyosarcoma;Rhabdoid Meningioma;gastric intestinal type adenocarcinoma;ovarian mucinous adenocarcinoma;Placental Choriocarcinoma;HER2 positive breast carcinoma;Lung adenocarcinoma;pancreatic carcinoma;Alveolar rhabdomyosarcoma;Hepatobiliary Neoplasm;Cholangiocarcinoma;cecum adenocarcinoma;brain glioblastoma;neoplasm of mature B-cells;Merkel cell skin cancer;vulvar intraepithelial neoplasia;large cell neuroendocrine carcinoma;skin carcinoma;Pancreatic Acinar Cell Carcinoma;B-cell acute lymphoblastic leukemia;Papillary thyroid carcinoma;Breast Cancer;ovarian teratoma;Cervical Small Cell Carcinoma;Ovarian Transitional Cell Carcinoma;Primary peritoneal carcinoma;salivary gland squamous cell carcinoma;prostate carcinoma;skin appendage carcinoma;Clear Cell Meningioma;MANTLE CELL LYMPHOMA;Hereditary breast and/or ovarian cancer syndrome;Poorly Differentiated Thyroid Gland Carcinoma;Dedifferentiated liposarcoma;Chronic myelomonocytic leukemia;Endometrial carcinoma;Hereditary breast cancer;Familial prostate cancer;Esophageal carcinoma;metaplastic breast carcinoma;Familial pancreatic carcinoma;ND;breast adenosis;Multiple myeloma;Malignant Laryngeal Neoplasm;Acute myeloid leukemia;pulmonary mucoepidermoid carcinoma;OSTEOSARCOMA;PANCREATIC CANCER, SUSCEPTIBILITY TO, 4;Ovarian Carcinosarcoma;Lung carcinoid tumor;Sinonasal Undifferentiated Carcinoma;thyroid carcinoma;Basal cell carcinoma;Thyroid Gland Undifferentiated (Anaplastic) Carcinoma;Malignant Ovarian Mixed Epithelial Tumor;Esophageal Squamous Cell Carcinoma;bile duct carcinoma;angiosarcoma;renal carcinoma;ovarian carcinoma;Gallbladder Small Cell Neuroendocrine Carcinoma;Thymoma Type B3;undifferentiated pleomorphic sarcoma;Small Intestinal Tubulovillous Adenoma;BRCA1-related Fanconi anaemia;Uterine Carcinosarcoma;adenosquamous lung carcinoma;rectal adenocarcinoma;Endometrial Clear Cell Adenocarcinoma;Pleural Biphasic Mesothelioma;Anaplastic astrocytoma;Neoplasm;Ovarian Endometrioid Adenocarcinoma;colon adenocarcinoma;diffuse large B-cell lymphoma;Appendix Goblet Cell Carcinoid;Atypical endometrial hyperplasia;Oligodendroglioma;Small cell lung carcinoma;small cell carcinoma;lobular breast carcinoma;Anaplastic oligodendroglioma;malignant epithelioid mesothelioma;Breast Carcinoma by Gene Expression Profile;HEPATOBLASTOMA;Duodenal Adenocarcinoma;Fibrous Meningioma;Mixed Lobular and Ductal Breast Carcinoma;ovarian clear cell adenocarcinoma;FANCONI ANEMIA, COMPLEMENTATION GROUP S;colorectal adenocarcinoma;Undifferentiated Ovarian Carcinoma;nasopharyngeal squamous cell carcinoma;pancreatic neuroendocrine tumor;Melanoma;Chromophobe renal cell carcinoma;adrenal cortex carcinoma;thyroid neoplasm;Lung carcinoma;Ovarian Dysgerminoma;Digestive System Carcinoma;Bladder Small Cell Neuroendocrine Carcinoma;nodular melanoma;Breast carcinoma;Cecum Villous Adenoma;gastric carcinoma;bronchoalveolar adenocarcinoma;Hodgkins lymphoma;lymphoid neoplasm;Papillary renal cell carcinoma;Acute lymphoblastic leukemia;Invasive Breast Carcinoma;Endometrial Endometrioid Adenocarcinoma;B-Cell Prolymphocytic Leukemia;testicular mixed germ cell tumor;Uveal melanoma;urothelial carcinoma;testicular seminoma;Hepatocellular Carcinoma;Langerhans cell histiocytosis;prostate adenocarcinoma;Thyroid Gland Oncocytic Follicular Carcinoma;BRCA1 related CANCER;Chronic lymphocytic leukemia;Clear cell renal carcinoma;Esophageal adenocarcinoma;Well-differentiated liposarcoma;oral squamous cell carcinoma;PANCREATIC CANCER, SUSCEPTIBILITY TO, 4;BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1;FANCONI ANEMIA, COMPLEMENTATION GROUP S;Breast Cancer"
BRCA1_aug1,BRCA1,"Gallbladder Adenocarcinoma;Malignant peripheral nerve sheath tumor;Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation;head and neck squamous cell carcinoma;non-small cell lung carcinoma;Extramammary Paget Disease;Small Intestinal Diffuse Large B-Cell Lymphoma;bladder transitional cell carcinoma;Lung Inflammatory Myofibroblastic Tumor;Atypical Meningioma;Carcinoma;cutaneous melanoma;Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant;amelanotic skin melanoma;BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1;T-cell acute lymphoblastic leukemia;cervical squamous cell carcinoma;Fanconi anemia;breast ductal adenocarcinoma;Glioma;squamous cell lung carcinoma;pharyngeal squamous cell carcinoma;kidney neoplasm;ovarian serous adenocarcinoma;embryonal rhabdomyosarcoma;gastric adenocarcinoma;Pleural Epithelioid Mesothelioma;cervical adenocarcinoma;Transitional Meningioma;leiomyosarcoma;Rhabdoid Meningioma;gastric intestinal type adenocarcinoma;ovarian mucinous adenocarcinoma;Placental Choriocarcinoma;HER2 positive breast carcinoma;Lung adenocarcinoma;pancreatic carcinoma;Alveolar rhabdomyosarcoma;Hepatobiliary Neoplasm;Cholangiocarcinoma;cecum adenocarcinoma;brain glioblastoma;neoplasm of mature B-cells;Merkel cell skin cancer;vulvar intraepithelial neoplasia;large cell neuroendocrine carcinoma;skin carcinoma;Pancreatic Acinar Cell Carcinoma;B-cell acute lymphoblastic leukemia;Papillary thyroid carcinoma;Breast Cancer;ovarian teratoma;Cervical Small Cell Carcinoma;Ovarian Transitional Cell Carcinoma;Primary peritoneal carcinoma;salivary gland squamous cell carcinoma;prostate carcinoma;skin appendage carcinoma;Clear Cell Meningioma;MANTLE CELL LYMPHOMA;Hereditary breast and/or ovarian cancer syndrome;Poorly Differentiated Thyroid Gland Carcinoma;Dedifferentiated liposarcoma;Chronic myelomonocytic leukemia;Endometrial carcinoma;Hereditary breast cancer;Familial prostate cancer;Esophageal carcinoma;metaplastic breast carcinoma;Familial pancreatic carcinoma;ND;breast adenosis;Multiple myeloma;Malignant Laryngeal Neoplasm;Acute myeloid leukemia;pulmonary mucoepidermoid carcinoma;OSTEOSARCOMA;PANCREATIC CANCER, SUSCEPTIBILITY TO, 4;Ovarian Carcinosarcoma;Lung carcinoid tumor;Sinonasal Undifferentiated Carcinoma;thyroid carcinoma;Basal cell carcinoma;Thyroid Gland Undifferentiated (Anaplastic) Carcinoma;Malignant Ovarian Mixed Epithelial Tumor;Esophageal Squamous Cell Carcinoma;bile duct carcinoma;angiosarcoma;renal carcinoma;ovarian carcinoma;Gallbladder Small Cell Neuroendocrine Carcinoma;Thymoma Type B3;undifferentiated pleomorphic sarcoma;Small Intestinal Tubulovillous Adenoma;BRCA1-related Fanconi anaemia;Uterine Carcinosarcoma;adenosquamous lung carcinoma;rectal adenocarcinoma;Endometrial Clear Cell Adenocarcinoma;Pleural Biphasic Mesothelioma;Anaplastic astrocytoma;Neoplasm;Ovarian Endometrioid Adenocarcinoma;colon adenocarcinoma;diffuse large B-cell lymphoma;Appendix Goblet Cell Carcinoid;Atypical endometrial hyperplasia;Oligodendroglioma;Small cell lung carcinoma;small cell carcinoma;lobular breast carcinoma;Anaplastic oligodendroglioma;malignant epithelioid mesothelioma;Breast Carcinoma by Gene Expression Profile;HEPATOBLASTOMA;Duodenal Adenocarcinoma;Fibrous Meningioma;Mixed Lobular and Ductal Breast Carcinoma;ovarian clear cell adenocarcinoma;FANCONI ANEMIA, COMPLEMENTATION GROUP S;colorectal adenocarcinoma;Undifferentiated Ovarian Carcinoma;nasopharyngeal squamous cell carcinoma;pancreatic neuroendocrine tumor;Melanoma;Chromophobe renal cell carcinoma;adrenal cortex carcinoma;thyroid neoplasm;Lung carcinoma;Ovarian Dysgerminoma;Digestive System Carcinoma;Bladder Small Cell Neuroendocrine Carcinoma;nodular melanoma;Breast carcinoma;Cecum Villous Adenoma;gastric carcinoma;bronchoalveolar adenocarcinoma;Hodgkins lymphoma;lymphoid neoplasm;Papillary renal cell carcinoma;Acute lymphoblastic leukemia;Invasive Breast Carcinoma;Endometrial Endometrioid Adenocarcinoma;B-Cell Prolymphocytic Leukemia;testicular mixed germ cell tumor;Uveal melanoma;urothelial carcinoma;testicular seminoma;Hepatocellular Carcinoma;Langerhans cell histiocytosis;prostate adenocarcinoma;Thyroid Gland Oncocytic Follicular Carcinoma;BRCA1 related CANCER;Chronic lymphocytic leukemia;Clear cell renal carcinoma;Esophageal adenocarcinoma;Well-differentiated liposarcoma;oral squamous cell carcinoma;PANCREATIC CANCER, SUSCEPTIBILITY TO, 4;BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1;FANCONI ANEMIA, COMPLEMENTATION GROUP S;Breast Cancer"
BRCA1_aug2,BRCA1,"Gallbladder Adenocarcinoma;Malignant peripheral nerve sheath tumor;Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation;head and neck squamous cell carcinoma;non-small cell lung carcinoma;Extramammary Paget Disease;Small Intestinal Diffuse Large B-Cell Lymphoma;bladder transitional cell carcinoma;Lung Inflammatory Myofibroblastic Tumor;Atypical Meningioma;Carcinoma;cutaneous melanoma;Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant;amelanotic skin melanoma;BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1;T-cell acute lymphoblastic leukemia;cervical squamous cell carcinoma;Fanconi anemia;breast ductal adenocarcinoma;Glioma;squamous cell lung carcinoma;pharyngeal squamous cell carcinoma;kidney neoplasm;ovarian serous adenocarcinoma;embryonal rhabdomyosarcoma;gastric adenocarcinoma;Pleural Epithelioid Mesothelioma;cervical adenocarcinoma;Transitional Meningioma;leiomyosarcoma;Rhabdoid Meningioma;gastric intestinal type adenocarcinoma;ovarian mucinous adenocarcinoma;Placental Choriocarcinoma;HER2 positive breast carcinoma;Lung adenocarcinoma;pancreatic carcinoma;Alveolar rhabdomyosarcoma;Hepatobiliary Neoplasm;Cholangiocarcinoma;cecum adenocarcinoma;brain glioblastoma;neoplasm of mature B-cells;Merkel cell skin cancer;vulvar intraepithelial neoplasia;large cell neuroendocrine carcinoma;skin carcinoma;Pancreatic Acinar Cell Carcinoma;B-cell acute lymphoblastic leukemia;Papillary thyroid carcinoma;Breast Cancer;ovarian teratoma;Cervical Small Cell Carcinoma;Ovarian Transitional Cell Carcinoma;Primary peritoneal carcinoma;salivary gland squamous cell carcinoma;prostate carcinoma;skin appendage carcinoma;Clear Cell Meningioma;MANTLE CELL LYMPHOMA;Hereditary breast and/or ovarian cancer syndrome;Poorly Differentiated Thyroid Gland Carcinoma;Dedifferentiated liposarcoma;Chronic myelomonocytic leukemia;Endometrial carcinoma;Hereditary breast cancer;Familial prostate cancer;Esophageal carcinoma;metaplastic breast carcinoma;Familial pancreatic carcinoma;ND;breast adenosis;Multiple myeloma;Malignant Laryngeal Neoplasm;Acute myeloid leukemia;pulmonary mucoepidermoid carcinoma;OSTEOSARCOMA;PANCREATIC CANCER, SUSCEPTIBILITY TO, 4;Ovarian Carcinosarcoma;Lung carcinoid tumor;Sinonasal Undifferentiated Carcinoma;thyroid carcinoma;Basal cell carcinoma;Thyroid Gland Undifferentiated (Anaplastic) Carcinoma;Malignant Ovarian Mixed Epithelial Tumor;Esophageal Squamous Cell Carcinoma;bile duct carcinoma;angiosarcoma;renal carcinoma;ovarian carcinoma;Gallbladder Small Cell Neuroendocrine Carcinoma;Thymoma Type B3;undifferentiated pleomorphic sarcoma;Small Intestinal Tubulovillous Adenoma;BRCA1-related Fanconi anaemia;Uterine Carcinosarcoma;adenosquamous lung carcinoma;rectal adenocarcinoma;Endometrial Clear Cell Adenocarcinoma;Pleural Biphasic Mesothelioma;Anaplastic astrocytoma;Neoplasm;Ovarian Endometrioid Adenocarcinoma;colon adenocarcinoma;diffuse large B-cell lymphoma;Appendix Goblet Cell Carcinoid;Atypical endometrial hyperplasia;Oligodendroglioma;Small cell lung carcinoma;small cell carcinoma;lobular breast carcinoma;Anaplastic oligodendroglioma;malignant epithelioid mesothelioma;Breast Carcinoma by Gene Expression Profile;HEPATOBLASTOMA;Duodenal Adenocarcinoma;Fibrous Meningioma;Mixed Lobular and Ductal Breast Carcinoma;ovarian clear cell adenocarcinoma;FANCONI ANEMIA, COMPLEMENTATION GROUP S;colorectal adenocarcinoma;Undifferentiated Ovarian Carcinoma;nasopharyngeal squamous cell carcinoma;pancreatic neuroendocrine tumor;Melanoma;Chromophobe renal cell carcinoma;adrenal cortex carcinoma;thyroid neoplasm;Lung carcinoma;Ovarian Dysgerminoma;Digestive System Carcinoma;Bladder Small Cell Neuroendocrine Carcinoma;nodular melanoma;Breast carcinoma;Cecum Villous Adenoma;gastric carcinoma;bronchoalveolar adenocarcinoma;Hodgkins lymphoma;lymphoid neoplasm;Papillary renal cell carcinoma;Acute lymphoblastic leukemia;Invasive Breast Carcinoma;Endometrial Endometrioid Adenocarcinoma;B-Cell Prolymphocytic Leukemia;testicular mixed germ cell tumor;Uveal melanoma;urothelial carcinoma;testicular seminoma;Hepatocellular Carcinoma;Langerhans cell histiocytosis;prostate adenocarcinoma;Thyroid Gland Oncocytic Follicular Carcinoma;BRCA1 related CANCER;Chronic lymphocytic leukemia;Clear cell renal carcinoma;Esophageal adenocarcinoma;Well-differentiated liposarcoma;oral squamous cell carcinoma;PANCREATIC CANCER, SUSCEPTIBILITY TO, 4;BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1;FANCONI ANEMIA, COMPLEMENTATION GROUP S;Breast Cancer"
BRCA1_aug3,BRCA1,"Gallbladder Adenocarcinoma;Malignant peripheral nerve sheath tumor;Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation;head and neck squamous cell carcinoma;non-small cell lung carcinoma;Extramammary Paget Disease;Small Intestinal Diffuse Large B-Cell Lymphoma;bladder transitional cell carcinoma;Lung Inflammatory Myofibroblastic Tumor;Atypical Meningioma;Carcinoma;cutaneous melanoma;Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant;amelanotic skin melanoma;BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1;T-cell acute lymphoblastic leukemia;cervical squamous cell carcinoma;Fanconi anemia;breast ductal adenocarcinoma;Glioma;squamous cell lung carcinoma;pharyngeal squamous cell carcinoma;kidney neoplasm;ovarian serous adenocarcinoma;embryonal rhabdomyosarcoma;gastric adenocarcinoma;Pleural Epithelioid Mesothelioma;cervical adenocarcinoma;Transitional Meningioma;leiomyosarcoma;Rhabdoid Meningioma;gastric intestinal type adenocarcinoma;ovarian mucinous adenocarcinoma;Placental Choriocarcinoma;HER2 positive breast carcinoma;Lung adenocarcinoma;pancreatic carcinoma;Alveolar rhabdomyosarcoma;Hepatobiliary Neoplasm;Cholangiocarcinoma;cecum adenocarcinoma;brain glioblastoma;neoplasm of mature B-cells;Merkel cell skin cancer;vulvar intraepithelial neoplasia;large cell neuroendocrine carcinoma;skin carcinoma;Pancreatic Acinar Cell Carcinoma;B-cell acute lymphoblastic leukemia;Papillary thyroid carcinoma;Breast Cancer;ovarian teratoma;Cervical Small Cell Carcinoma;Ovarian Transitional Cell Carcinoma;Primary peritoneal carcinoma;salivary gland squamous cell carcinoma;prostate carcinoma;skin appendage carcinoma;Clear Cell Meningioma;MANTLE CELL LYMPHOMA;Hereditary breast and/or ovarian cancer syndrome;Poorly Differentiated Thyroid Gland Carcinoma;Dedifferentiated liposarcoma;Chronic myelomonocytic leukemia;Endometrial carcinoma;Hereditary breast cancer;Familial prostate cancer;Esophageal carcinoma;metaplastic breast carcinoma;Familial pancreatic carcinoma;ND;breast adenosis;Multiple myeloma;Malignant Laryngeal Neoplasm;Acute myeloid leukemia;pulmonary mucoepidermoid carcinoma;OSTEOSARCOMA;PANCREATIC CANCER, SUSCEPTIBILITY TO, 4;Ovarian Carcinosarcoma;Lung carcinoid tumor;Sinonasal Undifferentiated Carcinoma;thyroid carcinoma;Basal cell carcinoma;Thyroid Gland Undifferentiated (Anaplastic) Carcinoma;Malignant Ovarian Mixed Epithelial Tumor;Esophageal Squamous Cell Carcinoma;bile duct carcinoma;angiosarcoma;renal carcinoma;ovarian carcinoma;Gallbladder Small Cell Neuroendocrine Carcinoma;Thymoma Type B3;undifferentiated pleomorphic sarcoma;Small Intestinal Tubulovillous Adenoma;BRCA1-related Fanconi anaemia;Uterine Carcinosarcoma;adenosquamous lung carcinoma;rectal adenocarcinoma;Endometrial Clear Cell Adenocarcinoma;Pleural Biphasic Mesothelioma;Anaplastic astrocytoma;Neoplasm;Ovarian Endometrioid Adenocarcinoma;colon adenocarcinoma;diffuse large B-cell lymphoma;Appendix Goblet Cell Carcinoid;Atypical endometrial hyperplasia;Oligodendroglioma;Small cell lung carcinoma;small cell carcinoma;lobular breast carcinoma;Anaplastic oligodendroglioma;malignant epithelioid mesothelioma;Breast Carcinoma by Gene Expression Profile;HEPATOBLASTOMA;Duodenal Adenocarcinoma;Fibrous Meningioma;Mixed Lobular and Ductal Breast Carcinoma;ovarian clear cell adenocarcinoma;FANCONI ANEMIA, COMPLEMENTATION GROUP S;colorectal adenocarcinoma;Undifferentiated Ovarian Carcinoma;nasopharyngeal squamous cell carcinoma;pancreatic neuroendocrine tumor;Melanoma;Chromophobe renal cell carcinoma;adrenal cortex carcinoma;thyroid neoplasm;Lung carcinoma;Ovarian Dysgerminoma;Digestive System Carcinoma;Bladder Small Cell Neuroendocrine Carcinoma;nodular melanoma;Breast carcinoma;Cecum Villous Adenoma;gastric carcinoma;bronchoalveolar adenocarcinoma;Hodgkins lymphoma;lymphoid neoplasm;Papillary renal cell carcinoma;Acute lymphoblastic leukemia;Invasive Breast Carcinoma;Endometrial Endometrioid Adenocarcinoma;B-Cell Prolymphocytic Leukemia;testicular mixed germ cell tumor;Uveal melanoma;urothelial carcinoma;testicular seminoma;Hepatocellular Carcinoma;Langerhans cell histiocytosis;prostate adenocarcinoma;Thyroid Gland Oncocytic Follicular Carcinoma;BRCA1 related CANCER;Chronic lymphocytic leukemia;Clear cell renal carcinoma;Esophageal adenocarcinoma;Well-differentiated liposarcoma;oral squamous cell carcinoma;PANCREATIC CANCER, SUSCEPTIBILITY TO, 4;BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1;FANCONI ANEMIA, COMPLEMENTATION GROUP S;Breast Cancer"
BRCA1_aug4,BRCA1,"Gallbladder Adenocarcinoma;Malignant peripheral nerve sheath tumor;Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation;head and neck squamous cell carcinoma;non-small cell lung carcinoma;Extramammary Paget Disease;Small Intestinal Diffuse Large B-Cell Lymphoma;bladder transitional cell carcinoma;Lung Inflammatory Myofibroblastic Tumor;Atypical Meningioma;Carcinoma;cutaneous melanoma;Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant;amelanotic skin melanoma;BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1;T-cell acute lymphoblastic leukemia;cervical squamous cell carcinoma;Fanconi anemia;breast ductal adenocarcinoma;Glioma;squamous cell lung carcinoma;pharyngeal squamous cell carcinoma;kidney neoplasm;ovarian serous adenocarcinoma;embryonal rhabdomyosarcoma;gastric adenocarcinoma;Pleural Epithelioid Mesothelioma;cervical adenocarcinoma;Transitional Meningioma;leiomyosarcoma;Rhabdoid Meningioma;gastric intestinal type adenocarcinoma;ovarian mucinous adenocarcinoma;Placental Choriocarcinoma;HER2 positive breast carcinoma;Lung adenocarcinoma;pancreatic carcinoma;Alveolar rhabdomyosarcoma;Hepatobiliary Neoplasm;Cholangiocarcinoma;cecum adenocarcinoma;brain glioblastoma;neoplasm of mature B-cells;Merkel cell skin cancer;vulvar intraepithelial neoplasia;large cell neuroendocrine carcinoma;skin carcinoma;Pancreatic Acinar Cell Carcinoma;B-cell acute lymphoblastic leukemia;Papillary thyroid carcinoma;Breast Cancer;ovarian teratoma;Cervical Small Cell Carcinoma;Ovarian Transitional Cell Carcinoma;Primary peritoneal carcinoma;salivary gland squamous cell carcinoma;prostate carcinoma;skin appendage carcinoma;Clear Cell Meningioma;MANTLE CELL LYMPHOMA;Hereditary breast and/or ovarian cancer syndrome;Poorly Differentiated Thyroid Gland Carcinoma;Dedifferentiated liposarcoma;Chronic myelomonocytic leukemia;Endometrial carcinoma;Hereditary breast cancer;Familial prostate cancer;Esophageal carcinoma;metaplastic breast carcinoma;Familial pancreatic carcinoma;ND;breast adenosis;Multiple myeloma;Malignant Laryngeal Neoplasm;Acute myeloid leukemia;pulmonary mucoepidermoid carcinoma;OSTEOSARCOMA;PANCREATIC CANCER, SUSCEPTIBILITY TO, 4;Ovarian Carcinosarcoma;Lung carcinoid tumor;Sinonasal Undifferentiated Carcinoma;thyroid carcinoma;Basal cell carcinoma;Thyroid Gland Undifferentiated (Anaplastic) Carcinoma;Malignant Ovarian Mixed Epithelial Tumor;Esophageal Squamous Cell Carcinoma;bile duct carcinoma;angiosarcoma;renal carcinoma;ovarian carcinoma;Gallbladder Small Cell Neuroendocrine Carcinoma;Thymoma Type B3;undifferentiated pleomorphic sarcoma;Small Intestinal Tubulovillous Adenoma;BRCA1-related Fanconi anaemia;Uterine Carcinosarcoma;adenosquamous lung carcinoma;rectal adenocarcinoma;Endometrial Clear Cell Adenocarcinoma;Pleural Biphasic Mesothelioma;Anaplastic astrocytoma;Neoplasm;Ovarian Endometrioid Adenocarcinoma;colon adenocarcinoma;diffuse large B-cell lymphoma;Appendix Goblet Cell Carcinoid;Atypical endometrial hyperplasia;Oligodendroglioma;Small cell lung carcinoma;small cell carcinoma;lobular breast carcinoma;Anaplastic oligodendroglioma;malignant epithelioid mesothelioma;Breast Carcinoma by Gene Expression Profile;HEPATOBLASTOMA;Duodenal Adenocarcinoma;Fibrous Meningioma;Mixed Lobular and Ductal Breast Carcinoma;ovarian clear cell adenocarcinoma;FANCONI ANEMIA, COMPLEMENTATION GROUP S;colorectal adenocarcinoma;Undifferentiated Ovarian Carcinoma;nasopharyngeal squamous cell carcinoma;pancreatic neuroendocrine tumor;Melanoma;Chromophobe renal cell carcinoma;adrenal cortex carcinoma;thyroid neoplasm;Lung carcinoma;Ovarian Dysgerminoma;Digestive System Carcinoma;Bladder Small Cell Neuroendocrine Carcinoma;nodular melanoma;Breast carcinoma;Cecum Villous Adenoma;gastric carcinoma;bronchoalveolar adenocarcinoma;Hodgkins lymphoma;lymphoid neoplasm;Papillary renal cell carcinoma;Acute lymphoblastic leukemia;Invasive Breast Carcinoma;Endometrial Endometrioid Adenocarcinoma;B-Cell Prolymphocytic Leukemia;testicular mixed germ cell tumor;Uveal melanoma;urothelial carcinoma;testicular seminoma;Hepatocellular Carcinoma;Langerhans cell histiocytosis;prostate adenocarcinoma;Thyroid Gland Oncocytic Follicular Carcinoma;BRCA1 related CANCER;Chronic lymphocytic leukemia;Clear cell renal carcinoma;Esophageal adenocarcinoma;Well-differentiated liposarcoma;oral squamous cell carcinoma;PANCREATIC CANCER, SUSCEPTIBILITY TO, 4;BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1;FANCONI ANEMIA, COMPLEMENTATION GROUP S;Breast Cancer"
BRCA1_aug5,BRCA1,"Gallbladder Adenocarcinoma;Malignant peripheral nerve sheath tumor;Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation;head and neck squamous cell carcinoma;non-small cell lung carcinoma;Extramammary Paget Disease;Small Intestinal Diffuse Large B-Cell Lymphoma;bladder transitional cell carcinoma;Lung Inflammatory Myofibroblastic Tumor;Atypical Meningioma;Carcinoma;cutaneous melanoma;Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant;amelanotic skin melanoma;BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1;T-cell acute lymphoblastic leukemia;cervical squamous cell carcinoma;Fanconi anemia;breast ductal adenocarcinoma;Glioma;squamous cell lung carcinoma;pharyngeal squamous cell carcinoma;kidney neoplasm;ovarian serous adenocarcinoma;embryonal rhabdomyosarcoma;gastric adenocarcinoma;Pleural Epithelioid Mesothelioma;cervical adenocarcinoma;Transitional Meningioma;leiomyosarcoma;Rhabdoid Meningioma;gastric intestinal type adenocarcinoma;ovarian mucinous adenocarcinoma;Placental Choriocarcinoma;HER2 positive breast carcinoma;Lung adenocarcinoma;pancreatic carcinoma;Alveolar rhabdomyosarcoma;Hepatobiliary Neoplasm;Cholangiocarcinoma;cecum adenocarcinoma;brain glioblastoma;neoplasm of mature B-cells;Merkel cell skin cancer;vulvar intraepithelial neoplasia;large cell neuroendocrine carcinoma;skin carcinoma;Pancreatic Acinar Cell Carcinoma;B-cell acute lymphoblastic leukemia;Papillary thyroid carcinoma;Breast Cancer;ovarian teratoma;Cervical Small Cell Carcinoma;Ovarian Transitional Cell Carcinoma;Primary peritoneal carcinoma;salivary gland squamous cell carcinoma;prostate carcinoma;skin appendage carcinoma;Clear Cell Meningioma;MANTLE CELL LYMPHOMA;Hereditary breast and/or ovarian cancer syndrome;Poorly Differentiated Thyroid Gland Carcinoma;Dedifferentiated liposarcoma;Chronic myelomonocytic leukemia;Endometrial carcinoma;Hereditary breast cancer;Familial prostate cancer;Esophageal carcinoma;metaplastic breast carcinoma;Familial pancreatic carcinoma;ND;breast adenosis;Multiple myeloma;Malignant Laryngeal Neoplasm;Acute myeloid leukemia;pulmonary mucoepidermoid carcinoma;OSTEOSARCOMA;PANCREATIC CANCER, SUSCEPTIBILITY TO, 4;Ovarian Carcinosarcoma;Lung carcinoid tumor;Sinonasal Undifferentiated Carcinoma;thyroid carcinoma;Basal cell carcinoma;Thyroid Gland Undifferentiated (Anaplastic) Carcinoma;Malignant Ovarian Mixed Epithelial Tumor;Esophageal Squamous Cell Carcinoma;bile duct carcinoma;angiosarcoma;renal carcinoma;ovarian carcinoma;Gallbladder Small Cell Neuroendocrine Carcinoma;Thymoma Type B3;undifferentiated pleomorphic sarcoma;Small Intestinal Tubulovillous Adenoma;BRCA1-related Fanconi anaemia;Uterine Carcinosarcoma;adenosquamous lung carcinoma;rectal adenocarcinoma;Endometrial Clear Cell Adenocarcinoma;Pleural Biphasic Mesothelioma;Anaplastic astrocytoma;Neoplasm;Ovarian Endometrioid Adenocarcinoma;colon adenocarcinoma;diffuse large B-cell lymphoma;Appendix Goblet Cell Carcinoid;Atypical endometrial hyperplasia;Oligodendroglioma;Small cell lung carcinoma;small cell carcinoma;lobular breast carcinoma;Anaplastic oligodendroglioma;malignant epithelioid mesothelioma;Breast Carcinoma by Gene Expression Profile;HEPATOBLASTOMA;Duodenal Adenocarcinoma;Fibrous Meningioma;Mixed Lobular and Ductal Breast Carcinoma;ovarian clear cell adenocarcinoma;FANCONI ANEMIA, COMPLEMENTATION GROUP S;colorectal adenocarcinoma;Undifferentiated Ovarian Carcinoma;nasopharyngeal squamous cell carcinoma;pancreatic neuroendocrine tumor;Melanoma;Chromophobe renal cell carcinoma;adrenal cortex carcinoma;thyroid neoplasm;Lung carcinoma;Ovarian Dysgerminoma;Digestive System Carcinoma;Bladder Small Cell Neuroendocrine Carcinoma;nodular melanoma;Breast carcinoma;Cecum Villous Adenoma;gastric carcinoma;bronchoalveolar adenocarcinoma;Hodgkins lymphoma;lymphoid neoplasm;Papillary renal cell carcinoma;Acute lymphoblastic leukemia;Invasive Breast Carcinoma;Endometrial Endometrioid Adenocarcinoma;B-Cell Prolymphocytic Leukemia;testicular mixed germ cell tumor;Uveal melanoma;urothelial carcinoma;testicular seminoma;Hepatocellular Carcinoma;Langerhans cell histiocytosis;prostate adenocarcinoma;Thyroid Gland Oncocytic Follicular Carcinoma;BRCA1 related CANCER;Chronic lymphocytic leukemia;Clear cell renal carcinoma;Esophageal adenocarcinoma;Well-differentiated liposarcoma;oral squamous cell carcinoma;PANCREATIC CANCER, SUSCEPTIBILITY TO, 4;BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1;FANCONI ANEMIA, COMPLEMENTATION GROUP S;Breast Cancer"
BRCA1_aug6,BRCA1,"Gallbladder Adenocarcinoma;Malignant peripheral nerve sheath tumor;Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation;head and neck squamous cell carcinoma;non-small cell lung carcinoma;Extramammary Paget Disease;Small Intestinal Diffuse Large B-Cell Lymphoma;bladder transitional cell carcinoma;Lung Inflammatory Myofibroblastic Tumor;Atypical Meningioma;Carcinoma;cutaneous melanoma;Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant;amelanotic skin melanoma;BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1;T-cell acute lymphoblastic leukemia;cervical squamous cell carcinoma;Fanconi anemia;breast ductal adenocarcinoma;Glioma;squamous cell lung carcinoma;pharyngeal squamous cell carcinoma;kidney neoplasm;ovarian serous adenocarcinoma;embryonal rhabdomyosarcoma;gastric adenocarcinoma;Pleural Epithelioid Mesothelioma;cervical adenocarcinoma;Transitional Meningioma;leiomyosarcoma;Rhabdoid Meningioma;gastric intestinal type adenocarcinoma;ovarian mucinous adenocarcinoma;Placental Choriocarcinoma;HER2 positive breast carcinoma;Lung adenocarcinoma;pancreatic carcinoma;Alveolar rhabdomyosarcoma;Hepatobiliary Neoplasm;Cholangiocarcinoma;cecum adenocarcinoma;brain glioblastoma;neoplasm of mature B-cells;Merkel cell skin cancer;vulvar intraepithelial neoplasia;large cell neuroendocrine carcinoma;skin carcinoma;Pancreatic Acinar Cell Carcinoma;B-cell acute lymphoblastic leukemia;Papillary thyroid carcinoma;Breast Cancer;ovarian teratoma;Cervical Small Cell Carcinoma;Ovarian Transitional Cell Carcinoma;Primary peritoneal carcinoma;salivary gland squamous cell carcinoma;prostate carcinoma;skin appendage carcinoma;Clear Cell Meningioma;MANTLE CELL LYMPHOMA;Hereditary breast and/or ovarian cancer syndrome;Poorly Differentiated Thyroid Gland Carcinoma;Dedifferentiated liposarcoma;Chronic myelomonocytic leukemia;Endometrial carcinoma;Hereditary breast cancer;Familial prostate cancer;Esophageal carcinoma;metaplastic breast carcinoma;Familial pancreatic carcinoma;ND;breast adenosis;Multiple myeloma;Malignant Laryngeal Neoplasm;Acute myeloid leukemia;pulmonary mucoepidermoid carcinoma;OSTEOSARCOMA;PANCREATIC CANCER, SUSCEPTIBILITY TO, 4;Ovarian Carcinosarcoma;Lung carcinoid tumor;Sinonasal Undifferentiated Carcinoma;thyroid carcinoma;Basal cell carcinoma;Thyroid Gland Undifferentiated (Anaplastic) Carcinoma;Malignant Ovarian Mixed Epithelial Tumor;Esophageal Squamous Cell Carcinoma;bile duct carcinoma;angiosarcoma;renal carcinoma;ovarian carcinoma;Gallbladder Small Cell Neuroendocrine Carcinoma;Thymoma Type B3;undifferentiated pleomorphic sarcoma;Small Intestinal Tubulovillous Adenoma;BRCA1-related Fanconi anaemia;Uterine Carcinosarcoma;adenosquamous lung carcinoma;rectal adenocarcinoma;Endometrial Clear Cell Adenocarcinoma;Pleural Biphasic Mesothelioma;Anaplastic astrocytoma;Neoplasm;Ovarian Endometrioid Adenocarcinoma;colon adenocarcinoma;diffuse large B-cell lymphoma;Appendix Goblet Cell Carcinoid;Atypical endometrial hyperplasia;Oligodendroglioma;Small cell lung carcinoma;small cell carcinoma;lobular breast carcinoma;Anaplastic oligodendroglioma;malignant epithelioid mesothelioma;Breast Carcinoma by Gene Expression Profile;HEPATOBLASTOMA;Duodenal Adenocarcinoma;Fibrous Meningioma;Mixed Lobular and Ductal Breast Carcinoma;ovarian clear cell adenocarcinoma;FANCONI ANEMIA, COMPLEMENTATION GROUP S;colorectal adenocarcinoma;Undifferentiated Ovarian Carcinoma;nasopharyngeal squamous cell carcinoma;pancreatic neuroendocrine tumor;Melanoma;Chromophobe renal cell carcinoma;adrenal cortex carcinoma;thyroid neoplasm;Lung carcinoma;Ovarian Dysgerminoma;Digestive System Carcinoma;Bladder Small Cell Neuroendocrine Carcinoma;nodular melanoma;Breast carcinoma;Cecum Villous Adenoma;gastric carcinoma;bronchoalveolar adenocarcinoma;Hodgkins lymphoma;lymphoid neoplasm;Papillary renal cell carcinoma;Acute lymphoblastic leukemia;Invasive Breast Carcinoma;Endometrial Endometrioid Adenocarcinoma;B-Cell Prolymphocytic Leukemia;testicular mixed germ cell tumor;Uveal melanoma;urothelial carcinoma;testicular seminoma;Hepatocellular Carcinoma;Langerhans cell histiocytosis;prostate adenocarcinoma;Thyroid Gland Oncocytic Follicular Carcinoma;BRCA1 related CANCER;Chronic lymphocytic leukemia;Clear cell renal carcinoma;Esophageal adenocarcinoma;Well-differentiated liposarcoma;oral squamous cell carcinoma;PANCREATIC CANCER, SUSCEPTIBILITY TO, 4;BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1;FANCONI ANEMIA, COMPLEMENTATION GROUP S;Breast Cancer"
BRCA1_aug7,BRCA1,"Gallbladder Adenocarcinoma;Malignant peripheral nerve sheath tumor;Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation;head and neck squamous cell carcinoma;non-small cell lung carcinoma;Extramammary Paget Disease;Small Intestinal Diffuse Large B-Cell Lymphoma;bladder transitional cell carcinoma;Lung Inflammatory Myofibroblastic Tumor;Atypical Meningioma;Carcinoma;cutaneous melanoma;Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant;amelanotic skin melanoma;BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1;T-cell acute lymphoblastic leukemia;cervical squamous cell carcinoma;Fanconi anemia;breast ductal adenocarcinoma;Glioma;squamous cell lung carcinoma;pharyngeal squamous cell carcinoma;kidney neoplasm;ovarian serous adenocarcinoma;embryonal rhabdomyosarcoma;gastric adenocarcinoma;Pleural Epithelioid Mesothelioma;cervical adenocarcinoma;Transitional Meningioma;leiomyosarcoma;Rhabdoid Meningioma;gastric intestinal type adenocarcinoma;ovarian mucinous adenocarcinoma;Placental Choriocarcinoma;HER2 positive breast carcinoma;Lung adenocarcinoma;pancreatic carcinoma;Alveolar rhabdomyosarcoma;Hepatobiliary Neoplasm;Cholangiocarcinoma;cecum adenocarcinoma;brain glioblastoma;neoplasm of mature B-cells;Merkel cell skin cancer;vulvar intraepithelial neoplasia;large cell neuroendocrine carcinoma;skin carcinoma;Pancreatic Acinar Cell Carcinoma;B-cell acute lymphoblastic leukemia;Papillary thyroid carcinoma;Breast Cancer;ovarian teratoma;Cervical Small Cell Carcinoma;Ovarian Transitional Cell Carcinoma;Primary peritoneal carcinoma;salivary gland squamous cell carcinoma;prostate carcinoma;skin appendage carcinoma;Clear Cell Meningioma;MANTLE CELL LYMPHOMA;Hereditary breast and/or ovarian cancer syndrome;Poorly Differentiated Thyroid Gland Carcinoma;Dedifferentiated liposarcoma;Chronic myelomonocytic leukemia;Endometrial carcinoma;Hereditary breast cancer;Familial prostate cancer;Esophageal carcinoma;metaplastic breast carcinoma;Familial pancreatic carcinoma;ND;breast adenosis;Multiple myeloma;Malignant Laryngeal Neoplasm;Acute myeloid leukemia;pulmonary mucoepidermoid carcinoma;OSTEOSARCOMA;PANCREATIC CANCER, SUSCEPTIBILITY TO, 4;Ovarian Carcinosarcoma;Lung carcinoid tumor;Sinonasal Undifferentiated Carcinoma;thyroid carcinoma;Basal cell carcinoma;Thyroid Gland Undifferentiated (Anaplastic) Carcinoma;Malignant Ovarian Mixed Epithelial Tumor;Esophageal Squamous Cell Carcinoma;bile duct carcinoma;angiosarcoma;renal carcinoma;ovarian carcinoma;Gallbladder Small Cell Neuroendocrine Carcinoma;Thymoma Type B3;undifferentiated pleomorphic sarcoma;Small Intestinal Tubulovillous Adenoma;BRCA1-related Fanconi anaemia;Uterine Carcinosarcoma;adenosquamous lung carcinoma;rectal adenocarcinoma;Endometrial Clear Cell Adenocarcinoma;Pleural Biphasic Mesothelioma;Anaplastic astrocytoma;Neoplasm;Ovarian Endometrioid Adenocarcinoma;colon adenocarcinoma;diffuse large B-cell lymphoma;Appendix Goblet Cell Carcinoid;Atypical endometrial hyperplasia;Oligodendroglioma;Small cell lung carcinoma;small cell carcinoma;lobular breast carcinoma;Anaplastic oligodendroglioma;malignant epithelioid mesothelioma;Breast Carcinoma by Gene Expression Profile;HEPATOBLASTOMA;Duodenal Adenocarcinoma;Fibrous Meningioma;Mixed Lobular and Ductal Breast Carcinoma;ovarian clear cell adenocarcinoma;FANCONI ANEMIA, COMPLEMENTATION GROUP S;colorectal adenocarcinoma;Undifferentiated Ovarian Carcinoma;nasopharyngeal squamous cell carcinoma;pancreatic neuroendocrine tumor;Melanoma;Chromophobe renal cell carcinoma;adrenal cortex carcinoma;thyroid neoplasm;Lung carcinoma;Ovarian Dysgerminoma;Digestive System Carcinoma;Bladder Small Cell Neuroendocrine Carcinoma;nodular melanoma;Breast carcinoma;Cecum Villous Adenoma;gastric carcinoma;bronchoalveolar adenocarcinoma;Hodgkins lymphoma;lymphoid neoplasm;Papillary renal cell carcinoma;Acute lymphoblastic leukemia;Invasive Breast Carcinoma;Endometrial Endometrioid Adenocarcinoma;B-Cell Prolymphocytic Leukemia;testicular mixed germ cell tumor;Uveal melanoma;urothelial carcinoma;testicular seminoma;Hepatocellular Carcinoma;Langerhans cell histiocytosis;prostate adenocarcinoma;Thyroid Gland Oncocytic Follicular Carcinoma;BRCA1 related CANCER;Chronic lymphocytic leukemia;Clear cell renal carcinoma;Esophageal adenocarcinoma;Well-differentiated liposarcoma;oral squamous cell carcinoma;PANCREATIC CANCER, SUSCEPTIBILITY TO, 4;BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1;FANCONI ANEMIA, COMPLEMENTATION GROUP S;Breast Cancer"
BRCA1_aug8,BRCA1,"Gallbladder Adenocarcinoma;Malignant peripheral nerve sheath tumor;Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation;head and neck squamous cell carcinoma;non-small cell lung carcinoma;Extramammary Paget Disease;Small Intestinal Diffuse Large B-Cell Lymphoma;bladder transitional cell carcinoma;Lung Inflammatory Myofibroblastic Tumor;Atypical Meningioma;Carcinoma;cutaneous melanoma;Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant;amelanotic skin melanoma;BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1;T-cell acute lymphoblastic leukemia;cervical squamous cell carcinoma;Fanconi anemia;breast ductal adenocarcinoma;Glioma;squamous cell lung carcinoma;pharyngeal squamous cell carcinoma;kidney neoplasm;ovarian serous adenocarcinoma;embryonal rhabdomyosarcoma;gastric adenocarcinoma;Pleural Epithelioid Mesothelioma;cervical adenocarcinoma;Transitional Meningioma;leiomyosarcoma;Rhabdoid Meningioma;gastric intestinal type adenocarcinoma;ovarian mucinous adenocarcinoma;Placental Choriocarcinoma;HER2 positive breast carcinoma;Lung adenocarcinoma;pancreatic carcinoma;Alveolar rhabdomyosarcoma;Hepatobiliary Neoplasm;Cholangiocarcinoma;cecum adenocarcinoma;brain glioblastoma;neoplasm of mature B-cells;Merkel cell skin cancer;vulvar intraepithelial neoplasia;large cell neuroendocrine carcinoma;skin carcinoma;Pancreatic Acinar Cell Carcinoma;B-cell acute lymphoblastic leukemia;Papillary thyroid carcinoma;Breast Cancer;ovarian teratoma;Cervical Small Cell Carcinoma;Ovarian Transitional Cell Carcinoma;Primary peritoneal carcinoma;salivary gland squamous cell carcinoma;prostate carcinoma;skin appendage carcinoma;Clear Cell Meningioma;MANTLE CELL LYMPHOMA;Hereditary breast and/or ovarian cancer syndrome;Poorly Differentiated Thyroid Gland Carcinoma;Dedifferentiated liposarcoma;Chronic myelomonocytic leukemia;Endometrial carcinoma;Hereditary breast cancer;Familial prostate cancer;Esophageal carcinoma;metaplastic breast carcinoma;Familial pancreatic carcinoma;ND;breast adenosis;Multiple myeloma;Malignant Laryngeal Neoplasm;Acute myeloid leukemia;pulmonary mucoepidermoid carcinoma;OSTEOSARCOMA;PANCREATIC CANCER, SUSCEPTIBILITY TO, 4;Ovarian Carcinosarcoma;Lung carcinoid tumor;Sinonasal Undifferentiated Carcinoma;thyroid carcinoma;Basal cell carcinoma;Thyroid Gland Undifferentiated (Anaplastic) Carcinoma;Malignant Ovarian Mixed Epithelial Tumor;Esophageal Squamous Cell Carcinoma;bile duct carcinoma;angiosarcoma;renal carcinoma;ovarian carcinoma;Gallbladder Small Cell Neuroendocrine Carcinoma;Thymoma Type B3;undifferentiated pleomorphic sarcoma;Small Intestinal Tubulovillous Adenoma;BRCA1-related Fanconi anaemia;Uterine Carcinosarcoma;adenosquamous lung carcinoma;rectal adenocarcinoma;Endometrial Clear Cell Adenocarcinoma;Pleural Biphasic Mesothelioma;Anaplastic astrocytoma;Neoplasm;Ovarian Endometrioid Adenocarcinoma;colon adenocarcinoma;diffuse large B-cell lymphoma;Appendix Goblet Cell Carcinoid;Atypical endometrial hyperplasia;Oligodendroglioma;Small cell lung carcinoma;small cell carcinoma;lobular breast carcinoma;Anaplastic oligodendroglioma;malignant epithelioid mesothelioma;Breast Carcinoma by Gene Expression Profile;HEPATOBLASTOMA;Duodenal Adenocarcinoma;Fibrous Meningioma;Mixed Lobular and Ductal Breast Carcinoma;ovarian clear cell adenocarcinoma;FANCONI ANEMIA, COMPLEMENTATION GROUP S;colorectal adenocarcinoma;Undifferentiated Ovarian Carcinoma;nasopharyngeal squamous cell carcinoma;pancreatic neuroendocrine tumor;Melanoma;Chromophobe renal cell carcinoma;adrenal cortex carcinoma;thyroid neoplasm;Lung carcinoma;Ovarian Dysgerminoma;Digestive System Carcinoma;Bladder Small Cell Neuroendocrine Carcinoma;nodular melanoma;Breast carcinoma;Cecum Villous Adenoma;gastric carcinoma;bronchoalveolar adenocarcinoma;Hodgkins lymphoma;lymphoid neoplasm;Papillary renal cell carcinoma;Acute lymphoblastic leukemia;Invasive Breast Carcinoma;Endometrial Endometrioid Adenocarcinoma;B-Cell Prolymphocytic Leukemia;testicular mixed germ cell tumor;Uveal melanoma;urothelial carcinoma;testicular seminoma;Hepatocellular Carcinoma;Langerhans cell histiocytosis;prostate adenocarcinoma;Thyroid Gland Oncocytic Follicular Carcinoma;BRCA1 related CANCER;Chronic lymphocytic leukemia;Clear cell renal carcinoma;Esophageal adenocarcinoma;Well-differentiated liposarcoma;oral squamous cell carcinoma;PANCREATIC CANCER, SUSCEPTIBILITY TO, 4;BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1;FANCONI ANEMIA, COMPLEMENTATION GROUP S;Breast Cancer"
BRCA1_aug9,BRCA1,"Gallbladder Adenocarcinoma;Malignant peripheral nerve sheath tumor;Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation;head and neck squamous cell carcinoma;non-small cell lung carcinoma;Extramammary Paget Disease;Small Intestinal Diffuse Large B-Cell Lymphoma;bladder transitional cell carcinoma;Lung Inflammatory Myofibroblastic Tumor;Atypical Meningioma;Carcinoma;cutaneous melanoma;Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant;amelanotic skin melanoma;BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1;T-cell acute lymphoblastic leukemia;cervical squamous cell carcinoma;Fanconi anemia;breast ductal adenocarcinoma;Glioma;squamous cell lung carcinoma;pharyngeal squamous cell carcinoma;kidney neoplasm;ovarian serous adenocarcinoma;embryonal rhabdomyosarcoma;gastric adenocarcinoma;Pleural Epithelioid Mesothelioma;cervical adenocarcinoma;Transitional Meningioma;leiomyosarcoma;Rhabdoid Meningioma;gastric intestinal type adenocarcinoma;ovarian mucinous adenocarcinoma;Placental Choriocarcinoma;HER2 positive breast carcinoma;Lung adenocarcinoma;pancreatic carcinoma;Alveolar rhabdomyosarcoma;Hepatobiliary Neoplasm;Cholangiocarcinoma;cecum adenocarcinoma;brain glioblastoma;neoplasm of mature B-cells;Merkel cell skin cancer;vulvar intraepithelial neoplasia;large cell neuroendocrine carcinoma;skin carcinoma;Pancreatic Acinar Cell Carcinoma;B-cell acute lymphoblastic leukemia;Papillary thyroid carcinoma;Breast Cancer;ovarian teratoma;Cervical Small Cell Carcinoma;Ovarian Transitional Cell Carcinoma;Primary peritoneal carcinoma;salivary gland squamous cell carcinoma;prostate carcinoma;skin appendage carcinoma;Clear Cell Meningioma;MANTLE CELL LYMPHOMA;Hereditary breast and/or ovarian cancer syndrome;Poorly Differentiated Thyroid Gland Carcinoma;Dedifferentiated liposarcoma;Chronic myelomonocytic leukemia;Endometrial carcinoma;Hereditary breast cancer;Familial prostate cancer;Esophageal carcinoma;metaplastic breast carcinoma;Familial pancreatic carcinoma;ND;breast adenosis;Multiple myeloma;Malignant Laryngeal Neoplasm;Acute myeloid leukemia;pulmonary mucoepidermoid carcinoma;OSTEOSARCOMA;PANCREATIC CANCER, SUSCEPTIBILITY TO, 4;Ovarian Carcinosarcoma;Lung carcinoid tumor;Sinonasal Undifferentiated Carcinoma;thyroid carcinoma;Basal cell carcinoma;Thyroid Gland Undifferentiated (Anaplastic) Carcinoma;Malignant Ovarian Mixed Epithelial Tumor;Esophageal Squamous Cell Carcinoma;bile duct carcinoma;angiosarcoma;renal carcinoma;ovarian carcinoma;Gallbladder Small Cell Neuroendocrine Carcinoma;Thymoma Type B3;undifferentiated pleomorphic sarcoma;Small Intestinal Tubulovillous Adenoma;BRCA1-related Fanconi anaemia;Uterine Carcinosarcoma;adenosquamous lung carcinoma;rectal adenocarcinoma;Endometrial Clear Cell Adenocarcinoma;Pleural Biphasic Mesothelioma;Anaplastic astrocytoma;Neoplasm;Ovarian Endometrioid Adenocarcinoma;colon adenocarcinoma;diffuse large B-cell lymphoma;Appendix Goblet Cell Carcinoid;Atypical endometrial hyperplasia;Oligodendroglioma;Small cell lung carcinoma;small cell carcinoma;lobular breast carcinoma;Anaplastic oligodendroglioma;malignant epithelioid mesothelioma;Breast Carcinoma by Gene Expression Profile;HEPATOBLASTOMA;Duodenal Adenocarcinoma;Fibrous Meningioma;Mixed Lobular and Ductal Breast Carcinoma;ovarian clear cell adenocarcinoma;FANCONI ANEMIA, COMPLEMENTATION GROUP S;colorectal adenocarcinoma;Undifferentiated Ovarian Carcinoma;nasopharyngeal squamous cell carcinoma;pancreatic neuroendocrine tumor;Melanoma;Chromophobe renal cell carcinoma;adrenal cortex carcinoma;thyroid neoplasm;Lung carcinoma;Ovarian Dysgerminoma;Digestive System Carcinoma;Bladder Small Cell Neuroendocrine Carcinoma;nodular melanoma;Breast carcinoma;Cecum Villous Adenoma;gastric carcinoma;bronchoalveolar adenocarcinoma;Hodgkins lymphoma;lymphoid neoplasm;Papillary renal cell carcinoma;Acute lymphoblastic leukemia;Invasive Breast Carcinoma;Endometrial Endometrioid Adenocarcinoma;B-Cell Prolymphocytic Leukemia;testicular mixed germ cell tumor;Uveal melanoma;urothelial carcinoma;testicular seminoma;Hepatocellular Carcinoma;Langerhans cell histiocytosis;prostate adenocarcinoma;Thyroid Gland Oncocytic Follicular Carcinoma;BRCA1 related CANCER;Chronic lymphocytic leukemia;Clear cell renal carcinoma;Esophageal adenocarcinoma;Well-differentiated liposarcoma;oral squamous cell carcinoma;PANCREATIC CANCER, SUSCEPTIBILITY TO, 4;BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1;FANCONI ANEMIA, COMPLEMENTATION GROUP S;Breast Cancer"
PARP1,PARP1,AUTOSOMAL RECESSIVE INTELLECTUAL DEVELOPMENTAL DISORDER
PARP1_aug1,PARP1,AUTOSOMAL RECESSIVE INTELLECTUAL DEVELOPMENTAL DISORDER
PARP1_aug2,PARP1,AUTOSOMAL RECESSIVE INTELLECTUAL DEVELOPMENTAL DISORDER
PARP1_aug3,PARP1,AUTOSOMAL RECESSIVE INTELLECTUAL DEVELOPMENTAL DISORDER
PARP1_aug4,PARP1,AUTOSOMAL RECESSIVE INTELLECTUAL DEVELOPMENTAL DISORDER
PARP1_aug5,PARP1,AUTOSOMAL RECESSIVE INTELLECTUAL DEVELOPMENTAL DISORDER
PARP1_aug6,PARP1,AUTOSOMAL RECESSIVE INTELLECTUAL DEVELOPMENTAL DISORDER
PARP1_aug7,PARP1,AUTOSOMAL RECESSIVE INTELLECTUAL DEVELOPMENTAL DISORDER
PARP1_aug8,PARP1,AUTOSOMAL RECESSIVE INTELLECTUAL DEVELOPMENTAL DISORDER
PARP1_aug9,PARP1,AUTOSOMAL RECESSIVE INTELLECTUAL DEVELOPMENTAL DISORDER
CHEK2,CHEK2,thyroid carcinoma;adrenal cortex carcinoma;Meningothelial Meningioma;Endometrial carcinoma;testicular mixed germ cell tumor;iatrogenic Kaposi's sarcoma;ovarian mucinous adenocarcinoma;Acute myeloid leukemia;radiologic finding;Transitional Meningioma;Duodenal Adenocarcinoma;Li-Fraumeni syndrome;Multiple myeloma;Peritoneal Mesothelioma;bladder transitional cell carcinoma;Glioma;Prostate Cancer;Fallopian Tube Serous Adenocarcinoma;Lung Inflammatory Myofibroblastic Tumor;Papillary renal cell carcinoma;squamous cell lung carcinoma;lymphoid neoplasm;head and neck squamous cell carcinoma;nasopharyngeal squamous cell carcinoma;Uterine Carcinosarcoma;brain glioblastoma;Hereditary breast and/or ovarian cancer syndrome;ovarian serous adenocarcinoma;skin carcinoma;follicular thyroid carcinoma;Appendix Adenocarcinoma;marginal zone B-cell lymphoma;Thyroid Gland Undifferentiated (Anaplastic) Carcinoma;rectal adenocarcinoma;Lung adenocarcinoma;Poorly Differentiated Thyroid Gland Carcinoma;Chromophobe renal cell carcinoma;POLYCYTHEMIA VERA;gastric carcinoma;Melanoma;MYELODYSPLASTIC SYNDROME;HER2 positive breast carcinoma;Fibrous Meningioma;Unclassified Renal Cell Carcinoma;Esophageal Squamous Cell Carcinoma;ovarian carcinoma;diffuse large B-cell lymphoma;Ovarian Endometrioid Adenocarcinoma;soft tissue sarcoma;pharyngeal squamous cell carcinoma;OSTEOGENIC SARCOMA;Rhabdoid Meningioma;Bladder Small Cell Neuroendocrine Carcinoma;Atypical Meningioma;cutaneous melanoma;breast ductal adenocarcinoma;Angioimmunoblastic T-cell lymphoma;endometrium adenocarcinoma;Lung sarcomatoid carcinoma;prostate adenocarcinoma;Esophageal adenocarcinoma;cervical squamous cell carcinoma;Vulvar Squamous Cell Carcinoma;T-cell prolymphocytic leukemia;Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation;Familial prostate cancer;colorectal adenocarcinoma;diffuse gastric adenocarcinoma;colon adenocarcinoma;cecum adenocarcinoma;Chronic lymphocytic leukemia;Well-differentiated liposarcoma;urothelial carcinoma;angiosarcoma;metaplastic breast carcinoma;anaplastic large cell lymphoma;TUMOR PREDISPOSITION SYNDROME 4;liposarcoma;ND;Appendix Goblet Cell Carcinoid;Papillary thyroid carcinoma;nodular melanoma;Hepatobiliary Neoplasm;B-cell acute lymphoblastic leukemia;Esophageal carcinoma;non-small cell lung carcinoma;HEPATOBLASTOMA;Clear Cell Meningioma;Breast carcinoma;follicular dendritic cell sarcoma;ovarian clear cell adenocarcinoma;Alveolar rhabdomyosarcoma;hairy cell leukemia;oral squamous cell carcinoma;Lung carcinoma;Anaplastic oligodendroglioma;Angiomatous Meningioma;Endometrial Endometrioid Adenocarcinoma;Digestive System Carcinoma;gastric intestinal type adenocarcinoma;gastric adenocarcinoma;lobular breast carcinoma;Breast Carcinoma by Gene Expression Profile;Small Intestinal Tubulovillous Adenoma;colon carcinoma;MANTLE CELL LYMPHOMA;Hepatocellular Carcinoma;undifferentiated pleomorphic sarcoma;Adamantinomatous Craniopharyngioma;prostate carcinoma;Gallbladder Adenocarcinoma;OSTEOSARCOMA;pancreatic neuroendocrine tumor;CHEK2-related cancer predisposition;kidney neoplasm;Pleural Epithelioid Mesothelioma;Malignant Ovarian Mixed Epithelial Tumor;Small cell lung carcinoma;leiomyosarcoma;Clear cell renal carcinoma;Merkel cell skin cancer;CHEK2 related CANCER;Essential thrombocythemia;Microcystic Meningioma;testicular seminoma;Malignant Germ Cell Tumor;Endometrial Clear Cell Adenocarcinoma;OSTEOSARCOMA;Dedifferentiated liposarcoma;bile duct carcinoma;Neoplasm;Familial colorectal cancer Type X;TUMOR PREDISPOSITION SYNDROME 4;Prostate Cancer;OSTEOGENIC SARCOMA
CHEK2_aug1,CHEK2,thyroid carcinoma;adrenal cortex carcinoma;Meningothelial Meningioma;Endometrial carcinoma;testicular mixed germ cell tumor;iatrogenic Kaposi's sarcoma;ovarian mucinous adenocarcinoma;Acute myeloid leukemia;radiologic finding;Transitional Meningioma;Duodenal Adenocarcinoma;Li-Fraumeni syndrome;Multiple myeloma;Peritoneal Mesothelioma;bladder transitional cell carcinoma;Glioma;Prostate Cancer;Fallopian Tube Serous Adenocarcinoma;Lung Inflammatory Myofibroblastic Tumor;Papillary renal cell carcinoma;squamous cell lung carcinoma;lymphoid neoplasm;head and neck squamous cell carcinoma;nasopharyngeal squamous cell carcinoma;Uterine Carcinosarcoma;brain glioblastoma;Hereditary breast and/or ovarian cancer syndrome;ovarian serous adenocarcinoma;skin carcinoma;follicular thyroid carcinoma;Appendix Adenocarcinoma;marginal zone B-cell lymphoma;Thyroid Gland Undifferentiated (Anaplastic) Carcinoma;rectal adenocarcinoma;Lung adenocarcinoma;Poorly Differentiated Thyroid Gland Carcinoma;Chromophobe renal cell carcinoma;POLYCYTHEMIA VERA;gastric carcinoma;Melanoma;MYELODYSPLASTIC SYNDROME;HER2 positive breast carcinoma;Fibrous Meningioma;Unclassified Renal Cell Carcinoma;Esophageal Squamous Cell Carcinoma;ovarian carcinoma;diffuse large B-cell lymphoma;Ovarian Endometrioid Adenocarcinoma;soft tissue sarcoma;pharyngeal squamous cell carcinoma;OSTEOGENIC SARCOMA;Rhabdoid Meningioma;Bladder Small Cell Neuroendocrine Carcinoma;Atypical Meningioma;cutaneous melanoma;breast ductal adenocarcinoma;Angioimmunoblastic T-cell lymphoma;endometrium adenocarcinoma;Lung sarcomatoid carcinoma;prostate adenocarcinoma;Esophageal adenocarcinoma;cervical squamous cell carcinoma;Vulvar Squamous Cell Carcinoma;T-cell prolymphocytic leukemia;Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation;Familial prostate cancer;colorectal adenocarcinoma;diffuse gastric adenocarcinoma;colon adenocarcinoma;cecum adenocarcinoma;Chronic lymphocytic leukemia;Well-differentiated liposarcoma;urothelial carcinoma;angiosarcoma;metaplastic breast carcinoma;anaplastic large cell lymphoma;TUMOR PREDISPOSITION SYNDROME 4;liposarcoma;ND;Appendix Goblet Cell Carcinoid;Papillary thyroid carcinoma;nodular melanoma;Hepatobiliary Neoplasm;B-cell acute lymphoblastic leukemia;Esophageal carcinoma;non-small cell lung carcinoma;HEPATOBLASTOMA;Clear Cell Meningioma;Breast carcinoma;follicular dendritic cell sarcoma;ovarian clear cell adenocarcinoma;Alveolar rhabdomyosarcoma;hairy cell leukemia;oral squamous cell carcinoma;Lung carcinoma;Anaplastic oligodendroglioma;Angiomatous Meningioma;Endometrial Endometrioid Adenocarcinoma;Digestive System Carcinoma;gastric intestinal type adenocarcinoma;gastric adenocarcinoma;lobular breast carcinoma;Breast Carcinoma by Gene Expression Profile;Small Intestinal Tubulovillous Adenoma;colon carcinoma;MANTLE CELL LYMPHOMA;Hepatocellular Carcinoma;undifferentiated pleomorphic sarcoma;Adamantinomatous Craniopharyngioma;prostate carcinoma;Gallbladder Adenocarcinoma;OSTEOSARCOMA;pancreatic neuroendocrine tumor;CHEK2-related cancer predisposition;kidney neoplasm;Pleural Epithelioid Mesothelioma;Malignant Ovarian Mixed Epithelial Tumor;Small cell lung carcinoma;leiomyosarcoma;Clear cell renal carcinoma;Merkel cell skin cancer;CHEK2 related CANCER;Essential thrombocythemia;Microcystic Meningioma;testicular seminoma;Malignant Germ Cell Tumor;Endometrial Clear Cell Adenocarcinoma;OSTEOSARCOMA;Dedifferentiated liposarcoma;bile duct carcinoma;Neoplasm;Familial colorectal cancer Type X;TUMOR PREDISPOSITION SYNDROME 4;Prostate Cancer;OSTEOGENIC SARCOMA
CHEK2_aug2,CHEK2,thyroid carcinoma;adrenal cortex carcinoma;Meningothelial Meningioma;Endometrial carcinoma;testicular mixed germ cell tumor;iatrogenic Kaposi's sarcoma;ovarian mucinous adenocarcinoma;Acute myeloid leukemia;radiologic finding;Transitional Meningioma;Duodenal Adenocarcinoma;Li-Fraumeni syndrome;Multiple myeloma;Peritoneal Mesothelioma;bladder transitional cell carcinoma;Glioma;Prostate Cancer;Fallopian Tube Serous Adenocarcinoma;Lung Inflammatory Myofibroblastic Tumor;Papillary renal cell carcinoma;squamous cell lung carcinoma;lymphoid neoplasm;head and neck squamous cell carcinoma;nasopharyngeal squamous cell carcinoma;Uterine Carcinosarcoma;brain glioblastoma;Hereditary breast and/or ovarian cancer syndrome;ovarian serous adenocarcinoma;skin carcinoma;follicular thyroid carcinoma;Appendix Adenocarcinoma;marginal zone B-cell lymphoma;Thyroid Gland Undifferentiated (Anaplastic) Carcinoma;rectal adenocarcinoma;Lung adenocarcinoma;Poorly Differentiated Thyroid Gland Carcinoma;Chromophobe renal cell carcinoma;POLYCYTHEMIA VERA;gastric carcinoma;Melanoma;MYELODYSPLASTIC SYNDROME;HER2 positive breast carcinoma;Fibrous Meningioma;Unclassified Renal Cell Carcinoma;Esophageal Squamous Cell Carcinoma;ovarian carcinoma;diffuse large B-cell lymphoma;Ovarian Endometrioid Adenocarcinoma;soft tissue sarcoma;pharyngeal squamous cell carcinoma;OSTEOGENIC SARCOMA;Rhabdoid Meningioma;Bladder Small Cell Neuroendocrine Carcinoma;Atypical Meningioma;cutaneous melanoma;breast ductal adenocarcinoma;Angioimmunoblastic T-cell lymphoma;endometrium adenocarcinoma;Lung sarcomatoid carcinoma;prostate adenocarcinoma;Esophageal adenocarcinoma;cervical squamous cell carcinoma;Vulvar Squamous Cell Carcinoma;T-cell prolymphocytic leukemia;Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation;Familial prostate cancer;colorectal adenocarcinoma;diffuse gastric adenocarcinoma;colon adenocarcinoma;cecum adenocarcinoma;Chronic lymphocytic leukemia;Well-differentiated liposarcoma;urothelial carcinoma;angiosarcoma;metaplastic breast carcinoma;anaplastic large cell lymphoma;TUMOR PREDISPOSITION SYNDROME 4;liposarcoma;ND;Appendix Goblet Cell Carcinoid;Papillary thyroid carcinoma;nodular melanoma;Hepatobiliary Neoplasm;B-cell acute lymphoblastic leukemia;Esophageal carcinoma;non-small cell lung carcinoma;HEPATOBLASTOMA;Clear Cell Meningioma;Breast carcinoma;follicular dendritic cell sarcoma;ovarian clear cell adenocarcinoma;Alveolar rhabdomyosarcoma;hairy cell leukemia;oral squamous cell carcinoma;Lung carcinoma;Anaplastic oligodendroglioma;Angiomatous Meningioma;Endometrial Endometrioid Adenocarcinoma;Digestive System Carcinoma;gastric intestinal type adenocarcinoma;gastric adenocarcinoma;lobular breast carcinoma;Breast Carcinoma by Gene Expression Profile;Small Intestinal Tubulovillous Adenoma;colon carcinoma;MANTLE CELL LYMPHOMA;Hepatocellular Carcinoma;undifferentiated pleomorphic sarcoma;Adamantinomatous Craniopharyngioma;prostate carcinoma;Gallbladder Adenocarcinoma;OSTEOSARCOMA;pancreatic neuroendocrine tumor;CHEK2-related cancer predisposition;kidney neoplasm;Pleural Epithelioid Mesothelioma;Malignant Ovarian Mixed Epithelial Tumor;Small cell lung carcinoma;leiomyosarcoma;Clear cell renal carcinoma;Merkel cell skin cancer;CHEK2 related CANCER;Essential thrombocythemia;Microcystic Meningioma;testicular seminoma;Malignant Germ Cell Tumor;Endometrial Clear Cell Adenocarcinoma;OSTEOSARCOMA;Dedifferentiated liposarcoma;bile duct carcinoma;Neoplasm;Familial colorectal cancer Type X;TUMOR PREDISPOSITION SYNDROME 4;Prostate Cancer;OSTEOGENIC SARCOMA
CHEK2_aug3,CHEK2,thyroid carcinoma;adrenal cortex carcinoma;Meningothelial Meningioma;Endometrial carcinoma;testicular mixed germ cell tumor;iatrogenic Kaposi's sarcoma;ovarian mucinous adenocarcinoma;Acute myeloid leukemia;radiologic finding;Transitional Meningioma;Duodenal Adenocarcinoma;Li-Fraumeni syndrome;Multiple myeloma;Peritoneal Mesothelioma;bladder transitional cell carcinoma;Glioma;Prostate Cancer;Fallopian Tube Serous Adenocarcinoma;Lung Inflammatory Myofibroblastic Tumor;Papillary renal cell carcinoma;squamous cell lung carcinoma;lymphoid neoplasm;head and neck squamous cell carcinoma;nasopharyngeal squamous cell carcinoma;Uterine Carcinosarcoma;brain glioblastoma;Hereditary breast and/or ovarian cancer syndrome;ovarian serous adenocarcinoma;skin carcinoma;follicular thyroid carcinoma;Appendix Adenocarcinoma;marginal zone B-cell lymphoma;Thyroid Gland Undifferentiated (Anaplastic) Carcinoma;rectal adenocarcinoma;Lung adenocarcinoma;Poorly Differentiated Thyroid Gland Carcinoma;Chromophobe renal cell carcinoma;POLYCYTHEMIA VERA;gastric carcinoma;Melanoma;MYELODYSPLASTIC SYNDROME;HER2 positive breast carcinoma;Fibrous Meningioma;Unclassified Renal Cell Carcinoma;Esophageal Squamous Cell Carcinoma;ovarian carcinoma;diffuse large B-cell lymphoma;Ovarian Endometrioid Adenocarcinoma;soft tissue sarcoma;pharyngeal squamous cell carcinoma;OSTEOGENIC SARCOMA;Rhabdoid Meningioma;Bladder Small Cell Neuroendocrine Carcinoma;Atypical Meningioma;cutaneous melanoma;breast ductal adenocarcinoma;Angioimmunoblastic T-cell lymphoma;endometrium adenocarcinoma;Lung sarcomatoid carcinoma;prostate adenocarcinoma;Esophageal adenocarcinoma;cervical squamous cell carcinoma;Vulvar Squamous Cell Carcinoma;T-cell prolymphocytic leukemia;Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation;Familial prostate cancer;colorectal adenocarcinoma;diffuse gastric adenocarcinoma;colon adenocarcinoma;cecum adenocarcinoma;Chronic lymphocytic leukemia;Well-differentiated liposarcoma;urothelial carcinoma;angiosarcoma;metaplastic breast carcinoma;anaplastic large cell lymphoma;TUMOR PREDISPOSITION SYNDROME 4;liposarcoma;ND;Appendix Goblet Cell Carcinoid;Papillary thyroid carcinoma;nodular melanoma;Hepatobiliary Neoplasm;B-cell acute lymphoblastic leukemia;Esophageal carcinoma;non-small cell lung carcinoma;HEPATOBLASTOMA;Clear Cell Meningioma;Breast carcinoma;follicular dendritic cell sarcoma;ovarian clear cell adenocarcinoma;Alveolar rhabdomyosarcoma;hairy cell leukemia;oral squamous cell carcinoma;Lung carcinoma;Anaplastic oligodendroglioma;Angiomatous Meningioma;Endometrial Endometrioid Adenocarcinoma;Digestive System Carcinoma;gastric intestinal type adenocarcinoma;gastric adenocarcinoma;lobular breast carcinoma;Breast Carcinoma by Gene Expression Profile;Small Intestinal Tubulovillous Adenoma;colon carcinoma;MANTLE CELL LYMPHOMA;Hepatocellular Carcinoma;undifferentiated pleomorphic sarcoma;Adamantinomatous Craniopharyngioma;prostate carcinoma;Gallbladder Adenocarcinoma;OSTEOSARCOMA;pancreatic neuroendocrine tumor;CHEK2-related cancer predisposition;kidney neoplasm;Pleural Epithelioid Mesothelioma;Malignant Ovarian Mixed Epithelial Tumor;Small cell lung carcinoma;leiomyosarcoma;Clear cell renal carcinoma;Merkel cell skin cancer;CHEK2 related CANCER;Essential thrombocythemia;Microcystic Meningioma;testicular seminoma;Malignant Germ Cell Tumor;Endometrial Clear Cell Adenocarcinoma;OSTEOSARCOMA;Dedifferentiated liposarcoma;bile duct carcinoma;Neoplasm;Familial colorectal cancer Type X;TUMOR PREDISPOSITION SYNDROME 4;Prostate Cancer;OSTEOGENIC SARCOMA
CHEK2_aug4,CHEK2,thyroid carcinoma;adrenal cortex carcinoma;Meningothelial Meningioma;Endometrial carcinoma;testicular mixed germ cell tumor;iatrogenic Kaposi's sarcoma;ovarian mucinous adenocarcinoma;Acute myeloid leukemia;radiologic finding;Transitional Meningioma;Duodenal Adenocarcinoma;Li-Fraumeni syndrome;Multiple myeloma;Peritoneal Mesothelioma;bladder transitional cell carcinoma;Glioma;Prostate Cancer;Fallopian Tube Serous Adenocarcinoma;Lung Inflammatory Myofibroblastic Tumor;Papillary renal cell carcinoma;squamous cell lung carcinoma;lymphoid neoplasm;head and neck squamous cell carcinoma;nasopharyngeal squamous cell carcinoma;Uterine Carcinosarcoma;brain glioblastoma;Hereditary breast and/or ovarian cancer syndrome;ovarian serous adenocarcinoma;skin carcinoma;follicular thyroid carcinoma;Appendix Adenocarcinoma;marginal zone B-cell lymphoma;Thyroid Gland Undifferentiated (Anaplastic) Carcinoma;rectal adenocarcinoma;Lung adenocarcinoma;Poorly Differentiated Thyroid Gland Carcinoma;Chromophobe renal cell carcinoma;POLYCYTHEMIA VERA;gastric carcinoma;Melanoma;MYELODYSPLASTIC SYNDROME;HER2 positive breast carcinoma;Fibrous Meningioma;Unclassified Renal Cell Carcinoma;Esophageal Squamous Cell Carcinoma;ovarian carcinoma;diffuse large B-cell lymphoma;Ovarian Endometrioid Adenocarcinoma;soft tissue sarcoma;pharyngeal squamous cell carcinoma;OSTEOGENIC SARCOMA;Rhabdoid Meningioma;Bladder Small Cell Neuroendocrine Carcinoma;Atypical Meningioma;cutaneous melanoma;breast ductal adenocarcinoma;Angioimmunoblastic T-cell lymphoma;endometrium adenocarcinoma;Lung sarcomatoid carcinoma;prostate adenocarcinoma;Esophageal adenocarcinoma;cervical squamous cell carcinoma;Vulvar Squamous Cell Carcinoma;T-cell prolymphocytic leukemia;Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation;Familial prostate cancer;colorectal adenocarcinoma;diffuse gastric adenocarcinoma;colon adenocarcinoma;cecum adenocarcinoma;Chronic lymphocytic leukemia;Well-differentiated liposarcoma;urothelial carcinoma;angiosarcoma;metaplastic breast carcinoma;anaplastic large cell lymphoma;TUMOR PREDISPOSITION SYNDROME 4;liposarcoma;ND;Appendix Goblet Cell Carcinoid;Papillary thyroid carcinoma;nodular melanoma;Hepatobiliary Neoplasm;B-cell acute lymphoblastic leukemia;Esophageal carcinoma;non-small cell lung carcinoma;HEPATOBLASTOMA;Clear Cell Meningioma;Breast carcinoma;follicular dendritic cell sarcoma;ovarian clear cell adenocarcinoma;Alveolar rhabdomyosarcoma;hairy cell leukemia;oral squamous cell carcinoma;Lung carcinoma;Anaplastic oligodendroglioma;Angiomatous Meningioma;Endometrial Endometrioid Adenocarcinoma;Digestive System Carcinoma;gastric intestinal type adenocarcinoma;gastric adenocarcinoma;lobular breast carcinoma;Breast Carcinoma by Gene Expression Profile;Small Intestinal Tubulovillous Adenoma;colon carcinoma;MANTLE CELL LYMPHOMA;Hepatocellular Carcinoma;undifferentiated pleomorphic sarcoma;Adamantinomatous Craniopharyngioma;prostate carcinoma;Gallbladder Adenocarcinoma;OSTEOSARCOMA;pancreatic neuroendocrine tumor;CHEK2-related cancer predisposition;kidney neoplasm;Pleural Epithelioid Mesothelioma;Malignant Ovarian Mixed Epithelial Tumor;Small cell lung carcinoma;leiomyosarcoma;Clear cell renal carcinoma;Merkel cell skin cancer;CHEK2 related CANCER;Essential thrombocythemia;Microcystic Meningioma;testicular seminoma;Malignant Germ Cell Tumor;Endometrial Clear Cell Adenocarcinoma;OSTEOSARCOMA;Dedifferentiated liposarcoma;bile duct carcinoma;Neoplasm;Familial colorectal cancer Type X;TUMOR PREDISPOSITION SYNDROME 4;Prostate Cancer;OSTEOGENIC SARCOMA
CHEK2_aug5,CHEK2,thyroid carcinoma;adrenal cortex carcinoma;Meningothelial Meningioma;Endometrial carcinoma;testicular mixed germ cell tumor;iatrogenic Kaposi's sarcoma;ovarian mucinous adenocarcinoma;Acute myeloid leukemia;radiologic finding;Transitional Meningioma;Duodenal Adenocarcinoma;Li-Fraumeni syndrome;Multiple myeloma;Peritoneal Mesothelioma;bladder transitional cell carcinoma;Glioma;Prostate Cancer;Fallopian Tube Serous Adenocarcinoma;Lung Inflammatory Myofibroblastic Tumor;Papillary renal cell carcinoma;squamous cell lung carcinoma;lymphoid neoplasm;head and neck squamous cell carcinoma;nasopharyngeal squamous cell carcinoma;Uterine Carcinosarcoma;brain glioblastoma;Hereditary breast and/or ovarian cancer syndrome;ovarian serous adenocarcinoma;skin carcinoma;follicular thyroid carcinoma;Appendix Adenocarcinoma;marginal zone B-cell lymphoma;Thyroid Gland Undifferentiated (Anaplastic) Carcinoma;rectal adenocarcinoma;Lung adenocarcinoma;Poorly Differentiated Thyroid Gland Carcinoma;Chromophobe renal cell carcinoma;POLYCYTHEMIA VERA;gastric carcinoma;Melanoma;MYELODYSPLASTIC SYNDROME;HER2 positive breast carcinoma;Fibrous Meningioma;Unclassified Renal Cell Carcinoma;Esophageal Squamous Cell Carcinoma;ovarian carcinoma;diffuse large B-cell lymphoma;Ovarian Endometrioid Adenocarcinoma;soft tissue sarcoma;pharyngeal squamous cell carcinoma;OSTEOGENIC SARCOMA;Rhabdoid Meningioma;Bladder Small Cell Neuroendocrine Carcinoma;Atypical Meningioma;cutaneous melanoma;breast ductal adenocarcinoma;Angioimmunoblastic T-cell lymphoma;endometrium adenocarcinoma;Lung sarcomatoid carcinoma;prostate adenocarcinoma;Esophageal adenocarcinoma;cervical squamous cell carcinoma;Vulvar Squamous Cell Carcinoma;T-cell prolymphocytic leukemia;Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation;Familial prostate cancer;colorectal adenocarcinoma;diffuse gastric adenocarcinoma;colon adenocarcinoma;cecum adenocarcinoma;Chronic lymphocytic leukemia;Well-differentiated liposarcoma;urothelial carcinoma;angiosarcoma;metaplastic breast carcinoma;anaplastic large cell lymphoma;TUMOR PREDISPOSITION SYNDROME 4;liposarcoma;ND;Appendix Goblet Cell Carcinoid;Papillary thyroid carcinoma;nodular melanoma;Hepatobiliary Neoplasm;B-cell acute lymphoblastic leukemia;Esophageal carcinoma;non-small cell lung carcinoma;HEPATOBLASTOMA;Clear Cell Meningioma;Breast carcinoma;follicular dendritic cell sarcoma;ovarian clear cell adenocarcinoma;Alveolar rhabdomyosarcoma;hairy cell leukemia;oral squamous cell carcinoma;Lung carcinoma;Anaplastic oligodendroglioma;Angiomatous Meningioma;Endometrial Endometrioid Adenocarcinoma;Digestive System Carcinoma;gastric intestinal type adenocarcinoma;gastric adenocarcinoma;lobular breast carcinoma;Breast Carcinoma by Gene Expression Profile;Small Intestinal Tubulovillous Adenoma;colon carcinoma;MANTLE CELL LYMPHOMA;Hepatocellular Carcinoma;undifferentiated pleomorphic sarcoma;Adamantinomatous Craniopharyngioma;prostate carcinoma;Gallbladder Adenocarcinoma;OSTEOSARCOMA;pancreatic neuroendocrine tumor;CHEK2-related cancer predisposition;kidney neoplasm;Pleural Epithelioid Mesothelioma;Malignant Ovarian Mixed Epithelial Tumor;Small cell lung carcinoma;leiomyosarcoma;Clear cell renal carcinoma;Merkel cell skin cancer;CHEK2 related CANCER;Essential thrombocythemia;Microcystic Meningioma;testicular seminoma;Malignant Germ Cell Tumor;Endometrial Clear Cell Adenocarcinoma;OSTEOSARCOMA;Dedifferentiated liposarcoma;bile duct carcinoma;Neoplasm;Familial colorectal cancer Type X;TUMOR PREDISPOSITION SYNDROME 4;Prostate Cancer;OSTEOGENIC SARCOMA
CHEK2_aug6,CHEK2,thyroid carcinoma;adrenal cortex carcinoma;Meningothelial Meningioma;Endometrial carcinoma;testicular mixed germ cell tumor;iatrogenic Kaposi's sarcoma;ovarian mucinous adenocarcinoma;Acute myeloid leukemia;radiologic finding;Transitional Meningioma;Duodenal Adenocarcinoma;Li-Fraumeni syndrome;Multiple myeloma;Peritoneal Mesothelioma;bladder transitional cell carcinoma;Glioma;Prostate Cancer;Fallopian Tube Serous Adenocarcinoma;Lung Inflammatory Myofibroblastic Tumor;Papillary renal cell carcinoma;squamous cell lung carcinoma;lymphoid neoplasm;head and neck squamous cell carcinoma;nasopharyngeal squamous cell carcinoma;Uterine Carcinosarcoma;brain glioblastoma;Hereditary breast and/or ovarian cancer syndrome;ovarian serous adenocarcinoma;skin carcinoma;follicular thyroid carcinoma;Appendix Adenocarcinoma;marginal zone B-cell lymphoma;Thyroid Gland Undifferentiated (Anaplastic) Carcinoma;rectal adenocarcinoma;Lung adenocarcinoma;Poorly Differentiated Thyroid Gland Carcinoma;Chromophobe renal cell carcinoma;POLYCYTHEMIA VERA;gastric carcinoma;Melanoma;MYELODYSPLASTIC SYNDROME;HER2 positive breast carcinoma;Fibrous Meningioma;Unclassified Renal Cell Carcinoma;Esophageal Squamous Cell Carcinoma;ovarian carcinoma;diffuse large B-cell lymphoma;Ovarian Endometrioid Adenocarcinoma;soft tissue sarcoma;pharyngeal squamous cell carcinoma;OSTEOGENIC SARCOMA;Rhabdoid Meningioma;Bladder Small Cell Neuroendocrine Carcinoma;Atypical Meningioma;cutaneous melanoma;breast ductal adenocarcinoma;Angioimmunoblastic T-cell lymphoma;endometrium adenocarcinoma;Lung sarcomatoid carcinoma;prostate adenocarcinoma;Esophageal adenocarcinoma;cervical squamous cell carcinoma;Vulvar Squamous Cell Carcinoma;T-cell prolymphocytic leukemia;Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation;Familial prostate cancer;colorectal adenocarcinoma;diffuse gastric adenocarcinoma;colon adenocarcinoma;cecum adenocarcinoma;Chronic lymphocytic leukemia;Well-differentiated liposarcoma;urothelial carcinoma;angiosarcoma;metaplastic breast carcinoma;anaplastic large cell lymphoma;TUMOR PREDISPOSITION SYNDROME 4;liposarcoma;ND;Appendix Goblet Cell Carcinoid;Papillary thyroid carcinoma;nodular melanoma;Hepatobiliary Neoplasm;B-cell acute lymphoblastic leukemia;Esophageal carcinoma;non-small cell lung carcinoma;HEPATOBLASTOMA;Clear Cell Meningioma;Breast carcinoma;follicular dendritic cell sarcoma;ovarian clear cell adenocarcinoma;Alveolar rhabdomyosarcoma;hairy cell leukemia;oral squamous cell carcinoma;Lung carcinoma;Anaplastic oligodendroglioma;Angiomatous Meningioma;Endometrial Endometrioid Adenocarcinoma;Digestive System Carcinoma;gastric intestinal type adenocarcinoma;gastric adenocarcinoma;lobular breast carcinoma;Breast Carcinoma by Gene Expression Profile;Small Intestinal Tubulovillous Adenoma;colon carcinoma;MANTLE CELL LYMPHOMA;Hepatocellular Carcinoma;undifferentiated pleomorphic sarcoma;Adamantinomatous Craniopharyngioma;prostate carcinoma;Gallbladder Adenocarcinoma;OSTEOSARCOMA;pancreatic neuroendocrine tumor;CHEK2-related cancer predisposition;kidney neoplasm;Pleural Epithelioid Mesothelioma;Malignant Ovarian Mixed Epithelial Tumor;Small cell lung carcinoma;leiomyosarcoma;Clear cell renal carcinoma;Merkel cell skin cancer;CHEK2 related CANCER;Essential thrombocythemia;Microcystic Meningioma;testicular seminoma;Malignant Germ Cell Tumor;Endometrial Clear Cell Adenocarcinoma;OSTEOSARCOMA;Dedifferentiated liposarcoma;bile duct carcinoma;Neoplasm;Familial colorectal cancer Type X;TUMOR PREDISPOSITION SYNDROME 4;Prostate Cancer;OSTEOGENIC SARCOMA
CHEK2_aug7,CHEK2,thyroid carcinoma;adrenal cortex carcinoma;Meningothelial Meningioma;Endometrial carcinoma;testicular mixed germ cell tumor;iatrogenic Kaposi's sarcoma;ovarian mucinous adenocarcinoma;Acute myeloid leukemia;radiologic finding;Transitional Meningioma;Duodenal Adenocarcinoma;Li-Fraumeni syndrome;Multiple myeloma;Peritoneal Mesothelioma;bladder transitional cell carcinoma;Glioma;Prostate Cancer;Fallopian Tube Serous Adenocarcinoma;Lung Inflammatory Myofibroblastic Tumor;Papillary renal cell carcinoma;squamous cell lung carcinoma;lymphoid neoplasm;head and neck squamous cell carcinoma;nasopharyngeal squamous cell carcinoma;Uterine Carcinosarcoma;brain glioblastoma;Hereditary breast and/or ovarian cancer syndrome;ovarian serous adenocarcinoma;skin carcinoma;follicular thyroid carcinoma;Appendix Adenocarcinoma;marginal zone B-cell lymphoma;Thyroid Gland Undifferentiated (Anaplastic) Carcinoma;rectal adenocarcinoma;Lung adenocarcinoma;Poorly Differentiated Thyroid Gland Carcinoma;Chromophobe renal cell carcinoma;POLYCYTHEMIA VERA;gastric carcinoma;Melanoma;MYELODYSPLASTIC SYNDROME;HER2 positive breast carcinoma;Fibrous Meningioma;Unclassified Renal Cell Carcinoma;Esophageal Squamous Cell Carcinoma;ovarian carcinoma;diffuse large B-cell lymphoma;Ovarian Endometrioid Adenocarcinoma;soft tissue sarcoma;pharyngeal squamous cell carcinoma;OSTEOGENIC SARCOMA;Rhabdoid Meningioma;Bladder Small Cell Neuroendocrine Carcinoma;Atypical Meningioma;cutaneous melanoma;breast ductal adenocarcinoma;Angioimmunoblastic T-cell lymphoma;endometrium adenocarcinoma;Lung sarcomatoid carcinoma;prostate adenocarcinoma;Esophageal adenocarcinoma;cervical squamous cell carcinoma;Vulvar Squamous Cell Carcinoma;T-cell prolymphocytic leukemia;Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation;Familial prostate cancer;colorectal adenocarcinoma;diffuse gastric adenocarcinoma;colon adenocarcinoma;cecum adenocarcinoma;Chronic lymphocytic leukemia;Well-differentiated liposarcoma;urothelial carcinoma;angiosarcoma;metaplastic breast carcinoma;anaplastic large cell lymphoma;TUMOR PREDISPOSITION SYNDROME 4;liposarcoma;ND;Appendix Goblet Cell Carcinoid;Papillary thyroid carcinoma;nodular melanoma;Hepatobiliary Neoplasm;B-cell acute lymphoblastic leukemia;Esophageal carcinoma;non-small cell lung carcinoma;HEPATOBLASTOMA;Clear Cell Meningioma;Breast carcinoma;follicular dendritic cell sarcoma;ovarian clear cell adenocarcinoma;Alveolar rhabdomyosarcoma;hairy cell leukemia;oral squamous cell carcinoma;Lung carcinoma;Anaplastic oligodendroglioma;Angiomatous Meningioma;Endometrial Endometrioid Adenocarcinoma;Digestive System Carcinoma;gastric intestinal type adenocarcinoma;gastric adenocarcinoma;lobular breast carcinoma;Breast Carcinoma by Gene Expression Profile;Small Intestinal Tubulovillous Adenoma;colon carcinoma;MANTLE CELL LYMPHOMA;Hepatocellular Carcinoma;undifferentiated pleomorphic sarcoma;Adamantinomatous Craniopharyngioma;prostate carcinoma;Gallbladder Adenocarcinoma;OSTEOSARCOMA;pancreatic neuroendocrine tumor;CHEK2-related cancer predisposition;kidney neoplasm;Pleural Epithelioid Mesothelioma;Malignant Ovarian Mixed Epithelial Tumor;Small cell lung carcinoma;leiomyosarcoma;Clear cell renal carcinoma;Merkel cell skin cancer;CHEK2 related CANCER;Essential thrombocythemia;Microcystic Meningioma;testicular seminoma;Malignant Germ Cell Tumor;Endometrial Clear Cell Adenocarcinoma;OSTEOSARCOMA;Dedifferentiated liposarcoma;bile duct carcinoma;Neoplasm;Familial colorectal cancer Type X;TUMOR PREDISPOSITION SYNDROME 4;Prostate Cancer;OSTEOGENIC SARCOMA
CHEK2_aug8,CHEK2,thyroid carcinoma;adrenal cortex carcinoma;Meningothelial Meningioma;Endometrial carcinoma;testicular mixed germ cell tumor;iatrogenic Kaposi's sarcoma;ovarian mucinous adenocarcinoma;Acute myeloid leukemia;radiologic finding;Transitional Meningioma;Duodenal Adenocarcinoma;Li-Fraumeni syndrome;Multiple myeloma;Peritoneal Mesothelioma;bladder transitional cell carcinoma;Glioma;Prostate Cancer;Fallopian Tube Serous Adenocarcinoma;Lung Inflammatory Myofibroblastic Tumor;Papillary renal cell carcinoma;squamous cell lung carcinoma;lymphoid neoplasm;head and neck squamous cell carcinoma;nasopharyngeal squamous cell carcinoma;Uterine Carcinosarcoma;brain glioblastoma;Hereditary breast and/or ovarian cancer syndrome;ovarian serous adenocarcinoma;skin carcinoma;follicular thyroid carcinoma;Appendix Adenocarcinoma;marginal zone B-cell lymphoma;Thyroid Gland Undifferentiated (Anaplastic) Carcinoma;rectal adenocarcinoma;Lung adenocarcinoma;Poorly Differentiated Thyroid Gland Carcinoma;Chromophobe renal cell carcinoma;POLYCYTHEMIA VERA;gastric carcinoma;Melanoma;MYELODYSPLASTIC SYNDROME;HER2 positive breast carcinoma;Fibrous Meningioma;Unclassified Renal Cell Carcinoma;Esophageal Squamous Cell Carcinoma;ovarian carcinoma;diffuse large B-cell lymphoma;Ovarian Endometrioid Adenocarcinoma;soft tissue sarcoma;pharyngeal squamous cell carcinoma;OSTEOGENIC SARCOMA;Rhabdoid Meningioma;Bladder Small Cell Neuroendocrine Carcinoma;Atypical Meningioma;cutaneous melanoma;breast ductal adenocarcinoma;Angioimmunoblastic T-cell lymphoma;endometrium adenocarcinoma;Lung sarcomatoid carcinoma;prostate adenocarcinoma;Esophageal adenocarcinoma;cervical squamous cell carcinoma;Vulvar Squamous Cell Carcinoma;T-cell prolymphocytic leukemia;Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation;Familial prostate cancer;colorectal adenocarcinoma;diffuse gastric adenocarcinoma;colon adenocarcinoma;cecum adenocarcinoma;Chronic lymphocytic leukemia;Well-differentiated liposarcoma;urothelial carcinoma;angiosarcoma;metaplastic breast carcinoma;anaplastic large cell lymphoma;TUMOR PREDISPOSITION SYNDROME 4;liposarcoma;ND;Appendix Goblet Cell Carcinoid;Papillary thyroid carcinoma;nodular melanoma;Hepatobiliary Neoplasm;B-cell acute lymphoblastic leukemia;Esophageal carcinoma;non-small cell lung carcinoma;HEPATOBLASTOMA;Clear Cell Meningioma;Breast carcinoma;follicular dendritic cell sarcoma;ovarian clear cell adenocarcinoma;Alveolar rhabdomyosarcoma;hairy cell leukemia;oral squamous cell carcinoma;Lung carcinoma;Anaplastic oligodendroglioma;Angiomatous Meningioma;Endometrial Endometrioid Adenocarcinoma;Digestive System Carcinoma;gastric intestinal type adenocarcinoma;gastric adenocarcinoma;lobular breast carcinoma;Breast Carcinoma by Gene Expression Profile;Small Intestinal Tubulovillous Adenoma;colon carcinoma;MANTLE CELL LYMPHOMA;Hepatocellular Carcinoma;undifferentiated pleomorphic sarcoma;Adamantinomatous Craniopharyngioma;prostate carcinoma;Gallbladder Adenocarcinoma;OSTEOSARCOMA;pancreatic neuroendocrine tumor;CHEK2-related cancer predisposition;kidney neoplasm;Pleural Epithelioid Mesothelioma;Malignant Ovarian Mixed Epithelial Tumor;Small cell lung carcinoma;leiomyosarcoma;Clear cell renal carcinoma;Merkel cell skin cancer;CHEK2 related CANCER;Essential thrombocythemia;Microcystic Meningioma;testicular seminoma;Malignant Germ Cell Tumor;Endometrial Clear Cell Adenocarcinoma;OSTEOSARCOMA;Dedifferentiated liposarcoma;bile duct carcinoma;Neoplasm;Familial colorectal cancer Type X;TUMOR PREDISPOSITION SYNDROME 4;Prostate Cancer;OSTEOGENIC SARCOMA
CHEK2_aug9,CHEK2,thyroid carcinoma;adrenal cortex carcinoma;Meningothelial Meningioma;Endometrial carcinoma;testicular mixed germ cell tumor;iatrogenic Kaposi's sarcoma;ovarian mucinous adenocarcinoma;Acute myeloid leukemia;radiologic finding;Transitional Meningioma;Duodenal Adenocarcinoma;Li-Fraumeni syndrome;Multiple myeloma;Peritoneal Mesothelioma;bladder transitional cell carcinoma;Glioma;Prostate Cancer;Fallopian Tube Serous Adenocarcinoma;Lung Inflammatory Myofibroblastic Tumor;Papillary renal cell carcinoma;squamous cell lung carcinoma;lymphoid neoplasm;head and neck squamous cell carcinoma;nasopharyngeal squamous cell carcinoma;Uterine Carcinosarcoma;brain glioblastoma;Hereditary breast and/or ovarian cancer syndrome;ovarian serous adenocarcinoma;skin carcinoma;follicular thyroid carcinoma;Appendix Adenocarcinoma;marginal zone B-cell lymphoma;Thyroid Gland Undifferentiated (Anaplastic) Carcinoma;rectal adenocarcinoma;Lung adenocarcinoma;Poorly Differentiated Thyroid Gland Carcinoma;Chromophobe renal cell carcinoma;POLYCYTHEMIA VERA;gastric carcinoma;Melanoma;MYELODYSPLASTIC SYNDROME;HER2 positive breast carcinoma;Fibrous Meningioma;Unclassified Renal Cell Carcinoma;Esophageal Squamous Cell Carcinoma;ovarian carcinoma;diffuse large B-cell lymphoma;Ovarian Endometrioid Adenocarcinoma;soft tissue sarcoma;pharyngeal squamous cell carcinoma;OSTEOGENIC SARCOMA;Rhabdoid Meningioma;Bladder Small Cell Neuroendocrine Carcinoma;Atypical Meningioma;cutaneous melanoma;breast ductal adenocarcinoma;Angioimmunoblastic T-cell lymphoma;endometrium adenocarcinoma;Lung sarcomatoid carcinoma;prostate adenocarcinoma;Esophageal adenocarcinoma;cervical squamous cell carcinoma;Vulvar Squamous Cell Carcinoma;T-cell prolymphocytic leukemia;Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation;Familial prostate cancer;colorectal adenocarcinoma;diffuse gastric adenocarcinoma;colon adenocarcinoma;cecum adenocarcinoma;Chronic lymphocytic leukemia;Well-differentiated liposarcoma;urothelial carcinoma;angiosarcoma;metaplastic breast carcinoma;anaplastic large cell lymphoma;TUMOR PREDISPOSITION SYNDROME 4;liposarcoma;ND;Appendix Goblet Cell Carcinoid;Papillary thyroid carcinoma;nodular melanoma;Hepatobiliary Neoplasm;B-cell acute lymphoblastic leukemia;Esophageal carcinoma;non-small cell lung carcinoma;HEPATOBLASTOMA;Clear Cell Meningioma;Breast carcinoma;follicular dendritic cell sarcoma;ovarian clear cell adenocarcinoma;Alveolar rhabdomyosarcoma;hairy cell leukemia;oral squamous cell carcinoma;Lung carcinoma;Anaplastic oligodendroglioma;Angiomatous Meningioma;Endometrial Endometrioid Adenocarcinoma;Digestive System Carcinoma;gastric intestinal type adenocarcinoma;gastric adenocarcinoma;lobular breast carcinoma;Breast Carcinoma by Gene Expression Profile;Small Intestinal Tubulovillous Adenoma;colon carcinoma;MANTLE CELL LYMPHOMA;Hepatocellular Carcinoma;undifferentiated pleomorphic sarcoma;Adamantinomatous Craniopharyngioma;prostate carcinoma;Gallbladder Adenocarcinoma;OSTEOSARCOMA;pancreatic neuroendocrine tumor;CHEK2-related cancer predisposition;kidney neoplasm;Pleural Epithelioid Mesothelioma;Malignant Ovarian Mixed Epithelial Tumor;Small cell lung carcinoma;leiomyosarcoma;Clear cell renal carcinoma;Merkel cell skin cancer;CHEK2 related CANCER;Essential thrombocythemia;Microcystic Meningioma;testicular seminoma;Malignant Germ Cell Tumor;Endometrial Clear Cell Adenocarcinoma;OSTEOSARCOMA;Dedifferentiated liposarcoma;bile duct carcinoma;Neoplasm;Familial colorectal cancer Type X;TUMOR PREDISPOSITION SYNDROME 4;Prostate Cancer;OSTEOGENIC SARCOMA
BRCA2,BRCA2,"squamous cell lung carcinoma;neoplasm of mature B-cells;Glioma;Meningothelial Meningioma;Esophageal carcinoma;mesonephric adenocarcinoma;Familial pancreatic carcinoma;large cell lung carcinoma;gastric adenocarcinoma;Bladder Adenocarcinoma;Lung adenocarcinoma;pulmonary blastoma;WILMS TUMOR 1;Chordoma;Melanoma;Anal Squamous Cell Carcinoma;Ovarian Carcinosarcoma;breast ductal adenocarcinoma;Anaplastic Malignant Meningioma;Hepatobiliary Neoplasm;nodular melanoma;Breast Cancer;adenosquamous lung carcinoma;undifferentiated pleomorphic sarcoma;Chronic lymphocytic leukemia;colorectal adenocarcinoma;non-small cell lung carcinoma;Uveal melanoma;pseudomyxoma peritonei;metaplastic breast carcinoma;Merkel cell skin cancer;Esophageal Squamous Cell Carcinoma;Pancreatic Acinar Cell Carcinoma;Parotid Gland Adenoid Cystic Carcinoma;Ovarian Choriocarcinoma;Breast Carcinoma by Gene Expression Profile;Hodgkins lymphoma;Burkitts lymphoma;Breast carcinoma;ovarian serous adenocarcinoma;Acute myeloid leukemia;Acute lymphoblastic leukemia;Sarcomatoid Carcinoma;T-cell acute lymphoblastic leukemia;ND;Atypical endometrial hyperplasia;cecum adenocarcinoma;Ovarian neoplasm;Hereditary breast and/or ovarian cancer syndrome;ganglioglioma;salivary gland squamous cell carcinoma;Malignant Laryngeal Neoplasm;Bladder Small Cell Neuroendocrine Carcinoma;adrenal cortex carcinoma;Familial colorectal cancer Type X;Laryngeal squamous cell carcinoma;Invasive Breast Carcinoma;Prostate Cancer;Thymoma Type AB;Pleural Biphasic Mesothelioma;Extramammary Paget Disease;colon carcinoma;FANCONI ANEMIA COMPLEMENTATION GROUP D TYPE 1;Fanconi anemia;BRCA2 associated CANCER;Small cell lung carcinoma;skin carcinoma;Gallbladder Small Cell Neuroendocrine Carcinoma;Anaplastic astrocytoma;Hereditary breast cancer;urothelial carcinoma;Rhabdoid Meningioma;oral squamous cell carcinoma;Vulvar Squamous Cell Carcinoma;Papillary thyroid carcinoma;Brain Stem Glioblastoma;cervical squamous cell carcinoma;Undifferentiated Pancreatic Carcinoma with Osteoclast-Like Giant Cells;BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2;pancreatic neuroendocrine tumor;Malignant Ovarian Mixed Epithelial Tumor;pancreatic carcinoma;Testicular Sertoli Cell Tumor;vulvar intraepithelial neoplasia;Prostate Small Cell Carcinoma;Anal Melanoma;Benign Thyroid Gland Neoplasm;Ampulla of Vater Carcinoma;Transitional Meningioma;endometrial serous adenocarcinoma;Mixed Lobular and Ductal Breast Carcinoma;Poorly Differentiated Thyroid Gland Carcinoma;Renal cell carcinoma;testicular seminoma;Pleural Mesothelioma;Inherited cancer-predisposing syndrome due to biallelic BRCA2 mutations;gastric carcinoma;pharyngeal squamous cell carcinoma;Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation;Small Intestinal Diffuse Large B-Cell Lymphoma;diffuse large B-cell lymphoma;adrenocortical adenoma;prostate carcinoma;Chronic myelomonocytic leukemia;Thyroid Gland Oncocytic Follicular Carcinoma;Digestive System Carcinoma;Cervical Adenosquamous Carcinoma;Fibrous Meningioma;Gallbladder Adenocarcinoma;bile duct carcinoma;MANTLE CELL LYMPHOMA;Alveolar rhabdomyosarcoma;ovarian clear cell adenocarcinoma;Hepatocellular Carcinoma;head and neck squamous cell carcinoma;Placental Choriocarcinoma;bronchoalveolar adenocarcinoma;Cervical Small Cell Carcinoma;liposarcoma;Appendix Adenocarcinoma;Pancreatic adenocarcinoma;renal carcinoma;bladder transitional cell carcinoma;Duodenal Adenocarcinoma;unspecified peripheral T-cell lymphoma;Fibrolamellar Carcinoma;embryonal rhabdomyosarcoma;Papillary renal cell carcinoma;angiosarcoma;HER2 positive breast carcinoma;Angiomatous Meningioma;Ileal Neuroendocrine Tumor G1;amelanotic skin melanoma;Chordoid Meningioma;ovarian mucinous adenocarcinoma;Adamantinomatous Craniopharyngioma;leiomyosarcoma;ovarian carcinoma;Cholangiocarcinoma;lymphoid neoplasm;pancreatic neoplasm;Nephroblastoma;ovarian teratoma;Endometrial Endometrioid Adenocarcinoma;soft tissue sarcoma;kidney neoplasm;Pleural Epithelioid Mesothelioma;Endometrial carcinoma;Thyroid Gland Undifferentiated (Anaplastic) Carcinoma;Anaplastic oligoastrocytoma;Unclassified Renal Cell Carcinoma;Appendix Goblet Cell Carcinoid;Anaplastic oligodendroglioma;B-cell acute lymphoblastic leukemia;malignant epithelioid mesothelioma;brain glioblastoma;Multiple myeloma;Well-differentiated liposarcoma;thyroid neoplasm;Primary Peritoneal Serous Adenocarcinoma;cutaneous melanoma;gastric intestinal type adenocarcinoma;Sinonasal Undifferentiated Carcinoma;skin appendage carcinoma;Clear cell renal carcinoma;rectal adenocarcinoma;OSTEOSARCOMA;Lung carcinoid tumor;Gastric Adenoma;Neuroblastoma;thyroid carcinoma;Secretory Meningioma;Astrocytoma;prostate adenocarcinoma;FANCONI ANEMIA, COMPLEMENTATION GROUP D1;Esophageal adenocarcinoma;Uterine Carcinosarcoma;Peritoneal Mesothelioma;Atypical Meningioma;Endometrial Undifferentiated Carcinoma;PANCREATIC CANCER, SUSCEPTIBILITY TO, 2;nasopharyngeal squamous cell carcinoma;hairy cell leukemia;Conjunctival Melanoma;Undifferentiated Ovarian Carcinoma;lobular breast carcinoma;diffuse gastric adenocarcinoma;Ovarian Endometrioid Adenocarcinoma;Medulloblastoma;Lung carcinoma;colon adenocarcinoma;Thymic Carcinoma;GLIOMA SUSCEPTIBILITY 3;Familial prostate cancer;WILMS TUMOR 1;Medulloblastoma;PANCREATIC CANCER, SUSCEPTIBILITY TO, 2;FANCONI ANEMIA, COMPLEMENTATION GROUP D1;Breast Cancer;Prostate Cancer;BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2;GLIOMA SUSCEPTIBILITY 3"
BRCA2_aug1,BRCA2,"squamous cell lung carcinoma;neoplasm of mature B-cells;Glioma;Meningothelial Meningioma;Esophageal carcinoma;mesonephric adenocarcinoma;Familial pancreatic carcinoma;large cell lung carcinoma;gastric adenocarcinoma;Bladder Adenocarcinoma;Lung adenocarcinoma;pulmonary blastoma;WILMS TUMOR 1;Chordoma;Melanoma;Anal Squamous Cell Carcinoma;Ovarian Carcinosarcoma;breast ductal adenocarcinoma;Anaplastic Malignant Meningioma;Hepatobiliary Neoplasm;nodular melanoma;Breast Cancer;adenosquamous lung carcinoma;undifferentiated pleomorphic sarcoma;Chronic lymphocytic leukemia;colorectal adenocarcinoma;non-small cell lung carcinoma;Uveal melanoma;pseudomyxoma peritonei;metaplastic breast carcinoma;Merkel cell skin cancer;Esophageal Squamous Cell Carcinoma;Pancreatic Acinar Cell Carcinoma;Parotid Gland Adenoid Cystic Carcinoma;Ovarian Choriocarcinoma;Breast Carcinoma by Gene Expression Profile;Hodgkins lymphoma;Burkitts lymphoma;Breast carcinoma;ovarian serous adenocarcinoma;Acute myeloid leukemia;Acute lymphoblastic leukemia;Sarcomatoid Carcinoma;T-cell acute lymphoblastic leukemia;ND;Atypical endometrial hyperplasia;cecum adenocarcinoma;Ovarian neoplasm;Hereditary breast and/or ovarian cancer syndrome;ganglioglioma;salivary gland squamous cell carcinoma;Malignant Laryngeal Neoplasm;Bladder Small Cell Neuroendocrine Carcinoma;adrenal cortex carcinoma;Familial colorectal cancer Type X;Laryngeal squamous cell carcinoma;Invasive Breast Carcinoma;Prostate Cancer;Thymoma Type AB;Pleural Biphasic Mesothelioma;Extramammary Paget Disease;colon carcinoma;FANCONI ANEMIA COMPLEMENTATION GROUP D TYPE 1;Fanconi anemia;BRCA2 associated CANCER;Small cell lung carcinoma;skin carcinoma;Gallbladder Small Cell Neuroendocrine Carcinoma;Anaplastic astrocytoma;Hereditary breast cancer;urothelial carcinoma;Rhabdoid Meningioma;oral squamous cell carcinoma;Vulvar Squamous Cell Carcinoma;Papillary thyroid carcinoma;Brain Stem Glioblastoma;cervical squamous cell carcinoma;Undifferentiated Pancreatic Carcinoma with Osteoclast-Like Giant Cells;BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2;pancreatic neuroendocrine tumor;Malignant Ovarian Mixed Epithelial Tumor;pancreatic carcinoma;Testicular Sertoli Cell Tumor;vulvar intraepithelial neoplasia;Prostate Small Cell Carcinoma;Anal Melanoma;Benign Thyroid Gland Neoplasm;Ampulla of Vater Carcinoma;Transitional Meningioma;endometrial serous adenocarcinoma;Mixed Lobular and Ductal Breast Carcinoma;Poorly Differentiated Thyroid Gland Carcinoma;Renal cell carcinoma;testicular seminoma;Pleural Mesothelioma;Inherited cancer-predisposing syndrome due to biallelic BRCA2 mutations;gastric carcinoma;pharyngeal squamous cell carcinoma;Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation;Small Intestinal Diffuse Large B-Cell Lymphoma;diffuse large B-cell lymphoma;adrenocortical adenoma;prostate carcinoma;Chronic myelomonocytic leukemia;Thyroid Gland Oncocytic Follicular Carcinoma;Digestive System Carcinoma;Cervical Adenosquamous Carcinoma;Fibrous Meningioma;Gallbladder Adenocarcinoma;bile duct carcinoma;MANTLE CELL LYMPHOMA;Alveolar rhabdomyosarcoma;ovarian clear cell adenocarcinoma;Hepatocellular Carcinoma;head and neck squamous cell carcinoma;Placental Choriocarcinoma;bronchoalveolar adenocarcinoma;Cervical Small Cell Carcinoma;liposarcoma;Appendix Adenocarcinoma;Pancreatic adenocarcinoma;renal carcinoma;bladder transitional cell carcinoma;Duodenal Adenocarcinoma;unspecified peripheral T-cell lymphoma;Fibrolamellar Carcinoma;embryonal rhabdomyosarcoma;Papillary renal cell carcinoma;angiosarcoma;HER2 positive breast carcinoma;Angiomatous Meningioma;Ileal Neuroendocrine Tumor G1;amelanotic skin melanoma;Chordoid Meningioma;ovarian mucinous adenocarcinoma;Adamantinomatous Craniopharyngioma;leiomyosarcoma;ovarian carcinoma;Cholangiocarcinoma;lymphoid neoplasm;pancreatic neoplasm;Nephroblastoma;ovarian teratoma;Endometrial Endometrioid Adenocarcinoma;soft tissue sarcoma;kidney neoplasm;Pleural Epithelioid Mesothelioma;Endometrial carcinoma;Thyroid Gland Undifferentiated (Anaplastic) Carcinoma;Anaplastic oligoastrocytoma;Unclassified Renal Cell Carcinoma;Appendix Goblet Cell Carcinoid;Anaplastic oligodendroglioma;B-cell acute lymphoblastic leukemia;malignant epithelioid mesothelioma;brain glioblastoma;Multiple myeloma;Well-differentiated liposarcoma;thyroid neoplasm;Primary Peritoneal Serous Adenocarcinoma;cutaneous melanoma;gastric intestinal type adenocarcinoma;Sinonasal Undifferentiated Carcinoma;skin appendage carcinoma;Clear cell renal carcinoma;rectal adenocarcinoma;OSTEOSARCOMA;Lung carcinoid tumor;Gastric Adenoma;Neuroblastoma;thyroid carcinoma;Secretory Meningioma;Astrocytoma;prostate adenocarcinoma;FANCONI ANEMIA, COMPLEMENTATION GROUP D1;Esophageal adenocarcinoma;Uterine Carcinosarcoma;Peritoneal Mesothelioma;Atypical Meningioma;Endometrial Undifferentiated Carcinoma;PANCREATIC CANCER, SUSCEPTIBILITY TO, 2;nasopharyngeal squamous cell carcinoma;hairy cell leukemia;Conjunctival Melanoma;Undifferentiated Ovarian Carcinoma;lobular breast carcinoma;diffuse gastric adenocarcinoma;Ovarian Endometrioid Adenocarcinoma;Medulloblastoma;Lung carcinoma;colon adenocarcinoma;Thymic Carcinoma;GLIOMA SUSCEPTIBILITY 3;Familial prostate cancer;WILMS TUMOR 1;Medulloblastoma;PANCREATIC CANCER, SUSCEPTIBILITY TO, 2;FANCONI ANEMIA, COMPLEMENTATION GROUP D1;Breast Cancer;Prostate Cancer;BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2;GLIOMA SUSCEPTIBILITY 3"
BRCA2_aug2,BRCA2,"squamous cell lung carcinoma;neoplasm of mature B-cells;Glioma;Meningothelial Meningioma;Esophageal carcinoma;mesonephric adenocarcinoma;Familial pancreatic carcinoma;large cell lung carcinoma;gastric adenocarcinoma;Bladder Adenocarcinoma;Lung adenocarcinoma;pulmonary blastoma;WILMS TUMOR 1;Chordoma;Melanoma;Anal Squamous Cell Carcinoma;Ovarian Carcinosarcoma;breast ductal adenocarcinoma;Anaplastic Malignant Meningioma;Hepatobiliary Neoplasm;nodular melanoma;Breast Cancer;adenosquamous lung carcinoma;undifferentiated pleomorphic sarcoma;Chronic lymphocytic leukemia;colorectal adenocarcinoma;non-small cell lung carcinoma;Uveal melanoma;pseudomyxoma peritonei;metaplastic breast carcinoma;Merkel cell skin cancer;Esophageal Squamous Cell Carcinoma;Pancreatic Acinar Cell Carcinoma;Parotid Gland Adenoid Cystic Carcinoma;Ovarian Choriocarcinoma;Breast Carcinoma by Gene Expression Profile;Hodgkins lymphoma;Burkitts lymphoma;Breast carcinoma;ovarian serous adenocarcinoma;Acute myeloid leukemia;Acute lymphoblastic leukemia;Sarcomatoid Carcinoma;T-cell acute lymphoblastic leukemia;ND;Atypical endometrial hyperplasia;cecum adenocarcinoma;Ovarian neoplasm;Hereditary breast and/or ovarian cancer syndrome;ganglioglioma;salivary gland squamous cell carcinoma;Malignant Laryngeal Neoplasm;Bladder Small Cell Neuroendocrine Carcinoma;adrenal cortex carcinoma;Familial colorectal cancer Type X;Laryngeal squamous cell carcinoma;Invasive Breast Carcinoma;Prostate Cancer;Thymoma Type AB;Pleural Biphasic Mesothelioma;Extramammary Paget Disease;colon carcinoma;FANCONI ANEMIA COMPLEMENTATION GROUP D TYPE 1;Fanconi anemia;BRCA2 associated CANCER;Small cell lung carcinoma;skin carcinoma;Gallbladder Small Cell Neuroendocrine Carcinoma;Anaplastic astrocytoma;Hereditary breast cancer;urothelial carcinoma;Rhabdoid Meningioma;oral squamous cell carcinoma;Vulvar Squamous Cell Carcinoma;Papillary thyroid carcinoma;Brain Stem Glioblastoma;cervical squamous cell carcinoma;Undifferentiated Pancreatic Carcinoma with Osteoclast-Like Giant Cells;BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2;pancreatic neuroendocrine tumor;Malignant Ovarian Mixed Epithelial Tumor;pancreatic carcinoma;Testicular Sertoli Cell Tumor;vulvar intraepithelial neoplasia;Prostate Small Cell Carcinoma;Anal Melanoma;Benign Thyroid Gland Neoplasm;Ampulla of Vater Carcinoma;Transitional Meningioma;endometrial serous adenocarcinoma;Mixed Lobular and Ductal Breast Carcinoma;Poorly Differentiated Thyroid Gland Carcinoma;Renal cell carcinoma;testicular seminoma;Pleural Mesothelioma;Inherited cancer-predisposing syndrome due to biallelic BRCA2 mutations;gastric carcinoma;pharyngeal squamous cell carcinoma;Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation;Small Intestinal Diffuse Large B-Cell Lymphoma;diffuse large B-cell lymphoma;adrenocortical adenoma;prostate carcinoma;Chronic myelomonocytic leukemia;Thyroid Gland Oncocytic Follicular Carcinoma;Digestive System Carcinoma;Cervical Adenosquamous Carcinoma;Fibrous Meningioma;Gallbladder Adenocarcinoma;bile duct carcinoma;MANTLE CELL LYMPHOMA;Alveolar rhabdomyosarcoma;ovarian clear cell adenocarcinoma;Hepatocellular Carcinoma;head and neck squamous cell carcinoma;Placental Choriocarcinoma;bronchoalveolar adenocarcinoma;Cervical Small Cell Carcinoma;liposarcoma;Appendix Adenocarcinoma;Pancreatic adenocarcinoma;renal carcinoma;bladder transitional cell carcinoma;Duodenal Adenocarcinoma;unspecified peripheral T-cell lymphoma;Fibrolamellar Carcinoma;embryonal rhabdomyosarcoma;Papillary renal cell carcinoma;angiosarcoma;HER2 positive breast carcinoma;Angiomatous Meningioma;Ileal Neuroendocrine Tumor G1;amelanotic skin melanoma;Chordoid Meningioma;ovarian mucinous adenocarcinoma;Adamantinomatous Craniopharyngioma;leiomyosarcoma;ovarian carcinoma;Cholangiocarcinoma;lymphoid neoplasm;pancreatic neoplasm;Nephroblastoma;ovarian teratoma;Endometrial Endometrioid Adenocarcinoma;soft tissue sarcoma;kidney neoplasm;Pleural Epithelioid Mesothelioma;Endometrial carcinoma;Thyroid Gland Undifferentiated (Anaplastic) Carcinoma;Anaplastic oligoastrocytoma;Unclassified Renal Cell Carcinoma;Appendix Goblet Cell Carcinoid;Anaplastic oligodendroglioma;B-cell acute lymphoblastic leukemia;malignant epithelioid mesothelioma;brain glioblastoma;Multiple myeloma;Well-differentiated liposarcoma;thyroid neoplasm;Primary Peritoneal Serous Adenocarcinoma;cutaneous melanoma;gastric intestinal type adenocarcinoma;Sinonasal Undifferentiated Carcinoma;skin appendage carcinoma;Clear cell renal carcinoma;rectal adenocarcinoma;OSTEOSARCOMA;Lung carcinoid tumor;Gastric Adenoma;Neuroblastoma;thyroid carcinoma;Secretory Meningioma;Astrocytoma;prostate adenocarcinoma;FANCONI ANEMIA, COMPLEMENTATION GROUP D1;Esophageal adenocarcinoma;Uterine Carcinosarcoma;Peritoneal Mesothelioma;Atypical Meningioma;Endometrial Undifferentiated Carcinoma;PANCREATIC CANCER, SUSCEPTIBILITY TO, 2;nasopharyngeal squamous cell carcinoma;hairy cell leukemia;Conjunctival Melanoma;Undifferentiated Ovarian Carcinoma;lobular breast carcinoma;diffuse gastric adenocarcinoma;Ovarian Endometrioid Adenocarcinoma;Medulloblastoma;Lung carcinoma;colon adenocarcinoma;Thymic Carcinoma;GLIOMA SUSCEPTIBILITY 3;Familial prostate cancer;WILMS TUMOR 1;Medulloblastoma;PANCREATIC CANCER, SUSCEPTIBILITY TO, 2;FANCONI ANEMIA, COMPLEMENTATION GROUP D1;Breast Cancer;Prostate Cancer;BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2;GLIOMA SUSCEPTIBILITY 3"
BRCA2_aug3,BRCA2,"squamous cell lung carcinoma;neoplasm of mature B-cells;Glioma;Meningothelial Meningioma;Esophageal carcinoma;mesonephric adenocarcinoma;Familial pancreatic carcinoma;large cell lung carcinoma;gastric adenocarcinoma;Bladder Adenocarcinoma;Lung adenocarcinoma;pulmonary blastoma;WILMS TUMOR 1;Chordoma;Melanoma;Anal Squamous Cell Carcinoma;Ovarian Carcinosarcoma;breast ductal adenocarcinoma;Anaplastic Malignant Meningioma;Hepatobiliary Neoplasm;nodular melanoma;Breast Cancer;adenosquamous lung carcinoma;undifferentiated pleomorphic sarcoma;Chronic lymphocytic leukemia;colorectal adenocarcinoma;non-small cell lung carcinoma;Uveal melanoma;pseudomyxoma peritonei;metaplastic breast carcinoma;Merkel cell skin cancer;Esophageal Squamous Cell Carcinoma;Pancreatic Acinar Cell Carcinoma;Parotid Gland Adenoid Cystic Carcinoma;Ovarian Choriocarcinoma;Breast Carcinoma by Gene Expression Profile;Hodgkins lymphoma;Burkitts lymphoma;Breast carcinoma;ovarian serous adenocarcinoma;Acute myeloid leukemia;Acute lymphoblastic leukemia;Sarcomatoid Carcinoma;T-cell acute lymphoblastic leukemia;ND;Atypical endometrial hyperplasia;cecum adenocarcinoma;Ovarian neoplasm;Hereditary breast and/or ovarian cancer syndrome;ganglioglioma;salivary gland squamous cell carcinoma;Malignant Laryngeal Neoplasm;Bladder Small Cell Neuroendocrine Carcinoma;adrenal cortex carcinoma;Familial colorectal cancer Type X;Laryngeal squamous cell carcinoma;Invasive Breast Carcinoma;Prostate Cancer;Thymoma Type AB;Pleural Biphasic Mesothelioma;Extramammary Paget Disease;colon carcinoma;FANCONI ANEMIA COMPLEMENTATION GROUP D TYPE 1;Fanconi anemia;BRCA2 associated CANCER;Small cell lung carcinoma;skin carcinoma;Gallbladder Small Cell Neuroendocrine Carcinoma;Anaplastic astrocytoma;Hereditary breast cancer;urothelial carcinoma;Rhabdoid Meningioma;oral squamous cell carcinoma;Vulvar Squamous Cell Carcinoma;Papillary thyroid carcinoma;Brain Stem Glioblastoma;cervical squamous cell carcinoma;Undifferentiated Pancreatic Carcinoma with Osteoclast-Like Giant Cells;BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2;pancreatic neuroendocrine tumor;Malignant Ovarian Mixed Epithelial Tumor;pancreatic carcinoma;Testicular Sertoli Cell Tumor;vulvar intraepithelial neoplasia;Prostate Small Cell Carcinoma;Anal Melanoma;Benign Thyroid Gland Neoplasm;Ampulla of Vater Carcinoma;Transitional Meningioma;endometrial serous adenocarcinoma;Mixed Lobular and Ductal Breast Carcinoma;Poorly Differentiated Thyroid Gland Carcinoma;Renal cell carcinoma;testicular seminoma;Pleural Mesothelioma;Inherited cancer-predisposing syndrome due to biallelic BRCA2 mutations;gastric carcinoma;pharyngeal squamous cell carcinoma;Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation;Small Intestinal Diffuse Large B-Cell Lymphoma;diffuse large B-cell lymphoma;adrenocortical adenoma;prostate carcinoma;Chronic myelomonocytic leukemia;Thyroid Gland Oncocytic Follicular Carcinoma;Digestive System Carcinoma;Cervical Adenosquamous Carcinoma;Fibrous Meningioma;Gallbladder Adenocarcinoma;bile duct carcinoma;MANTLE CELL LYMPHOMA;Alveolar rhabdomyosarcoma;ovarian clear cell adenocarcinoma;Hepatocellular Carcinoma;head and neck squamous cell carcinoma;Placental Choriocarcinoma;bronchoalveolar adenocarcinoma;Cervical Small Cell Carcinoma;liposarcoma;Appendix Adenocarcinoma;Pancreatic adenocarcinoma;renal carcinoma;bladder transitional cell carcinoma;Duodenal Adenocarcinoma;unspecified peripheral T-cell lymphoma;Fibrolamellar Carcinoma;embryonal rhabdomyosarcoma;Papillary renal cell carcinoma;angiosarcoma;HER2 positive breast carcinoma;Angiomatous Meningioma;Ileal Neuroendocrine Tumor G1;amelanotic skin melanoma;Chordoid Meningioma;ovarian mucinous adenocarcinoma;Adamantinomatous Craniopharyngioma;leiomyosarcoma;ovarian carcinoma;Cholangiocarcinoma;lymphoid neoplasm;pancreatic neoplasm;Nephroblastoma;ovarian teratoma;Endometrial Endometrioid Adenocarcinoma;soft tissue sarcoma;kidney neoplasm;Pleural Epithelioid Mesothelioma;Endometrial carcinoma;Thyroid Gland Undifferentiated (Anaplastic) Carcinoma;Anaplastic oligoastrocytoma;Unclassified Renal Cell Carcinoma;Appendix Goblet Cell Carcinoid;Anaplastic oligodendroglioma;B-cell acute lymphoblastic leukemia;malignant epithelioid mesothelioma;brain glioblastoma;Multiple myeloma;Well-differentiated liposarcoma;thyroid neoplasm;Primary Peritoneal Serous Adenocarcinoma;cutaneous melanoma;gastric intestinal type adenocarcinoma;Sinonasal Undifferentiated Carcinoma;skin appendage carcinoma;Clear cell renal carcinoma;rectal adenocarcinoma;OSTEOSARCOMA;Lung carcinoid tumor;Gastric Adenoma;Neuroblastoma;thyroid carcinoma;Secretory Meningioma;Astrocytoma;prostate adenocarcinoma;FANCONI ANEMIA, COMPLEMENTATION GROUP D1;Esophageal adenocarcinoma;Uterine Carcinosarcoma;Peritoneal Mesothelioma;Atypical Meningioma;Endometrial Undifferentiated Carcinoma;PANCREATIC CANCER, SUSCEPTIBILITY TO, 2;nasopharyngeal squamous cell carcinoma;hairy cell leukemia;Conjunctival Melanoma;Undifferentiated Ovarian Carcinoma;lobular breast carcinoma;diffuse gastric adenocarcinoma;Ovarian Endometrioid Adenocarcinoma;Medulloblastoma;Lung carcinoma;colon adenocarcinoma;Thymic Carcinoma;GLIOMA SUSCEPTIBILITY 3;Familial prostate cancer;WILMS TUMOR 1;Medulloblastoma;PANCREATIC CANCER, SUSCEPTIBILITY TO, 2;FANCONI ANEMIA, COMPLEMENTATION GROUP D1;Breast Cancer;Prostate Cancer;BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2;GLIOMA SUSCEPTIBILITY 3"
BRCA2_aug4,BRCA2,"squamous cell lung carcinoma;neoplasm of mature B-cells;Glioma;Meningothelial Meningioma;Esophageal carcinoma;mesonephric adenocarcinoma;Familial pancreatic carcinoma;large cell lung carcinoma;gastric adenocarcinoma;Bladder Adenocarcinoma;Lung adenocarcinoma;pulmonary blastoma;WILMS TUMOR 1;Chordoma;Melanoma;Anal Squamous Cell Carcinoma;Ovarian Carcinosarcoma;breast ductal adenocarcinoma;Anaplastic Malignant Meningioma;Hepatobiliary Neoplasm;nodular melanoma;Breast Cancer;adenosquamous lung carcinoma;undifferentiated pleomorphic sarcoma;Chronic lymphocytic leukemia;colorectal adenocarcinoma;non-small cell lung carcinoma;Uveal melanoma;pseudomyxoma peritonei;metaplastic breast carcinoma;Merkel cell skin cancer;Esophageal Squamous Cell Carcinoma;Pancreatic Acinar Cell Carcinoma;Parotid Gland Adenoid Cystic Carcinoma;Ovarian Choriocarcinoma;Breast Carcinoma by Gene Expression Profile;Hodgkins lymphoma;Burkitts lymphoma;Breast carcinoma;ovarian serous adenocarcinoma;Acute myeloid leukemia;Acute lymphoblastic leukemia;Sarcomatoid Carcinoma;T-cell acute lymphoblastic leukemia;ND;Atypical endometrial hyperplasia;cecum adenocarcinoma;Ovarian neoplasm;Hereditary breast and/or ovarian cancer syndrome;ganglioglioma;salivary gland squamous cell carcinoma;Malignant Laryngeal Neoplasm;Bladder Small Cell Neuroendocrine Carcinoma;adrenal cortex carcinoma;Familial colorectal cancer Type X;Laryngeal squamous cell carcinoma;Invasive Breast Carcinoma;Prostate Cancer;Thymoma Type AB;Pleural Biphasic Mesothelioma;Extramammary Paget Disease;colon carcinoma;FANCONI ANEMIA COMPLEMENTATION GROUP D TYPE 1;Fanconi anemia;BRCA2 associated CANCER;Small cell lung carcinoma;skin carcinoma;Gallbladder Small Cell Neuroendocrine Carcinoma;Anaplastic astrocytoma;Hereditary breast cancer;urothelial carcinoma;Rhabdoid Meningioma;oral squamous cell carcinoma;Vulvar Squamous Cell Carcinoma;Papillary thyroid carcinoma;Brain Stem Glioblastoma;cervical squamous cell carcinoma;Undifferentiated Pancreatic Carcinoma with Osteoclast-Like Giant Cells;BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2;pancreatic neuroendocrine tumor;Malignant Ovarian Mixed Epithelial Tumor;pancreatic carcinoma;Testicular Sertoli Cell Tumor;vulvar intraepithelial neoplasia;Prostate Small Cell Carcinoma;Anal Melanoma;Benign Thyroid Gland Neoplasm;Ampulla of Vater Carcinoma;Transitional Meningioma;endometrial serous adenocarcinoma;Mixed Lobular and Ductal Breast Carcinoma;Poorly Differentiated Thyroid Gland Carcinoma;Renal cell carcinoma;testicular seminoma;Pleural Mesothelioma;Inherited cancer-predisposing syndrome due to biallelic BRCA2 mutations;gastric carcinoma;pharyngeal squamous cell carcinoma;Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation;Small Intestinal Diffuse Large B-Cell Lymphoma;diffuse large B-cell lymphoma;adrenocortical adenoma;prostate carcinoma;Chronic myelomonocytic leukemia;Thyroid Gland Oncocytic Follicular Carcinoma;Digestive System Carcinoma;Cervical Adenosquamous Carcinoma;Fibrous Meningioma;Gallbladder Adenocarcinoma;bile duct carcinoma;MANTLE CELL LYMPHOMA;Alveolar rhabdomyosarcoma;ovarian clear cell adenocarcinoma;Hepatocellular Carcinoma;head and neck squamous cell carcinoma;Placental Choriocarcinoma;bronchoalveolar adenocarcinoma;Cervical Small Cell Carcinoma;liposarcoma;Appendix Adenocarcinoma;Pancreatic adenocarcinoma;renal carcinoma;bladder transitional cell carcinoma;Duodenal Adenocarcinoma;unspecified peripheral T-cell lymphoma;Fibrolamellar Carcinoma;embryonal rhabdomyosarcoma;Papillary renal cell carcinoma;angiosarcoma;HER2 positive breast carcinoma;Angiomatous Meningioma;Ileal Neuroendocrine Tumor G1;amelanotic skin melanoma;Chordoid Meningioma;ovarian mucinous adenocarcinoma;Adamantinomatous Craniopharyngioma;leiomyosarcoma;ovarian carcinoma;Cholangiocarcinoma;lymphoid neoplasm;pancreatic neoplasm;Nephroblastoma;ovarian teratoma;Endometrial Endometrioid Adenocarcinoma;soft tissue sarcoma;kidney neoplasm;Pleural Epithelioid Mesothelioma;Endometrial carcinoma;Thyroid Gland Undifferentiated (Anaplastic) Carcinoma;Anaplastic oligoastrocytoma;Unclassified Renal Cell Carcinoma;Appendix Goblet Cell Carcinoid;Anaplastic oligodendroglioma;B-cell acute lymphoblastic leukemia;malignant epithelioid mesothelioma;brain glioblastoma;Multiple myeloma;Well-differentiated liposarcoma;thyroid neoplasm;Primary Peritoneal Serous Adenocarcinoma;cutaneous melanoma;gastric intestinal type adenocarcinoma;Sinonasal Undifferentiated Carcinoma;skin appendage carcinoma;Clear cell renal carcinoma;rectal adenocarcinoma;OSTEOSARCOMA;Lung carcinoid tumor;Gastric Adenoma;Neuroblastoma;thyroid carcinoma;Secretory Meningioma;Astrocytoma;prostate adenocarcinoma;FANCONI ANEMIA, COMPLEMENTATION GROUP D1;Esophageal adenocarcinoma;Uterine Carcinosarcoma;Peritoneal Mesothelioma;Atypical Meningioma;Endometrial Undifferentiated Carcinoma;PANCREATIC CANCER, SUSCEPTIBILITY TO, 2;nasopharyngeal squamous cell carcinoma;hairy cell leukemia;Conjunctival Melanoma;Undifferentiated Ovarian Carcinoma;lobular breast carcinoma;diffuse gastric adenocarcinoma;Ovarian Endometrioid Adenocarcinoma;Medulloblastoma;Lung carcinoma;colon adenocarcinoma;Thymic Carcinoma;GLIOMA SUSCEPTIBILITY 3;Familial prostate cancer;WILMS TUMOR 1;Medulloblastoma;PANCREATIC CANCER, SUSCEPTIBILITY TO, 2;FANCONI ANEMIA, COMPLEMENTATION GROUP D1;Breast Cancer;Prostate Cancer;BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2;GLIOMA SUSCEPTIBILITY 3"
BRCA2_aug5,BRCA2,"squamous cell lung carcinoma;neoplasm of mature B-cells;Glioma;Meningothelial Meningioma;Esophageal carcinoma;mesonephric adenocarcinoma;Familial pancreatic carcinoma;large cell lung carcinoma;gastric adenocarcinoma;Bladder Adenocarcinoma;Lung adenocarcinoma;pulmonary blastoma;WILMS TUMOR 1;Chordoma;Melanoma;Anal Squamous Cell Carcinoma;Ovarian Carcinosarcoma;breast ductal adenocarcinoma;Anaplastic Malignant Meningioma;Hepatobiliary Neoplasm;nodular melanoma;Breast Cancer;adenosquamous lung carcinoma;undifferentiated pleomorphic sarcoma;Chronic lymphocytic leukemia;colorectal adenocarcinoma;non-small cell lung carcinoma;Uveal melanoma;pseudomyxoma peritonei;metaplastic breast carcinoma;Merkel cell skin cancer;Esophageal Squamous Cell Carcinoma;Pancreatic Acinar Cell Carcinoma;Parotid Gland Adenoid Cystic Carcinoma;Ovarian Choriocarcinoma;Breast Carcinoma by Gene Expression Profile;Hodgkins lymphoma;Burkitts lymphoma;Breast carcinoma;ovarian serous adenocarcinoma;Acute myeloid leukemia;Acute lymphoblastic leukemia;Sarcomatoid Carcinoma;T-cell acute lymphoblastic leukemia;ND;Atypical endometrial hyperplasia;cecum adenocarcinoma;Ovarian neoplasm;Hereditary breast and/or ovarian cancer syndrome;ganglioglioma;salivary gland squamous cell carcinoma;Malignant Laryngeal Neoplasm;Bladder Small Cell Neuroendocrine Carcinoma;adrenal cortex carcinoma;Familial colorectal cancer Type X;Laryngeal squamous cell carcinoma;Invasive Breast Carcinoma;Prostate Cancer;Thymoma Type AB;Pleural Biphasic Mesothelioma;Extramammary Paget Disease;colon carcinoma;FANCONI ANEMIA COMPLEMENTATION GROUP D TYPE 1;Fanconi anemia;BRCA2 associated CANCER;Small cell lung carcinoma;skin carcinoma;Gallbladder Small Cell Neuroendocrine Carcinoma;Anaplastic astrocytoma;Hereditary breast cancer;urothelial carcinoma;Rhabdoid Meningioma;oral squamous cell carcinoma;Vulvar Squamous Cell Carcinoma;Papillary thyroid carcinoma;Brain Stem Glioblastoma;cervical squamous cell carcinoma;Undifferentiated Pancreatic Carcinoma with Osteoclast-Like Giant Cells;BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2;pancreatic neuroendocrine tumor;Malignant Ovarian Mixed Epithelial Tumor;pancreatic carcinoma;Testicular Sertoli Cell Tumor;vulvar intraepithelial neoplasia;Prostate Small Cell Carcinoma;Anal Melanoma;Benign Thyroid Gland Neoplasm;Ampulla of Vater Carcinoma;Transitional Meningioma;endometrial serous adenocarcinoma;Mixed Lobular and Ductal Breast Carcinoma;Poorly Differentiated Thyroid Gland Carcinoma;Renal cell carcinoma;testicular seminoma;Pleural Mesothelioma;Inherited cancer-predisposing syndrome due to biallelic BRCA2 mutations;gastric carcinoma;pharyngeal squamous cell carcinoma;Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation;Small Intestinal Diffuse Large B-Cell Lymphoma;diffuse large B-cell lymphoma;adrenocortical adenoma;prostate carcinoma;Chronic myelomonocytic leukemia;Thyroid Gland Oncocytic Follicular Carcinoma;Digestive System Carcinoma;Cervical Adenosquamous Carcinoma;Fibrous Meningioma;Gallbladder Adenocarcinoma;bile duct carcinoma;MANTLE CELL LYMPHOMA;Alveolar rhabdomyosarcoma;ovarian clear cell adenocarcinoma;Hepatocellular Carcinoma;head and neck squamous cell carcinoma;Placental Choriocarcinoma;bronchoalveolar adenocarcinoma;Cervical Small Cell Carcinoma;liposarcoma;Appendix Adenocarcinoma;Pancreatic adenocarcinoma;renal carcinoma;bladder transitional cell carcinoma;Duodenal Adenocarcinoma;unspecified peripheral T-cell lymphoma;Fibrolamellar Carcinoma;embryonal rhabdomyosarcoma;Papillary renal cell carcinoma;angiosarcoma;HER2 positive breast carcinoma;Angiomatous Meningioma;Ileal Neuroendocrine Tumor G1;amelanotic skin melanoma;Chordoid Meningioma;ovarian mucinous adenocarcinoma;Adamantinomatous Craniopharyngioma;leiomyosarcoma;ovarian carcinoma;Cholangiocarcinoma;lymphoid neoplasm;pancreatic neoplasm;Nephroblastoma;ovarian teratoma;Endometrial Endometrioid Adenocarcinoma;soft tissue sarcoma;kidney neoplasm;Pleural Epithelioid Mesothelioma;Endometrial carcinoma;Thyroid Gland Undifferentiated (Anaplastic) Carcinoma;Anaplastic oligoastrocytoma;Unclassified Renal Cell Carcinoma;Appendix Goblet Cell Carcinoid;Anaplastic oligodendroglioma;B-cell acute lymphoblastic leukemia;malignant epithelioid mesothelioma;brain glioblastoma;Multiple myeloma;Well-differentiated liposarcoma;thyroid neoplasm;Primary Peritoneal Serous Adenocarcinoma;cutaneous melanoma;gastric intestinal type adenocarcinoma;Sinonasal Undifferentiated Carcinoma;skin appendage carcinoma;Clear cell renal carcinoma;rectal adenocarcinoma;OSTEOSARCOMA;Lung carcinoid tumor;Gastric Adenoma;Neuroblastoma;thyroid carcinoma;Secretory Meningioma;Astrocytoma;prostate adenocarcinoma;FANCONI ANEMIA, COMPLEMENTATION GROUP D1;Esophageal adenocarcinoma;Uterine Carcinosarcoma;Peritoneal Mesothelioma;Atypical Meningioma;Endometrial Undifferentiated Carcinoma;PANCREATIC CANCER, SUSCEPTIBILITY TO, 2;nasopharyngeal squamous cell carcinoma;hairy cell leukemia;Conjunctival Melanoma;Undifferentiated Ovarian Carcinoma;lobular breast carcinoma;diffuse gastric adenocarcinoma;Ovarian Endometrioid Adenocarcinoma;Medulloblastoma;Lung carcinoma;colon adenocarcinoma;Thymic Carcinoma;GLIOMA SUSCEPTIBILITY 3;Familial prostate cancer;WILMS TUMOR 1;Medulloblastoma;PANCREATIC CANCER, SUSCEPTIBILITY TO, 2;FANCONI ANEMIA, COMPLEMENTATION GROUP D1;Breast Cancer;Prostate Cancer;BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2;GLIOMA SUSCEPTIBILITY 3"
BRCA2_aug6,BRCA2,"squamous cell lung carcinoma;neoplasm of mature B-cells;Glioma;Meningothelial Meningioma;Esophageal carcinoma;mesonephric adenocarcinoma;Familial pancreatic carcinoma;large cell lung carcinoma;gastric adenocarcinoma;Bladder Adenocarcinoma;Lung adenocarcinoma;pulmonary blastoma;WILMS TUMOR 1;Chordoma;Melanoma;Anal Squamous Cell Carcinoma;Ovarian Carcinosarcoma;breast ductal adenocarcinoma;Anaplastic Malignant Meningioma;Hepatobiliary Neoplasm;nodular melanoma;Breast Cancer;adenosquamous lung carcinoma;undifferentiated pleomorphic sarcoma;Chronic lymphocytic leukemia;colorectal adenocarcinoma;non-small cell lung carcinoma;Uveal melanoma;pseudomyxoma peritonei;metaplastic breast carcinoma;Merkel cell skin cancer;Esophageal Squamous Cell Carcinoma;Pancreatic Acinar Cell Carcinoma;Parotid Gland Adenoid Cystic Carcinoma;Ovarian Choriocarcinoma;Breast Carcinoma by Gene Expression Profile;Hodgkins lymphoma;Burkitts lymphoma;Breast carcinoma;ovarian serous adenocarcinoma;Acute myeloid leukemia;Acute lymphoblastic leukemia;Sarcomatoid Carcinoma;T-cell acute lymphoblastic leukemia;ND;Atypical endometrial hyperplasia;cecum adenocarcinoma;Ovarian neoplasm;Hereditary breast and/or ovarian cancer syndrome;ganglioglioma;salivary gland squamous cell carcinoma;Malignant Laryngeal Neoplasm;Bladder Small Cell Neuroendocrine Carcinoma;adrenal cortex carcinoma;Familial colorectal cancer Type X;Laryngeal squamous cell carcinoma;Invasive Breast Carcinoma;Prostate Cancer;Thymoma Type AB;Pleural Biphasic Mesothelioma;Extramammary Paget Disease;colon carcinoma;FANCONI ANEMIA COMPLEMENTATION GROUP D TYPE 1;Fanconi anemia;BRCA2 associated CANCER;Small cell lung carcinoma;skin carcinoma;Gallbladder Small Cell Neuroendocrine Carcinoma;Anaplastic astrocytoma;Hereditary breast cancer;urothelial carcinoma;Rhabdoid Meningioma;oral squamous cell carcinoma;Vulvar Squamous Cell Carcinoma;Papillary thyroid carcinoma;Brain Stem Glioblastoma;cervical squamous cell carcinoma;Undifferentiated Pancreatic Carcinoma with Osteoclast-Like Giant Cells;BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2;pancreatic neuroendocrine tumor;Malignant Ovarian Mixed Epithelial Tumor;pancreatic carcinoma;Testicular Sertoli Cell Tumor;vulvar intraepithelial neoplasia;Prostate Small Cell Carcinoma;Anal Melanoma;Benign Thyroid Gland Neoplasm;Ampulla of Vater Carcinoma;Transitional Meningioma;endometrial serous adenocarcinoma;Mixed Lobular and Ductal Breast Carcinoma;Poorly Differentiated Thyroid Gland Carcinoma;Renal cell carcinoma;testicular seminoma;Pleural Mesothelioma;Inherited cancer-predisposing syndrome due to biallelic BRCA2 mutations;gastric carcinoma;pharyngeal squamous cell carcinoma;Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation;Small Intestinal Diffuse Large B-Cell Lymphoma;diffuse large B-cell lymphoma;adrenocortical adenoma;prostate carcinoma;Chronic myelomonocytic leukemia;Thyroid Gland Oncocytic Follicular Carcinoma;Digestive System Carcinoma;Cervical Adenosquamous Carcinoma;Fibrous Meningioma;Gallbladder Adenocarcinoma;bile duct carcinoma;MANTLE CELL LYMPHOMA;Alveolar rhabdomyosarcoma;ovarian clear cell adenocarcinoma;Hepatocellular Carcinoma;head and neck squamous cell carcinoma;Placental Choriocarcinoma;bronchoalveolar adenocarcinoma;Cervical Small Cell Carcinoma;liposarcoma;Appendix Adenocarcinoma;Pancreatic adenocarcinoma;renal carcinoma;bladder transitional cell carcinoma;Duodenal Adenocarcinoma;unspecified peripheral T-cell lymphoma;Fibrolamellar Carcinoma;embryonal rhabdomyosarcoma;Papillary renal cell carcinoma;angiosarcoma;HER2 positive breast carcinoma;Angiomatous Meningioma;Ileal Neuroendocrine Tumor G1;amelanotic skin melanoma;Chordoid Meningioma;ovarian mucinous adenocarcinoma;Adamantinomatous Craniopharyngioma;leiomyosarcoma;ovarian carcinoma;Cholangiocarcinoma;lymphoid neoplasm;pancreatic neoplasm;Nephroblastoma;ovarian teratoma;Endometrial Endometrioid Adenocarcinoma;soft tissue sarcoma;kidney neoplasm;Pleural Epithelioid Mesothelioma;Endometrial carcinoma;Thyroid Gland Undifferentiated (Anaplastic) Carcinoma;Anaplastic oligoastrocytoma;Unclassified Renal Cell Carcinoma;Appendix Goblet Cell Carcinoid;Anaplastic oligodendroglioma;B-cell acute lymphoblastic leukemia;malignant epithelioid mesothelioma;brain glioblastoma;Multiple myeloma;Well-differentiated liposarcoma;thyroid neoplasm;Primary Peritoneal Serous Adenocarcinoma;cutaneous melanoma;gastric intestinal type adenocarcinoma;Sinonasal Undifferentiated Carcinoma;skin appendage carcinoma;Clear cell renal carcinoma;rectal adenocarcinoma;OSTEOSARCOMA;Lung carcinoid tumor;Gastric Adenoma;Neuroblastoma;thyroid carcinoma;Secretory Meningioma;Astrocytoma;prostate adenocarcinoma;FANCONI ANEMIA, COMPLEMENTATION GROUP D1;Esophageal adenocarcinoma;Uterine Carcinosarcoma;Peritoneal Mesothelioma;Atypical Meningioma;Endometrial Undifferentiated Carcinoma;PANCREATIC CANCER, SUSCEPTIBILITY TO, 2;nasopharyngeal squamous cell carcinoma;hairy cell leukemia;Conjunctival Melanoma;Undifferentiated Ovarian Carcinoma;lobular breast carcinoma;diffuse gastric adenocarcinoma;Ovarian Endometrioid Adenocarcinoma;Medulloblastoma;Lung carcinoma;colon adenocarcinoma;Thymic Carcinoma;GLIOMA SUSCEPTIBILITY 3;Familial prostate cancer;WILMS TUMOR 1;Medulloblastoma;PANCREATIC CANCER, SUSCEPTIBILITY TO, 2;FANCONI ANEMIA, COMPLEMENTATION GROUP D1;Breast Cancer;Prostate Cancer;BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2;GLIOMA SUSCEPTIBILITY 3"
BRCA2_aug7,BRCA2,"squamous cell lung carcinoma;neoplasm of mature B-cells;Glioma;Meningothelial Meningioma;Esophageal carcinoma;mesonephric adenocarcinoma;Familial pancreatic carcinoma;large cell lung carcinoma;gastric adenocarcinoma;Bladder Adenocarcinoma;Lung adenocarcinoma;pulmonary blastoma;WILMS TUMOR 1;Chordoma;Melanoma;Anal Squamous Cell Carcinoma;Ovarian Carcinosarcoma;breast ductal adenocarcinoma;Anaplastic Malignant Meningioma;Hepatobiliary Neoplasm;nodular melanoma;Breast Cancer;adenosquamous lung carcinoma;undifferentiated pleomorphic sarcoma;Chronic lymphocytic leukemia;colorectal adenocarcinoma;non-small cell lung carcinoma;Uveal melanoma;pseudomyxoma peritonei;metaplastic breast carcinoma;Merkel cell skin cancer;Esophageal Squamous Cell Carcinoma;Pancreatic Acinar Cell Carcinoma;Parotid Gland Adenoid Cystic Carcinoma;Ovarian Choriocarcinoma;Breast Carcinoma by Gene Expression Profile;Hodgkins lymphoma;Burkitts lymphoma;Breast carcinoma;ovarian serous adenocarcinoma;Acute myeloid leukemia;Acute lymphoblastic leukemia;Sarcomatoid Carcinoma;T-cell acute lymphoblastic leukemia;ND;Atypical endometrial hyperplasia;cecum adenocarcinoma;Ovarian neoplasm;Hereditary breast and/or ovarian cancer syndrome;ganglioglioma;salivary gland squamous cell carcinoma;Malignant Laryngeal Neoplasm;Bladder Small Cell Neuroendocrine Carcinoma;adrenal cortex carcinoma;Familial colorectal cancer Type X;Laryngeal squamous cell carcinoma;Invasive Breast Carcinoma;Prostate Cancer;Thymoma Type AB;Pleural Biphasic Mesothelioma;Extramammary Paget Disease;colon carcinoma;FANCONI ANEMIA COMPLEMENTATION GROUP D TYPE 1;Fanconi anemia;BRCA2 associated CANCER;Small cell lung carcinoma;skin carcinoma;Gallbladder Small Cell Neuroendocrine Carcinoma;Anaplastic astrocytoma;Hereditary breast cancer;urothelial carcinoma;Rhabdoid Meningioma;oral squamous cell carcinoma;Vulvar Squamous Cell Carcinoma;Papillary thyroid carcinoma;Brain Stem Glioblastoma;cervical squamous cell carcinoma;Undifferentiated Pancreatic Carcinoma with Osteoclast-Like Giant Cells;BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2;pancreatic neuroendocrine tumor;Malignant Ovarian Mixed Epithelial Tumor;pancreatic carcinoma;Testicular Sertoli Cell Tumor;vulvar intraepithelial neoplasia;Prostate Small Cell Carcinoma;Anal Melanoma;Benign Thyroid Gland Neoplasm;Ampulla of Vater Carcinoma;Transitional Meningioma;endometrial serous adenocarcinoma;Mixed Lobular and Ductal Breast Carcinoma;Poorly Differentiated Thyroid Gland Carcinoma;Renal cell carcinoma;testicular seminoma;Pleural Mesothelioma;Inherited cancer-predisposing syndrome due to biallelic BRCA2 mutations;gastric carcinoma;pharyngeal squamous cell carcinoma;Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation;Small Intestinal Diffuse Large B-Cell Lymphoma;diffuse large B-cell lymphoma;adrenocortical adenoma;prostate carcinoma;Chronic myelomonocytic leukemia;Thyroid Gland Oncocytic Follicular Carcinoma;Digestive System Carcinoma;Cervical Adenosquamous Carcinoma;Fibrous Meningioma;Gallbladder Adenocarcinoma;bile duct carcinoma;MANTLE CELL LYMPHOMA;Alveolar rhabdomyosarcoma;ovarian clear cell adenocarcinoma;Hepatocellular Carcinoma;head and neck squamous cell carcinoma;Placental Choriocarcinoma;bronchoalveolar adenocarcinoma;Cervical Small Cell Carcinoma;liposarcoma;Appendix Adenocarcinoma;Pancreatic adenocarcinoma;renal carcinoma;bladder transitional cell carcinoma;Duodenal Adenocarcinoma;unspecified peripheral T-cell lymphoma;Fibrolamellar Carcinoma;embryonal rhabdomyosarcoma;Papillary renal cell carcinoma;angiosarcoma;HER2 positive breast carcinoma;Angiomatous Meningioma;Ileal Neuroendocrine Tumor G1;amelanotic skin melanoma;Chordoid Meningioma;ovarian mucinous adenocarcinoma;Adamantinomatous Craniopharyngioma;leiomyosarcoma;ovarian carcinoma;Cholangiocarcinoma;lymphoid neoplasm;pancreatic neoplasm;Nephroblastoma;ovarian teratoma;Endometrial Endometrioid Adenocarcinoma;soft tissue sarcoma;kidney neoplasm;Pleural Epithelioid Mesothelioma;Endometrial carcinoma;Thyroid Gland Undifferentiated (Anaplastic) Carcinoma;Anaplastic oligoastrocytoma;Unclassified Renal Cell Carcinoma;Appendix Goblet Cell Carcinoid;Anaplastic oligodendroglioma;B-cell acute lymphoblastic leukemia;malignant epithelioid mesothelioma;brain glioblastoma;Multiple myeloma;Well-differentiated liposarcoma;thyroid neoplasm;Primary Peritoneal Serous Adenocarcinoma;cutaneous melanoma;gastric intestinal type adenocarcinoma;Sinonasal Undifferentiated Carcinoma;skin appendage carcinoma;Clear cell renal carcinoma;rectal adenocarcinoma;OSTEOSARCOMA;Lung carcinoid tumor;Gastric Adenoma;Neuroblastoma;thyroid carcinoma;Secretory Meningioma;Astrocytoma;prostate adenocarcinoma;FANCONI ANEMIA, COMPLEMENTATION GROUP D1;Esophageal adenocarcinoma;Uterine Carcinosarcoma;Peritoneal Mesothelioma;Atypical Meningioma;Endometrial Undifferentiated Carcinoma;PANCREATIC CANCER, SUSCEPTIBILITY TO, 2;nasopharyngeal squamous cell carcinoma;hairy cell leukemia;Conjunctival Melanoma;Undifferentiated Ovarian Carcinoma;lobular breast carcinoma;diffuse gastric adenocarcinoma;Ovarian Endometrioid Adenocarcinoma;Medulloblastoma;Lung carcinoma;colon adenocarcinoma;Thymic Carcinoma;GLIOMA SUSCEPTIBILITY 3;Familial prostate cancer;WILMS TUMOR 1;Medulloblastoma;PANCREATIC CANCER, SUSCEPTIBILITY TO, 2;FANCONI ANEMIA, COMPLEMENTATION GROUP D1;Breast Cancer;Prostate Cancer;BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2;GLIOMA SUSCEPTIBILITY 3"
BRCA2_aug8,BRCA2,"squamous cell lung carcinoma;neoplasm of mature B-cells;Glioma;Meningothelial Meningioma;Esophageal carcinoma;mesonephric adenocarcinoma;Familial pancreatic carcinoma;large cell lung carcinoma;gastric adenocarcinoma;Bladder Adenocarcinoma;Lung adenocarcinoma;pulmonary blastoma;WILMS TUMOR 1;Chordoma;Melanoma;Anal Squamous Cell Carcinoma;Ovarian Carcinosarcoma;breast ductal adenocarcinoma;Anaplastic Malignant Meningioma;Hepatobiliary Neoplasm;nodular melanoma;Breast Cancer;adenosquamous lung carcinoma;undifferentiated pleomorphic sarcoma;Chronic lymphocytic leukemia;colorectal adenocarcinoma;non-small cell lung carcinoma;Uveal melanoma;pseudomyxoma peritonei;metaplastic breast carcinoma;Merkel cell skin cancer;Esophageal Squamous Cell Carcinoma;Pancreatic Acinar Cell Carcinoma;Parotid Gland Adenoid Cystic Carcinoma;Ovarian Choriocarcinoma;Breast Carcinoma by Gene Expression Profile;Hodgkins lymphoma;Burkitts lymphoma;Breast carcinoma;ovarian serous adenocarcinoma;Acute myeloid leukemia;Acute lymphoblastic leukemia;Sarcomatoid Carcinoma;T-cell acute lymphoblastic leukemia;ND;Atypical endometrial hyperplasia;cecum adenocarcinoma;Ovarian neoplasm;Hereditary breast and/or ovarian cancer syndrome;ganglioglioma;salivary gland squamous cell carcinoma;Malignant Laryngeal Neoplasm;Bladder Small Cell Neuroendocrine Carcinoma;adrenal cortex carcinoma;Familial colorectal cancer Type X;Laryngeal squamous cell carcinoma;Invasive Breast Carcinoma;Prostate Cancer;Thymoma Type AB;Pleural Biphasic Mesothelioma;Extramammary Paget Disease;colon carcinoma;FANCONI ANEMIA COMPLEMENTATION GROUP D TYPE 1;Fanconi anemia;BRCA2 associated CANCER;Small cell lung carcinoma;skin carcinoma;Gallbladder Small Cell Neuroendocrine Carcinoma;Anaplastic astrocytoma;Hereditary breast cancer;urothelial carcinoma;Rhabdoid Meningioma;oral squamous cell carcinoma;Vulvar Squamous Cell Carcinoma;Papillary thyroid carcinoma;Brain Stem Glioblastoma;cervical squamous cell carcinoma;Undifferentiated Pancreatic Carcinoma with Osteoclast-Like Giant Cells;BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2;pancreatic neuroendocrine tumor;Malignant Ovarian Mixed Epithelial Tumor;pancreatic carcinoma;Testicular Sertoli Cell Tumor;vulvar intraepithelial neoplasia;Prostate Small Cell Carcinoma;Anal Melanoma;Benign Thyroid Gland Neoplasm;Ampulla of Vater Carcinoma;Transitional Meningioma;endometrial serous adenocarcinoma;Mixed Lobular and Ductal Breast Carcinoma;Poorly Differentiated Thyroid Gland Carcinoma;Renal cell carcinoma;testicular seminoma;Pleural Mesothelioma;Inherited cancer-predisposing syndrome due to biallelic BRCA2 mutations;gastric carcinoma;pharyngeal squamous cell carcinoma;Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation;Small Intestinal Diffuse Large B-Cell Lymphoma;diffuse large B-cell lymphoma;adrenocortical adenoma;prostate carcinoma;Chronic myelomonocytic leukemia;Thyroid Gland Oncocytic Follicular Carcinoma;Digestive System Carcinoma;Cervical Adenosquamous Carcinoma;Fibrous Meningioma;Gallbladder Adenocarcinoma;bile duct carcinoma;MANTLE CELL LYMPHOMA;Alveolar rhabdomyosarcoma;ovarian clear cell adenocarcinoma;Hepatocellular Carcinoma;head and neck squamous cell carcinoma;Placental Choriocarcinoma;bronchoalveolar adenocarcinoma;Cervical Small Cell Carcinoma;liposarcoma;Appendix Adenocarcinoma;Pancreatic adenocarcinoma;renal carcinoma;bladder transitional cell carcinoma;Duodenal Adenocarcinoma;unspecified peripheral T-cell lymphoma;Fibrolamellar Carcinoma;embryonal rhabdomyosarcoma;Papillary renal cell carcinoma;angiosarcoma;HER2 positive breast carcinoma;Angiomatous Meningioma;Ileal Neuroendocrine Tumor G1;amelanotic skin melanoma;Chordoid Meningioma;ovarian mucinous adenocarcinoma;Adamantinomatous Craniopharyngioma;leiomyosarcoma;ovarian carcinoma;Cholangiocarcinoma;lymphoid neoplasm;pancreatic neoplasm;Nephroblastoma;ovarian teratoma;Endometrial Endometrioid Adenocarcinoma;soft tissue sarcoma;kidney neoplasm;Pleural Epithelioid Mesothelioma;Endometrial carcinoma;Thyroid Gland Undifferentiated (Anaplastic) Carcinoma;Anaplastic oligoastrocytoma;Unclassified Renal Cell Carcinoma;Appendix Goblet Cell Carcinoid;Anaplastic oligodendroglioma;B-cell acute lymphoblastic leukemia;malignant epithelioid mesothelioma;brain glioblastoma;Multiple myeloma;Well-differentiated liposarcoma;thyroid neoplasm;Primary Peritoneal Serous Adenocarcinoma;cutaneous melanoma;gastric intestinal type adenocarcinoma;Sinonasal Undifferentiated Carcinoma;skin appendage carcinoma;Clear cell renal carcinoma;rectal adenocarcinoma;OSTEOSARCOMA;Lung carcinoid tumor;Gastric Adenoma;Neuroblastoma;thyroid carcinoma;Secretory Meningioma;Astrocytoma;prostate adenocarcinoma;FANCONI ANEMIA, COMPLEMENTATION GROUP D1;Esophageal adenocarcinoma;Uterine Carcinosarcoma;Peritoneal Mesothelioma;Atypical Meningioma;Endometrial Undifferentiated Carcinoma;PANCREATIC CANCER, SUSCEPTIBILITY TO, 2;nasopharyngeal squamous cell carcinoma;hairy cell leukemia;Conjunctival Melanoma;Undifferentiated Ovarian Carcinoma;lobular breast carcinoma;diffuse gastric adenocarcinoma;Ovarian Endometrioid Adenocarcinoma;Medulloblastoma;Lung carcinoma;colon adenocarcinoma;Thymic Carcinoma;GLIOMA SUSCEPTIBILITY 3;Familial prostate cancer;WILMS TUMOR 1;Medulloblastoma;PANCREATIC CANCER, SUSCEPTIBILITY TO, 2;FANCONI ANEMIA, COMPLEMENTATION GROUP D1;Breast Cancer;Prostate Cancer;BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2;GLIOMA SUSCEPTIBILITY 3"
BRCA2_aug9,BRCA2,"squamous cell lung carcinoma;neoplasm of mature B-cells;Glioma;Meningothelial Meningioma;Esophageal carcinoma;mesonephric adenocarcinoma;Familial pancreatic carcinoma;large cell lung carcinoma;gastric adenocarcinoma;Bladder Adenocarcinoma;Lung adenocarcinoma;pulmonary blastoma;WILMS TUMOR 1;Chordoma;Melanoma;Anal Squamous Cell Carcinoma;Ovarian Carcinosarcoma;breast ductal adenocarcinoma;Anaplastic Malignant Meningioma;Hepatobiliary Neoplasm;nodular melanoma;Breast Cancer;adenosquamous lung carcinoma;undifferentiated pleomorphic sarcoma;Chronic lymphocytic leukemia;colorectal adenocarcinoma;non-small cell lung carcinoma;Uveal melanoma;pseudomyxoma peritonei;metaplastic breast carcinoma;Merkel cell skin cancer;Esophageal Squamous Cell Carcinoma;Pancreatic Acinar Cell Carcinoma;Parotid Gland Adenoid Cystic Carcinoma;Ovarian Choriocarcinoma;Breast Carcinoma by Gene Expression Profile;Hodgkins lymphoma;Burkitts lymphoma;Breast carcinoma;ovarian serous adenocarcinoma;Acute myeloid leukemia;Acute lymphoblastic leukemia;Sarcomatoid Carcinoma;T-cell acute lymphoblastic leukemia;ND;Atypical endometrial hyperplasia;cecum adenocarcinoma;Ovarian neoplasm;Hereditary breast and/or ovarian cancer syndrome;ganglioglioma;salivary gland squamous cell carcinoma;Malignant Laryngeal Neoplasm;Bladder Small Cell Neuroendocrine Carcinoma;adrenal cortex carcinoma;Familial colorectal cancer Type X;Laryngeal squamous cell carcinoma;Invasive Breast Carcinoma;Prostate Cancer;Thymoma Type AB;Pleural Biphasic Mesothelioma;Extramammary Paget Disease;colon carcinoma;FANCONI ANEMIA COMPLEMENTATION GROUP D TYPE 1;Fanconi anemia;BRCA2 associated CANCER;Small cell lung carcinoma;skin carcinoma;Gallbladder Small Cell Neuroendocrine Carcinoma;Anaplastic astrocytoma;Hereditary breast cancer;urothelial carcinoma;Rhabdoid Meningioma;oral squamous cell carcinoma;Vulvar Squamous Cell Carcinoma;Papillary thyroid carcinoma;Brain Stem Glioblastoma;cervical squamous cell carcinoma;Undifferentiated Pancreatic Carcinoma with Osteoclast-Like Giant Cells;BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2;pancreatic neuroendocrine tumor;Malignant Ovarian Mixed Epithelial Tumor;pancreatic carcinoma;Testicular Sertoli Cell Tumor;vulvar intraepithelial neoplasia;Prostate Small Cell Carcinoma;Anal Melanoma;Benign Thyroid Gland Neoplasm;Ampulla of Vater Carcinoma;Transitional Meningioma;endometrial serous adenocarcinoma;Mixed Lobular and Ductal Breast Carcinoma;Poorly Differentiated Thyroid Gland Carcinoma;Renal cell carcinoma;testicular seminoma;Pleural Mesothelioma;Inherited cancer-predisposing syndrome due to biallelic BRCA2 mutations;gastric carcinoma;pharyngeal squamous cell carcinoma;Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation;Small Intestinal Diffuse Large B-Cell Lymphoma;diffuse large B-cell lymphoma;adrenocortical adenoma;prostate carcinoma;Chronic myelomonocytic leukemia;Thyroid Gland Oncocytic Follicular Carcinoma;Digestive System Carcinoma;Cervical Adenosquamous Carcinoma;Fibrous Meningioma;Gallbladder Adenocarcinoma;bile duct carcinoma;MANTLE CELL LYMPHOMA;Alveolar rhabdomyosarcoma;ovarian clear cell adenocarcinoma;Hepatocellular Carcinoma;head and neck squamous cell carcinoma;Placental Choriocarcinoma;bronchoalveolar adenocarcinoma;Cervical Small Cell Carcinoma;liposarcoma;Appendix Adenocarcinoma;Pancreatic adenocarcinoma;renal carcinoma;bladder transitional cell carcinoma;Duodenal Adenocarcinoma;unspecified peripheral T-cell lymphoma;Fibrolamellar Carcinoma;embryonal rhabdomyosarcoma;Papillary renal cell carcinoma;angiosarcoma;HER2 positive breast carcinoma;Angiomatous Meningioma;Ileal Neuroendocrine Tumor G1;amelanotic skin melanoma;Chordoid Meningioma;ovarian mucinous adenocarcinoma;Adamantinomatous Craniopharyngioma;leiomyosarcoma;ovarian carcinoma;Cholangiocarcinoma;lymphoid neoplasm;pancreatic neoplasm;Nephroblastoma;ovarian teratoma;Endometrial Endometrioid Adenocarcinoma;soft tissue sarcoma;kidney neoplasm;Pleural Epithelioid Mesothelioma;Endometrial carcinoma;Thyroid Gland Undifferentiated (Anaplastic) Carcinoma;Anaplastic oligoastrocytoma;Unclassified Renal Cell Carcinoma;Appendix Goblet Cell Carcinoid;Anaplastic oligodendroglioma;B-cell acute lymphoblastic leukemia;malignant epithelioid mesothelioma;brain glioblastoma;Multiple myeloma;Well-differentiated liposarcoma;thyroid neoplasm;Primary Peritoneal Serous Adenocarcinoma;cutaneous melanoma;gastric intestinal type adenocarcinoma;Sinonasal Undifferentiated Carcinoma;skin appendage carcinoma;Clear cell renal carcinoma;rectal adenocarcinoma;OSTEOSARCOMA;Lung carcinoid tumor;Gastric Adenoma;Neuroblastoma;thyroid carcinoma;Secretory Meningioma;Astrocytoma;prostate adenocarcinoma;FANCONI ANEMIA, COMPLEMENTATION GROUP D1;Esophageal adenocarcinoma;Uterine Carcinosarcoma;Peritoneal Mesothelioma;Atypical Meningioma;Endometrial Undifferentiated Carcinoma;PANCREATIC CANCER, SUSCEPTIBILITY TO, 2;nasopharyngeal squamous cell carcinoma;hairy cell leukemia;Conjunctival Melanoma;Undifferentiated Ovarian Carcinoma;lobular breast carcinoma;diffuse gastric adenocarcinoma;Ovarian Endometrioid Adenocarcinoma;Medulloblastoma;Lung carcinoma;colon adenocarcinoma;Thymic Carcinoma;GLIOMA SUSCEPTIBILITY 3;Familial prostate cancer;WILMS TUMOR 1;Medulloblastoma;PANCREATIC CANCER, SUSCEPTIBILITY TO, 2;FANCONI ANEMIA, COMPLEMENTATION GROUP D1;Breast Cancer;Prostate Cancer;BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2;GLIOMA SUSCEPTIBILITY 3"
ATM,ATM,"Lung carcinoid tumor;cecum adenocarcinoma;Lung Sclerosing Hemangioma;Clear Cell Meningioma;testicular seminoma;Brain Stem Glioblastoma;bile duct carcinoma;Testicular Non-Seminomatous Germ Cell Tumor;gastric intestinal type adenocarcinoma;brain glioblastoma;Mixed Lobular and Ductal Breast Carcinoma;ganglioglioma;Malignant Pancreatic Neoplasm;schwannoma;kidney neoplasm;follicular thyroid carcinoma;endometrial serous adenocarcinoma;Endometrial Undifferentiated Carcinoma;T-cell acute lymphoblastic leukemia;large cell lung carcinoma;prostate carcinoma;cervical carcinoma;Breast Carcinoma by Gene Expression Profile;Anaplastic oligoastrocytoma;pancreatic neuroendocrine tumor;head and neck squamous cell carcinoma;Small Intestinal Tubulovillous Adenoma;T-cell prolymphocytic leukemia;gastric carcinoma;ATAXIA-TELANGIECTASIA;cutaneous melanoma;Non-Functional Pancreatic Neuroendocrine Tumor;Kidney Oncocytoma;Thyroid Gland Oncocytic Follicular Carcinoma;Clear cell renal carcinoma;Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive;Primary Peritoneal Serous Adenocarcinoma;plasmacytoma;skin carcinoma;Astrocytoma;pseudomyxoma peritonei;HER2 positive breast carcinoma;neoplasm of mature B-cells;MANTLE CELL LYMPHOMA;Ovarian Granulosa Cell Tumor;Acute myeloid leukemia;Lung adenocarcinoma;undifferentiated pleomorphic sarcoma;Atypical endometrial hyperplasia;OSTEOSARCOMA;Anal Squamous Cell Carcinoma;Lung carcinoma;Hepatobiliary Neoplasm;Microcystic Meningioma;Oligodendroglioma;Breast Diffuse Large B-Cell Lymphoma;endometrium adenocarcinoma;Thymic Carcinoma;nasopharyngeal squamous cell carcinoma;Dedifferentiated liposarcoma;hairy cell leukemia;Dysplasia in Ulcerative Colitis;Malignant Ovarian Mixed Epithelial Tumor;Glioma;thyroid carcinoma;Poorly Differentiated Thyroid Gland Carcinoma;POLYCYTHEMIA VERA;Conjunctival Melanoma;pancreatic carcinoma;rectal adenocarcinoma;Gastric Mantle Cell Lymphoma;lymphoid neoplasm;Pleural Mesothelioma;Thyroid Gland Undifferentiated (Anaplastic) Carcinoma;small intestinal adenocarcinoma;ovarian serous adenocarcinoma;ATAXIA-TELANGIECTASIA VARIANT;Familial colorectal cancer Type X;Laryngeal squamous cell carcinoma;ND;Breast Cancer;thyroid neoplasm;soft tissue sarcoma;colorectal adenocarcinoma;Lung sarcomatoid carcinoma;Chronic lymphocytic leukemia;bladder transitional cell carcinoma;Anaplastic Malignant Meningioma;breast ductal adenocarcinoma;Testicular Leydig Cell Tumor;Anaplastic oligodendroglioma;nodular melanoma;Alveolar rhabdomyosarcoma;Extramammary Paget Disease;Choroid plexus papilloma;unspecified peripheral T-cell lymphoma;Pancreatic Acinar Cell Carcinoma;Digestive System Carcinoma;diffuse large B-cell lymphoma;Merkel cell skin cancer;Meningothelial Meningioma;Fibrous Meningioma;Endometrial stromal sarcoma;Prostate Small Cell Carcinoma;Anaplastic astrocytoma;Hodgkins lymphoma;adrenal cortex carcinoma;Placental Choriocarcinoma;Lung Inflammatory Myofibroblastic Tumor;Splenic Mantle Cell Lymphoma;anaplastic large cell lymphoma;adenosquamous lung carcinoma;ovarian teratoma;Chronic myelomonocytic leukemia;Vaginal Melanoma;Rhabdoid Meningioma;Ulcerative colitis;ATAXIA-TELANGIECTASIA;prostate adenocarcinoma;Tracheal Adenoid Cystic Carcinoma;ovarian clear cell adenocarcinoma;Well-differentiated liposarcoma;marginal zone B-cell lymphoma;Adenoid Cystic Breast Carcinoma;squamous cell lung carcinoma;non-small cell lung carcinoma;Atypical Meningioma;Hepatocellular Carcinoma;cervical squamous cell carcinoma;PEComa;Parotid Gland Adenoid Cystic Carcinoma;Chronic Eosinophilic Leukemia, Not Otherwise Specified;Malignant Mesothelioma;gallbladder carcinoma;ATM-related cancer;embryonal rhabdomyosarcoma;Bladder Small Cell Neuroendocrine Carcinoma;Chronic neutrophilic leukemia;Sarcomatoid Carcinoma;metaplastic breast carcinoma;oral squamous cell carcinoma;urothelial carcinoma;Neoplasm;pulmonary blastoma;Chronic myelogenous leukemia;Pleural Epithelioid Mesothelioma;Appendix Adenocarcinoma;Borderline Ovarian Mucinous Tumor;B-cell acute lymphoblastic leukemia;Renal cell carcinoma;Langerhans cell histiocytosis;Colorectal adenoma;Gastric Adenoma;Testicular Yolk Sac Tumor;Ampulla of Vater Carcinoma;Burkitts lymphoma;non-functioning pituitary adenoma;Ovarian Endometrioid Adenocarcinoma;Breast carcinoma;ovarian mucinous adenocarcinoma;Esophageal carcinoma;Gastric Neuroendocrine Tumor G1;Melanoma;Angioimmunoblastic T-cell lymphoma;Follicular Variant Thyroid Gland Papillary Carcinoma;Pancreatic adenocarcinoma;Unclassified Renal Cell Carcinoma;Benign Smooth Muscle Neoplasm;gastric adenocarcinoma;Papillary renal cell carcinoma;blastic plasmacytoid dendritic cell neoplasm;Spinal Cord Astrocytoma;adrenocortical adenoma;Duodenal Adenocarcinoma;MYELODYSPLASTIC SYNDROME;bronchoalveolar adenocarcinoma;Parathyroid Gland Carcinoma;cervical adenocarcinoma;Small cell lung carcinoma;skin appendage carcinoma;ovarian carcinoma;Multiple myeloma;Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation;pharyngeal squamous cell carcinoma;ovarian adenocarcinoma;Eccrine porocarcinoma;Salivary Gland Carcinoma ex Pleomorphic Adenoma;leiomyosarcoma;renal carcinoma;Uterine Carcinosarcoma;MANTLE CELL LYMPHOMA;Endometrial Clear Cell Adenocarcinoma;ATAXIA-TELANGIECTASIA;Chordoid Meningioma;Chromophobe renal cell carcinoma;Gallbladder Adenocarcinoma;angiosarcoma;colon adenocarcinoma;lobular breast carcinoma;Esophageal adenocarcinoma;Transitional Meningioma;breast adenosis;B-cell chronic lymphocytic leukemia;Endometrial Endometrioid Adenocarcinoma;Esophageal Squamous Cell Carcinoma;Endometrial carcinoma;Papillary thyroid carcinoma;Familial prostate cancer;Extraskeletal Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor;colonic neoplasm;amelanotic skin melanoma;pancreatic neoplasm;Acute lymphoblastic leukemia;Gallbladder Small Cell Neuroendocrine Carcinoma;diffuse gastric adenocarcinoma;Breast Cancer;ATAXIA-TELANGIECTASIA"
ATM_aug1,ATM,"Lung carcinoid tumor;cecum adenocarcinoma;Lung Sclerosing Hemangioma;Clear Cell Meningioma;testicular seminoma;Brain Stem Glioblastoma;bile duct carcinoma;Testicular Non-Seminomatous Germ Cell Tumor;gastric intestinal type adenocarcinoma;brain glioblastoma;Mixed Lobular and Ductal Breast Carcinoma;ganglioglioma;Malignant Pancreatic Neoplasm;schwannoma;kidney neoplasm;follicular thyroid carcinoma;endometrial serous adenocarcinoma;Endometrial Undifferentiated Carcinoma;T-cell acute lymphoblastic leukemia;large cell lung carcinoma;prostate carcinoma;cervical carcinoma;Breast Carcinoma by Gene Expression Profile;Anaplastic oligoastrocytoma;pancreatic neuroendocrine tumor;head and neck squamous cell carcinoma;Small Intestinal Tubulovillous Adenoma;T-cell prolymphocytic leukemia;gastric carcinoma;ATAXIA-TELANGIECTASIA;cutaneous melanoma;Non-Functional Pancreatic Neuroendocrine Tumor;Kidney Oncocytoma;Thyroid Gland Oncocytic Follicular Carcinoma;Clear cell renal carcinoma;Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive;Primary Peritoneal Serous Adenocarcinoma;plasmacytoma;skin carcinoma;Astrocytoma;pseudomyxoma peritonei;HER2 positive breast carcinoma;neoplasm of mature B-cells;MANTLE CELL LYMPHOMA;Ovarian Granulosa Cell Tumor;Acute myeloid leukemia;Lung adenocarcinoma;undifferentiated pleomorphic sarcoma;Atypical endometrial hyperplasia;OSTEOSARCOMA;Anal Squamous Cell Carcinoma;Lung carcinoma;Hepatobiliary Neoplasm;Microcystic Meningioma;Oligodendroglioma;Breast Diffuse Large B-Cell Lymphoma;endometrium adenocarcinoma;Thymic Carcinoma;nasopharyngeal squamous cell carcinoma;Dedifferentiated liposarcoma;hairy cell leukemia;Dysplasia in Ulcerative Colitis;Malignant Ovarian Mixed Epithelial Tumor;Glioma;thyroid carcinoma;Poorly Differentiated Thyroid Gland Carcinoma;POLYCYTHEMIA VERA;Conjunctival Melanoma;pancreatic carcinoma;rectal adenocarcinoma;Gastric Mantle Cell Lymphoma;lymphoid neoplasm;Pleural Mesothelioma;Thyroid Gland Undifferentiated (Anaplastic) Carcinoma;small intestinal adenocarcinoma;ovarian serous adenocarcinoma;ATAXIA-TELANGIECTASIA VARIANT;Familial colorectal cancer Type X;Laryngeal squamous cell carcinoma;ND;Breast Cancer;thyroid neoplasm;soft tissue sarcoma;colorectal adenocarcinoma;Lung sarcomatoid carcinoma;Chronic lymphocytic leukemia;bladder transitional cell carcinoma;Anaplastic Malignant Meningioma;breast ductal adenocarcinoma;Testicular Leydig Cell Tumor;Anaplastic oligodendroglioma;nodular melanoma;Alveolar rhabdomyosarcoma;Extramammary Paget Disease;Choroid plexus papilloma;unspecified peripheral T-cell lymphoma;Pancreatic Acinar Cell Carcinoma;Digestive System Carcinoma;diffuse large B-cell lymphoma;Merkel cell skin cancer;Meningothelial Meningioma;Fibrous Meningioma;Endometrial stromal sarcoma;Prostate Small Cell Carcinoma;Anaplastic astrocytoma;Hodgkins lymphoma;adrenal cortex carcinoma;Placental Choriocarcinoma;Lung Inflammatory Myofibroblastic Tumor;Splenic Mantle Cell Lymphoma;anaplastic large cell lymphoma;adenosquamous lung carcinoma;ovarian teratoma;Chronic myelomonocytic leukemia;Vaginal Melanoma;Rhabdoid Meningioma;Ulcerative colitis;ATAXIA-TELANGIECTASIA;prostate adenocarcinoma;Tracheal Adenoid Cystic Carcinoma;ovarian clear cell adenocarcinoma;Well-differentiated liposarcoma;marginal zone B-cell lymphoma;Adenoid Cystic Breast Carcinoma;squamous cell lung carcinoma;non-small cell lung carcinoma;Atypical Meningioma;Hepatocellular Carcinoma;cervical squamous cell carcinoma;PEComa;Parotid Gland Adenoid Cystic Carcinoma;Chronic Eosinophilic Leukemia, Not Otherwise Specified;Malignant Mesothelioma;gallbladder carcinoma;ATM-related cancer;embryonal rhabdomyosarcoma;Bladder Small Cell Neuroendocrine Carcinoma;Chronic neutrophilic leukemia;Sarcomatoid Carcinoma;metaplastic breast carcinoma;oral squamous cell carcinoma;urothelial carcinoma;Neoplasm;pulmonary blastoma;Chronic myelogenous leukemia;Pleural Epithelioid Mesothelioma;Appendix Adenocarcinoma;Borderline Ovarian Mucinous Tumor;B-cell acute lymphoblastic leukemia;Renal cell carcinoma;Langerhans cell histiocytosis;Colorectal adenoma;Gastric Adenoma;Testicular Yolk Sac Tumor;Ampulla of Vater Carcinoma;Burkitts lymphoma;non-functioning pituitary adenoma;Ovarian Endometrioid Adenocarcinoma;Breast carcinoma;ovarian mucinous adenocarcinoma;Esophageal carcinoma;Gastric Neuroendocrine Tumor G1;Melanoma;Angioimmunoblastic T-cell lymphoma;Follicular Variant Thyroid Gland Papillary Carcinoma;Pancreatic adenocarcinoma;Unclassified Renal Cell Carcinoma;Benign Smooth Muscle Neoplasm;gastric adenocarcinoma;Papillary renal cell carcinoma;blastic plasmacytoid dendritic cell neoplasm;Spinal Cord Astrocytoma;adrenocortical adenoma;Duodenal Adenocarcinoma;MYELODYSPLASTIC SYNDROME;bronchoalveolar adenocarcinoma;Parathyroid Gland Carcinoma;cervical adenocarcinoma;Small cell lung carcinoma;skin appendage carcinoma;ovarian carcinoma;Multiple myeloma;Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation;pharyngeal squamous cell carcinoma;ovarian adenocarcinoma;Eccrine porocarcinoma;Salivary Gland Carcinoma ex Pleomorphic Adenoma;leiomyosarcoma;renal carcinoma;Uterine Carcinosarcoma;MANTLE CELL LYMPHOMA;Endometrial Clear Cell Adenocarcinoma;ATAXIA-TELANGIECTASIA;Chordoid Meningioma;Chromophobe renal cell carcinoma;Gallbladder Adenocarcinoma;angiosarcoma;colon adenocarcinoma;lobular breast carcinoma;Esophageal adenocarcinoma;Transitional Meningioma;breast adenosis;B-cell chronic lymphocytic leukemia;Endometrial Endometrioid Adenocarcinoma;Esophageal Squamous Cell Carcinoma;Endometrial carcinoma;Papillary thyroid carcinoma;Familial prostate cancer;Extraskeletal Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor;colonic neoplasm;amelanotic skin melanoma;pancreatic neoplasm;Acute lymphoblastic leukemia;Gallbladder Small Cell Neuroendocrine Carcinoma;diffuse gastric adenocarcinoma;Breast Cancer;ATAXIA-TELANGIECTASIA"
ATM_aug2,ATM,"Lung carcinoid tumor;cecum adenocarcinoma;Lung Sclerosing Hemangioma;Clear Cell Meningioma;testicular seminoma;Brain Stem Glioblastoma;bile duct carcinoma;Testicular Non-Seminomatous Germ Cell Tumor;gastric intestinal type adenocarcinoma;brain glioblastoma;Mixed Lobular and Ductal Breast Carcinoma;ganglioglioma;Malignant Pancreatic Neoplasm;schwannoma;kidney neoplasm;follicular thyroid carcinoma;endometrial serous adenocarcinoma;Endometrial Undifferentiated Carcinoma;T-cell acute lymphoblastic leukemia;large cell lung carcinoma;prostate carcinoma;cervical carcinoma;Breast Carcinoma by Gene Expression Profile;Anaplastic oligoastrocytoma;pancreatic neuroendocrine tumor;head and neck squamous cell carcinoma;Small Intestinal Tubulovillous Adenoma;T-cell prolymphocytic leukemia;gastric carcinoma;ATAXIA-TELANGIECTASIA;cutaneous melanoma;Non-Functional Pancreatic Neuroendocrine Tumor;Kidney Oncocytoma;Thyroid Gland Oncocytic Follicular Carcinoma;Clear cell renal carcinoma;Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive;Primary Peritoneal Serous Adenocarcinoma;plasmacytoma;skin carcinoma;Astrocytoma;pseudomyxoma peritonei;HER2 positive breast carcinoma;neoplasm of mature B-cells;MANTLE CELL LYMPHOMA;Ovarian Granulosa Cell Tumor;Acute myeloid leukemia;Lung adenocarcinoma;undifferentiated pleomorphic sarcoma;Atypical endometrial hyperplasia;OSTEOSARCOMA;Anal Squamous Cell Carcinoma;Lung carcinoma;Hepatobiliary Neoplasm;Microcystic Meningioma;Oligodendroglioma;Breast Diffuse Large B-Cell Lymphoma;endometrium adenocarcinoma;Thymic Carcinoma;nasopharyngeal squamous cell carcinoma;Dedifferentiated liposarcoma;hairy cell leukemia;Dysplasia in Ulcerative Colitis;Malignant Ovarian Mixed Epithelial Tumor;Glioma;thyroid carcinoma;Poorly Differentiated Thyroid Gland Carcinoma;POLYCYTHEMIA VERA;Conjunctival Melanoma;pancreatic carcinoma;rectal adenocarcinoma;Gastric Mantle Cell Lymphoma;lymphoid neoplasm;Pleural Mesothelioma;Thyroid Gland Undifferentiated (Anaplastic) Carcinoma;small intestinal adenocarcinoma;ovarian serous adenocarcinoma;ATAXIA-TELANGIECTASIA VARIANT;Familial colorectal cancer Type X;Laryngeal squamous cell carcinoma;ND;Breast Cancer;thyroid neoplasm;soft tissue sarcoma;colorectal adenocarcinoma;Lung sarcomatoid carcinoma;Chronic lymphocytic leukemia;bladder transitional cell carcinoma;Anaplastic Malignant Meningioma;breast ductal adenocarcinoma;Testicular Leydig Cell Tumor;Anaplastic oligodendroglioma;nodular melanoma;Alveolar rhabdomyosarcoma;Extramammary Paget Disease;Choroid plexus papilloma;unspecified peripheral T-cell lymphoma;Pancreatic Acinar Cell Carcinoma;Digestive System Carcinoma;diffuse large B-cell lymphoma;Merkel cell skin cancer;Meningothelial Meningioma;Fibrous Meningioma;Endometrial stromal sarcoma;Prostate Small Cell Carcinoma;Anaplastic astrocytoma;Hodgkins lymphoma;adrenal cortex carcinoma;Placental Choriocarcinoma;Lung Inflammatory Myofibroblastic Tumor;Splenic Mantle Cell Lymphoma;anaplastic large cell lymphoma;adenosquamous lung carcinoma;ovarian teratoma;Chronic myelomonocytic leukemia;Vaginal Melanoma;Rhabdoid Meningioma;Ulcerative colitis;ATAXIA-TELANGIECTASIA;prostate adenocarcinoma;Tracheal Adenoid Cystic Carcinoma;ovarian clear cell adenocarcinoma;Well-differentiated liposarcoma;marginal zone B-cell lymphoma;Adenoid Cystic Breast Carcinoma;squamous cell lung carcinoma;non-small cell lung carcinoma;Atypical Meningioma;Hepatocellular Carcinoma;cervical squamous cell carcinoma;PEComa;Parotid Gland Adenoid Cystic Carcinoma;Chronic Eosinophilic Leukemia, Not Otherwise Specified;Malignant Mesothelioma;gallbladder carcinoma;ATM-related cancer;embryonal rhabdomyosarcoma;Bladder Small Cell Neuroendocrine Carcinoma;Chronic neutrophilic leukemia;Sarcomatoid Carcinoma;metaplastic breast carcinoma;oral squamous cell carcinoma;urothelial carcinoma;Neoplasm;pulmonary blastoma;Chronic myelogenous leukemia;Pleural Epithelioid Mesothelioma;Appendix Adenocarcinoma;Borderline Ovarian Mucinous Tumor;B-cell acute lymphoblastic leukemia;Renal cell carcinoma;Langerhans cell histiocytosis;Colorectal adenoma;Gastric Adenoma;Testicular Yolk Sac Tumor;Ampulla of Vater Carcinoma;Burkitts lymphoma;non-functioning pituitary adenoma;Ovarian Endometrioid Adenocarcinoma;Breast carcinoma;ovarian mucinous adenocarcinoma;Esophageal carcinoma;Gastric Neuroendocrine Tumor G1;Melanoma;Angioimmunoblastic T-cell lymphoma;Follicular Variant Thyroid Gland Papillary Carcinoma;Pancreatic adenocarcinoma;Unclassified Renal Cell Carcinoma;Benign Smooth Muscle Neoplasm;gastric adenocarcinoma;Papillary renal cell carcinoma;blastic plasmacytoid dendritic cell neoplasm;Spinal Cord Astrocytoma;adrenocortical adenoma;Duodenal Adenocarcinoma;MYELODYSPLASTIC SYNDROME;bronchoalveolar adenocarcinoma;Parathyroid Gland Carcinoma;cervical adenocarcinoma;Small cell lung carcinoma;skin appendage carcinoma;ovarian carcinoma;Multiple myeloma;Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation;pharyngeal squamous cell carcinoma;ovarian adenocarcinoma;Eccrine porocarcinoma;Salivary Gland Carcinoma ex Pleomorphic Adenoma;leiomyosarcoma;renal carcinoma;Uterine Carcinosarcoma;MANTLE CELL LYMPHOMA;Endometrial Clear Cell Adenocarcinoma;ATAXIA-TELANGIECTASIA;Chordoid Meningioma;Chromophobe renal cell carcinoma;Gallbladder Adenocarcinoma;angiosarcoma;colon adenocarcinoma;lobular breast carcinoma;Esophageal adenocarcinoma;Transitional Meningioma;breast adenosis;B-cell chronic lymphocytic leukemia;Endometrial Endometrioid Adenocarcinoma;Esophageal Squamous Cell Carcinoma;Endometrial carcinoma;Papillary thyroid carcinoma;Familial prostate cancer;Extraskeletal Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor;colonic neoplasm;amelanotic skin melanoma;pancreatic neoplasm;Acute lymphoblastic leukemia;Gallbladder Small Cell Neuroendocrine Carcinoma;diffuse gastric adenocarcinoma;Breast Cancer;ATAXIA-TELANGIECTASIA"
ATM_aug3,ATM,"Lung carcinoid tumor;cecum adenocarcinoma;Lung Sclerosing Hemangioma;Clear Cell Meningioma;testicular seminoma;Brain Stem Glioblastoma;bile duct carcinoma;Testicular Non-Seminomatous Germ Cell Tumor;gastric intestinal type adenocarcinoma;brain glioblastoma;Mixed Lobular and Ductal Breast Carcinoma;ganglioglioma;Malignant Pancreatic Neoplasm;schwannoma;kidney neoplasm;follicular thyroid carcinoma;endometrial serous adenocarcinoma;Endometrial Undifferentiated Carcinoma;T-cell acute lymphoblastic leukemia;large cell lung carcinoma;prostate carcinoma;cervical carcinoma;Breast Carcinoma by Gene Expression Profile;Anaplastic oligoastrocytoma;pancreatic neuroendocrine tumor;head and neck squamous cell carcinoma;Small Intestinal Tubulovillous Adenoma;T-cell prolymphocytic leukemia;gastric carcinoma;ATAXIA-TELANGIECTASIA;cutaneous melanoma;Non-Functional Pancreatic Neuroendocrine Tumor;Kidney Oncocytoma;Thyroid Gland Oncocytic Follicular Carcinoma;Clear cell renal carcinoma;Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive;Primary Peritoneal Serous Adenocarcinoma;plasmacytoma;skin carcinoma;Astrocytoma;pseudomyxoma peritonei;HER2 positive breast carcinoma;neoplasm of mature B-cells;MANTLE CELL LYMPHOMA;Ovarian Granulosa Cell Tumor;Acute myeloid leukemia;Lung adenocarcinoma;undifferentiated pleomorphic sarcoma;Atypical endometrial hyperplasia;OSTEOSARCOMA;Anal Squamous Cell Carcinoma;Lung carcinoma;Hepatobiliary Neoplasm;Microcystic Meningioma;Oligodendroglioma;Breast Diffuse Large B-Cell Lymphoma;endometrium adenocarcinoma;Thymic Carcinoma;nasopharyngeal squamous cell carcinoma;Dedifferentiated liposarcoma;hairy cell leukemia;Dysplasia in Ulcerative Colitis;Malignant Ovarian Mixed Epithelial Tumor;Glioma;thyroid carcinoma;Poorly Differentiated Thyroid Gland Carcinoma;POLYCYTHEMIA VERA;Conjunctival Melanoma;pancreatic carcinoma;rectal adenocarcinoma;Gastric Mantle Cell Lymphoma;lymphoid neoplasm;Pleural Mesothelioma;Thyroid Gland Undifferentiated (Anaplastic) Carcinoma;small intestinal adenocarcinoma;ovarian serous adenocarcinoma;ATAXIA-TELANGIECTASIA VARIANT;Familial colorectal cancer Type X;Laryngeal squamous cell carcinoma;ND;Breast Cancer;thyroid neoplasm;soft tissue sarcoma;colorectal adenocarcinoma;Lung sarcomatoid carcinoma;Chronic lymphocytic leukemia;bladder transitional cell carcinoma;Anaplastic Malignant Meningioma;breast ductal adenocarcinoma;Testicular Leydig Cell Tumor;Anaplastic oligodendroglioma;nodular melanoma;Alveolar rhabdomyosarcoma;Extramammary Paget Disease;Choroid plexus papilloma;unspecified peripheral T-cell lymphoma;Pancreatic Acinar Cell Carcinoma;Digestive System Carcinoma;diffuse large B-cell lymphoma;Merkel cell skin cancer;Meningothelial Meningioma;Fibrous Meningioma;Endometrial stromal sarcoma;Prostate Small Cell Carcinoma;Anaplastic astrocytoma;Hodgkins lymphoma;adrenal cortex carcinoma;Placental Choriocarcinoma;Lung Inflammatory Myofibroblastic Tumor;Splenic Mantle Cell Lymphoma;anaplastic large cell lymphoma;adenosquamous lung carcinoma;ovarian teratoma;Chronic myelomonocytic leukemia;Vaginal Melanoma;Rhabdoid Meningioma;Ulcerative colitis;ATAXIA-TELANGIECTASIA;prostate adenocarcinoma;Tracheal Adenoid Cystic Carcinoma;ovarian clear cell adenocarcinoma;Well-differentiated liposarcoma;marginal zone B-cell lymphoma;Adenoid Cystic Breast Carcinoma;squamous cell lung carcinoma;non-small cell lung carcinoma;Atypical Meningioma;Hepatocellular Carcinoma;cervical squamous cell carcinoma;PEComa;Parotid Gland Adenoid Cystic Carcinoma;Chronic Eosinophilic Leukemia, Not Otherwise Specified;Malignant Mesothelioma;gallbladder carcinoma;ATM-related cancer;embryonal rhabdomyosarcoma;Bladder Small Cell Neuroendocrine Carcinoma;Chronic neutrophilic leukemia;Sarcomatoid Carcinoma;metaplastic breast carcinoma;oral squamous cell carcinoma;urothelial carcinoma;Neoplasm;pulmonary blastoma;Chronic myelogenous leukemia;Pleural Epithelioid Mesothelioma;Appendix Adenocarcinoma;Borderline Ovarian Mucinous Tumor;B-cell acute lymphoblastic leukemia;Renal cell carcinoma;Langerhans cell histiocytosis;Colorectal adenoma;Gastric Adenoma;Testicular Yolk Sac Tumor;Ampulla of Vater Carcinoma;Burkitts lymphoma;non-functioning pituitary adenoma;Ovarian Endometrioid Adenocarcinoma;Breast carcinoma;ovarian mucinous adenocarcinoma;Esophageal carcinoma;Gastric Neuroendocrine Tumor G1;Melanoma;Angioimmunoblastic T-cell lymphoma;Follicular Variant Thyroid Gland Papillary Carcinoma;Pancreatic adenocarcinoma;Unclassified Renal Cell Carcinoma;Benign Smooth Muscle Neoplasm;gastric adenocarcinoma;Papillary renal cell carcinoma;blastic plasmacytoid dendritic cell neoplasm;Spinal Cord Astrocytoma;adrenocortical adenoma;Duodenal Adenocarcinoma;MYELODYSPLASTIC SYNDROME;bronchoalveolar adenocarcinoma;Parathyroid Gland Carcinoma;cervical adenocarcinoma;Small cell lung carcinoma;skin appendage carcinoma;ovarian carcinoma;Multiple myeloma;Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation;pharyngeal squamous cell carcinoma;ovarian adenocarcinoma;Eccrine porocarcinoma;Salivary Gland Carcinoma ex Pleomorphic Adenoma;leiomyosarcoma;renal carcinoma;Uterine Carcinosarcoma;MANTLE CELL LYMPHOMA;Endometrial Clear Cell Adenocarcinoma;ATAXIA-TELANGIECTASIA;Chordoid Meningioma;Chromophobe renal cell carcinoma;Gallbladder Adenocarcinoma;angiosarcoma;colon adenocarcinoma;lobular breast carcinoma;Esophageal adenocarcinoma;Transitional Meningioma;breast adenosis;B-cell chronic lymphocytic leukemia;Endometrial Endometrioid Adenocarcinoma;Esophageal Squamous Cell Carcinoma;Endometrial carcinoma;Papillary thyroid carcinoma;Familial prostate cancer;Extraskeletal Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor;colonic neoplasm;amelanotic skin melanoma;pancreatic neoplasm;Acute lymphoblastic leukemia;Gallbladder Small Cell Neuroendocrine Carcinoma;diffuse gastric adenocarcinoma;Breast Cancer;ATAXIA-TELANGIECTASIA"
ATM_aug4,ATM,"Lung carcinoid tumor;cecum adenocarcinoma;Lung Sclerosing Hemangioma;Clear Cell Meningioma;testicular seminoma;Brain Stem Glioblastoma;bile duct carcinoma;Testicular Non-Seminomatous Germ Cell Tumor;gastric intestinal type adenocarcinoma;brain glioblastoma;Mixed Lobular and Ductal Breast Carcinoma;ganglioglioma;Malignant Pancreatic Neoplasm;schwannoma;kidney neoplasm;follicular thyroid carcinoma;endometrial serous adenocarcinoma;Endometrial Undifferentiated Carcinoma;T-cell acute lymphoblastic leukemia;large cell lung carcinoma;prostate carcinoma;cervical carcinoma;Breast Carcinoma by Gene Expression Profile;Anaplastic oligoastrocytoma;pancreatic neuroendocrine tumor;head and neck squamous cell carcinoma;Small Intestinal Tubulovillous Adenoma;T-cell prolymphocytic leukemia;gastric carcinoma;ATAXIA-TELANGIECTASIA;cutaneous melanoma;Non-Functional Pancreatic Neuroendocrine Tumor;Kidney Oncocytoma;Thyroid Gland Oncocytic Follicular Carcinoma;Clear cell renal carcinoma;Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive;Primary Peritoneal Serous Adenocarcinoma;plasmacytoma;skin carcinoma;Astrocytoma;pseudomyxoma peritonei;HER2 positive breast carcinoma;neoplasm of mature B-cells;MANTLE CELL LYMPHOMA;Ovarian Granulosa Cell Tumor;Acute myeloid leukemia;Lung adenocarcinoma;undifferentiated pleomorphic sarcoma;Atypical endometrial hyperplasia;OSTEOSARCOMA;Anal Squamous Cell Carcinoma;Lung carcinoma;Hepatobiliary Neoplasm;Microcystic Meningioma;Oligodendroglioma;Breast Diffuse Large B-Cell Lymphoma;endometrium adenocarcinoma;Thymic Carcinoma;nasopharyngeal squamous cell carcinoma;Dedifferentiated liposarcoma;hairy cell leukemia;Dysplasia in Ulcerative Colitis;Malignant Ovarian Mixed Epithelial Tumor;Glioma;thyroid carcinoma;Poorly Differentiated Thyroid Gland Carcinoma;POLYCYTHEMIA VERA;Conjunctival Melanoma;pancreatic carcinoma;rectal adenocarcinoma;Gastric Mantle Cell Lymphoma;lymphoid neoplasm;Pleural Mesothelioma;Thyroid Gland Undifferentiated (Anaplastic) Carcinoma;small intestinal adenocarcinoma;ovarian serous adenocarcinoma;ATAXIA-TELANGIECTASIA VARIANT;Familial colorectal cancer Type X;Laryngeal squamous cell carcinoma;ND;Breast Cancer;thyroid neoplasm;soft tissue sarcoma;colorectal adenocarcinoma;Lung sarcomatoid carcinoma;Chronic lymphocytic leukemia;bladder transitional cell carcinoma;Anaplastic Malignant Meningioma;breast ductal adenocarcinoma;Testicular Leydig Cell Tumor;Anaplastic oligodendroglioma;nodular melanoma;Alveolar rhabdomyosarcoma;Extramammary Paget Disease;Choroid plexus papilloma;unspecified peripheral T-cell lymphoma;Pancreatic Acinar Cell Carcinoma;Digestive System Carcinoma;diffuse large B-cell lymphoma;Merkel cell skin cancer;Meningothelial Meningioma;Fibrous Meningioma;Endometrial stromal sarcoma;Prostate Small Cell Carcinoma;Anaplastic astrocytoma;Hodgkins lymphoma;adrenal cortex carcinoma;Placental Choriocarcinoma;Lung Inflammatory Myofibroblastic Tumor;Splenic Mantle Cell Lymphoma;anaplastic large cell lymphoma;adenosquamous lung carcinoma;ovarian teratoma;Chronic myelomonocytic leukemia;Vaginal Melanoma;Rhabdoid Meningioma;Ulcerative colitis;ATAXIA-TELANGIECTASIA;prostate adenocarcinoma;Tracheal Adenoid Cystic Carcinoma;ovarian clear cell adenocarcinoma;Well-differentiated liposarcoma;marginal zone B-cell lymphoma;Adenoid Cystic Breast Carcinoma;squamous cell lung carcinoma;non-small cell lung carcinoma;Atypical Meningioma;Hepatocellular Carcinoma;cervical squamous cell carcinoma;PEComa;Parotid Gland Adenoid Cystic Carcinoma;Chronic Eosinophilic Leukemia, Not Otherwise Specified;Malignant Mesothelioma;gallbladder carcinoma;ATM-related cancer;embryonal rhabdomyosarcoma;Bladder Small Cell Neuroendocrine Carcinoma;Chronic neutrophilic leukemia;Sarcomatoid Carcinoma;metaplastic breast carcinoma;oral squamous cell carcinoma;urothelial carcinoma;Neoplasm;pulmonary blastoma;Chronic myelogenous leukemia;Pleural Epithelioid Mesothelioma;Appendix Adenocarcinoma;Borderline Ovarian Mucinous Tumor;B-cell acute lymphoblastic leukemia;Renal cell carcinoma;Langerhans cell histiocytosis;Colorectal adenoma;Gastric Adenoma;Testicular Yolk Sac Tumor;Ampulla of Vater Carcinoma;Burkitts lymphoma;non-functioning pituitary adenoma;Ovarian Endometrioid Adenocarcinoma;Breast carcinoma;ovarian mucinous adenocarcinoma;Esophageal carcinoma;Gastric Neuroendocrine Tumor G1;Melanoma;Angioimmunoblastic T-cell lymphoma;Follicular Variant Thyroid Gland Papillary Carcinoma;Pancreatic adenocarcinoma;Unclassified Renal Cell Carcinoma;Benign Smooth Muscle Neoplasm;gastric adenocarcinoma;Papillary renal cell carcinoma;blastic plasmacytoid dendritic cell neoplasm;Spinal Cord Astrocytoma;adrenocortical adenoma;Duodenal Adenocarcinoma;MYELODYSPLASTIC SYNDROME;bronchoalveolar adenocarcinoma;Parathyroid Gland Carcinoma;cervical adenocarcinoma;Small cell lung carcinoma;skin appendage carcinoma;ovarian carcinoma;Multiple myeloma;Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation;pharyngeal squamous cell carcinoma;ovarian adenocarcinoma;Eccrine porocarcinoma;Salivary Gland Carcinoma ex Pleomorphic Adenoma;leiomyosarcoma;renal carcinoma;Uterine Carcinosarcoma;MANTLE CELL LYMPHOMA;Endometrial Clear Cell Adenocarcinoma;ATAXIA-TELANGIECTASIA;Chordoid Meningioma;Chromophobe renal cell carcinoma;Gallbladder Adenocarcinoma;angiosarcoma;colon adenocarcinoma;lobular breast carcinoma;Esophageal adenocarcinoma;Transitional Meningioma;breast adenosis;B-cell chronic lymphocytic leukemia;Endometrial Endometrioid Adenocarcinoma;Esophageal Squamous Cell Carcinoma;Endometrial carcinoma;Papillary thyroid carcinoma;Familial prostate cancer;Extraskeletal Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor;colonic neoplasm;amelanotic skin melanoma;pancreatic neoplasm;Acute lymphoblastic leukemia;Gallbladder Small Cell Neuroendocrine Carcinoma;diffuse gastric adenocarcinoma;Breast Cancer;ATAXIA-TELANGIECTASIA"
ATM_aug5,ATM,"Lung carcinoid tumor;cecum adenocarcinoma;Lung Sclerosing Hemangioma;Clear Cell Meningioma;testicular seminoma;Brain Stem Glioblastoma;bile duct carcinoma;Testicular Non-Seminomatous Germ Cell Tumor;gastric intestinal type adenocarcinoma;brain glioblastoma;Mixed Lobular and Ductal Breast Carcinoma;ganglioglioma;Malignant Pancreatic Neoplasm;schwannoma;kidney neoplasm;follicular thyroid carcinoma;endometrial serous adenocarcinoma;Endometrial Undifferentiated Carcinoma;T-cell acute lymphoblastic leukemia;large cell lung carcinoma;prostate carcinoma;cervical carcinoma;Breast Carcinoma by Gene Expression Profile;Anaplastic oligoastrocytoma;pancreatic neuroendocrine tumor;head and neck squamous cell carcinoma;Small Intestinal Tubulovillous Adenoma;T-cell prolymphocytic leukemia;gastric carcinoma;ATAXIA-TELANGIECTASIA;cutaneous melanoma;Non-Functional Pancreatic Neuroendocrine Tumor;Kidney Oncocytoma;Thyroid Gland Oncocytic Follicular Carcinoma;Clear cell renal carcinoma;Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive;Primary Peritoneal Serous Adenocarcinoma;plasmacytoma;skin carcinoma;Astrocytoma;pseudomyxoma peritonei;HER2 positive breast carcinoma;neoplasm of mature B-cells;MANTLE CELL LYMPHOMA;Ovarian Granulosa Cell Tumor;Acute myeloid leukemia;Lung adenocarcinoma;undifferentiated pleomorphic sarcoma;Atypical endometrial hyperplasia;OSTEOSARCOMA;Anal Squamous Cell Carcinoma;Lung carcinoma;Hepatobiliary Neoplasm;Microcystic Meningioma;Oligodendroglioma;Breast Diffuse Large B-Cell Lymphoma;endometrium adenocarcinoma;Thymic Carcinoma;nasopharyngeal squamous cell carcinoma;Dedifferentiated liposarcoma;hairy cell leukemia;Dysplasia in Ulcerative Colitis;Malignant Ovarian Mixed Epithelial Tumor;Glioma;thyroid carcinoma;Poorly Differentiated Thyroid Gland Carcinoma;POLYCYTHEMIA VERA;Conjunctival Melanoma;pancreatic carcinoma;rectal adenocarcinoma;Gastric Mantle Cell Lymphoma;lymphoid neoplasm;Pleural Mesothelioma;Thyroid Gland Undifferentiated (Anaplastic) Carcinoma;small intestinal adenocarcinoma;ovarian serous adenocarcinoma;ATAXIA-TELANGIECTASIA VARIANT;Familial colorectal cancer Type X;Laryngeal squamous cell carcinoma;ND;Breast Cancer;thyroid neoplasm;soft tissue sarcoma;colorectal adenocarcinoma;Lung sarcomatoid carcinoma;Chronic lymphocytic leukemia;bladder transitional cell carcinoma;Anaplastic Malignant Meningioma;breast ductal adenocarcinoma;Testicular Leydig Cell Tumor;Anaplastic oligodendroglioma;nodular melanoma;Alveolar rhabdomyosarcoma;Extramammary Paget Disease;Choroid plexus papilloma;unspecified peripheral T-cell lymphoma;Pancreatic Acinar Cell Carcinoma;Digestive System Carcinoma;diffuse large B-cell lymphoma;Merkel cell skin cancer;Meningothelial Meningioma;Fibrous Meningioma;Endometrial stromal sarcoma;Prostate Small Cell Carcinoma;Anaplastic astrocytoma;Hodgkins lymphoma;adrenal cortex carcinoma;Placental Choriocarcinoma;Lung Inflammatory Myofibroblastic Tumor;Splenic Mantle Cell Lymphoma;anaplastic large cell lymphoma;adenosquamous lung carcinoma;ovarian teratoma;Chronic myelomonocytic leukemia;Vaginal Melanoma;Rhabdoid Meningioma;Ulcerative colitis;ATAXIA-TELANGIECTASIA;prostate adenocarcinoma;Tracheal Adenoid Cystic Carcinoma;ovarian clear cell adenocarcinoma;Well-differentiated liposarcoma;marginal zone B-cell lymphoma;Adenoid Cystic Breast Carcinoma;squamous cell lung carcinoma;non-small cell lung carcinoma;Atypical Meningioma;Hepatocellular Carcinoma;cervical squamous cell carcinoma;PEComa;Parotid Gland Adenoid Cystic Carcinoma;Chronic Eosinophilic Leukemia, Not Otherwise Specified;Malignant Mesothelioma;gallbladder carcinoma;ATM-related cancer;embryonal rhabdomyosarcoma;Bladder Small Cell Neuroendocrine Carcinoma;Chronic neutrophilic leukemia;Sarcomatoid Carcinoma;metaplastic breast carcinoma;oral squamous cell carcinoma;urothelial carcinoma;Neoplasm;pulmonary blastoma;Chronic myelogenous leukemia;Pleural Epithelioid Mesothelioma;Appendix Adenocarcinoma;Borderline Ovarian Mucinous Tumor;B-cell acute lymphoblastic leukemia;Renal cell carcinoma;Langerhans cell histiocytosis;Colorectal adenoma;Gastric Adenoma;Testicular Yolk Sac Tumor;Ampulla of Vater Carcinoma;Burkitts lymphoma;non-functioning pituitary adenoma;Ovarian Endometrioid Adenocarcinoma;Breast carcinoma;ovarian mucinous adenocarcinoma;Esophageal carcinoma;Gastric Neuroendocrine Tumor G1;Melanoma;Angioimmunoblastic T-cell lymphoma;Follicular Variant Thyroid Gland Papillary Carcinoma;Pancreatic adenocarcinoma;Unclassified Renal Cell Carcinoma;Benign Smooth Muscle Neoplasm;gastric adenocarcinoma;Papillary renal cell carcinoma;blastic plasmacytoid dendritic cell neoplasm;Spinal Cord Astrocytoma;adrenocortical adenoma;Duodenal Adenocarcinoma;MYELODYSPLASTIC SYNDROME;bronchoalveolar adenocarcinoma;Parathyroid Gland Carcinoma;cervical adenocarcinoma;Small cell lung carcinoma;skin appendage carcinoma;ovarian carcinoma;Multiple myeloma;Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation;pharyngeal squamous cell carcinoma;ovarian adenocarcinoma;Eccrine porocarcinoma;Salivary Gland Carcinoma ex Pleomorphic Adenoma;leiomyosarcoma;renal carcinoma;Uterine Carcinosarcoma;MANTLE CELL LYMPHOMA;Endometrial Clear Cell Adenocarcinoma;ATAXIA-TELANGIECTASIA;Chordoid Meningioma;Chromophobe renal cell carcinoma;Gallbladder Adenocarcinoma;angiosarcoma;colon adenocarcinoma;lobular breast carcinoma;Esophageal adenocarcinoma;Transitional Meningioma;breast adenosis;B-cell chronic lymphocytic leukemia;Endometrial Endometrioid Adenocarcinoma;Esophageal Squamous Cell Carcinoma;Endometrial carcinoma;Papillary thyroid carcinoma;Familial prostate cancer;Extraskeletal Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor;colonic neoplasm;amelanotic skin melanoma;pancreatic neoplasm;Acute lymphoblastic leukemia;Gallbladder Small Cell Neuroendocrine Carcinoma;diffuse gastric adenocarcinoma;Breast Cancer;ATAXIA-TELANGIECTASIA"
ATM_aug6,ATM,"Lung carcinoid tumor;cecum adenocarcinoma;Lung Sclerosing Hemangioma;Clear Cell Meningioma;testicular seminoma;Brain Stem Glioblastoma;bile duct carcinoma;Testicular Non-Seminomatous Germ Cell Tumor;gastric intestinal type adenocarcinoma;brain glioblastoma;Mixed Lobular and Ductal Breast Carcinoma;ganglioglioma;Malignant Pancreatic Neoplasm;schwannoma;kidney neoplasm;follicular thyroid carcinoma;endometrial serous adenocarcinoma;Endometrial Undifferentiated Carcinoma;T-cell acute lymphoblastic leukemia;large cell lung carcinoma;prostate carcinoma;cervical carcinoma;Breast Carcinoma by Gene Expression Profile;Anaplastic oligoastrocytoma;pancreatic neuroendocrine tumor;head and neck squamous cell carcinoma;Small Intestinal Tubulovillous Adenoma;T-cell prolymphocytic leukemia;gastric carcinoma;ATAXIA-TELANGIECTASIA;cutaneous melanoma;Non-Functional Pancreatic Neuroendocrine Tumor;Kidney Oncocytoma;Thyroid Gland Oncocytic Follicular Carcinoma;Clear cell renal carcinoma;Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive;Primary Peritoneal Serous Adenocarcinoma;plasmacytoma;skin carcinoma;Astrocytoma;pseudomyxoma peritonei;HER2 positive breast carcinoma;neoplasm of mature B-cells;MANTLE CELL LYMPHOMA;Ovarian Granulosa Cell Tumor;Acute myeloid leukemia;Lung adenocarcinoma;undifferentiated pleomorphic sarcoma;Atypical endometrial hyperplasia;OSTEOSARCOMA;Anal Squamous Cell Carcinoma;Lung carcinoma;Hepatobiliary Neoplasm;Microcystic Meningioma;Oligodendroglioma;Breast Diffuse Large B-Cell Lymphoma;endometrium adenocarcinoma;Thymic Carcinoma;nasopharyngeal squamous cell carcinoma;Dedifferentiated liposarcoma;hairy cell leukemia;Dysplasia in Ulcerative Colitis;Malignant Ovarian Mixed Epithelial Tumor;Glioma;thyroid carcinoma;Poorly Differentiated Thyroid Gland Carcinoma;POLYCYTHEMIA VERA;Conjunctival Melanoma;pancreatic carcinoma;rectal adenocarcinoma;Gastric Mantle Cell Lymphoma;lymphoid neoplasm;Pleural Mesothelioma;Thyroid Gland Undifferentiated (Anaplastic) Carcinoma;small intestinal adenocarcinoma;ovarian serous adenocarcinoma;ATAXIA-TELANGIECTASIA VARIANT;Familial colorectal cancer Type X;Laryngeal squamous cell carcinoma;ND;Breast Cancer;thyroid neoplasm;soft tissue sarcoma;colorectal adenocarcinoma;Lung sarcomatoid carcinoma;Chronic lymphocytic leukemia;bladder transitional cell carcinoma;Anaplastic Malignant Meningioma;breast ductal adenocarcinoma;Testicular Leydig Cell Tumor;Anaplastic oligodendroglioma;nodular melanoma;Alveolar rhabdomyosarcoma;Extramammary Paget Disease;Choroid plexus papilloma;unspecified peripheral T-cell lymphoma;Pancreatic Acinar Cell Carcinoma;Digestive System Carcinoma;diffuse large B-cell lymphoma;Merkel cell skin cancer;Meningothelial Meningioma;Fibrous Meningioma;Endometrial stromal sarcoma;Prostate Small Cell Carcinoma;Anaplastic astrocytoma;Hodgkins lymphoma;adrenal cortex carcinoma;Placental Choriocarcinoma;Lung Inflammatory Myofibroblastic Tumor;Splenic Mantle Cell Lymphoma;anaplastic large cell lymphoma;adenosquamous lung carcinoma;ovarian teratoma;Chronic myelomonocytic leukemia;Vaginal Melanoma;Rhabdoid Meningioma;Ulcerative colitis;ATAXIA-TELANGIECTASIA;prostate adenocarcinoma;Tracheal Adenoid Cystic Carcinoma;ovarian clear cell adenocarcinoma;Well-differentiated liposarcoma;marginal zone B-cell lymphoma;Adenoid Cystic Breast Carcinoma;squamous cell lung carcinoma;non-small cell lung carcinoma;Atypical Meningioma;Hepatocellular Carcinoma;cervical squamous cell carcinoma;PEComa;Parotid Gland Adenoid Cystic Carcinoma;Chronic Eosinophilic Leukemia, Not Otherwise Specified;Malignant Mesothelioma;gallbladder carcinoma;ATM-related cancer;embryonal rhabdomyosarcoma;Bladder Small Cell Neuroendocrine Carcinoma;Chronic neutrophilic leukemia;Sarcomatoid Carcinoma;metaplastic breast carcinoma;oral squamous cell carcinoma;urothelial carcinoma;Neoplasm;pulmonary blastoma;Chronic myelogenous leukemia;Pleural Epithelioid Mesothelioma;Appendix Adenocarcinoma;Borderline Ovarian Mucinous Tumor;B-cell acute lymphoblastic leukemia;Renal cell carcinoma;Langerhans cell histiocytosis;Colorectal adenoma;Gastric Adenoma;Testicular Yolk Sac Tumor;Ampulla of Vater Carcinoma;Burkitts lymphoma;non-functioning pituitary adenoma;Ovarian Endometrioid Adenocarcinoma;Breast carcinoma;ovarian mucinous adenocarcinoma;Esophageal carcinoma;Gastric Neuroendocrine Tumor G1;Melanoma;Angioimmunoblastic T-cell lymphoma;Follicular Variant Thyroid Gland Papillary Carcinoma;Pancreatic adenocarcinoma;Unclassified Renal Cell Carcinoma;Benign Smooth Muscle Neoplasm;gastric adenocarcinoma;Papillary renal cell carcinoma;blastic plasmacytoid dendritic cell neoplasm;Spinal Cord Astrocytoma;adrenocortical adenoma;Duodenal Adenocarcinoma;MYELODYSPLASTIC SYNDROME;bronchoalveolar adenocarcinoma;Parathyroid Gland Carcinoma;cervical adenocarcinoma;Small cell lung carcinoma;skin appendage carcinoma;ovarian carcinoma;Multiple myeloma;Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation;pharyngeal squamous cell carcinoma;ovarian adenocarcinoma;Eccrine porocarcinoma;Salivary Gland Carcinoma ex Pleomorphic Adenoma;leiomyosarcoma;renal carcinoma;Uterine Carcinosarcoma;MANTLE CELL LYMPHOMA;Endometrial Clear Cell Adenocarcinoma;ATAXIA-TELANGIECTASIA;Chordoid Meningioma;Chromophobe renal cell carcinoma;Gallbladder Adenocarcinoma;angiosarcoma;colon adenocarcinoma;lobular breast carcinoma;Esophageal adenocarcinoma;Transitional Meningioma;breast adenosis;B-cell chronic lymphocytic leukemia;Endometrial Endometrioid Adenocarcinoma;Esophageal Squamous Cell Carcinoma;Endometrial carcinoma;Papillary thyroid carcinoma;Familial prostate cancer;Extraskeletal Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor;colonic neoplasm;amelanotic skin melanoma;pancreatic neoplasm;Acute lymphoblastic leukemia;Gallbladder Small Cell Neuroendocrine Carcinoma;diffuse gastric adenocarcinoma;Breast Cancer;ATAXIA-TELANGIECTASIA"
ATM_aug7,ATM,"Lung carcinoid tumor;cecum adenocarcinoma;Lung Sclerosing Hemangioma;Clear Cell Meningioma;testicular seminoma;Brain Stem Glioblastoma;bile duct carcinoma;Testicular Non-Seminomatous Germ Cell Tumor;gastric intestinal type adenocarcinoma;brain glioblastoma;Mixed Lobular and Ductal Breast Carcinoma;ganglioglioma;Malignant Pancreatic Neoplasm;schwannoma;kidney neoplasm;follicular thyroid carcinoma;endometrial serous adenocarcinoma;Endometrial Undifferentiated Carcinoma;T-cell acute lymphoblastic leukemia;large cell lung carcinoma;prostate carcinoma;cervical carcinoma;Breast Carcinoma by Gene Expression Profile;Anaplastic oligoastrocytoma;pancreatic neuroendocrine tumor;head and neck squamous cell carcinoma;Small Intestinal Tubulovillous Adenoma;T-cell prolymphocytic leukemia;gastric carcinoma;ATAXIA-TELANGIECTASIA;cutaneous melanoma;Non-Functional Pancreatic Neuroendocrine Tumor;Kidney Oncocytoma;Thyroid Gland Oncocytic Follicular Carcinoma;Clear cell renal carcinoma;Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive;Primary Peritoneal Serous Adenocarcinoma;plasmacytoma;skin carcinoma;Astrocytoma;pseudomyxoma peritonei;HER2 positive breast carcinoma;neoplasm of mature B-cells;MANTLE CELL LYMPHOMA;Ovarian Granulosa Cell Tumor;Acute myeloid leukemia;Lung adenocarcinoma;undifferentiated pleomorphic sarcoma;Atypical endometrial hyperplasia;OSTEOSARCOMA;Anal Squamous Cell Carcinoma;Lung carcinoma;Hepatobiliary Neoplasm;Microcystic Meningioma;Oligodendroglioma;Breast Diffuse Large B-Cell Lymphoma;endometrium adenocarcinoma;Thymic Carcinoma;nasopharyngeal squamous cell carcinoma;Dedifferentiated liposarcoma;hairy cell leukemia;Dysplasia in Ulcerative Colitis;Malignant Ovarian Mixed Epithelial Tumor;Glioma;thyroid carcinoma;Poorly Differentiated Thyroid Gland Carcinoma;POLYCYTHEMIA VERA;Conjunctival Melanoma;pancreatic carcinoma;rectal adenocarcinoma;Gastric Mantle Cell Lymphoma;lymphoid neoplasm;Pleural Mesothelioma;Thyroid Gland Undifferentiated (Anaplastic) Carcinoma;small intestinal adenocarcinoma;ovarian serous adenocarcinoma;ATAXIA-TELANGIECTASIA VARIANT;Familial colorectal cancer Type X;Laryngeal squamous cell carcinoma;ND;Breast Cancer;thyroid neoplasm;soft tissue sarcoma;colorectal adenocarcinoma;Lung sarcomatoid carcinoma;Chronic lymphocytic leukemia;bladder transitional cell carcinoma;Anaplastic Malignant Meningioma;breast ductal adenocarcinoma;Testicular Leydig Cell Tumor;Anaplastic oligodendroglioma;nodular melanoma;Alveolar rhabdomyosarcoma;Extramammary Paget Disease;Choroid plexus papilloma;unspecified peripheral T-cell lymphoma;Pancreatic Acinar Cell Carcinoma;Digestive System Carcinoma;diffuse large B-cell lymphoma;Merkel cell skin cancer;Meningothelial Meningioma;Fibrous Meningioma;Endometrial stromal sarcoma;Prostate Small Cell Carcinoma;Anaplastic astrocytoma;Hodgkins lymphoma;adrenal cortex carcinoma;Placental Choriocarcinoma;Lung Inflammatory Myofibroblastic Tumor;Splenic Mantle Cell Lymphoma;anaplastic large cell lymphoma;adenosquamous lung carcinoma;ovarian teratoma;Chronic myelomonocytic leukemia;Vaginal Melanoma;Rhabdoid Meningioma;Ulcerative colitis;ATAXIA-TELANGIECTASIA;prostate adenocarcinoma;Tracheal Adenoid Cystic Carcinoma;ovarian clear cell adenocarcinoma;Well-differentiated liposarcoma;marginal zone B-cell lymphoma;Adenoid Cystic Breast Carcinoma;squamous cell lung carcinoma;non-small cell lung carcinoma;Atypical Meningioma;Hepatocellular Carcinoma;cervical squamous cell carcinoma;PEComa;Parotid Gland Adenoid Cystic Carcinoma;Chronic Eosinophilic Leukemia, Not Otherwise Specified;Malignant Mesothelioma;gallbladder carcinoma;ATM-related cancer;embryonal rhabdomyosarcoma;Bladder Small Cell Neuroendocrine Carcinoma;Chronic neutrophilic leukemia;Sarcomatoid Carcinoma;metaplastic breast carcinoma;oral squamous cell carcinoma;urothelial carcinoma;Neoplasm;pulmonary blastoma;Chronic myelogenous leukemia;Pleural Epithelioid Mesothelioma;Appendix Adenocarcinoma;Borderline Ovarian Mucinous Tumor;B-cell acute lymphoblastic leukemia;Renal cell carcinoma;Langerhans cell histiocytosis;Colorectal adenoma;Gastric Adenoma;Testicular Yolk Sac Tumor;Ampulla of Vater Carcinoma;Burkitts lymphoma;non-functioning pituitary adenoma;Ovarian Endometrioid Adenocarcinoma;Breast carcinoma;ovarian mucinous adenocarcinoma;Esophageal carcinoma;Gastric Neuroendocrine Tumor G1;Melanoma;Angioimmunoblastic T-cell lymphoma;Follicular Variant Thyroid Gland Papillary Carcinoma;Pancreatic adenocarcinoma;Unclassified Renal Cell Carcinoma;Benign Smooth Muscle Neoplasm;gastric adenocarcinoma;Papillary renal cell carcinoma;blastic plasmacytoid dendritic cell neoplasm;Spinal Cord Astrocytoma;adrenocortical adenoma;Duodenal Adenocarcinoma;MYELODYSPLASTIC SYNDROME;bronchoalveolar adenocarcinoma;Parathyroid Gland Carcinoma;cervical adenocarcinoma;Small cell lung carcinoma;skin appendage carcinoma;ovarian carcinoma;Multiple myeloma;Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation;pharyngeal squamous cell carcinoma;ovarian adenocarcinoma;Eccrine porocarcinoma;Salivary Gland Carcinoma ex Pleomorphic Adenoma;leiomyosarcoma;renal carcinoma;Uterine Carcinosarcoma;MANTLE CELL LYMPHOMA;Endometrial Clear Cell Adenocarcinoma;ATAXIA-TELANGIECTASIA;Chordoid Meningioma;Chromophobe renal cell carcinoma;Gallbladder Adenocarcinoma;angiosarcoma;colon adenocarcinoma;lobular breast carcinoma;Esophageal adenocarcinoma;Transitional Meningioma;breast adenosis;B-cell chronic lymphocytic leukemia;Endometrial Endometrioid Adenocarcinoma;Esophageal Squamous Cell Carcinoma;Endometrial carcinoma;Papillary thyroid carcinoma;Familial prostate cancer;Extraskeletal Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor;colonic neoplasm;amelanotic skin melanoma;pancreatic neoplasm;Acute lymphoblastic leukemia;Gallbladder Small Cell Neuroendocrine Carcinoma;diffuse gastric adenocarcinoma;Breast Cancer;ATAXIA-TELANGIECTASIA"
ATM_aug8,ATM,"Lung carcinoid tumor;cecum adenocarcinoma;Lung Sclerosing Hemangioma;Clear Cell Meningioma;testicular seminoma;Brain Stem Glioblastoma;bile duct carcinoma;Testicular Non-Seminomatous Germ Cell Tumor;gastric intestinal type adenocarcinoma;brain glioblastoma;Mixed Lobular and Ductal Breast Carcinoma;ganglioglioma;Malignant Pancreatic Neoplasm;schwannoma;kidney neoplasm;follicular thyroid carcinoma;endometrial serous adenocarcinoma;Endometrial Undifferentiated Carcinoma;T-cell acute lymphoblastic leukemia;large cell lung carcinoma;prostate carcinoma;cervical carcinoma;Breast Carcinoma by Gene Expression Profile;Anaplastic oligoastrocytoma;pancreatic neuroendocrine tumor;head and neck squamous cell carcinoma;Small Intestinal Tubulovillous Adenoma;T-cell prolymphocytic leukemia;gastric carcinoma;ATAXIA-TELANGIECTASIA;cutaneous melanoma;Non-Functional Pancreatic Neuroendocrine Tumor;Kidney Oncocytoma;Thyroid Gland Oncocytic Follicular Carcinoma;Clear cell renal carcinoma;Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive;Primary Peritoneal Serous Adenocarcinoma;plasmacytoma;skin carcinoma;Astrocytoma;pseudomyxoma peritonei;HER2 positive breast carcinoma;neoplasm of mature B-cells;MANTLE CELL LYMPHOMA;Ovarian Granulosa Cell Tumor;Acute myeloid leukemia;Lung adenocarcinoma;undifferentiated pleomorphic sarcoma;Atypical endometrial hyperplasia;OSTEOSARCOMA;Anal Squamous Cell Carcinoma;Lung carcinoma;Hepatobiliary Neoplasm;Microcystic Meningioma;Oligodendroglioma;Breast Diffuse Large B-Cell Lymphoma;endometrium adenocarcinoma;Thymic Carcinoma;nasopharyngeal squamous cell carcinoma;Dedifferentiated liposarcoma;hairy cell leukemia;Dysplasia in Ulcerative Colitis;Malignant Ovarian Mixed Epithelial Tumor;Glioma;thyroid carcinoma;Poorly Differentiated Thyroid Gland Carcinoma;POLYCYTHEMIA VERA;Conjunctival Melanoma;pancreatic carcinoma;rectal adenocarcinoma;Gastric Mantle Cell Lymphoma;lymphoid neoplasm;Pleural Mesothelioma;Thyroid Gland Undifferentiated (Anaplastic) Carcinoma;small intestinal adenocarcinoma;ovarian serous adenocarcinoma;ATAXIA-TELANGIECTASIA VARIANT;Familial colorectal cancer Type X;Laryngeal squamous cell carcinoma;ND;Breast Cancer;thyroid neoplasm;soft tissue sarcoma;colorectal adenocarcinoma;Lung sarcomatoid carcinoma;Chronic lymphocytic leukemia;bladder transitional cell carcinoma;Anaplastic Malignant Meningioma;breast ductal adenocarcinoma;Testicular Leydig Cell Tumor;Anaplastic oligodendroglioma;nodular melanoma;Alveolar rhabdomyosarcoma;Extramammary Paget Disease;Choroid plexus papilloma;unspecified peripheral T-cell lymphoma;Pancreatic Acinar Cell Carcinoma;Digestive System Carcinoma;diffuse large B-cell lymphoma;Merkel cell skin cancer;Meningothelial Meningioma;Fibrous Meningioma;Endometrial stromal sarcoma;Prostate Small Cell Carcinoma;Anaplastic astrocytoma;Hodgkins lymphoma;adrenal cortex carcinoma;Placental Choriocarcinoma;Lung Inflammatory Myofibroblastic Tumor;Splenic Mantle Cell Lymphoma;anaplastic large cell lymphoma;adenosquamous lung carcinoma;ovarian teratoma;Chronic myelomonocytic leukemia;Vaginal Melanoma;Rhabdoid Meningioma;Ulcerative colitis;ATAXIA-TELANGIECTASIA;prostate adenocarcinoma;Tracheal Adenoid Cystic Carcinoma;ovarian clear cell adenocarcinoma;Well-differentiated liposarcoma;marginal zone B-cell lymphoma;Adenoid Cystic Breast Carcinoma;squamous cell lung carcinoma;non-small cell lung carcinoma;Atypical Meningioma;Hepatocellular Carcinoma;cervical squamous cell carcinoma;PEComa;Parotid Gland Adenoid Cystic Carcinoma;Chronic Eosinophilic Leukemia, Not Otherwise Specified;Malignant Mesothelioma;gallbladder carcinoma;ATM-related cancer;embryonal rhabdomyosarcoma;Bladder Small Cell Neuroendocrine Carcinoma;Chronic neutrophilic leukemia;Sarcomatoid Carcinoma;metaplastic breast carcinoma;oral squamous cell carcinoma;urothelial carcinoma;Neoplasm;pulmonary blastoma;Chronic myelogenous leukemia;Pleural Epithelioid Mesothelioma;Appendix Adenocarcinoma;Borderline Ovarian Mucinous Tumor;B-cell acute lymphoblastic leukemia;Renal cell carcinoma;Langerhans cell histiocytosis;Colorectal adenoma;Gastric Adenoma;Testicular Yolk Sac Tumor;Ampulla of Vater Carcinoma;Burkitts lymphoma;non-functioning pituitary adenoma;Ovarian Endometrioid Adenocarcinoma;Breast carcinoma;ovarian mucinous adenocarcinoma;Esophageal carcinoma;Gastric Neuroendocrine Tumor G1;Melanoma;Angioimmunoblastic T-cell lymphoma;Follicular Variant Thyroid Gland Papillary Carcinoma;Pancreatic adenocarcinoma;Unclassified Renal Cell Carcinoma;Benign Smooth Muscle Neoplasm;gastric adenocarcinoma;Papillary renal cell carcinoma;blastic plasmacytoid dendritic cell neoplasm;Spinal Cord Astrocytoma;adrenocortical adenoma;Duodenal Adenocarcinoma;MYELODYSPLASTIC SYNDROME;bronchoalveolar adenocarcinoma;Parathyroid Gland Carcinoma;cervical adenocarcinoma;Small cell lung carcinoma;skin appendage carcinoma;ovarian carcinoma;Multiple myeloma;Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation;pharyngeal squamous cell carcinoma;ovarian adenocarcinoma;Eccrine porocarcinoma;Salivary Gland Carcinoma ex Pleomorphic Adenoma;leiomyosarcoma;renal carcinoma;Uterine Carcinosarcoma;MANTLE CELL LYMPHOMA;Endometrial Clear Cell Adenocarcinoma;ATAXIA-TELANGIECTASIA;Chordoid Meningioma;Chromophobe renal cell carcinoma;Gallbladder Adenocarcinoma;angiosarcoma;colon adenocarcinoma;lobular breast carcinoma;Esophageal adenocarcinoma;Transitional Meningioma;breast adenosis;B-cell chronic lymphocytic leukemia;Endometrial Endometrioid Adenocarcinoma;Esophageal Squamous Cell Carcinoma;Endometrial carcinoma;Papillary thyroid carcinoma;Familial prostate cancer;Extraskeletal Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor;colonic neoplasm;amelanotic skin melanoma;pancreatic neoplasm;Acute lymphoblastic leukemia;Gallbladder Small Cell Neuroendocrine Carcinoma;diffuse gastric adenocarcinoma;Breast Cancer;ATAXIA-TELANGIECTASIA"
ATM_aug9,ATM,"Lung carcinoid tumor;cecum adenocarcinoma;Lung Sclerosing Hemangioma;Clear Cell Meningioma;testicular seminoma;Brain Stem Glioblastoma;bile duct carcinoma;Testicular Non-Seminomatous Germ Cell Tumor;gastric intestinal type adenocarcinoma;brain glioblastoma;Mixed Lobular and Ductal Breast Carcinoma;ganglioglioma;Malignant Pancreatic Neoplasm;schwannoma;kidney neoplasm;follicular thyroid carcinoma;endometrial serous adenocarcinoma;Endometrial Undifferentiated Carcinoma;T-cell acute lymphoblastic leukemia;large cell lung carcinoma;prostate carcinoma;cervical carcinoma;Breast Carcinoma by Gene Expression Profile;Anaplastic oligoastrocytoma;pancreatic neuroendocrine tumor;head and neck squamous cell carcinoma;Small Intestinal Tubulovillous Adenoma;T-cell prolymphocytic leukemia;gastric carcinoma;ATAXIA-TELANGIECTASIA;cutaneous melanoma;Non-Functional Pancreatic Neuroendocrine Tumor;Kidney Oncocytoma;Thyroid Gland Oncocytic Follicular Carcinoma;Clear cell renal carcinoma;Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive;Primary Peritoneal Serous Adenocarcinoma;plasmacytoma;skin carcinoma;Astrocytoma;pseudomyxoma peritonei;HER2 positive breast carcinoma;neoplasm of mature B-cells;MANTLE CELL LYMPHOMA;Ovarian Granulosa Cell Tumor;Acute myeloid leukemia;Lung adenocarcinoma;undifferentiated pleomorphic sarcoma;Atypical endometrial hyperplasia;OSTEOSARCOMA;Anal Squamous Cell Carcinoma;Lung carcinoma;Hepatobiliary Neoplasm;Microcystic Meningioma;Oligodendroglioma;Breast Diffuse Large B-Cell Lymphoma;endometrium adenocarcinoma;Thymic Carcinoma;nasopharyngeal squamous cell carcinoma;Dedifferentiated liposarcoma;hairy cell leukemia;Dysplasia in Ulcerative Colitis;Malignant Ovarian Mixed Epithelial Tumor;Glioma;thyroid carcinoma;Poorly Differentiated Thyroid Gland Carcinoma;POLYCYTHEMIA VERA;Conjunctival Melanoma;pancreatic carcinoma;rectal adenocarcinoma;Gastric Mantle Cell Lymphoma;lymphoid neoplasm;Pleural Mesothelioma;Thyroid Gland Undifferentiated (Anaplastic) Carcinoma;small intestinal adenocarcinoma;ovarian serous adenocarcinoma;ATAXIA-TELANGIECTASIA VARIANT;Familial colorectal cancer Type X;Laryngeal squamous cell carcinoma;ND;Breast Cancer;thyroid neoplasm;soft tissue sarcoma;colorectal adenocarcinoma;Lung sarcomatoid carcinoma;Chronic lymphocytic leukemia;bladder transitional cell carcinoma;Anaplastic Malignant Meningioma;breast ductal adenocarcinoma;Testicular Leydig Cell Tumor;Anaplastic oligodendroglioma;nodular melanoma;Alveolar rhabdomyosarcoma;Extramammary Paget Disease;Choroid plexus papilloma;unspecified peripheral T-cell lymphoma;Pancreatic Acinar Cell Carcinoma;Digestive System Carcinoma;diffuse large B-cell lymphoma;Merkel cell skin cancer;Meningothelial Meningioma;Fibrous Meningioma;Endometrial stromal sarcoma;Prostate Small Cell Carcinoma;Anaplastic astrocytoma;Hodgkins lymphoma;adrenal cortex carcinoma;Placental Choriocarcinoma;Lung Inflammatory Myofibroblastic Tumor;Splenic Mantle Cell Lymphoma;anaplastic large cell lymphoma;adenosquamous lung carcinoma;ovarian teratoma;Chronic myelomonocytic leukemia;Vaginal Melanoma;Rhabdoid Meningioma;Ulcerative colitis;ATAXIA-TELANGIECTASIA;prostate adenocarcinoma;Tracheal Adenoid Cystic Carcinoma;ovarian clear cell adenocarcinoma;Well-differentiated liposarcoma;marginal zone B-cell lymphoma;Adenoid Cystic Breast Carcinoma;squamous cell lung carcinoma;non-small cell lung carcinoma;Atypical Meningioma;Hepatocellular Carcinoma;cervical squamous cell carcinoma;PEComa;Parotid Gland Adenoid Cystic Carcinoma;Chronic Eosinophilic Leukemia, Not Otherwise Specified;Malignant Mesothelioma;gallbladder carcinoma;ATM-related cancer;embryonal rhabdomyosarcoma;Bladder Small Cell Neuroendocrine Carcinoma;Chronic neutrophilic leukemia;Sarcomatoid Carcinoma;metaplastic breast carcinoma;oral squamous cell carcinoma;urothelial carcinoma;Neoplasm;pulmonary blastoma;Chronic myelogenous leukemia;Pleural Epithelioid Mesothelioma;Appendix Adenocarcinoma;Borderline Ovarian Mucinous Tumor;B-cell acute lymphoblastic leukemia;Renal cell carcinoma;Langerhans cell histiocytosis;Colorectal adenoma;Gastric Adenoma;Testicular Yolk Sac Tumor;Ampulla of Vater Carcinoma;Burkitts lymphoma;non-functioning pituitary adenoma;Ovarian Endometrioid Adenocarcinoma;Breast carcinoma;ovarian mucinous adenocarcinoma;Esophageal carcinoma;Gastric Neuroendocrine Tumor G1;Melanoma;Angioimmunoblastic T-cell lymphoma;Follicular Variant Thyroid Gland Papillary Carcinoma;Pancreatic adenocarcinoma;Unclassified Renal Cell Carcinoma;Benign Smooth Muscle Neoplasm;gastric adenocarcinoma;Papillary renal cell carcinoma;blastic plasmacytoid dendritic cell neoplasm;Spinal Cord Astrocytoma;adrenocortical adenoma;Duodenal Adenocarcinoma;MYELODYSPLASTIC SYNDROME;bronchoalveolar adenocarcinoma;Parathyroid Gland Carcinoma;cervical adenocarcinoma;Small cell lung carcinoma;skin appendage carcinoma;ovarian carcinoma;Multiple myeloma;Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation;pharyngeal squamous cell carcinoma;ovarian adenocarcinoma;Eccrine porocarcinoma;Salivary Gland Carcinoma ex Pleomorphic Adenoma;leiomyosarcoma;renal carcinoma;Uterine Carcinosarcoma;MANTLE CELL LYMPHOMA;Endometrial Clear Cell Adenocarcinoma;ATAXIA-TELANGIECTASIA;Chordoid Meningioma;Chromophobe renal cell carcinoma;Gallbladder Adenocarcinoma;angiosarcoma;colon adenocarcinoma;lobular breast carcinoma;Esophageal adenocarcinoma;Transitional Meningioma;breast adenosis;B-cell chronic lymphocytic leukemia;Endometrial Endometrioid Adenocarcinoma;Esophageal Squamous Cell Carcinoma;Endometrial carcinoma;Papillary thyroid carcinoma;Familial prostate cancer;Extraskeletal Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor;colonic neoplasm;amelanotic skin melanoma;pancreatic neoplasm;Acute lymphoblastic leukemia;Gallbladder Small Cell Neuroendocrine Carcinoma;diffuse gastric adenocarcinoma;Breast Cancer;ATAXIA-TELANGIECTASIA"
MLH1,MLH1,"pharyngeal squamous cell carcinoma;Breast Carcinoma by Gene Expression Profile;kidney neoplasm;Renal cell carcinoma;angiosarcoma;Appendix Adenocarcinoma;non-small cell lung carcinoma;Ovarian Carcinosarcoma;Mixed Lobular and Ductal Breast Carcinoma;lobular breast carcinoma;Colorectal adenoma;ovarian serous adenocarcinoma;Pancreatic Acinar Cell Carcinoma;ND;T-cell acute lymphoblastic leukemia;Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive;endometrium adenocarcinoma;Merkel cell skin cancer;Constitutional mismatch repair deficiency syndrome;urothelial carcinoma;Dysplasia in Ulcerative Colitis;blastic plasmacytoid dendritic cell neoplasm;Constitutional mismatch repair deficiency syndrome;Kidney Oncocytoma;Thyroid Gland Undifferentiated (Anaplastic) Carcinoma;gastric carcinoma;adenosquamous lung carcinoma;pancreatic carcinoma;Alveolar rhabdomyosarcoma;Papillary renal cell carcinoma;soft tissue sarcoma;Endometrial Endometrioid Adenocarcinoma;Breast carcinoma;Pleural Biphasic Mesothelioma;oral squamous cell carcinoma;sebaceous adenocarcinoma;hairy cell leukemia;prostate carcinoma;Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation;Parathyroid Gland Carcinoma;Acute myeloid leukemia;embryonal rhabdomyosarcoma;gastric intestinal type adenocarcinoma;Ovarian Granulosa Cell Tumor;pancreatic neuroendocrine tumor;Adenoid Cystic Breast Carcinoma;Melanoma;Atypical endometrial hyperplasia;Carcinoma;Lung carcinoma;Clear cell renal carcinoma;cervical squamous cell carcinoma;Rhabdomyosarcoma;gastric adenocarcinoma;Adrenal Gland Neuroblastoma;Muir-Torre syndrome;Acute lymphoblastic leukemia;ovarian carcinoma;Ulcerative colitis;HER2 positive breast carcinoma;Ovarian Endometrioid Adenocarcinoma;cutaneous melanoma;LYNCH SYNDROME 2;Laryngeal squamous cell carcinoma;Anaplastic oligodendroglioma;skin carcinoma;Transitional Meningioma;Fibrous Meningioma;Lung sarcomatoid carcinoma;prostate adenocarcinoma;Bladder Small Cell Neuroendocrine Carcinoma;Hepatocellular Carcinoma;Small cell lung carcinoma;Chronic lymphocytic leukemia;Chronic myelogenous leukemia;Multiple myeloma;MANTLE CELL LYMPHOMA;ovarian clear cell adenocarcinoma;colorectal adenocarcinoma;Muir-Torre syndrome;Digestive System Carcinoma;Unclassified Renal Cell Carcinoma;Atypical Meningioma;colon carcinoma;breast ductal adenocarcinoma;Glioma;lymphoid neoplasm;metaplastic breast carcinoma;cecum adenocarcinoma;Esophageal carcinoma;Thymic Carcinoma;Endometrial Clear Cell Adenocarcinoma;ovarian mucinous adenocarcinoma;Pleural Epithelioid Mesothelioma;Esophageal Squamous Cell Carcinoma;plasmacytoma;Extraskeletal Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor;colon adenocarcinoma;Synovial sarcoma;bladder transitional cell carcinoma;Anaplastic astrocytoma;Uterine Carcinosarcoma;Gallbladder Adenocarcinoma;Malignancy in Giant Cell Tumor of Bone;CONSTITUTIONAL MISMATCH REPAIR DEFICIENCY SYNDROME CCMRD;nodular melanoma;Endometrial Undifferentiated Carcinoma;Small Intestinal Tubulovillous Adenoma;Appendix Goblet Cell Carcinoid;rectal adenocarcinoma;OSTEOSARCOMA;Lynch syndrome;brain glioblastoma;head and neck squamous cell carcinoma;diffuse large B-cell lymphoma;Lynch syndrome;adrenal cortex carcinoma;B-cell acute lymphoblastic leukemia;squamous cell lung carcinoma;Lung adenocarcinoma;Duodenal Adenocarcinoma;marginal zone B-cell lymphoma;testicular seminoma;MISMATCH REPAIR CANCER SYNDROME 1;Extramammary Paget Disease;Gastric Adenoma;Hepatobiliary Neoplasm;bile duct carcinoma;Endometrial carcinoma;Eccrine porocarcinoma;Brain Stem Glioblastoma;ovarian teratoma;follicular thyroid carcinoma;Esophageal adenocarcinoma;nasopharyngeal squamous cell carcinoma;Ovarian Endometriosis;LYNCH SYNDROME 2;Muir-Torre syndrome;MISMATCH REPAIR CANCER SYNDROME 1"
MLH1_aug1,MLH1,"pharyngeal squamous cell carcinoma;Breast Carcinoma by Gene Expression Profile;kidney neoplasm;Renal cell carcinoma;angiosarcoma;Appendix Adenocarcinoma;non-small cell lung carcinoma;Ovarian Carcinosarcoma;Mixed Lobular and Ductal Breast Carcinoma;lobular breast carcinoma;Colorectal adenoma;ovarian serous adenocarcinoma;Pancreatic Acinar Cell Carcinoma;ND;T-cell acute lymphoblastic leukemia;Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive;endometrium adenocarcinoma;Merkel cell skin cancer;Constitutional mismatch repair deficiency syndrome;urothelial carcinoma;Dysplasia in Ulcerative Colitis;blastic plasmacytoid dendritic cell neoplasm;Constitutional mismatch repair deficiency syndrome;Kidney Oncocytoma;Thyroid Gland Undifferentiated (Anaplastic) Carcinoma;gastric carcinoma;adenosquamous lung carcinoma;pancreatic carcinoma;Alveolar rhabdomyosarcoma;Papillary renal cell carcinoma;soft tissue sarcoma;Endometrial Endometrioid Adenocarcinoma;Breast carcinoma;Pleural Biphasic Mesothelioma;oral squamous cell carcinoma;sebaceous adenocarcinoma;hairy cell leukemia;prostate carcinoma;Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation;Parathyroid Gland Carcinoma;Acute myeloid leukemia;embryonal rhabdomyosarcoma;gastric intestinal type adenocarcinoma;Ovarian Granulosa Cell Tumor;pancreatic neuroendocrine tumor;Adenoid Cystic Breast Carcinoma;Melanoma;Atypical endometrial hyperplasia;Carcinoma;Lung carcinoma;Clear cell renal carcinoma;cervical squamous cell carcinoma;Rhabdomyosarcoma;gastric adenocarcinoma;Adrenal Gland Neuroblastoma;Muir-Torre syndrome;Acute lymphoblastic leukemia;ovarian carcinoma;Ulcerative colitis;HER2 positive breast carcinoma;Ovarian Endometrioid Adenocarcinoma;cutaneous melanoma;LYNCH SYNDROME 2;Laryngeal squamous cell carcinoma;Anaplastic oligodendroglioma;skin carcinoma;Transitional Meningioma;Fibrous Meningioma;Lung sarcomatoid carcinoma;prostate adenocarcinoma;Bladder Small Cell Neuroendocrine Carcinoma;Hepatocellular Carcinoma;Small cell lung carcinoma;Chronic lymphocytic leukemia;Chronic myelogenous leukemia;Multiple myeloma;MANTLE CELL LYMPHOMA;ovarian clear cell adenocarcinoma;colorectal adenocarcinoma;Muir-Torre syndrome;Digestive System Carcinoma;Unclassified Renal Cell Carcinoma;Atypical Meningioma;colon carcinoma;breast ductal adenocarcinoma;Glioma;lymphoid neoplasm;metaplastic breast carcinoma;cecum adenocarcinoma;Esophageal carcinoma;Thymic Carcinoma;Endometrial Clear Cell Adenocarcinoma;ovarian mucinous adenocarcinoma;Pleural Epithelioid Mesothelioma;Esophageal Squamous Cell Carcinoma;plasmacytoma;Extraskeletal Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor;colon adenocarcinoma;Synovial sarcoma;bladder transitional cell carcinoma;Anaplastic astrocytoma;Uterine Carcinosarcoma;Gallbladder Adenocarcinoma;Malignancy in Giant Cell Tumor of Bone;CONSTITUTIONAL MISMATCH REPAIR DEFICIENCY SYNDROME CCMRD;nodular melanoma;Endometrial Undifferentiated Carcinoma;Small Intestinal Tubulovillous Adenoma;Appendix Goblet Cell Carcinoid;rectal adenocarcinoma;OSTEOSARCOMA;Lynch syndrome;brain glioblastoma;head and neck squamous cell carcinoma;diffuse large B-cell lymphoma;Lynch syndrome;adrenal cortex carcinoma;B-cell acute lymphoblastic leukemia;squamous cell lung carcinoma;Lung adenocarcinoma;Duodenal Adenocarcinoma;marginal zone B-cell lymphoma;testicular seminoma;MISMATCH REPAIR CANCER SYNDROME 1;Extramammary Paget Disease;Gastric Adenoma;Hepatobiliary Neoplasm;bile duct carcinoma;Endometrial carcinoma;Eccrine porocarcinoma;Brain Stem Glioblastoma;ovarian teratoma;follicular thyroid carcinoma;Esophageal adenocarcinoma;nasopharyngeal squamous cell carcinoma;Ovarian Endometriosis;LYNCH SYNDROME 2;Muir-Torre syndrome;MISMATCH REPAIR CANCER SYNDROME 1"
MLH1_aug2,MLH1,"pharyngeal squamous cell carcinoma;Breast Carcinoma by Gene Expression Profile;kidney neoplasm;Renal cell carcinoma;angiosarcoma;Appendix Adenocarcinoma;non-small cell lung carcinoma;Ovarian Carcinosarcoma;Mixed Lobular and Ductal Breast Carcinoma;lobular breast carcinoma;Colorectal adenoma;ovarian serous adenocarcinoma;Pancreatic Acinar Cell Carcinoma;ND;T-cell acute lymphoblastic leukemia;Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive;endometrium adenocarcinoma;Merkel cell skin cancer;Constitutional mismatch repair deficiency syndrome;urothelial carcinoma;Dysplasia in Ulcerative Colitis;blastic plasmacytoid dendritic cell neoplasm;Constitutional mismatch repair deficiency syndrome;Kidney Oncocytoma;Thyroid Gland Undifferentiated (Anaplastic) Carcinoma;gastric carcinoma;adenosquamous lung carcinoma;pancreatic carcinoma;Alveolar rhabdomyosarcoma;Papillary renal cell carcinoma;soft tissue sarcoma;Endometrial Endometrioid Adenocarcinoma;Breast carcinoma;Pleural Biphasic Mesothelioma;oral squamous cell carcinoma;sebaceous adenocarcinoma;hairy cell leukemia;prostate carcinoma;Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation;Parathyroid Gland Carcinoma;Acute myeloid leukemia;embryonal rhabdomyosarcoma;gastric intestinal type adenocarcinoma;Ovarian Granulosa Cell Tumor;pancreatic neuroendocrine tumor;Adenoid Cystic Breast Carcinoma;Melanoma;Atypical endometrial hyperplasia;Carcinoma;Lung carcinoma;Clear cell renal carcinoma;cervical squamous cell carcinoma;Rhabdomyosarcoma;gastric adenocarcinoma;Adrenal Gland Neuroblastoma;Muir-Torre syndrome;Acute lymphoblastic leukemia;ovarian carcinoma;Ulcerative colitis;HER2 positive breast carcinoma;Ovarian Endometrioid Adenocarcinoma;cutaneous melanoma;LYNCH SYNDROME 2;Laryngeal squamous cell carcinoma;Anaplastic oligodendroglioma;skin carcinoma;Transitional Meningioma;Fibrous Meningioma;Lung sarcomatoid carcinoma;prostate adenocarcinoma;Bladder Small Cell Neuroendocrine Carcinoma;Hepatocellular Carcinoma;Small cell lung carcinoma;Chronic lymphocytic leukemia;Chronic myelogenous leukemia;Multiple myeloma;MANTLE CELL LYMPHOMA;ovarian clear cell adenocarcinoma;colorectal adenocarcinoma;Muir-Torre syndrome;Digestive System Carcinoma;Unclassified Renal Cell Carcinoma;Atypical Meningioma;colon carcinoma;breast ductal adenocarcinoma;Glioma;lymphoid neoplasm;metaplastic breast carcinoma;cecum adenocarcinoma;Esophageal carcinoma;Thymic Carcinoma;Endometrial Clear Cell Adenocarcinoma;ovarian mucinous adenocarcinoma;Pleural Epithelioid Mesothelioma;Esophageal Squamous Cell Carcinoma;plasmacytoma;Extraskeletal Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor;colon adenocarcinoma;Synovial sarcoma;bladder transitional cell carcinoma;Anaplastic astrocytoma;Uterine Carcinosarcoma;Gallbladder Adenocarcinoma;Malignancy in Giant Cell Tumor of Bone;CONSTITUTIONAL MISMATCH REPAIR DEFICIENCY SYNDROME CCMRD;nodular melanoma;Endometrial Undifferentiated Carcinoma;Small Intestinal Tubulovillous Adenoma;Appendix Goblet Cell Carcinoid;rectal adenocarcinoma;OSTEOSARCOMA;Lynch syndrome;brain glioblastoma;head and neck squamous cell carcinoma;diffuse large B-cell lymphoma;Lynch syndrome;adrenal cortex carcinoma;B-cell acute lymphoblastic leukemia;squamous cell lung carcinoma;Lung adenocarcinoma;Duodenal Adenocarcinoma;marginal zone B-cell lymphoma;testicular seminoma;MISMATCH REPAIR CANCER SYNDROME 1;Extramammary Paget Disease;Gastric Adenoma;Hepatobiliary Neoplasm;bile duct carcinoma;Endometrial carcinoma;Eccrine porocarcinoma;Brain Stem Glioblastoma;ovarian teratoma;follicular thyroid carcinoma;Esophageal adenocarcinoma;nasopharyngeal squamous cell carcinoma;Ovarian Endometriosis;LYNCH SYNDROME 2;Muir-Torre syndrome;MISMATCH REPAIR CANCER SYNDROME 1"
MLH1_aug3,MLH1,"pharyngeal squamous cell carcinoma;Breast Carcinoma by Gene Expression Profile;kidney neoplasm;Renal cell carcinoma;angiosarcoma;Appendix Adenocarcinoma;non-small cell lung carcinoma;Ovarian Carcinosarcoma;Mixed Lobular and Ductal Breast Carcinoma;lobular breast carcinoma;Colorectal adenoma;ovarian serous adenocarcinoma;Pancreatic Acinar Cell Carcinoma;ND;T-cell acute lymphoblastic leukemia;Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive;endometrium adenocarcinoma;Merkel cell skin cancer;Constitutional mismatch repair deficiency syndrome;urothelial carcinoma;Dysplasia in Ulcerative Colitis;blastic plasmacytoid dendritic cell neoplasm;Constitutional mismatch repair deficiency syndrome;Kidney Oncocytoma;Thyroid Gland Undifferentiated (Anaplastic) Carcinoma;gastric carcinoma;adenosquamous lung carcinoma;pancreatic carcinoma;Alveolar rhabdomyosarcoma;Papillary renal cell carcinoma;soft tissue sarcoma;Endometrial Endometrioid Adenocarcinoma;Breast carcinoma;Pleural Biphasic Mesothelioma;oral squamous cell carcinoma;sebaceous adenocarcinoma;hairy cell leukemia;prostate carcinoma;Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation;Parathyroid Gland Carcinoma;Acute myeloid leukemia;embryonal rhabdomyosarcoma;gastric intestinal type adenocarcinoma;Ovarian Granulosa Cell Tumor;pancreatic neuroendocrine tumor;Adenoid Cystic Breast Carcinoma;Melanoma;Atypical endometrial hyperplasia;Carcinoma;Lung carcinoma;Clear cell renal carcinoma;cervical squamous cell carcinoma;Rhabdomyosarcoma;gastric adenocarcinoma;Adrenal Gland Neuroblastoma;Muir-Torre syndrome;Acute lymphoblastic leukemia;ovarian carcinoma;Ulcerative colitis;HER2 positive breast carcinoma;Ovarian Endometrioid Adenocarcinoma;cutaneous melanoma;LYNCH SYNDROME 2;Laryngeal squamous cell carcinoma;Anaplastic oligodendroglioma;skin carcinoma;Transitional Meningioma;Fibrous Meningioma;Lung sarcomatoid carcinoma;prostate adenocarcinoma;Bladder Small Cell Neuroendocrine Carcinoma;Hepatocellular Carcinoma;Small cell lung carcinoma;Chronic lymphocytic leukemia;Chronic myelogenous leukemia;Multiple myeloma;MANTLE CELL LYMPHOMA;ovarian clear cell adenocarcinoma;colorectal adenocarcinoma;Muir-Torre syndrome;Digestive System Carcinoma;Unclassified Renal Cell Carcinoma;Atypical Meningioma;colon carcinoma;breast ductal adenocarcinoma;Glioma;lymphoid neoplasm;metaplastic breast carcinoma;cecum adenocarcinoma;Esophageal carcinoma;Thymic Carcinoma;Endometrial Clear Cell Adenocarcinoma;ovarian mucinous adenocarcinoma;Pleural Epithelioid Mesothelioma;Esophageal Squamous Cell Carcinoma;plasmacytoma;Extraskeletal Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor;colon adenocarcinoma;Synovial sarcoma;bladder transitional cell carcinoma;Anaplastic astrocytoma;Uterine Carcinosarcoma;Gallbladder Adenocarcinoma;Malignancy in Giant Cell Tumor of Bone;CONSTITUTIONAL MISMATCH REPAIR DEFICIENCY SYNDROME CCMRD;nodular melanoma;Endometrial Undifferentiated Carcinoma;Small Intestinal Tubulovillous Adenoma;Appendix Goblet Cell Carcinoid;rectal adenocarcinoma;OSTEOSARCOMA;Lynch syndrome;brain glioblastoma;head and neck squamous cell carcinoma;diffuse large B-cell lymphoma;Lynch syndrome;adrenal cortex carcinoma;B-cell acute lymphoblastic leukemia;squamous cell lung carcinoma;Lung adenocarcinoma;Duodenal Adenocarcinoma;marginal zone B-cell lymphoma;testicular seminoma;MISMATCH REPAIR CANCER SYNDROME 1;Extramammary Paget Disease;Gastric Adenoma;Hepatobiliary Neoplasm;bile duct carcinoma;Endometrial carcinoma;Eccrine porocarcinoma;Brain Stem Glioblastoma;ovarian teratoma;follicular thyroid carcinoma;Esophageal adenocarcinoma;nasopharyngeal squamous cell carcinoma;Ovarian Endometriosis;LYNCH SYNDROME 2;Muir-Torre syndrome;MISMATCH REPAIR CANCER SYNDROME 1"
MLH1_aug4,MLH1,"pharyngeal squamous cell carcinoma;Breast Carcinoma by Gene Expression Profile;kidney neoplasm;Renal cell carcinoma;angiosarcoma;Appendix Adenocarcinoma;non-small cell lung carcinoma;Ovarian Carcinosarcoma;Mixed Lobular and Ductal Breast Carcinoma;lobular breast carcinoma;Colorectal adenoma;ovarian serous adenocarcinoma;Pancreatic Acinar Cell Carcinoma;ND;T-cell acute lymphoblastic leukemia;Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive;endometrium adenocarcinoma;Merkel cell skin cancer;Constitutional mismatch repair deficiency syndrome;urothelial carcinoma;Dysplasia in Ulcerative Colitis;blastic plasmacytoid dendritic cell neoplasm;Constitutional mismatch repair deficiency syndrome;Kidney Oncocytoma;Thyroid Gland Undifferentiated (Anaplastic) Carcinoma;gastric carcinoma;adenosquamous lung carcinoma;pancreatic carcinoma;Alveolar rhabdomyosarcoma;Papillary renal cell carcinoma;soft tissue sarcoma;Endometrial Endometrioid Adenocarcinoma;Breast carcinoma;Pleural Biphasic Mesothelioma;oral squamous cell carcinoma;sebaceous adenocarcinoma;hairy cell leukemia;prostate carcinoma;Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation;Parathyroid Gland Carcinoma;Acute myeloid leukemia;embryonal rhabdomyosarcoma;gastric intestinal type adenocarcinoma;Ovarian Granulosa Cell Tumor;pancreatic neuroendocrine tumor;Adenoid Cystic Breast Carcinoma;Melanoma;Atypical endometrial hyperplasia;Carcinoma;Lung carcinoma;Clear cell renal carcinoma;cervical squamous cell carcinoma;Rhabdomyosarcoma;gastric adenocarcinoma;Adrenal Gland Neuroblastoma;Muir-Torre syndrome;Acute lymphoblastic leukemia;ovarian carcinoma;Ulcerative colitis;HER2 positive breast carcinoma;Ovarian Endometrioid Adenocarcinoma;cutaneous melanoma;LYNCH SYNDROME 2;Laryngeal squamous cell carcinoma;Anaplastic oligodendroglioma;skin carcinoma;Transitional Meningioma;Fibrous Meningioma;Lung sarcomatoid carcinoma;prostate adenocarcinoma;Bladder Small Cell Neuroendocrine Carcinoma;Hepatocellular Carcinoma;Small cell lung carcinoma;Chronic lymphocytic leukemia;Chronic myelogenous leukemia;Multiple myeloma;MANTLE CELL LYMPHOMA;ovarian clear cell adenocarcinoma;colorectal adenocarcinoma;Muir-Torre syndrome;Digestive System Carcinoma;Unclassified Renal Cell Carcinoma;Atypical Meningioma;colon carcinoma;breast ductal adenocarcinoma;Glioma;lymphoid neoplasm;metaplastic breast carcinoma;cecum adenocarcinoma;Esophageal carcinoma;Thymic Carcinoma;Endometrial Clear Cell Adenocarcinoma;ovarian mucinous adenocarcinoma;Pleural Epithelioid Mesothelioma;Esophageal Squamous Cell Carcinoma;plasmacytoma;Extraskeletal Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor;colon adenocarcinoma;Synovial sarcoma;bladder transitional cell carcinoma;Anaplastic astrocytoma;Uterine Carcinosarcoma;Gallbladder Adenocarcinoma;Malignancy in Giant Cell Tumor of Bone;CONSTITUTIONAL MISMATCH REPAIR DEFICIENCY SYNDROME CCMRD;nodular melanoma;Endometrial Undifferentiated Carcinoma;Small Intestinal Tubulovillous Adenoma;Appendix Goblet Cell Carcinoid;rectal adenocarcinoma;OSTEOSARCOMA;Lynch syndrome;brain glioblastoma;head and neck squamous cell carcinoma;diffuse large B-cell lymphoma;Lynch syndrome;adrenal cortex carcinoma;B-cell acute lymphoblastic leukemia;squamous cell lung carcinoma;Lung adenocarcinoma;Duodenal Adenocarcinoma;marginal zone B-cell lymphoma;testicular seminoma;MISMATCH REPAIR CANCER SYNDROME 1;Extramammary Paget Disease;Gastric Adenoma;Hepatobiliary Neoplasm;bile duct carcinoma;Endometrial carcinoma;Eccrine porocarcinoma;Brain Stem Glioblastoma;ovarian teratoma;follicular thyroid carcinoma;Esophageal adenocarcinoma;nasopharyngeal squamous cell carcinoma;Ovarian Endometriosis;LYNCH SYNDROME 2;Muir-Torre syndrome;MISMATCH REPAIR CANCER SYNDROME 1"
MLH1_aug5,MLH1,"pharyngeal squamous cell carcinoma;Breast Carcinoma by Gene Expression Profile;kidney neoplasm;Renal cell carcinoma;angiosarcoma;Appendix Adenocarcinoma;non-small cell lung carcinoma;Ovarian Carcinosarcoma;Mixed Lobular and Ductal Breast Carcinoma;lobular breast carcinoma;Colorectal adenoma;ovarian serous adenocarcinoma;Pancreatic Acinar Cell Carcinoma;ND;T-cell acute lymphoblastic leukemia;Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive;endometrium adenocarcinoma;Merkel cell skin cancer;Constitutional mismatch repair deficiency syndrome;urothelial carcinoma;Dysplasia in Ulcerative Colitis;blastic plasmacytoid dendritic cell neoplasm;Constitutional mismatch repair deficiency syndrome;Kidney Oncocytoma;Thyroid Gland Undifferentiated (Anaplastic) Carcinoma;gastric carcinoma;adenosquamous lung carcinoma;pancreatic carcinoma;Alveolar rhabdomyosarcoma;Papillary renal cell carcinoma;soft tissue sarcoma;Endometrial Endometrioid Adenocarcinoma;Breast carcinoma;Pleural Biphasic Mesothelioma;oral squamous cell carcinoma;sebaceous adenocarcinoma;hairy cell leukemia;prostate carcinoma;Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation;Parathyroid Gland Carcinoma;Acute myeloid leukemia;embryonal rhabdomyosarcoma;gastric intestinal type adenocarcinoma;Ovarian Granulosa Cell Tumor;pancreatic neuroendocrine tumor;Adenoid Cystic Breast Carcinoma;Melanoma;Atypical endometrial hyperplasia;Carcinoma;Lung carcinoma;Clear cell renal carcinoma;cervical squamous cell carcinoma;Rhabdomyosarcoma;gastric adenocarcinoma;Adrenal Gland Neuroblastoma;Muir-Torre syndrome;Acute lymphoblastic leukemia;ovarian carcinoma;Ulcerative colitis;HER2 positive breast carcinoma;Ovarian Endometrioid Adenocarcinoma;cutaneous melanoma;LYNCH SYNDROME 2;Laryngeal squamous cell carcinoma;Anaplastic oligodendroglioma;skin carcinoma;Transitional Meningioma;Fibrous Meningioma;Lung sarcomatoid carcinoma;prostate adenocarcinoma;Bladder Small Cell Neuroendocrine Carcinoma;Hepatocellular Carcinoma;Small cell lung carcinoma;Chronic lymphocytic leukemia;Chronic myelogenous leukemia;Multiple myeloma;MANTLE CELL LYMPHOMA;ovarian clear cell adenocarcinoma;colorectal adenocarcinoma;Muir-Torre syndrome;Digestive System Carcinoma;Unclassified Renal Cell Carcinoma;Atypical Meningioma;colon carcinoma;breast ductal adenocarcinoma;Glioma;lymphoid neoplasm;metaplastic breast carcinoma;cecum adenocarcinoma;Esophageal carcinoma;Thymic Carcinoma;Endometrial Clear Cell Adenocarcinoma;ovarian mucinous adenocarcinoma;Pleural Epithelioid Mesothelioma;Esophageal Squamous Cell Carcinoma;plasmacytoma;Extraskeletal Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor;colon adenocarcinoma;Synovial sarcoma;bladder transitional cell carcinoma;Anaplastic astrocytoma;Uterine Carcinosarcoma;Gallbladder Adenocarcinoma;Malignancy in Giant Cell Tumor of Bone;CONSTITUTIONAL MISMATCH REPAIR DEFICIENCY SYNDROME CCMRD;nodular melanoma;Endometrial Undifferentiated Carcinoma;Small Intestinal Tubulovillous Adenoma;Appendix Goblet Cell Carcinoid;rectal adenocarcinoma;OSTEOSARCOMA;Lynch syndrome;brain glioblastoma;head and neck squamous cell carcinoma;diffuse large B-cell lymphoma;Lynch syndrome;adrenal cortex carcinoma;B-cell acute lymphoblastic leukemia;squamous cell lung carcinoma;Lung adenocarcinoma;Duodenal Adenocarcinoma;marginal zone B-cell lymphoma;testicular seminoma;MISMATCH REPAIR CANCER SYNDROME 1;Extramammary Paget Disease;Gastric Adenoma;Hepatobiliary Neoplasm;bile duct carcinoma;Endometrial carcinoma;Eccrine porocarcinoma;Brain Stem Glioblastoma;ovarian teratoma;follicular thyroid carcinoma;Esophageal adenocarcinoma;nasopharyngeal squamous cell carcinoma;Ovarian Endometriosis;LYNCH SYNDROME 2;Muir-Torre syndrome;MISMATCH REPAIR CANCER SYNDROME 1"
MLH1_aug6,MLH1,"pharyngeal squamous cell carcinoma;Breast Carcinoma by Gene Expression Profile;kidney neoplasm;Renal cell carcinoma;angiosarcoma;Appendix Adenocarcinoma;non-small cell lung carcinoma;Ovarian Carcinosarcoma;Mixed Lobular and Ductal Breast Carcinoma;lobular breast carcinoma;Colorectal adenoma;ovarian serous adenocarcinoma;Pancreatic Acinar Cell Carcinoma;ND;T-cell acute lymphoblastic leukemia;Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive;endometrium adenocarcinoma;Merkel cell skin cancer;Constitutional mismatch repair deficiency syndrome;urothelial carcinoma;Dysplasia in Ulcerative Colitis;blastic plasmacytoid dendritic cell neoplasm;Constitutional mismatch repair deficiency syndrome;Kidney Oncocytoma;Thyroid Gland Undifferentiated (Anaplastic) Carcinoma;gastric carcinoma;adenosquamous lung carcinoma;pancreatic carcinoma;Alveolar rhabdomyosarcoma;Papillary renal cell carcinoma;soft tissue sarcoma;Endometrial Endometrioid Adenocarcinoma;Breast carcinoma;Pleural Biphasic Mesothelioma;oral squamous cell carcinoma;sebaceous adenocarcinoma;hairy cell leukemia;prostate carcinoma;Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation;Parathyroid Gland Carcinoma;Acute myeloid leukemia;embryonal rhabdomyosarcoma;gastric intestinal type adenocarcinoma;Ovarian Granulosa Cell Tumor;pancreatic neuroendocrine tumor;Adenoid Cystic Breast Carcinoma;Melanoma;Atypical endometrial hyperplasia;Carcinoma;Lung carcinoma;Clear cell renal carcinoma;cervical squamous cell carcinoma;Rhabdomyosarcoma;gastric adenocarcinoma;Adrenal Gland Neuroblastoma;Muir-Torre syndrome;Acute lymphoblastic leukemia;ovarian carcinoma;Ulcerative colitis;HER2 positive breast carcinoma;Ovarian Endometrioid Adenocarcinoma;cutaneous melanoma;LYNCH SYNDROME 2;Laryngeal squamous cell carcinoma;Anaplastic oligodendroglioma;skin carcinoma;Transitional Meningioma;Fibrous Meningioma;Lung sarcomatoid carcinoma;prostate adenocarcinoma;Bladder Small Cell Neuroendocrine Carcinoma;Hepatocellular Carcinoma;Small cell lung carcinoma;Chronic lymphocytic leukemia;Chronic myelogenous leukemia;Multiple myeloma;MANTLE CELL LYMPHOMA;ovarian clear cell adenocarcinoma;colorectal adenocarcinoma;Muir-Torre syndrome;Digestive System Carcinoma;Unclassified Renal Cell Carcinoma;Atypical Meningioma;colon carcinoma;breast ductal adenocarcinoma;Glioma;lymphoid neoplasm;metaplastic breast carcinoma;cecum adenocarcinoma;Esophageal carcinoma;Thymic Carcinoma;Endometrial Clear Cell Adenocarcinoma;ovarian mucinous adenocarcinoma;Pleural Epithelioid Mesothelioma;Esophageal Squamous Cell Carcinoma;plasmacytoma;Extraskeletal Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor;colon adenocarcinoma;Synovial sarcoma;bladder transitional cell carcinoma;Anaplastic astrocytoma;Uterine Carcinosarcoma;Gallbladder Adenocarcinoma;Malignancy in Giant Cell Tumor of Bone;CONSTITUTIONAL MISMATCH REPAIR DEFICIENCY SYNDROME CCMRD;nodular melanoma;Endometrial Undifferentiated Carcinoma;Small Intestinal Tubulovillous Adenoma;Appendix Goblet Cell Carcinoid;rectal adenocarcinoma;OSTEOSARCOMA;Lynch syndrome;brain glioblastoma;head and neck squamous cell carcinoma;diffuse large B-cell lymphoma;Lynch syndrome;adrenal cortex carcinoma;B-cell acute lymphoblastic leukemia;squamous cell lung carcinoma;Lung adenocarcinoma;Duodenal Adenocarcinoma;marginal zone B-cell lymphoma;testicular seminoma;MISMATCH REPAIR CANCER SYNDROME 1;Extramammary Paget Disease;Gastric Adenoma;Hepatobiliary Neoplasm;bile duct carcinoma;Endometrial carcinoma;Eccrine porocarcinoma;Brain Stem Glioblastoma;ovarian teratoma;follicular thyroid carcinoma;Esophageal adenocarcinoma;nasopharyngeal squamous cell carcinoma;Ovarian Endometriosis;LYNCH SYNDROME 2;Muir-Torre syndrome;MISMATCH REPAIR CANCER SYNDROME 1"
MLH1_aug7,MLH1,"pharyngeal squamous cell carcinoma;Breast Carcinoma by Gene Expression Profile;kidney neoplasm;Renal cell carcinoma;angiosarcoma;Appendix Adenocarcinoma;non-small cell lung carcinoma;Ovarian Carcinosarcoma;Mixed Lobular and Ductal Breast Carcinoma;lobular breast carcinoma;Colorectal adenoma;ovarian serous adenocarcinoma;Pancreatic Acinar Cell Carcinoma;ND;T-cell acute lymphoblastic leukemia;Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive;endometrium adenocarcinoma;Merkel cell skin cancer;Constitutional mismatch repair deficiency syndrome;urothelial carcinoma;Dysplasia in Ulcerative Colitis;blastic plasmacytoid dendritic cell neoplasm;Constitutional mismatch repair deficiency syndrome;Kidney Oncocytoma;Thyroid Gland Undifferentiated (Anaplastic) Carcinoma;gastric carcinoma;adenosquamous lung carcinoma;pancreatic carcinoma;Alveolar rhabdomyosarcoma;Papillary renal cell carcinoma;soft tissue sarcoma;Endometrial Endometrioid Adenocarcinoma;Breast carcinoma;Pleural Biphasic Mesothelioma;oral squamous cell carcinoma;sebaceous adenocarcinoma;hairy cell leukemia;prostate carcinoma;Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation;Parathyroid Gland Carcinoma;Acute myeloid leukemia;embryonal rhabdomyosarcoma;gastric intestinal type adenocarcinoma;Ovarian Granulosa Cell Tumor;pancreatic neuroendocrine tumor;Adenoid Cystic Breast Carcinoma;Melanoma;Atypical endometrial hyperplasia;Carcinoma;Lung carcinoma;Clear cell renal carcinoma;cervical squamous cell carcinoma;Rhabdomyosarcoma;gastric adenocarcinoma;Adrenal Gland Neuroblastoma;Muir-Torre syndrome;Acute lymphoblastic leukemia;ovarian carcinoma;Ulcerative colitis;HER2 positive breast carcinoma;Ovarian Endometrioid Adenocarcinoma;cutaneous melanoma;LYNCH SYNDROME 2;Laryngeal squamous cell carcinoma;Anaplastic oligodendroglioma;skin carcinoma;Transitional Meningioma;Fibrous Meningioma;Lung sarcomatoid carcinoma;prostate adenocarcinoma;Bladder Small Cell Neuroendocrine Carcinoma;Hepatocellular Carcinoma;Small cell lung carcinoma;Chronic lymphocytic leukemia;Chronic myelogenous leukemia;Multiple myeloma;MANTLE CELL LYMPHOMA;ovarian clear cell adenocarcinoma;colorectal adenocarcinoma;Muir-Torre syndrome;Digestive System Carcinoma;Unclassified Renal Cell Carcinoma;Atypical Meningioma;colon carcinoma;breast ductal adenocarcinoma;Glioma;lymphoid neoplasm;metaplastic breast carcinoma;cecum adenocarcinoma;Esophageal carcinoma;Thymic Carcinoma;Endometrial Clear Cell Adenocarcinoma;ovarian mucinous adenocarcinoma;Pleural Epithelioid Mesothelioma;Esophageal Squamous Cell Carcinoma;plasmacytoma;Extraskeletal Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor;colon adenocarcinoma;Synovial sarcoma;bladder transitional cell carcinoma;Anaplastic astrocytoma;Uterine Carcinosarcoma;Gallbladder Adenocarcinoma;Malignancy in Giant Cell Tumor of Bone;CONSTITUTIONAL MISMATCH REPAIR DEFICIENCY SYNDROME CCMRD;nodular melanoma;Endometrial Undifferentiated Carcinoma;Small Intestinal Tubulovillous Adenoma;Appendix Goblet Cell Carcinoid;rectal adenocarcinoma;OSTEOSARCOMA;Lynch syndrome;brain glioblastoma;head and neck squamous cell carcinoma;diffuse large B-cell lymphoma;Lynch syndrome;adrenal cortex carcinoma;B-cell acute lymphoblastic leukemia;squamous cell lung carcinoma;Lung adenocarcinoma;Duodenal Adenocarcinoma;marginal zone B-cell lymphoma;testicular seminoma;MISMATCH REPAIR CANCER SYNDROME 1;Extramammary Paget Disease;Gastric Adenoma;Hepatobiliary Neoplasm;bile duct carcinoma;Endometrial carcinoma;Eccrine porocarcinoma;Brain Stem Glioblastoma;ovarian teratoma;follicular thyroid carcinoma;Esophageal adenocarcinoma;nasopharyngeal squamous cell carcinoma;Ovarian Endometriosis;LYNCH SYNDROME 2;Muir-Torre syndrome;MISMATCH REPAIR CANCER SYNDROME 1"
MLH1_aug8,MLH1,"pharyngeal squamous cell carcinoma;Breast Carcinoma by Gene Expression Profile;kidney neoplasm;Renal cell carcinoma;angiosarcoma;Appendix Adenocarcinoma;non-small cell lung carcinoma;Ovarian Carcinosarcoma;Mixed Lobular and Ductal Breast Carcinoma;lobular breast carcinoma;Colorectal adenoma;ovarian serous adenocarcinoma;Pancreatic Acinar Cell Carcinoma;ND;T-cell acute lymphoblastic leukemia;Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive;endometrium adenocarcinoma;Merkel cell skin cancer;Constitutional mismatch repair deficiency syndrome;urothelial carcinoma;Dysplasia in Ulcerative Colitis;blastic plasmacytoid dendritic cell neoplasm;Constitutional mismatch repair deficiency syndrome;Kidney Oncocytoma;Thyroid Gland Undifferentiated (Anaplastic) Carcinoma;gastric carcinoma;adenosquamous lung carcinoma;pancreatic carcinoma;Alveolar rhabdomyosarcoma;Papillary renal cell carcinoma;soft tissue sarcoma;Endometrial Endometrioid Adenocarcinoma;Breast carcinoma;Pleural Biphasic Mesothelioma;oral squamous cell carcinoma;sebaceous adenocarcinoma;hairy cell leukemia;prostate carcinoma;Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation;Parathyroid Gland Carcinoma;Acute myeloid leukemia;embryonal rhabdomyosarcoma;gastric intestinal type adenocarcinoma;Ovarian Granulosa Cell Tumor;pancreatic neuroendocrine tumor;Adenoid Cystic Breast Carcinoma;Melanoma;Atypical endometrial hyperplasia;Carcinoma;Lung carcinoma;Clear cell renal carcinoma;cervical squamous cell carcinoma;Rhabdomyosarcoma;gastric adenocarcinoma;Adrenal Gland Neuroblastoma;Muir-Torre syndrome;Acute lymphoblastic leukemia;ovarian carcinoma;Ulcerative colitis;HER2 positive breast carcinoma;Ovarian Endometrioid Adenocarcinoma;cutaneous melanoma;LYNCH SYNDROME 2;Laryngeal squamous cell carcinoma;Anaplastic oligodendroglioma;skin carcinoma;Transitional Meningioma;Fibrous Meningioma;Lung sarcomatoid carcinoma;prostate adenocarcinoma;Bladder Small Cell Neuroendocrine Carcinoma;Hepatocellular Carcinoma;Small cell lung carcinoma;Chronic lymphocytic leukemia;Chronic myelogenous leukemia;Multiple myeloma;MANTLE CELL LYMPHOMA;ovarian clear cell adenocarcinoma;colorectal adenocarcinoma;Muir-Torre syndrome;Digestive System Carcinoma;Unclassified Renal Cell Carcinoma;Atypical Meningioma;colon carcinoma;breast ductal adenocarcinoma;Glioma;lymphoid neoplasm;metaplastic breast carcinoma;cecum adenocarcinoma;Esophageal carcinoma;Thymic Carcinoma;Endometrial Clear Cell Adenocarcinoma;ovarian mucinous adenocarcinoma;Pleural Epithelioid Mesothelioma;Esophageal Squamous Cell Carcinoma;plasmacytoma;Extraskeletal Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor;colon adenocarcinoma;Synovial sarcoma;bladder transitional cell carcinoma;Anaplastic astrocytoma;Uterine Carcinosarcoma;Gallbladder Adenocarcinoma;Malignancy in Giant Cell Tumor of Bone;CONSTITUTIONAL MISMATCH REPAIR DEFICIENCY SYNDROME CCMRD;nodular melanoma;Endometrial Undifferentiated Carcinoma;Small Intestinal Tubulovillous Adenoma;Appendix Goblet Cell Carcinoid;rectal adenocarcinoma;OSTEOSARCOMA;Lynch syndrome;brain glioblastoma;head and neck squamous cell carcinoma;diffuse large B-cell lymphoma;Lynch syndrome;adrenal cortex carcinoma;B-cell acute lymphoblastic leukemia;squamous cell lung carcinoma;Lung adenocarcinoma;Duodenal Adenocarcinoma;marginal zone B-cell lymphoma;testicular seminoma;MISMATCH REPAIR CANCER SYNDROME 1;Extramammary Paget Disease;Gastric Adenoma;Hepatobiliary Neoplasm;bile duct carcinoma;Endometrial carcinoma;Eccrine porocarcinoma;Brain Stem Glioblastoma;ovarian teratoma;follicular thyroid carcinoma;Esophageal adenocarcinoma;nasopharyngeal squamous cell carcinoma;Ovarian Endometriosis;LYNCH SYNDROME 2;Muir-Torre syndrome;MISMATCH REPAIR CANCER SYNDROME 1"
MLH1_aug9,MLH1,"pharyngeal squamous cell carcinoma;Breast Carcinoma by Gene Expression Profile;kidney neoplasm;Renal cell carcinoma;angiosarcoma;Appendix Adenocarcinoma;non-small cell lung carcinoma;Ovarian Carcinosarcoma;Mixed Lobular and Ductal Breast Carcinoma;lobular breast carcinoma;Colorectal adenoma;ovarian serous adenocarcinoma;Pancreatic Acinar Cell Carcinoma;ND;T-cell acute lymphoblastic leukemia;Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive;endometrium adenocarcinoma;Merkel cell skin cancer;Constitutional mismatch repair deficiency syndrome;urothelial carcinoma;Dysplasia in Ulcerative Colitis;blastic plasmacytoid dendritic cell neoplasm;Constitutional mismatch repair deficiency syndrome;Kidney Oncocytoma;Thyroid Gland Undifferentiated (Anaplastic) Carcinoma;gastric carcinoma;adenosquamous lung carcinoma;pancreatic carcinoma;Alveolar rhabdomyosarcoma;Papillary renal cell carcinoma;soft tissue sarcoma;Endometrial Endometrioid Adenocarcinoma;Breast carcinoma;Pleural Biphasic Mesothelioma;oral squamous cell carcinoma;sebaceous adenocarcinoma;hairy cell leukemia;prostate carcinoma;Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation;Parathyroid Gland Carcinoma;Acute myeloid leukemia;embryonal rhabdomyosarcoma;gastric intestinal type adenocarcinoma;Ovarian Granulosa Cell Tumor;pancreatic neuroendocrine tumor;Adenoid Cystic Breast Carcinoma;Melanoma;Atypical endometrial hyperplasia;Carcinoma;Lung carcinoma;Clear cell renal carcinoma;cervical squamous cell carcinoma;Rhabdomyosarcoma;gastric adenocarcinoma;Adrenal Gland Neuroblastoma;Muir-Torre syndrome;Acute lymphoblastic leukemia;ovarian carcinoma;Ulcerative colitis;HER2 positive breast carcinoma;Ovarian Endometrioid Adenocarcinoma;cutaneous melanoma;LYNCH SYNDROME 2;Laryngeal squamous cell carcinoma;Anaplastic oligodendroglioma;skin carcinoma;Transitional Meningioma;Fibrous Meningioma;Lung sarcomatoid carcinoma;prostate adenocarcinoma;Bladder Small Cell Neuroendocrine Carcinoma;Hepatocellular Carcinoma;Small cell lung carcinoma;Chronic lymphocytic leukemia;Chronic myelogenous leukemia;Multiple myeloma;MANTLE CELL LYMPHOMA;ovarian clear cell adenocarcinoma;colorectal adenocarcinoma;Muir-Torre syndrome;Digestive System Carcinoma;Unclassified Renal Cell Carcinoma;Atypical Meningioma;colon carcinoma;breast ductal adenocarcinoma;Glioma;lymphoid neoplasm;metaplastic breast carcinoma;cecum adenocarcinoma;Esophageal carcinoma;Thymic Carcinoma;Endometrial Clear Cell Adenocarcinoma;ovarian mucinous adenocarcinoma;Pleural Epithelioid Mesothelioma;Esophageal Squamous Cell Carcinoma;plasmacytoma;Extraskeletal Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor;colon adenocarcinoma;Synovial sarcoma;bladder transitional cell carcinoma;Anaplastic astrocytoma;Uterine Carcinosarcoma;Gallbladder Adenocarcinoma;Malignancy in Giant Cell Tumor of Bone;CONSTITUTIONAL MISMATCH REPAIR DEFICIENCY SYNDROME CCMRD;nodular melanoma;Endometrial Undifferentiated Carcinoma;Small Intestinal Tubulovillous Adenoma;Appendix Goblet Cell Carcinoid;rectal adenocarcinoma;OSTEOSARCOMA;Lynch syndrome;brain glioblastoma;head and neck squamous cell carcinoma;diffuse large B-cell lymphoma;Lynch syndrome;adrenal cortex carcinoma;B-cell acute lymphoblastic leukemia;squamous cell lung carcinoma;Lung adenocarcinoma;Duodenal Adenocarcinoma;marginal zone B-cell lymphoma;testicular seminoma;MISMATCH REPAIR CANCER SYNDROME 1;Extramammary Paget Disease;Gastric Adenoma;Hepatobiliary Neoplasm;bile duct carcinoma;Endometrial carcinoma;Eccrine porocarcinoma;Brain Stem Glioblastoma;ovarian teratoma;follicular thyroid carcinoma;Esophageal adenocarcinoma;nasopharyngeal squamous cell carcinoma;Ovarian Endometriosis;LYNCH SYNDROME 2;Muir-Torre syndrome;MISMATCH REPAIR CANCER SYNDROME 1"
RAD51,RAD51,"Breast Cancer;Fanconi anemia;MIRROR MOVEMENTS 2;Hereditary breast and/or ovarian cancer syndrome;MIRROR MOVEMENTS 2;Familial congenital mirror movements;FANCONI ANEMIA, COMPLEMENTATION GROUP R;Breast Cancer;MIRROR MOVEMENTS 2;FANCONI ANEMIA, COMPLEMENTATION GROUP R"
RAD51_aug1,RAD51,"Breast Cancer;Fanconi anemia;MIRROR MOVEMENTS 2;Hereditary breast and/or ovarian cancer syndrome;MIRROR MOVEMENTS 2;Familial congenital mirror movements;FANCONI ANEMIA, COMPLEMENTATION GROUP R;Breast Cancer;MIRROR MOVEMENTS 2;FANCONI ANEMIA, COMPLEMENTATION GROUP R"
RAD51_aug2,RAD51,"Breast Cancer;Fanconi anemia;MIRROR MOVEMENTS 2;Hereditary breast and/or ovarian cancer syndrome;MIRROR MOVEMENTS 2;Familial congenital mirror movements;FANCONI ANEMIA, COMPLEMENTATION GROUP R;Breast Cancer;MIRROR MOVEMENTS 2;FANCONI ANEMIA, COMPLEMENTATION GROUP R"
RAD51_aug3,RAD51,"Breast Cancer;Fanconi anemia;MIRROR MOVEMENTS 2;Hereditary breast and/or ovarian cancer syndrome;MIRROR MOVEMENTS 2;Familial congenital mirror movements;FANCONI ANEMIA, COMPLEMENTATION GROUP R;Breast Cancer;MIRROR MOVEMENTS 2;FANCONI ANEMIA, COMPLEMENTATION GROUP R"
RAD51_aug4,RAD51,"Breast Cancer;Fanconi anemia;MIRROR MOVEMENTS 2;Hereditary breast and/or ovarian cancer syndrome;MIRROR MOVEMENTS 2;Familial congenital mirror movements;FANCONI ANEMIA, COMPLEMENTATION GROUP R;Breast Cancer;MIRROR MOVEMENTS 2;FANCONI ANEMIA, COMPLEMENTATION GROUP R"
RAD51_aug5,RAD51,"Breast Cancer;Fanconi anemia;MIRROR MOVEMENTS 2;Hereditary breast and/or ovarian cancer syndrome;MIRROR MOVEMENTS 2;Familial congenital mirror movements;FANCONI ANEMIA, COMPLEMENTATION GROUP R;Breast Cancer;MIRROR MOVEMENTS 2;FANCONI ANEMIA, COMPLEMENTATION GROUP R"
RAD51_aug6,RAD51,"Breast Cancer;Fanconi anemia;MIRROR MOVEMENTS 2;Hereditary breast and/or ovarian cancer syndrome;MIRROR MOVEMENTS 2;Familial congenital mirror movements;FANCONI ANEMIA, COMPLEMENTATION GROUP R;Breast Cancer;MIRROR MOVEMENTS 2;FANCONI ANEMIA, COMPLEMENTATION GROUP R"
RAD51_aug7,RAD51,"Breast Cancer;Fanconi anemia;MIRROR MOVEMENTS 2;Hereditary breast and/or ovarian cancer syndrome;MIRROR MOVEMENTS 2;Familial congenital mirror movements;FANCONI ANEMIA, COMPLEMENTATION GROUP R;Breast Cancer;MIRROR MOVEMENTS 2;FANCONI ANEMIA, COMPLEMENTATION GROUP R"
RAD51_aug8,RAD51,"Breast Cancer;Fanconi anemia;MIRROR MOVEMENTS 2;Hereditary breast and/or ovarian cancer syndrome;MIRROR MOVEMENTS 2;Familial congenital mirror movements;FANCONI ANEMIA, COMPLEMENTATION GROUP R;Breast Cancer;MIRROR MOVEMENTS 2;FANCONI ANEMIA, COMPLEMENTATION GROUP R"
RAD51_aug9,RAD51,"Breast Cancer;Fanconi anemia;MIRROR MOVEMENTS 2;Hereditary breast and/or ovarian cancer syndrome;MIRROR MOVEMENTS 2;Familial congenital mirror movements;FANCONI ANEMIA, COMPLEMENTATION GROUP R;Breast Cancer;MIRROR MOVEMENTS 2;FANCONI ANEMIA, COMPLEMENTATION GROUP R"
PALB2,PALB2,"Pancreatic Acinar Cell Carcinoma;Esophageal adenocarcinoma;nasopharyngeal squamous cell carcinoma;Anaplastic oligodendroglioma;Hepatobiliary Neoplasm;Multiple myeloma;Salivary Gland Carcinoma ex Pleomorphic Adenoma;Endometrial Endometrioid Adenocarcinoma;colon carcinoma;cecum adenocarcinoma;bronchoalveolar adenocarcinoma;colon adenocarcinoma;Esophageal Squamous Cell Carcinoma;Breast Carcinoma by Gene Expression Profile;ovarian serous adenocarcinoma;Small cell lung carcinoma;embryonal rhabdomyosarcoma;Astrocytoma;kidney neoplasm;Chronic lymphocytic leukemia;cervical squamous cell carcinoma;Placental Choriocarcinoma;Mixed Lobular and Ductal Breast Carcinoma;gastric intestinal type adenocarcinoma;Synovial sarcoma;Lung carcinoma;brain glioblastoma;prostate adenocarcinoma;Breast carcinoma;breast ductal adenocarcinoma;Ampulla of Vater Carcinoma;Thyroid Gland Undifferentiated (Anaplastic) Carcinoma;Clear cell renal carcinoma;Acute myeloid leukemia;gastric carcinoma;nodular melanoma;Breast-ovarian cancer, familial, susceptibility to, 5;ovarian mucinous adenocarcinoma;salivary gland squamous cell carcinoma;PALB2 related CANCER;Poroma;Chordoma;FANCONI ANEMIA, COMPLEMENTATION GROUP N;Anaplastic Malignant Meningioma;prostate carcinoma;pancreatic neuroendocrine tumor;pancreatic carcinoma;Uterine Carcinosarcoma;Hereditary breast and/or ovarian cancer syndrome;Melanoma;lymphoid neoplasm;Poorly Differentiated Thyroid Gland Carcinoma;skin carcinoma;Papillary renal cell carcinoma;HER2 positive breast carcinoma;Merkel cell skin cancer;PANCREATIC CANCER, SUSCEPTIBILITY TO, 3;rectal adenocarcinoma;Hepatocellular Carcinoma;pharyngeal squamous cell carcinoma;Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation;non-small cell lung carcinoma;thyroid carcinoma;Bladder Small Cell Neuroendocrine Carcinoma;CHONDROSARCOMA;gastric adenocarcinoma;Appendix Goblet Cell Carcinoid;Eccrine porocarcinoma;adenosquamous lung carcinoma;bladder transitional cell carcinoma;large cell lung carcinoma;Laryngeal squamous cell carcinoma;Epithelioid Cell Uveal Melanoma;Hereditary breast cancer;cutaneous melanoma;soft tissue sarcoma;head and neck squamous cell carcinoma;Neoplasm;Esophageal carcinoma;testicular seminoma;lobular breast carcinoma;Digestive System Carcinoma;Gastric Adenoma;Fanconi anemia;ND;undifferentiated pleomorphic sarcoma;FANCONI ANEMIA, COMPLEMENTATION GROUP N;diffuse large B-cell lymphoma;urothelial carcinoma;Familial pancreatic carcinoma;Atypical endometrial hyperplasia;Benign Adrenal Gland Pheochromocytoma;Gallbladder Adenocarcinoma;Lung adenocarcinoma;Duodenal Adenocarcinoma;adrenal cortex carcinoma;Alveolar rhabdomyosarcoma;oral squamous cell carcinoma;Lung carcinoid tumor;bile duct carcinoma;squamous cell lung carcinoma;colorectal adenocarcinoma;Breast-ovarian cancer, familial, susceptibility to, 5;FANCONI ANEMIA, COMPLEMENTATION GROUP N;PANCREATIC CANCER, SUSCEPTIBILITY TO, 3"
PALB2_aug1,PALB2,"Pancreatic Acinar Cell Carcinoma;Esophageal adenocarcinoma;nasopharyngeal squamous cell carcinoma;Anaplastic oligodendroglioma;Hepatobiliary Neoplasm;Multiple myeloma;Salivary Gland Carcinoma ex Pleomorphic Adenoma;Endometrial Endometrioid Adenocarcinoma;colon carcinoma;cecum adenocarcinoma;bronchoalveolar adenocarcinoma;colon adenocarcinoma;Esophageal Squamous Cell Carcinoma;Breast Carcinoma by Gene Expression Profile;ovarian serous adenocarcinoma;Small cell lung carcinoma;embryonal rhabdomyosarcoma;Astrocytoma;kidney neoplasm;Chronic lymphocytic leukemia;cervical squamous cell carcinoma;Placental Choriocarcinoma;Mixed Lobular and Ductal Breast Carcinoma;gastric intestinal type adenocarcinoma;Synovial sarcoma;Lung carcinoma;brain glioblastoma;prostate adenocarcinoma;Breast carcinoma;breast ductal adenocarcinoma;Ampulla of Vater Carcinoma;Thyroid Gland Undifferentiated (Anaplastic) Carcinoma;Clear cell renal carcinoma;Acute myeloid leukemia;gastric carcinoma;nodular melanoma;Breast-ovarian cancer, familial, susceptibility to, 5;ovarian mucinous adenocarcinoma;salivary gland squamous cell carcinoma;PALB2 related CANCER;Poroma;Chordoma;FANCONI ANEMIA, COMPLEMENTATION GROUP N;Anaplastic Malignant Meningioma;prostate carcinoma;pancreatic neuroendocrine tumor;pancreatic carcinoma;Uterine Carcinosarcoma;Hereditary breast and/or ovarian cancer syndrome;Melanoma;lymphoid neoplasm;Poorly Differentiated Thyroid Gland Carcinoma;skin carcinoma;Papillary renal cell carcinoma;HER2 positive breast carcinoma;Merkel cell skin cancer;PANCREATIC CANCER, SUSCEPTIBILITY TO, 3;rectal adenocarcinoma;Hepatocellular Carcinoma;pharyngeal squamous cell carcinoma;Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation;non-small cell lung carcinoma;thyroid carcinoma;Bladder Small Cell Neuroendocrine Carcinoma;CHONDROSARCOMA;gastric adenocarcinoma;Appendix Goblet Cell Carcinoid;Eccrine porocarcinoma;adenosquamous lung carcinoma;bladder transitional cell carcinoma;large cell lung carcinoma;Laryngeal squamous cell carcinoma;Epithelioid Cell Uveal Melanoma;Hereditary breast cancer;cutaneous melanoma;soft tissue sarcoma;head and neck squamous cell carcinoma;Neoplasm;Esophageal carcinoma;testicular seminoma;lobular breast carcinoma;Digestive System Carcinoma;Gastric Adenoma;Fanconi anemia;ND;undifferentiated pleomorphic sarcoma;FANCONI ANEMIA, COMPLEMENTATION GROUP N;diffuse large B-cell lymphoma;urothelial carcinoma;Familial pancreatic carcinoma;Atypical endometrial hyperplasia;Benign Adrenal Gland Pheochromocytoma;Gallbladder Adenocarcinoma;Lung adenocarcinoma;Duodenal Adenocarcinoma;adrenal cortex carcinoma;Alveolar rhabdomyosarcoma;oral squamous cell carcinoma;Lung carcinoid tumor;bile duct carcinoma;squamous cell lung carcinoma;colorectal adenocarcinoma;Breast-ovarian cancer, familial, susceptibility to, 5;FANCONI ANEMIA, COMPLEMENTATION GROUP N;PANCREATIC CANCER, SUSCEPTIBILITY TO, 3"
PALB2_aug2,PALB2,"Pancreatic Acinar Cell Carcinoma;Esophageal adenocarcinoma;nasopharyngeal squamous cell carcinoma;Anaplastic oligodendroglioma;Hepatobiliary Neoplasm;Multiple myeloma;Salivary Gland Carcinoma ex Pleomorphic Adenoma;Endometrial Endometrioid Adenocarcinoma;colon carcinoma;cecum adenocarcinoma;bronchoalveolar adenocarcinoma;colon adenocarcinoma;Esophageal Squamous Cell Carcinoma;Breast Carcinoma by Gene Expression Profile;ovarian serous adenocarcinoma;Small cell lung carcinoma;embryonal rhabdomyosarcoma;Astrocytoma;kidney neoplasm;Chronic lymphocytic leukemia;cervical squamous cell carcinoma;Placental Choriocarcinoma;Mixed Lobular and Ductal Breast Carcinoma;gastric intestinal type adenocarcinoma;Synovial sarcoma;Lung carcinoma;brain glioblastoma;prostate adenocarcinoma;Breast carcinoma;breast ductal adenocarcinoma;Ampulla of Vater Carcinoma;Thyroid Gland Undifferentiated (Anaplastic) Carcinoma;Clear cell renal carcinoma;Acute myeloid leukemia;gastric carcinoma;nodular melanoma;Breast-ovarian cancer, familial, susceptibility to, 5;ovarian mucinous adenocarcinoma;salivary gland squamous cell carcinoma;PALB2 related CANCER;Poroma;Chordoma;FANCONI ANEMIA, COMPLEMENTATION GROUP N;Anaplastic Malignant Meningioma;prostate carcinoma;pancreatic neuroendocrine tumor;pancreatic carcinoma;Uterine Carcinosarcoma;Hereditary breast and/or ovarian cancer syndrome;Melanoma;lymphoid neoplasm;Poorly Differentiated Thyroid Gland Carcinoma;skin carcinoma;Papillary renal cell carcinoma;HER2 positive breast carcinoma;Merkel cell skin cancer;PANCREATIC CANCER, SUSCEPTIBILITY TO, 3;rectal adenocarcinoma;Hepatocellular Carcinoma;pharyngeal squamous cell carcinoma;Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation;non-small cell lung carcinoma;thyroid carcinoma;Bladder Small Cell Neuroendocrine Carcinoma;CHONDROSARCOMA;gastric adenocarcinoma;Appendix Goblet Cell Carcinoid;Eccrine porocarcinoma;adenosquamous lung carcinoma;bladder transitional cell carcinoma;large cell lung carcinoma;Laryngeal squamous cell carcinoma;Epithelioid Cell Uveal Melanoma;Hereditary breast cancer;cutaneous melanoma;soft tissue sarcoma;head and neck squamous cell carcinoma;Neoplasm;Esophageal carcinoma;testicular seminoma;lobular breast carcinoma;Digestive System Carcinoma;Gastric Adenoma;Fanconi anemia;ND;undifferentiated pleomorphic sarcoma;FANCONI ANEMIA, COMPLEMENTATION GROUP N;diffuse large B-cell lymphoma;urothelial carcinoma;Familial pancreatic carcinoma;Atypical endometrial hyperplasia;Benign Adrenal Gland Pheochromocytoma;Gallbladder Adenocarcinoma;Lung adenocarcinoma;Duodenal Adenocarcinoma;adrenal cortex carcinoma;Alveolar rhabdomyosarcoma;oral squamous cell carcinoma;Lung carcinoid tumor;bile duct carcinoma;squamous cell lung carcinoma;colorectal adenocarcinoma;Breast-ovarian cancer, familial, susceptibility to, 5;FANCONI ANEMIA, COMPLEMENTATION GROUP N;PANCREATIC CANCER, SUSCEPTIBILITY TO, 3"
PALB2_aug3,PALB2,"Pancreatic Acinar Cell Carcinoma;Esophageal adenocarcinoma;nasopharyngeal squamous cell carcinoma;Anaplastic oligodendroglioma;Hepatobiliary Neoplasm;Multiple myeloma;Salivary Gland Carcinoma ex Pleomorphic Adenoma;Endometrial Endometrioid Adenocarcinoma;colon carcinoma;cecum adenocarcinoma;bronchoalveolar adenocarcinoma;colon adenocarcinoma;Esophageal Squamous Cell Carcinoma;Breast Carcinoma by Gene Expression Profile;ovarian serous adenocarcinoma;Small cell lung carcinoma;embryonal rhabdomyosarcoma;Astrocytoma;kidney neoplasm;Chronic lymphocytic leukemia;cervical squamous cell carcinoma;Placental Choriocarcinoma;Mixed Lobular and Ductal Breast Carcinoma;gastric intestinal type adenocarcinoma;Synovial sarcoma;Lung carcinoma;brain glioblastoma;prostate adenocarcinoma;Breast carcinoma;breast ductal adenocarcinoma;Ampulla of Vater Carcinoma;Thyroid Gland Undifferentiated (Anaplastic) Carcinoma;Clear cell renal carcinoma;Acute myeloid leukemia;gastric carcinoma;nodular melanoma;Breast-ovarian cancer, familial, susceptibility to, 5;ovarian mucinous adenocarcinoma;salivary gland squamous cell carcinoma;PALB2 related CANCER;Poroma;Chordoma;FANCONI ANEMIA, COMPLEMENTATION GROUP N;Anaplastic Malignant Meningioma;prostate carcinoma;pancreatic neuroendocrine tumor;pancreatic carcinoma;Uterine Carcinosarcoma;Hereditary breast and/or ovarian cancer syndrome;Melanoma;lymphoid neoplasm;Poorly Differentiated Thyroid Gland Carcinoma;skin carcinoma;Papillary renal cell carcinoma;HER2 positive breast carcinoma;Merkel cell skin cancer;PANCREATIC CANCER, SUSCEPTIBILITY TO, 3;rectal adenocarcinoma;Hepatocellular Carcinoma;pharyngeal squamous cell carcinoma;Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation;non-small cell lung carcinoma;thyroid carcinoma;Bladder Small Cell Neuroendocrine Carcinoma;CHONDROSARCOMA;gastric adenocarcinoma;Appendix Goblet Cell Carcinoid;Eccrine porocarcinoma;adenosquamous lung carcinoma;bladder transitional cell carcinoma;large cell lung carcinoma;Laryngeal squamous cell carcinoma;Epithelioid Cell Uveal Melanoma;Hereditary breast cancer;cutaneous melanoma;soft tissue sarcoma;head and neck squamous cell carcinoma;Neoplasm;Esophageal carcinoma;testicular seminoma;lobular breast carcinoma;Digestive System Carcinoma;Gastric Adenoma;Fanconi anemia;ND;undifferentiated pleomorphic sarcoma;FANCONI ANEMIA, COMPLEMENTATION GROUP N;diffuse large B-cell lymphoma;urothelial carcinoma;Familial pancreatic carcinoma;Atypical endometrial hyperplasia;Benign Adrenal Gland Pheochromocytoma;Gallbladder Adenocarcinoma;Lung adenocarcinoma;Duodenal Adenocarcinoma;adrenal cortex carcinoma;Alveolar rhabdomyosarcoma;oral squamous cell carcinoma;Lung carcinoid tumor;bile duct carcinoma;squamous cell lung carcinoma;colorectal adenocarcinoma;Breast-ovarian cancer, familial, susceptibility to, 5;FANCONI ANEMIA, COMPLEMENTATION GROUP N;PANCREATIC CANCER, SUSCEPTIBILITY TO, 3"
PALB2_aug4,PALB2,"Pancreatic Acinar Cell Carcinoma;Esophageal adenocarcinoma;nasopharyngeal squamous cell carcinoma;Anaplastic oligodendroglioma;Hepatobiliary Neoplasm;Multiple myeloma;Salivary Gland Carcinoma ex Pleomorphic Adenoma;Endometrial Endometrioid Adenocarcinoma;colon carcinoma;cecum adenocarcinoma;bronchoalveolar adenocarcinoma;colon adenocarcinoma;Esophageal Squamous Cell Carcinoma;Breast Carcinoma by Gene Expression Profile;ovarian serous adenocarcinoma;Small cell lung carcinoma;embryonal rhabdomyosarcoma;Astrocytoma;kidney neoplasm;Chronic lymphocytic leukemia;cervical squamous cell carcinoma;Placental Choriocarcinoma;Mixed Lobular and Ductal Breast Carcinoma;gastric intestinal type adenocarcinoma;Synovial sarcoma;Lung carcinoma;brain glioblastoma;prostate adenocarcinoma;Breast carcinoma;breast ductal adenocarcinoma;Ampulla of Vater Carcinoma;Thyroid Gland Undifferentiated (Anaplastic) Carcinoma;Clear cell renal carcinoma;Acute myeloid leukemia;gastric carcinoma;nodular melanoma;Breast-ovarian cancer, familial, susceptibility to, 5;ovarian mucinous adenocarcinoma;salivary gland squamous cell carcinoma;PALB2 related CANCER;Poroma;Chordoma;FANCONI ANEMIA, COMPLEMENTATION GROUP N;Anaplastic Malignant Meningioma;prostate carcinoma;pancreatic neuroendocrine tumor;pancreatic carcinoma;Uterine Carcinosarcoma;Hereditary breast and/or ovarian cancer syndrome;Melanoma;lymphoid neoplasm;Poorly Differentiated Thyroid Gland Carcinoma;skin carcinoma;Papillary renal cell carcinoma;HER2 positive breast carcinoma;Merkel cell skin cancer;PANCREATIC CANCER, SUSCEPTIBILITY TO, 3;rectal adenocarcinoma;Hepatocellular Carcinoma;pharyngeal squamous cell carcinoma;Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation;non-small cell lung carcinoma;thyroid carcinoma;Bladder Small Cell Neuroendocrine Carcinoma;CHONDROSARCOMA;gastric adenocarcinoma;Appendix Goblet Cell Carcinoid;Eccrine porocarcinoma;adenosquamous lung carcinoma;bladder transitional cell carcinoma;large cell lung carcinoma;Laryngeal squamous cell carcinoma;Epithelioid Cell Uveal Melanoma;Hereditary breast cancer;cutaneous melanoma;soft tissue sarcoma;head and neck squamous cell carcinoma;Neoplasm;Esophageal carcinoma;testicular seminoma;lobular breast carcinoma;Digestive System Carcinoma;Gastric Adenoma;Fanconi anemia;ND;undifferentiated pleomorphic sarcoma;FANCONI ANEMIA, COMPLEMENTATION GROUP N;diffuse large B-cell lymphoma;urothelial carcinoma;Familial pancreatic carcinoma;Atypical endometrial hyperplasia;Benign Adrenal Gland Pheochromocytoma;Gallbladder Adenocarcinoma;Lung adenocarcinoma;Duodenal Adenocarcinoma;adrenal cortex carcinoma;Alveolar rhabdomyosarcoma;oral squamous cell carcinoma;Lung carcinoid tumor;bile duct carcinoma;squamous cell lung carcinoma;colorectal adenocarcinoma;Breast-ovarian cancer, familial, susceptibility to, 5;FANCONI ANEMIA, COMPLEMENTATION GROUP N;PANCREATIC CANCER, SUSCEPTIBILITY TO, 3"
PALB2_aug5,PALB2,"Pancreatic Acinar Cell Carcinoma;Esophageal adenocarcinoma;nasopharyngeal squamous cell carcinoma;Anaplastic oligodendroglioma;Hepatobiliary Neoplasm;Multiple myeloma;Salivary Gland Carcinoma ex Pleomorphic Adenoma;Endometrial Endometrioid Adenocarcinoma;colon carcinoma;cecum adenocarcinoma;bronchoalveolar adenocarcinoma;colon adenocarcinoma;Esophageal Squamous Cell Carcinoma;Breast Carcinoma by Gene Expression Profile;ovarian serous adenocarcinoma;Small cell lung carcinoma;embryonal rhabdomyosarcoma;Astrocytoma;kidney neoplasm;Chronic lymphocytic leukemia;cervical squamous cell carcinoma;Placental Choriocarcinoma;Mixed Lobular and Ductal Breast Carcinoma;gastric intestinal type adenocarcinoma;Synovial sarcoma;Lung carcinoma;brain glioblastoma;prostate adenocarcinoma;Breast carcinoma;breast ductal adenocarcinoma;Ampulla of Vater Carcinoma;Thyroid Gland Undifferentiated (Anaplastic) Carcinoma;Clear cell renal carcinoma;Acute myeloid leukemia;gastric carcinoma;nodular melanoma;Breast-ovarian cancer, familial, susceptibility to, 5;ovarian mucinous adenocarcinoma;salivary gland squamous cell carcinoma;PALB2 related CANCER;Poroma;Chordoma;FANCONI ANEMIA, COMPLEMENTATION GROUP N;Anaplastic Malignant Meningioma;prostate carcinoma;pancreatic neuroendocrine tumor;pancreatic carcinoma;Uterine Carcinosarcoma;Hereditary breast and/or ovarian cancer syndrome;Melanoma;lymphoid neoplasm;Poorly Differentiated Thyroid Gland Carcinoma;skin carcinoma;Papillary renal cell carcinoma;HER2 positive breast carcinoma;Merkel cell skin cancer;PANCREATIC CANCER, SUSCEPTIBILITY TO, 3;rectal adenocarcinoma;Hepatocellular Carcinoma;pharyngeal squamous cell carcinoma;Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation;non-small cell lung carcinoma;thyroid carcinoma;Bladder Small Cell Neuroendocrine Carcinoma;CHONDROSARCOMA;gastric adenocarcinoma;Appendix Goblet Cell Carcinoid;Eccrine porocarcinoma;adenosquamous lung carcinoma;bladder transitional cell carcinoma;large cell lung carcinoma;Laryngeal squamous cell carcinoma;Epithelioid Cell Uveal Melanoma;Hereditary breast cancer;cutaneous melanoma;soft tissue sarcoma;head and neck squamous cell carcinoma;Neoplasm;Esophageal carcinoma;testicular seminoma;lobular breast carcinoma;Digestive System Carcinoma;Gastric Adenoma;Fanconi anemia;ND;undifferentiated pleomorphic sarcoma;FANCONI ANEMIA, COMPLEMENTATION GROUP N;diffuse large B-cell lymphoma;urothelial carcinoma;Familial pancreatic carcinoma;Atypical endometrial hyperplasia;Benign Adrenal Gland Pheochromocytoma;Gallbladder Adenocarcinoma;Lung adenocarcinoma;Duodenal Adenocarcinoma;adrenal cortex carcinoma;Alveolar rhabdomyosarcoma;oral squamous cell carcinoma;Lung carcinoid tumor;bile duct carcinoma;squamous cell lung carcinoma;colorectal adenocarcinoma;Breast-ovarian cancer, familial, susceptibility to, 5;FANCONI ANEMIA, COMPLEMENTATION GROUP N;PANCREATIC CANCER, SUSCEPTIBILITY TO, 3"
PALB2_aug6,PALB2,"Pancreatic Acinar Cell Carcinoma;Esophageal adenocarcinoma;nasopharyngeal squamous cell carcinoma;Anaplastic oligodendroglioma;Hepatobiliary Neoplasm;Multiple myeloma;Salivary Gland Carcinoma ex Pleomorphic Adenoma;Endometrial Endometrioid Adenocarcinoma;colon carcinoma;cecum adenocarcinoma;bronchoalveolar adenocarcinoma;colon adenocarcinoma;Esophageal Squamous Cell Carcinoma;Breast Carcinoma by Gene Expression Profile;ovarian serous adenocarcinoma;Small cell lung carcinoma;embryonal rhabdomyosarcoma;Astrocytoma;kidney neoplasm;Chronic lymphocytic leukemia;cervical squamous cell carcinoma;Placental Choriocarcinoma;Mixed Lobular and Ductal Breast Carcinoma;gastric intestinal type adenocarcinoma;Synovial sarcoma;Lung carcinoma;brain glioblastoma;prostate adenocarcinoma;Breast carcinoma;breast ductal adenocarcinoma;Ampulla of Vater Carcinoma;Thyroid Gland Undifferentiated (Anaplastic) Carcinoma;Clear cell renal carcinoma;Acute myeloid leukemia;gastric carcinoma;nodular melanoma;Breast-ovarian cancer, familial, susceptibility to, 5;ovarian mucinous adenocarcinoma;salivary gland squamous cell carcinoma;PALB2 related CANCER;Poroma;Chordoma;FANCONI ANEMIA, COMPLEMENTATION GROUP N;Anaplastic Malignant Meningioma;prostate carcinoma;pancreatic neuroendocrine tumor;pancreatic carcinoma;Uterine Carcinosarcoma;Hereditary breast and/or ovarian cancer syndrome;Melanoma;lymphoid neoplasm;Poorly Differentiated Thyroid Gland Carcinoma;skin carcinoma;Papillary renal cell carcinoma;HER2 positive breast carcinoma;Merkel cell skin cancer;PANCREATIC CANCER, SUSCEPTIBILITY TO, 3;rectal adenocarcinoma;Hepatocellular Carcinoma;pharyngeal squamous cell carcinoma;Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation;non-small cell lung carcinoma;thyroid carcinoma;Bladder Small Cell Neuroendocrine Carcinoma;CHONDROSARCOMA;gastric adenocarcinoma;Appendix Goblet Cell Carcinoid;Eccrine porocarcinoma;adenosquamous lung carcinoma;bladder transitional cell carcinoma;large cell lung carcinoma;Laryngeal squamous cell carcinoma;Epithelioid Cell Uveal Melanoma;Hereditary breast cancer;cutaneous melanoma;soft tissue sarcoma;head and neck squamous cell carcinoma;Neoplasm;Esophageal carcinoma;testicular seminoma;lobular breast carcinoma;Digestive System Carcinoma;Gastric Adenoma;Fanconi anemia;ND;undifferentiated pleomorphic sarcoma;FANCONI ANEMIA, COMPLEMENTATION GROUP N;diffuse large B-cell lymphoma;urothelial carcinoma;Familial pancreatic carcinoma;Atypical endometrial hyperplasia;Benign Adrenal Gland Pheochromocytoma;Gallbladder Adenocarcinoma;Lung adenocarcinoma;Duodenal Adenocarcinoma;adrenal cortex carcinoma;Alveolar rhabdomyosarcoma;oral squamous cell carcinoma;Lung carcinoid tumor;bile duct carcinoma;squamous cell lung carcinoma;colorectal adenocarcinoma;Breast-ovarian cancer, familial, susceptibility to, 5;FANCONI ANEMIA, COMPLEMENTATION GROUP N;PANCREATIC CANCER, SUSCEPTIBILITY TO, 3"
PALB2_aug7,PALB2,"Pancreatic Acinar Cell Carcinoma;Esophageal adenocarcinoma;nasopharyngeal squamous cell carcinoma;Anaplastic oligodendroglioma;Hepatobiliary Neoplasm;Multiple myeloma;Salivary Gland Carcinoma ex Pleomorphic Adenoma;Endometrial Endometrioid Adenocarcinoma;colon carcinoma;cecum adenocarcinoma;bronchoalveolar adenocarcinoma;colon adenocarcinoma;Esophageal Squamous Cell Carcinoma;Breast Carcinoma by Gene Expression Profile;ovarian serous adenocarcinoma;Small cell lung carcinoma;embryonal rhabdomyosarcoma;Astrocytoma;kidney neoplasm;Chronic lymphocytic leukemia;cervical squamous cell carcinoma;Placental Choriocarcinoma;Mixed Lobular and Ductal Breast Carcinoma;gastric intestinal type adenocarcinoma;Synovial sarcoma;Lung carcinoma;brain glioblastoma;prostate adenocarcinoma;Breast carcinoma;breast ductal adenocarcinoma;Ampulla of Vater Carcinoma;Thyroid Gland Undifferentiated (Anaplastic) Carcinoma;Clear cell renal carcinoma;Acute myeloid leukemia;gastric carcinoma;nodular melanoma;Breast-ovarian cancer, familial, susceptibility to, 5;ovarian mucinous adenocarcinoma;salivary gland squamous cell carcinoma;PALB2 related CANCER;Poroma;Chordoma;FANCONI ANEMIA, COMPLEMENTATION GROUP N;Anaplastic Malignant Meningioma;prostate carcinoma;pancreatic neuroendocrine tumor;pancreatic carcinoma;Uterine Carcinosarcoma;Hereditary breast and/or ovarian cancer syndrome;Melanoma;lymphoid neoplasm;Poorly Differentiated Thyroid Gland Carcinoma;skin carcinoma;Papillary renal cell carcinoma;HER2 positive breast carcinoma;Merkel cell skin cancer;PANCREATIC CANCER, SUSCEPTIBILITY TO, 3;rectal adenocarcinoma;Hepatocellular Carcinoma;pharyngeal squamous cell carcinoma;Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation;non-small cell lung carcinoma;thyroid carcinoma;Bladder Small Cell Neuroendocrine Carcinoma;CHONDROSARCOMA;gastric adenocarcinoma;Appendix Goblet Cell Carcinoid;Eccrine porocarcinoma;adenosquamous lung carcinoma;bladder transitional cell carcinoma;large cell lung carcinoma;Laryngeal squamous cell carcinoma;Epithelioid Cell Uveal Melanoma;Hereditary breast cancer;cutaneous melanoma;soft tissue sarcoma;head and neck squamous cell carcinoma;Neoplasm;Esophageal carcinoma;testicular seminoma;lobular breast carcinoma;Digestive System Carcinoma;Gastric Adenoma;Fanconi anemia;ND;undifferentiated pleomorphic sarcoma;FANCONI ANEMIA, COMPLEMENTATION GROUP N;diffuse large B-cell lymphoma;urothelial carcinoma;Familial pancreatic carcinoma;Atypical endometrial hyperplasia;Benign Adrenal Gland Pheochromocytoma;Gallbladder Adenocarcinoma;Lung adenocarcinoma;Duodenal Adenocarcinoma;adrenal cortex carcinoma;Alveolar rhabdomyosarcoma;oral squamous cell carcinoma;Lung carcinoid tumor;bile duct carcinoma;squamous cell lung carcinoma;colorectal adenocarcinoma;Breast-ovarian cancer, familial, susceptibility to, 5;FANCONI ANEMIA, COMPLEMENTATION GROUP N;PANCREATIC CANCER, SUSCEPTIBILITY TO, 3"
PALB2_aug8,PALB2,"Pancreatic Acinar Cell Carcinoma;Esophageal adenocarcinoma;nasopharyngeal squamous cell carcinoma;Anaplastic oligodendroglioma;Hepatobiliary Neoplasm;Multiple myeloma;Salivary Gland Carcinoma ex Pleomorphic Adenoma;Endometrial Endometrioid Adenocarcinoma;colon carcinoma;cecum adenocarcinoma;bronchoalveolar adenocarcinoma;colon adenocarcinoma;Esophageal Squamous Cell Carcinoma;Breast Carcinoma by Gene Expression Profile;ovarian serous adenocarcinoma;Small cell lung carcinoma;embryonal rhabdomyosarcoma;Astrocytoma;kidney neoplasm;Chronic lymphocytic leukemia;cervical squamous cell carcinoma;Placental Choriocarcinoma;Mixed Lobular and Ductal Breast Carcinoma;gastric intestinal type adenocarcinoma;Synovial sarcoma;Lung carcinoma;brain glioblastoma;prostate adenocarcinoma;Breast carcinoma;breast ductal adenocarcinoma;Ampulla of Vater Carcinoma;Thyroid Gland Undifferentiated (Anaplastic) Carcinoma;Clear cell renal carcinoma;Acute myeloid leukemia;gastric carcinoma;nodular melanoma;Breast-ovarian cancer, familial, susceptibility to, 5;ovarian mucinous adenocarcinoma;salivary gland squamous cell carcinoma;PALB2 related CANCER;Poroma;Chordoma;FANCONI ANEMIA, COMPLEMENTATION GROUP N;Anaplastic Malignant Meningioma;prostate carcinoma;pancreatic neuroendocrine tumor;pancreatic carcinoma;Uterine Carcinosarcoma;Hereditary breast and/or ovarian cancer syndrome;Melanoma;lymphoid neoplasm;Poorly Differentiated Thyroid Gland Carcinoma;skin carcinoma;Papillary renal cell carcinoma;HER2 positive breast carcinoma;Merkel cell skin cancer;PANCREATIC CANCER, SUSCEPTIBILITY TO, 3;rectal adenocarcinoma;Hepatocellular Carcinoma;pharyngeal squamous cell carcinoma;Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation;non-small cell lung carcinoma;thyroid carcinoma;Bladder Small Cell Neuroendocrine Carcinoma;CHONDROSARCOMA;gastric adenocarcinoma;Appendix Goblet Cell Carcinoid;Eccrine porocarcinoma;adenosquamous lung carcinoma;bladder transitional cell carcinoma;large cell lung carcinoma;Laryngeal squamous cell carcinoma;Epithelioid Cell Uveal Melanoma;Hereditary breast cancer;cutaneous melanoma;soft tissue sarcoma;head and neck squamous cell carcinoma;Neoplasm;Esophageal carcinoma;testicular seminoma;lobular breast carcinoma;Digestive System Carcinoma;Gastric Adenoma;Fanconi anemia;ND;undifferentiated pleomorphic sarcoma;FANCONI ANEMIA, COMPLEMENTATION GROUP N;diffuse large B-cell lymphoma;urothelial carcinoma;Familial pancreatic carcinoma;Atypical endometrial hyperplasia;Benign Adrenal Gland Pheochromocytoma;Gallbladder Adenocarcinoma;Lung adenocarcinoma;Duodenal Adenocarcinoma;adrenal cortex carcinoma;Alveolar rhabdomyosarcoma;oral squamous cell carcinoma;Lung carcinoid tumor;bile duct carcinoma;squamous cell lung carcinoma;colorectal adenocarcinoma;Breast-ovarian cancer, familial, susceptibility to, 5;FANCONI ANEMIA, COMPLEMENTATION GROUP N;PANCREATIC CANCER, SUSCEPTIBILITY TO, 3"
PALB2_aug9,PALB2,"Pancreatic Acinar Cell Carcinoma;Esophageal adenocarcinoma;nasopharyngeal squamous cell carcinoma;Anaplastic oligodendroglioma;Hepatobiliary Neoplasm;Multiple myeloma;Salivary Gland Carcinoma ex Pleomorphic Adenoma;Endometrial Endometrioid Adenocarcinoma;colon carcinoma;cecum adenocarcinoma;bronchoalveolar adenocarcinoma;colon adenocarcinoma;Esophageal Squamous Cell Carcinoma;Breast Carcinoma by Gene Expression Profile;ovarian serous adenocarcinoma;Small cell lung carcinoma;embryonal rhabdomyosarcoma;Astrocytoma;kidney neoplasm;Chronic lymphocytic leukemia;cervical squamous cell carcinoma;Placental Choriocarcinoma;Mixed Lobular and Ductal Breast Carcinoma;gastric intestinal type adenocarcinoma;Synovial sarcoma;Lung carcinoma;brain glioblastoma;prostate adenocarcinoma;Breast carcinoma;breast ductal adenocarcinoma;Ampulla of Vater Carcinoma;Thyroid Gland Undifferentiated (Anaplastic) Carcinoma;Clear cell renal carcinoma;Acute myeloid leukemia;gastric carcinoma;nodular melanoma;Breast-ovarian cancer, familial, susceptibility to, 5;ovarian mucinous adenocarcinoma;salivary gland squamous cell carcinoma;PALB2 related CANCER;Poroma;Chordoma;FANCONI ANEMIA, COMPLEMENTATION GROUP N;Anaplastic Malignant Meningioma;prostate carcinoma;pancreatic neuroendocrine tumor;pancreatic carcinoma;Uterine Carcinosarcoma;Hereditary breast and/or ovarian cancer syndrome;Melanoma;lymphoid neoplasm;Poorly Differentiated Thyroid Gland Carcinoma;skin carcinoma;Papillary renal cell carcinoma;HER2 positive breast carcinoma;Merkel cell skin cancer;PANCREATIC CANCER, SUSCEPTIBILITY TO, 3;rectal adenocarcinoma;Hepatocellular Carcinoma;pharyngeal squamous cell carcinoma;Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation;non-small cell lung carcinoma;thyroid carcinoma;Bladder Small Cell Neuroendocrine Carcinoma;CHONDROSARCOMA;gastric adenocarcinoma;Appendix Goblet Cell Carcinoid;Eccrine porocarcinoma;adenosquamous lung carcinoma;bladder transitional cell carcinoma;large cell lung carcinoma;Laryngeal squamous cell carcinoma;Epithelioid Cell Uveal Melanoma;Hereditary breast cancer;cutaneous melanoma;soft tissue sarcoma;head and neck squamous cell carcinoma;Neoplasm;Esophageal carcinoma;testicular seminoma;lobular breast carcinoma;Digestive System Carcinoma;Gastric Adenoma;Fanconi anemia;ND;undifferentiated pleomorphic sarcoma;FANCONI ANEMIA, COMPLEMENTATION GROUP N;diffuse large B-cell lymphoma;urothelial carcinoma;Familial pancreatic carcinoma;Atypical endometrial hyperplasia;Benign Adrenal Gland Pheochromocytoma;Gallbladder Adenocarcinoma;Lung adenocarcinoma;Duodenal Adenocarcinoma;adrenal cortex carcinoma;Alveolar rhabdomyosarcoma;oral squamous cell carcinoma;Lung carcinoid tumor;bile duct carcinoma;squamous cell lung carcinoma;colorectal adenocarcinoma;Breast-ovarian cancer, familial, susceptibility to, 5;FANCONI ANEMIA, COMPLEMENTATION GROUP N;PANCREATIC CANCER, SUSCEPTIBILITY TO, 3"
TP53,TP53,"Liver Diffuse Large B-Cell Lymphoma;Choroid plexus carcinoma;ovarian serous adenocarcinoma;Myelodysplastic/Myeloproliferative Neoplasm;Poorly Differentiated Thyroid Gland Carcinoma;Adenocarcinoma;Ovarian Transitional Cell Carcinoma;Thyroid Gland Diffuse Large B-Cell Lymphoma;ovarian teratoma;Colorectal Cancer;Sarcomatoid Carcinoma;Adrenal Gland Neuroblastoma;Lung Sclerosing Hemangioma;Pleural Mesothelioma;large cell medulloblastoma;Ovarian Endometrioid Adenocarcinoma;B-cell acute lymphoblastic leukemia;Gastric Adenoma;Thymic Small Cell Carcinoma;pancreatic neuroendocrine tumor;prostate adenocarcinoma;Granulocytic Sarcoma;Gastric Metaplasia;Small cell lung carcinoma;Spindle Cell Melanoma;Breast Carcinoma by Gene Expression Profile;NASOPHARYNGEAL CARCINOMA;Ovarian Yolk Sac Tumor;Unclassified Renal Cell Carcinoma;Neoplasm;Thymic Sarcomatoid Carcinoma;Glioma;Carcinoma;lymphoid neoplasm;Rectal Tubular Adenoma;Acute lymphoblastic leukemia;PAPILLOMA OF CHOROID PLEXUS;Intimal Sarcoma;ganglioglioma;Acute basophilic leukemia;marginal zone B-cell lymphoma;dysplastic nevus;Bladder Small Cell Neuroendocrine Carcinoma;Cervical Endometrioid Adenocarcinoma;Ocular Sebaceous Carcinoma;Adenoid cystic carcinoma;Meningeal Melanocytoma;Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant;Colorectal adenoma;Invasive Breast Carcinoma;Ampulla of Vater Carcinoma;Merkel cell skin cancer;nasopharyngeal squamous cell carcinoma;cutaneous melanoma;Olfactory Neuroblastoma;primary central chondrosarcoma;metaplastic breast carcinoma;Dedifferentiated Solitary Fibrous Tumor;colorectal adenocarcinoma;Ependymoma;Conjunctival Melanoma;gastric intestinal type adenocarcinoma;vascular sarcoma;OSTEOSARCOMA;endodermal sinus tumor;Pleural Epithelioid Mesothelioma;Mucinous Gastric Adenocarcinoma;CHONDROSARCOMA;large cell neuroendocrine carcinoma;Conjunctival Disorder;Esophageal adenocarcinoma;Papillary thyroid carcinoma;Medullomyoblastoma with Myogenic Differentiation;tonsil cancer;Endometrial Endometrioid Adenocarcinoma;testicular mixed germ cell tumor;Actinic keratosis;Dysplasia in Ulcerative Colitis;soft tissue sarcoma;medullary breast carcinoma;Papillary renal cell carcinoma;Mixed Lobular and Ductal Breast Carcinoma;Vaginal Melanoma;BONE MARROW FAILURE SYNDROME 5;Gastric Papillary Adenocarcinoma;bronchoalveolar adenocarcinoma;Cervical Clear Cell Adenocarcinoma;Hidradenocarcinoma;Bladder Adenocarcinoma;Aldosterone producing adenoma;Duodenal Adenocarcinoma;Basal cell carcinoma;thyroid neoplasm;Breast Cancer;cervical squamous cell carcinoma;Submandibular Gland Adenoid Cystic Carcinoma;Extraskeletal Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor;diffuse large B-cell lymphoma;Alveolar rhabdomyosarcoma;kidney neoplasm;Li-Fraumeni syndrome;Barrett's esophagus;Ethmoid Sinus Adenoid Cystic Carcinoma;Jejunal Neuroendocrine Tumor G1;non-functioning pituitary adenoma;Pleural Sarcomatoid Mesothelioma;Primary Peritoneal Serous Adenocarcinoma;ossifying fibroma;Penile Carcinoma;plasmacytoma;Cervical Small Cell Carcinoma;Malignant Urinary System Neoplasm;Poroma;endometrial serous adenocarcinoma;Fibroadenoma;Chordoid Meningioma;Benign Ovarian Mucinous Tumor;Endometrial stromal sarcoma;Anal Squamous Cell Carcinoma;Sinonasal Undifferentiated Carcinoma;myeloid neoplasm;Primary Pulmonary Diffuse Large B-Cell Lymphoma;Placental Choriocarcinoma;radiologic finding;Benign Ovarian Neoplasm;Ovarian Mixed Epithelial Tumor;Mediastinal Malignant Germ Cell Tumor;neoplasm of mature B-cells;Thyroid Gland Undifferentiated (Anaplastic) Carcinoma;Ovarian Serous Adenocarcinofibroma;Oligodendroglioma;Well-differentiated liposarcoma;Squamous cell carcinoma;brain glioblastoma;Chronic Eosinophilic Leukemia, Not Otherwise Specified;Cushing disease;Malignant Laryngeal Neoplasm;Testicular Sertoli Cell Tumor;Anaplastic oligodendroglioma;Pleomorphic rhabdomyosarcoma;Malignant Pancreatic Neoplasm;Maxillary Sinus Adenoid Cystic Carcinoma;ACTH-Producing Pituitary Gland Adenoma;urothelial carcinoma;Gliosarcoma;Esophageal Squamous Cell Carcinoma;Thymic Carcinoma;Borderline Ovarian Mucinous Tumor;Acute myeloid leukemia;Intestinal Type Adenocarcinoma;embryonal rhabdomyosarcoma;T-cell prolymphocytic leukemia;Central Nervous System Neoplasm;Benign Salivary Gland Myoepithelioma;Chronic lymphocytic leukemia;MYELODYSPLASTIC SYNDROME;Tracheal Adenoid Cystic Carcinoma;Signet Ring Cell Gastric Adenocarcinoma;Dysplasia of Larynx;Lung Giant Cell Carcinoma;Transitional Meningioma;Gastric Squamous Cell Carcinoma;Parathyroid Gland Carcinoma;Malignant Ovarian Brenner Tumor;Endometrial Clear Cell Adenocarcinoma;skin appendage carcinoma;Small cell lung cancer;Lung adenocarcinoma;Salivary Gland Acinic Cell Carcinoma;Colon Dysplasia;pancreatic neoplasm;carcinoid tumor;Tracheal Squamous Cell Carcinoma;Tonsillar Squamous Cell Carcinoma;Gliosarcoma;Pancreatic Acinar Cell Carcinoma;endometrium adenocarcinoma;squamous cell lung carcinoma;Vulvar Squamous Cell Carcinoma;ND;non-small cell lung carcinoma;Crohn's disease;Middle Ear Squamous Cell Carcinoma;Cervical Adenosquamous Carcinoma;collecting duct carcinoma;adrenal cortex carcinoma;malignant epithelioid mesothelioma;Epithelioid Malignant Peripheral Nerve Sheath Tumor;dedifferentiated chondrosarcoma;renal carcinoma;Kaposi's sarcoma;Adrenocortical carcinoma;benign prostatic hyperplasia;Clear cell renal carcinoma;Renal cell carcinoma;pseudomyxoma peritonei;Malignant peripheral nerve sheath tumor;POLYCYTHEMIA VERA;Hepatocellular Carcinoma;Benign Ovarian Brenner Tumor;Burkitts lymphoma;Endometrial Mucinous Adenocarcinoma;mucinous carcinoma;Splenic Mantle Cell Lymphoma;anaplastic large cell lymphoma;small cell carcinoma;Chronic neutrophilic leukemia;Pleomorphic salivary gland adenoma;Li-Fraumeni syndrome;Gonadal Teratoma;thyroid carcinoma;Appendix Neuroendocrine Tumor G1;Malignant Ovarian Mixed Epithelial Tumor;Pancreatic Small Cell Neuroendocrine Carcinoma;Ovarian Small Cell Carcinoma;Pleural Biphasic Mesothelioma;breast neoplasm;Parotid Gland Acinic Cell Carcinoma;Kidney Angiomyolipoma;Undifferentiated Gallbladder Carcinoma;Fibrous Meningioma;Benign Conjunctival Neoplasm;epithelial neoplasm;Solid Pseudopapillary Neoplasm of the Pancreas;Angioimmunoblastic T-cell lymphoma;Langerhans cell histiocytosis;Colorectal Diffuse Large B-Cell Lymphoma;Digestive System Carcinoma;Central Nervous System Lymphoma;GLIOMA SUSCEPTIBILITY 1;Appendix Goblet Cell Carcinoid;Rectal Traditional Serrated Adenoma;Benign Thyroid Gland Neoplasm;adrenocortical adenoma;leiomyosarcoma;Hodgkins lymphoma;Appendix Villous Adenoma;Major Salivary Gland Mucoepidermoid Carcinoma;Thymic Undifferentiated Carcinoma;gallbladder carcinoma;gastric tubular adenocarcinoma;B-Cell Prolymphocytic Leukemia;hepatocellular adenoma;Familial pancreatic carcinoma;Li-Fraumeni syndrome;Lymphoepithelioma-Like Lung Carcinoma;hyperplasia;Gastric Diffuse Large B-Cell Lymphoma;Major Salivary Gland Carcinoma;Chronic myelomonocytic leukemia;B-lymphoblastic leukemia/lymphoma with t9;22q34.1;q11.2;Thymic Squamous Cell Carcinoma;Anaplastic oligoastrocytoma;Testicular Leydig Cell Tumor;ALVEOLAR SOFT PART SARCOMA;colon carcinoma;follicular dendritic cell sarcoma;prostate carcinoma;Atypical teratoid rhabdoid tumor;ovarian clear cell adenocarcinoma;testicular seminoma;salivary gland squamous cell carcinoma;vulvar carcinoma;Appendix Adenocarcinoma;Minor Salivary Gland Adenocarcinoma;liposarcoma;Gallbladder Squamous Cell Carcinoma;HEPATOBLASTOMA;malignant rhabdoid tumour;Esophageal carcinoma;Lung carcinoid tumor;Malignancy in Giant Cell Tumor of Bone;Adult hepatocellular carcinoma;Cecum Villous Adenoma;Gallbladder Adenosquamous Carcinoma;Peritoneal Mesothelioma;transitional cell carcinoma of kidney;Anal Melanoma;ADRENOCORTICAL CARCINOMA, HEREDITARY;Testicular Choriocarcinoma;Anaplastic Malignant Meningioma;Ovarian Granulosa Cell Tumor;Sex Hormone-Producing Adrenal Cortex Adenoma;Undifferentiated Ovarian Carcinoma;Thyroid Gland Oncocytic Follicular Carcinoma;Malignant Adrenal Gland Pheochromocytoma;Endometrial Undifferentiated Carcinoma;Non-Functional Pancreatic Neuroendocrine Tumor;ovarian adenocarcinoma;Spinal Cord Astrocytoma;Multiple myeloma;Uterine Carcinosarcoma;pharyngeal squamous cell carcinoma;Borderline Ovarian Serous Tumor;embryonal rhabdomyosarcoma;HER2 positive breast carcinoma;oral squamous cell carcinoma;head and neck squamous cell carcinoma;Myeloproliferative disorder;Astrocytoma;small intestinal adenocarcinoma;cervical carcinoma;Ovarian neoplasm;Endometrial carcinoma;Parotid Gland Pleomorphic Adenoma;Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive;pleomorphic liposarcoma;Lung sarcomatoid carcinoma;Malignant Mesothelioma;Laryngeal squamous cell carcinoma;Grade III Prostatic Intraepithelial Neoplasia;Testicular Embryonal Carcinoma;pancreatic carcinoma;adenosquamous lung carcinoma;unspecified peripheral T-cell lymphoma;Digestive System Adenoma;Gastric Neuroendocrine Tumor G1;nodular melanoma;adrenal gland pheochromocytoma;Thymoma;ovarian carcinoma;MANTLE CELL LYMPHOMA;large cell lung carcinoma;breast ductal adenocarcinoma;Lung carcinoma;colonic neoplasm;PAPILLOMA OF CHOROID PLEXUS;Teratoma with Malignant Transformation;Rectal Villous Adenoma;mesenchymal chondrosarcoma;Ulcerative colitis;sebaceous adenocarcinoma;Normal Breast-Like Subtype of Breast Carcinoma;Rhabdoid Meningioma;Skin Basosquamous Cell Carcinoma;Keloid;Thymoma Type B3;Hepatocellular Carcinoma;Medulloblastoma;Major Salivary Gland Carcinoma ex Pleomorphic Adenoma;Kidney Oncocytoma;Ileal Neuroendocrine Tumor G1;blastic plasmacytoid dendritic cell neoplasm;Atypical Meningioma;folliculitis;Parotid Gland Squamous Cell Carcinoma;Lymphomatoid papulosis;colon adenocarcinoma;Essential thrombocythemia;Rhabdomyosarcoma;central neurocytoma;pulmonary blastoma;Colorectal Neuroendocrine Tumor G1;Biphasic Mesothelioma;Colorectal Hamartoma;cecum adenocarcinoma;Non-Functioning Adrenal Cortex Adenoma;Brain Stem Glioblastoma;Secretory Meningioma;PEComa;Prostate Small Cell Carcinoma;bladder tumor;Oligoastrocytoma;T-cell acute lymphoblastic leukemia;undifferentiated pleomorphic sarcoma;skin carcinoma;ovarian mucinous adenocarcinoma;Essential thrombocythemia;hairy cell leukemia;breast hyperplasia;lobular breast carcinoma;cervical adenocarcinoma;Uveal melanoma;Chromophobe renal cell carcinoma;Angiomatous Meningioma;Alveolar rhabdomyosarcoma;uterine corpus undifferentiated sarcoma;Salivary Gland Carcinoma ex Pleomorphic Adenoma;Splenic Diffuse Large B-Cell Lymphoma;Kidney Medullary Carcinoma;gastric adenocarcinoma;Basaloid Carcinoma;smooth muscle tumor;Pancreatic Large Cell Neuroendocrine Carcinoma;Fallopian Tube Carcinoma;OSTEOGENIC SARCOMA;angiosarcoma;ureter urothelial carcinoma;Malignant Mixed Neoplasm;Pancreatic Cancer;Hydatidiform mole;Parotid Gland Adenoid Cystic Carcinoma;Small Intestinal Diffuse Large B-Cell Lymphoma;Undifferentiated Pancreatic Carcinoma with Osteoclast-Like Giant Cells;breast adenosis;Choroid plexus papilloma;Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation;Therapy-Related Myeloid Neoplasm;Chronic myelogenous leukemia;Atypical endometrial hyperplasia;Parotid Gland Carcinoma;Salivary Gland Large Cell Carcinoma;Gallbladder Adenocarcinoma;bile duct carcinoma;bladder transitional cell carcinoma;Undifferentiated Pancreatic Carcinoma;brain neoplasm;Ovarian Carcinosarcoma;gastric carcinoma;Bladder Squamous Cell Carcinoma;Small Intestinal Tubulovillous Adenoma;Pituitary Gland Adenoma;Parotid Gland Carcinoma ex Pleomorphic Adenoma;Dedifferentiated liposarcoma;Hereditary breast and/or ovarian cancer syndrome;Hepatobiliary Neoplasm;Histiocytic and Dendritic Cell Neoplasm;gastric adenosquamous carcinoma;Synovial sarcoma;Adenoid Cystic Breast Carcinoma;Melanoma;Meningothelial Meningioma;Anaplastic astrocytoma;follicular thyroid carcinoma;diffuse gastric adenocarcinoma;Breast carcinoma;Testicular Yolk Sac Tumor;Sarcomatoid Mesothelioma;OSTEOSARCOMA;B-cell chronic lymphocytic leukemia;Extramammary Paget Disease;BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 7;Giant cell glioblastoma;rectal adenocarcinoma;Fallopian Tube Carcinosarcoma;stomach neoplasm;Conjunctival Squamous Cell Carcinoma;Testicular Teratoma;Eccrine porocarcinoma;Gallbladder Small Cell Neuroendocrine Carcinoma;clear cell sarcoma;Fallopian Tube Serous Adenocarcinoma;Cortisol-Producing Adrenal Cortex Adenoma;breast ductal carcinoma in situ;leukoplakia of tongue;BONE MARROW FAILURE SYNDROME 5;Breast Cancer;ADRENOCORTICAL CARCINOMA, HEREDITARY;OSTEOGENIC SARCOMA;Li-Fraumeni syndrome;Colorectal Cancer;BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 7;NASOPHARYNGEAL CARCINOMA;GLIOMA SUSCEPTIBILITY 1;PAPILLOMA OF CHOROID PLEXUS;Hepatocellular Carcinoma;Pancreatic Cancer"
TP53_aug1,TP53,"Liver Diffuse Large B-Cell Lymphoma;Choroid plexus carcinoma;ovarian serous adenocarcinoma;Myelodysplastic/Myeloproliferative Neoplasm;Poorly Differentiated Thyroid Gland Carcinoma;Adenocarcinoma;Ovarian Transitional Cell Carcinoma;Thyroid Gland Diffuse Large B-Cell Lymphoma;ovarian teratoma;Colorectal Cancer;Sarcomatoid Carcinoma;Adrenal Gland Neuroblastoma;Lung Sclerosing Hemangioma;Pleural Mesothelioma;large cell medulloblastoma;Ovarian Endometrioid Adenocarcinoma;B-cell acute lymphoblastic leukemia;Gastric Adenoma;Thymic Small Cell Carcinoma;pancreatic neuroendocrine tumor;prostate adenocarcinoma;Granulocytic Sarcoma;Gastric Metaplasia;Small cell lung carcinoma;Spindle Cell Melanoma;Breast Carcinoma by Gene Expression Profile;NASOPHARYNGEAL CARCINOMA;Ovarian Yolk Sac Tumor;Unclassified Renal Cell Carcinoma;Neoplasm;Thymic Sarcomatoid Carcinoma;Glioma;Carcinoma;lymphoid neoplasm;Rectal Tubular Adenoma;Acute lymphoblastic leukemia;PAPILLOMA OF CHOROID PLEXUS;Intimal Sarcoma;ganglioglioma;Acute basophilic leukemia;marginal zone B-cell lymphoma;dysplastic nevus;Bladder Small Cell Neuroendocrine Carcinoma;Cervical Endometrioid Adenocarcinoma;Ocular Sebaceous Carcinoma;Adenoid cystic carcinoma;Meningeal Melanocytoma;Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant;Colorectal adenoma;Invasive Breast Carcinoma;Ampulla of Vater Carcinoma;Merkel cell skin cancer;nasopharyngeal squamous cell carcinoma;cutaneous melanoma;Olfactory Neuroblastoma;primary central chondrosarcoma;metaplastic breast carcinoma;Dedifferentiated Solitary Fibrous Tumor;colorectal adenocarcinoma;Ependymoma;Conjunctival Melanoma;gastric intestinal type adenocarcinoma;vascular sarcoma;OSTEOSARCOMA;endodermal sinus tumor;Pleural Epithelioid Mesothelioma;Mucinous Gastric Adenocarcinoma;CHONDROSARCOMA;large cell neuroendocrine carcinoma;Conjunctival Disorder;Esophageal adenocarcinoma;Papillary thyroid carcinoma;Medullomyoblastoma with Myogenic Differentiation;tonsil cancer;Endometrial Endometrioid Adenocarcinoma;testicular mixed germ cell tumor;Actinic keratosis;Dysplasia in Ulcerative Colitis;soft tissue sarcoma;medullary breast carcinoma;Papillary renal cell carcinoma;Mixed Lobular and Ductal Breast Carcinoma;Vaginal Melanoma;BONE MARROW FAILURE SYNDROME 5;Gastric Papillary Adenocarcinoma;bronchoalveolar adenocarcinoma;Cervical Clear Cell Adenocarcinoma;Hidradenocarcinoma;Bladder Adenocarcinoma;Aldosterone producing adenoma;Duodenal Adenocarcinoma;Basal cell carcinoma;thyroid neoplasm;Breast Cancer;cervical squamous cell carcinoma;Submandibular Gland Adenoid Cystic Carcinoma;Extraskeletal Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor;diffuse large B-cell lymphoma;Alveolar rhabdomyosarcoma;kidney neoplasm;Li-Fraumeni syndrome;Barrett's esophagus;Ethmoid Sinus Adenoid Cystic Carcinoma;Jejunal Neuroendocrine Tumor G1;non-functioning pituitary adenoma;Pleural Sarcomatoid Mesothelioma;Primary Peritoneal Serous Adenocarcinoma;ossifying fibroma;Penile Carcinoma;plasmacytoma;Cervical Small Cell Carcinoma;Malignant Urinary System Neoplasm;Poroma;endometrial serous adenocarcinoma;Fibroadenoma;Chordoid Meningioma;Benign Ovarian Mucinous Tumor;Endometrial stromal sarcoma;Anal Squamous Cell Carcinoma;Sinonasal Undifferentiated Carcinoma;myeloid neoplasm;Primary Pulmonary Diffuse Large B-Cell Lymphoma;Placental Choriocarcinoma;radiologic finding;Benign Ovarian Neoplasm;Ovarian Mixed Epithelial Tumor;Mediastinal Malignant Germ Cell Tumor;neoplasm of mature B-cells;Thyroid Gland Undifferentiated (Anaplastic) Carcinoma;Ovarian Serous Adenocarcinofibroma;Oligodendroglioma;Well-differentiated liposarcoma;Squamous cell carcinoma;brain glioblastoma;Chronic Eosinophilic Leukemia, Not Otherwise Specified;Cushing disease;Malignant Laryngeal Neoplasm;Testicular Sertoli Cell Tumor;Anaplastic oligodendroglioma;Pleomorphic rhabdomyosarcoma;Malignant Pancreatic Neoplasm;Maxillary Sinus Adenoid Cystic Carcinoma;ACTH-Producing Pituitary Gland Adenoma;urothelial carcinoma;Gliosarcoma;Esophageal Squamous Cell Carcinoma;Thymic Carcinoma;Borderline Ovarian Mucinous Tumor;Acute myeloid leukemia;Intestinal Type Adenocarcinoma;embryonal rhabdomyosarcoma;T-cell prolymphocytic leukemia;Central Nervous System Neoplasm;Benign Salivary Gland Myoepithelioma;Chronic lymphocytic leukemia;MYELODYSPLASTIC SYNDROME;Tracheal Adenoid Cystic Carcinoma;Signet Ring Cell Gastric Adenocarcinoma;Dysplasia of Larynx;Lung Giant Cell Carcinoma;Transitional Meningioma;Gastric Squamous Cell Carcinoma;Parathyroid Gland Carcinoma;Malignant Ovarian Brenner Tumor;Endometrial Clear Cell Adenocarcinoma;skin appendage carcinoma;Small cell lung cancer;Lung adenocarcinoma;Salivary Gland Acinic Cell Carcinoma;Colon Dysplasia;pancreatic neoplasm;carcinoid tumor;Tracheal Squamous Cell Carcinoma;Tonsillar Squamous Cell Carcinoma;Gliosarcoma;Pancreatic Acinar Cell Carcinoma;endometrium adenocarcinoma;squamous cell lung carcinoma;Vulvar Squamous Cell Carcinoma;ND;non-small cell lung carcinoma;Crohn's disease;Middle Ear Squamous Cell Carcinoma;Cervical Adenosquamous Carcinoma;collecting duct carcinoma;adrenal cortex carcinoma;malignant epithelioid mesothelioma;Epithelioid Malignant Peripheral Nerve Sheath Tumor;dedifferentiated chondrosarcoma;renal carcinoma;Kaposi's sarcoma;Adrenocortical carcinoma;benign prostatic hyperplasia;Clear cell renal carcinoma;Renal cell carcinoma;pseudomyxoma peritonei;Malignant peripheral nerve sheath tumor;POLYCYTHEMIA VERA;Hepatocellular Carcinoma;Benign Ovarian Brenner Tumor;Burkitts lymphoma;Endometrial Mucinous Adenocarcinoma;mucinous carcinoma;Splenic Mantle Cell Lymphoma;anaplastic large cell lymphoma;small cell carcinoma;Chronic neutrophilic leukemia;Pleomorphic salivary gland adenoma;Li-Fraumeni syndrome;Gonadal Teratoma;thyroid carcinoma;Appendix Neuroendocrine Tumor G1;Malignant Ovarian Mixed Epithelial Tumor;Pancreatic Small Cell Neuroendocrine Carcinoma;Ovarian Small Cell Carcinoma;Pleural Biphasic Mesothelioma;breast neoplasm;Parotid Gland Acinic Cell Carcinoma;Kidney Angiomyolipoma;Undifferentiated Gallbladder Carcinoma;Fibrous Meningioma;Benign Conjunctival Neoplasm;epithelial neoplasm;Solid Pseudopapillary Neoplasm of the Pancreas;Angioimmunoblastic T-cell lymphoma;Langerhans cell histiocytosis;Colorectal Diffuse Large B-Cell Lymphoma;Digestive System Carcinoma;Central Nervous System Lymphoma;GLIOMA SUSCEPTIBILITY 1;Appendix Goblet Cell Carcinoid;Rectal Traditional Serrated Adenoma;Benign Thyroid Gland Neoplasm;adrenocortical adenoma;leiomyosarcoma;Hodgkins lymphoma;Appendix Villous Adenoma;Major Salivary Gland Mucoepidermoid Carcinoma;Thymic Undifferentiated Carcinoma;gallbladder carcinoma;gastric tubular adenocarcinoma;B-Cell Prolymphocytic Leukemia;hepatocellular adenoma;Familial pancreatic carcinoma;Li-Fraumeni syndrome;Lymphoepithelioma-Like Lung Carcinoma;hyperplasia;Gastric Diffuse Large B-Cell Lymphoma;Major Salivary Gland Carcinoma;Chronic myelomonocytic leukemia;B-lymphoblastic leukemia/lymphoma with t9;22q34.1;q11.2;Thymic Squamous Cell Carcinoma;Anaplastic oligoastrocytoma;Testicular Leydig Cell Tumor;ALVEOLAR SOFT PART SARCOMA;colon carcinoma;follicular dendritic cell sarcoma;prostate carcinoma;Atypical teratoid rhabdoid tumor;ovarian clear cell adenocarcinoma;testicular seminoma;salivary gland squamous cell carcinoma;vulvar carcinoma;Appendix Adenocarcinoma;Minor Salivary Gland Adenocarcinoma;liposarcoma;Gallbladder Squamous Cell Carcinoma;HEPATOBLASTOMA;malignant rhabdoid tumour;Esophageal carcinoma;Lung carcinoid tumor;Malignancy in Giant Cell Tumor of Bone;Adult hepatocellular carcinoma;Cecum Villous Adenoma;Gallbladder Adenosquamous Carcinoma;Peritoneal Mesothelioma;transitional cell carcinoma of kidney;Anal Melanoma;ADRENOCORTICAL CARCINOMA, HEREDITARY;Testicular Choriocarcinoma;Anaplastic Malignant Meningioma;Ovarian Granulosa Cell Tumor;Sex Hormone-Producing Adrenal Cortex Adenoma;Undifferentiated Ovarian Carcinoma;Thyroid Gland Oncocytic Follicular Carcinoma;Malignant Adrenal Gland Pheochromocytoma;Endometrial Undifferentiated Carcinoma;Non-Functional Pancreatic Neuroendocrine Tumor;ovarian adenocarcinoma;Spinal Cord Astrocytoma;Multiple myeloma;Uterine Carcinosarcoma;pharyngeal squamous cell carcinoma;Borderline Ovarian Serous Tumor;embryonal rhabdomyosarcoma;HER2 positive breast carcinoma;oral squamous cell carcinoma;head and neck squamous cell carcinoma;Myeloproliferative disorder;Astrocytoma;small intestinal adenocarcinoma;cervical carcinoma;Ovarian neoplasm;Endometrial carcinoma;Parotid Gland Pleomorphic Adenoma;Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive;pleomorphic liposarcoma;Lung sarcomatoid carcinoma;Malignant Mesothelioma;Laryngeal squamous cell carcinoma;Grade III Prostatic Intraepithelial Neoplasia;Testicular Embryonal Carcinoma;pancreatic carcinoma;adenosquamous lung carcinoma;unspecified peripheral T-cell lymphoma;Digestive System Adenoma;Gastric Neuroendocrine Tumor G1;nodular melanoma;adrenal gland pheochromocytoma;Thymoma;ovarian carcinoma;MANTLE CELL LYMPHOMA;large cell lung carcinoma;breast ductal adenocarcinoma;Lung carcinoma;colonic neoplasm;PAPILLOMA OF CHOROID PLEXUS;Teratoma with Malignant Transformation;Rectal Villous Adenoma;mesenchymal chondrosarcoma;Ulcerative colitis;sebaceous adenocarcinoma;Normal Breast-Like Subtype of Breast Carcinoma;Rhabdoid Meningioma;Skin Basosquamous Cell Carcinoma;Keloid;Thymoma Type B3;Hepatocellular Carcinoma;Medulloblastoma;Major Salivary Gland Carcinoma ex Pleomorphic Adenoma;Kidney Oncocytoma;Ileal Neuroendocrine Tumor G1;blastic plasmacytoid dendritic cell neoplasm;Atypical Meningioma;folliculitis;Parotid Gland Squamous Cell Carcinoma;Lymphomatoid papulosis;colon adenocarcinoma;Essential thrombocythemia;Rhabdomyosarcoma;central neurocytoma;pulmonary blastoma;Colorectal Neuroendocrine Tumor G1;Biphasic Mesothelioma;Colorectal Hamartoma;cecum adenocarcinoma;Non-Functioning Adrenal Cortex Adenoma;Brain Stem Glioblastoma;Secretory Meningioma;PEComa;Prostate Small Cell Carcinoma;bladder tumor;Oligoastrocytoma;T-cell acute lymphoblastic leukemia;undifferentiated pleomorphic sarcoma;skin carcinoma;ovarian mucinous adenocarcinoma;Essential thrombocythemia;hairy cell leukemia;breast hyperplasia;lobular breast carcinoma;cervical adenocarcinoma;Uveal melanoma;Chromophobe renal cell carcinoma;Angiomatous Meningioma;Alveolar rhabdomyosarcoma;uterine corpus undifferentiated sarcoma;Salivary Gland Carcinoma ex Pleomorphic Adenoma;Splenic Diffuse Large B-Cell Lymphoma;Kidney Medullary Carcinoma;gastric adenocarcinoma;Basaloid Carcinoma;smooth muscle tumor;Pancreatic Large Cell Neuroendocrine Carcinoma;Fallopian Tube Carcinoma;OSTEOGENIC SARCOMA;angiosarcoma;ureter urothelial carcinoma;Malignant Mixed Neoplasm;Pancreatic Cancer;Hydatidiform mole;Parotid Gland Adenoid Cystic Carcinoma;Small Intestinal Diffuse Large B-Cell Lymphoma;Undifferentiated Pancreatic Carcinoma with Osteoclast-Like Giant Cells;breast adenosis;Choroid plexus papilloma;Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation;Therapy-Related Myeloid Neoplasm;Chronic myelogenous leukemia;Atypical endometrial hyperplasia;Parotid Gland Carcinoma;Salivary Gland Large Cell Carcinoma;Gallbladder Adenocarcinoma;bile duct carcinoma;bladder transitional cell carcinoma;Undifferentiated Pancreatic Carcinoma;brain neoplasm;Ovarian Carcinosarcoma;gastric carcinoma;Bladder Squamous Cell Carcinoma;Small Intestinal Tubulovillous Adenoma;Pituitary Gland Adenoma;Parotid Gland Carcinoma ex Pleomorphic Adenoma;Dedifferentiated liposarcoma;Hereditary breast and/or ovarian cancer syndrome;Hepatobiliary Neoplasm;Histiocytic and Dendritic Cell Neoplasm;gastric adenosquamous carcinoma;Synovial sarcoma;Adenoid Cystic Breast Carcinoma;Melanoma;Meningothelial Meningioma;Anaplastic astrocytoma;follicular thyroid carcinoma;diffuse gastric adenocarcinoma;Breast carcinoma;Testicular Yolk Sac Tumor;Sarcomatoid Mesothelioma;OSTEOSARCOMA;B-cell chronic lymphocytic leukemia;Extramammary Paget Disease;BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 7;Giant cell glioblastoma;rectal adenocarcinoma;Fallopian Tube Carcinosarcoma;stomach neoplasm;Conjunctival Squamous Cell Carcinoma;Testicular Teratoma;Eccrine porocarcinoma;Gallbladder Small Cell Neuroendocrine Carcinoma;clear cell sarcoma;Fallopian Tube Serous Adenocarcinoma;Cortisol-Producing Adrenal Cortex Adenoma;breast ductal carcinoma in situ;leukoplakia of tongue;BONE MARROW FAILURE SYNDROME 5;Breast Cancer;ADRENOCORTICAL CARCINOMA, HEREDITARY;OSTEOGENIC SARCOMA;Li-Fraumeni syndrome;Colorectal Cancer;BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 7;NASOPHARYNGEAL CARCINOMA;GLIOMA SUSCEPTIBILITY 1;PAPILLOMA OF CHOROID PLEXUS;Hepatocellular Carcinoma;Pancreatic Cancer"
TP53_aug2,TP53,"Liver Diffuse Large B-Cell Lymphoma;Choroid plexus carcinoma;ovarian serous adenocarcinoma;Myelodysplastic/Myeloproliferative Neoplasm;Poorly Differentiated Thyroid Gland Carcinoma;Adenocarcinoma;Ovarian Transitional Cell Carcinoma;Thyroid Gland Diffuse Large B-Cell Lymphoma;ovarian teratoma;Colorectal Cancer;Sarcomatoid Carcinoma;Adrenal Gland Neuroblastoma;Lung Sclerosing Hemangioma;Pleural Mesothelioma;large cell medulloblastoma;Ovarian Endometrioid Adenocarcinoma;B-cell acute lymphoblastic leukemia;Gastric Adenoma;Thymic Small Cell Carcinoma;pancreatic neuroendocrine tumor;prostate adenocarcinoma;Granulocytic Sarcoma;Gastric Metaplasia;Small cell lung carcinoma;Spindle Cell Melanoma;Breast Carcinoma by Gene Expression Profile;NASOPHARYNGEAL CARCINOMA;Ovarian Yolk Sac Tumor;Unclassified Renal Cell Carcinoma;Neoplasm;Thymic Sarcomatoid Carcinoma;Glioma;Carcinoma;lymphoid neoplasm;Rectal Tubular Adenoma;Acute lymphoblastic leukemia;PAPILLOMA OF CHOROID PLEXUS;Intimal Sarcoma;ganglioglioma;Acute basophilic leukemia;marginal zone B-cell lymphoma;dysplastic nevus;Bladder Small Cell Neuroendocrine Carcinoma;Cervical Endometrioid Adenocarcinoma;Ocular Sebaceous Carcinoma;Adenoid cystic carcinoma;Meningeal Melanocytoma;Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant;Colorectal adenoma;Invasive Breast Carcinoma;Ampulla of Vater Carcinoma;Merkel cell skin cancer;nasopharyngeal squamous cell carcinoma;cutaneous melanoma;Olfactory Neuroblastoma;primary central chondrosarcoma;metaplastic breast carcinoma;Dedifferentiated Solitary Fibrous Tumor;colorectal adenocarcinoma;Ependymoma;Conjunctival Melanoma;gastric intestinal type adenocarcinoma;vascular sarcoma;OSTEOSARCOMA;endodermal sinus tumor;Pleural Epithelioid Mesothelioma;Mucinous Gastric Adenocarcinoma;CHONDROSARCOMA;large cell neuroendocrine carcinoma;Conjunctival Disorder;Esophageal adenocarcinoma;Papillary thyroid carcinoma;Medullomyoblastoma with Myogenic Differentiation;tonsil cancer;Endometrial Endometrioid Adenocarcinoma;testicular mixed germ cell tumor;Actinic keratosis;Dysplasia in Ulcerative Colitis;soft tissue sarcoma;medullary breast carcinoma;Papillary renal cell carcinoma;Mixed Lobular and Ductal Breast Carcinoma;Vaginal Melanoma;BONE MARROW FAILURE SYNDROME 5;Gastric Papillary Adenocarcinoma;bronchoalveolar adenocarcinoma;Cervical Clear Cell Adenocarcinoma;Hidradenocarcinoma;Bladder Adenocarcinoma;Aldosterone producing adenoma;Duodenal Adenocarcinoma;Basal cell carcinoma;thyroid neoplasm;Breast Cancer;cervical squamous cell carcinoma;Submandibular Gland Adenoid Cystic Carcinoma;Extraskeletal Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor;diffuse large B-cell lymphoma;Alveolar rhabdomyosarcoma;kidney neoplasm;Li-Fraumeni syndrome;Barrett's esophagus;Ethmoid Sinus Adenoid Cystic Carcinoma;Jejunal Neuroendocrine Tumor G1;non-functioning pituitary adenoma;Pleural Sarcomatoid Mesothelioma;Primary Peritoneal Serous Adenocarcinoma;ossifying fibroma;Penile Carcinoma;plasmacytoma;Cervical Small Cell Carcinoma;Malignant Urinary System Neoplasm;Poroma;endometrial serous adenocarcinoma;Fibroadenoma;Chordoid Meningioma;Benign Ovarian Mucinous Tumor;Endometrial stromal sarcoma;Anal Squamous Cell Carcinoma;Sinonasal Undifferentiated Carcinoma;myeloid neoplasm;Primary Pulmonary Diffuse Large B-Cell Lymphoma;Placental Choriocarcinoma;radiologic finding;Benign Ovarian Neoplasm;Ovarian Mixed Epithelial Tumor;Mediastinal Malignant Germ Cell Tumor;neoplasm of mature B-cells;Thyroid Gland Undifferentiated (Anaplastic) Carcinoma;Ovarian Serous Adenocarcinofibroma;Oligodendroglioma;Well-differentiated liposarcoma;Squamous cell carcinoma;brain glioblastoma;Chronic Eosinophilic Leukemia, Not Otherwise Specified;Cushing disease;Malignant Laryngeal Neoplasm;Testicular Sertoli Cell Tumor;Anaplastic oligodendroglioma;Pleomorphic rhabdomyosarcoma;Malignant Pancreatic Neoplasm;Maxillary Sinus Adenoid Cystic Carcinoma;ACTH-Producing Pituitary Gland Adenoma;urothelial carcinoma;Gliosarcoma;Esophageal Squamous Cell Carcinoma;Thymic Carcinoma;Borderline Ovarian Mucinous Tumor;Acute myeloid leukemia;Intestinal Type Adenocarcinoma;embryonal rhabdomyosarcoma;T-cell prolymphocytic leukemia;Central Nervous System Neoplasm;Benign Salivary Gland Myoepithelioma;Chronic lymphocytic leukemia;MYELODYSPLASTIC SYNDROME;Tracheal Adenoid Cystic Carcinoma;Signet Ring Cell Gastric Adenocarcinoma;Dysplasia of Larynx;Lung Giant Cell Carcinoma;Transitional Meningioma;Gastric Squamous Cell Carcinoma;Parathyroid Gland Carcinoma;Malignant Ovarian Brenner Tumor;Endometrial Clear Cell Adenocarcinoma;skin appendage carcinoma;Small cell lung cancer;Lung adenocarcinoma;Salivary Gland Acinic Cell Carcinoma;Colon Dysplasia;pancreatic neoplasm;carcinoid tumor;Tracheal Squamous Cell Carcinoma;Tonsillar Squamous Cell Carcinoma;Gliosarcoma;Pancreatic Acinar Cell Carcinoma;endometrium adenocarcinoma;squamous cell lung carcinoma;Vulvar Squamous Cell Carcinoma;ND;non-small cell lung carcinoma;Crohn's disease;Middle Ear Squamous Cell Carcinoma;Cervical Adenosquamous Carcinoma;collecting duct carcinoma;adrenal cortex carcinoma;malignant epithelioid mesothelioma;Epithelioid Malignant Peripheral Nerve Sheath Tumor;dedifferentiated chondrosarcoma;renal carcinoma;Kaposi's sarcoma;Adrenocortical carcinoma;benign prostatic hyperplasia;Clear cell renal carcinoma;Renal cell carcinoma;pseudomyxoma peritonei;Malignant peripheral nerve sheath tumor;POLYCYTHEMIA VERA;Hepatocellular Carcinoma;Benign Ovarian Brenner Tumor;Burkitts lymphoma;Endometrial Mucinous Adenocarcinoma;mucinous carcinoma;Splenic Mantle Cell Lymphoma;anaplastic large cell lymphoma;small cell carcinoma;Chronic neutrophilic leukemia;Pleomorphic salivary gland adenoma;Li-Fraumeni syndrome;Gonadal Teratoma;thyroid carcinoma;Appendix Neuroendocrine Tumor G1;Malignant Ovarian Mixed Epithelial Tumor;Pancreatic Small Cell Neuroendocrine Carcinoma;Ovarian Small Cell Carcinoma;Pleural Biphasic Mesothelioma;breast neoplasm;Parotid Gland Acinic Cell Carcinoma;Kidney Angiomyolipoma;Undifferentiated Gallbladder Carcinoma;Fibrous Meningioma;Benign Conjunctival Neoplasm;epithelial neoplasm;Solid Pseudopapillary Neoplasm of the Pancreas;Angioimmunoblastic T-cell lymphoma;Langerhans cell histiocytosis;Colorectal Diffuse Large B-Cell Lymphoma;Digestive System Carcinoma;Central Nervous System Lymphoma;GLIOMA SUSCEPTIBILITY 1;Appendix Goblet Cell Carcinoid;Rectal Traditional Serrated Adenoma;Benign Thyroid Gland Neoplasm;adrenocortical adenoma;leiomyosarcoma;Hodgkins lymphoma;Appendix Villous Adenoma;Major Salivary Gland Mucoepidermoid Carcinoma;Thymic Undifferentiated Carcinoma;gallbladder carcinoma;gastric tubular adenocarcinoma;B-Cell Prolymphocytic Leukemia;hepatocellular adenoma;Familial pancreatic carcinoma;Li-Fraumeni syndrome;Lymphoepithelioma-Like Lung Carcinoma;hyperplasia;Gastric Diffuse Large B-Cell Lymphoma;Major Salivary Gland Carcinoma;Chronic myelomonocytic leukemia;B-lymphoblastic leukemia/lymphoma with t9;22q34.1;q11.2;Thymic Squamous Cell Carcinoma;Anaplastic oligoastrocytoma;Testicular Leydig Cell Tumor;ALVEOLAR SOFT PART SARCOMA;colon carcinoma;follicular dendritic cell sarcoma;prostate carcinoma;Atypical teratoid rhabdoid tumor;ovarian clear cell adenocarcinoma;testicular seminoma;salivary gland squamous cell carcinoma;vulvar carcinoma;Appendix Adenocarcinoma;Minor Salivary Gland Adenocarcinoma;liposarcoma;Gallbladder Squamous Cell Carcinoma;HEPATOBLASTOMA;malignant rhabdoid tumour;Esophageal carcinoma;Lung carcinoid tumor;Malignancy in Giant Cell Tumor of Bone;Adult hepatocellular carcinoma;Cecum Villous Adenoma;Gallbladder Adenosquamous Carcinoma;Peritoneal Mesothelioma;transitional cell carcinoma of kidney;Anal Melanoma;ADRENOCORTICAL CARCINOMA, HEREDITARY;Testicular Choriocarcinoma;Anaplastic Malignant Meningioma;Ovarian Granulosa Cell Tumor;Sex Hormone-Producing Adrenal Cortex Adenoma;Undifferentiated Ovarian Carcinoma;Thyroid Gland Oncocytic Follicular Carcinoma;Malignant Adrenal Gland Pheochromocytoma;Endometrial Undifferentiated Carcinoma;Non-Functional Pancreatic Neuroendocrine Tumor;ovarian adenocarcinoma;Spinal Cord Astrocytoma;Multiple myeloma;Uterine Carcinosarcoma;pharyngeal squamous cell carcinoma;Borderline Ovarian Serous Tumor;embryonal rhabdomyosarcoma;HER2 positive breast carcinoma;oral squamous cell carcinoma;head and neck squamous cell carcinoma;Myeloproliferative disorder;Astrocytoma;small intestinal adenocarcinoma;cervical carcinoma;Ovarian neoplasm;Endometrial carcinoma;Parotid Gland Pleomorphic Adenoma;Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive;pleomorphic liposarcoma;Lung sarcomatoid carcinoma;Malignant Mesothelioma;Laryngeal squamous cell carcinoma;Grade III Prostatic Intraepithelial Neoplasia;Testicular Embryonal Carcinoma;pancreatic carcinoma;adenosquamous lung carcinoma;unspecified peripheral T-cell lymphoma;Digestive System Adenoma;Gastric Neuroendocrine Tumor G1;nodular melanoma;adrenal gland pheochromocytoma;Thymoma;ovarian carcinoma;MANTLE CELL LYMPHOMA;large cell lung carcinoma;breast ductal adenocarcinoma;Lung carcinoma;colonic neoplasm;PAPILLOMA OF CHOROID PLEXUS;Teratoma with Malignant Transformation;Rectal Villous Adenoma;mesenchymal chondrosarcoma;Ulcerative colitis;sebaceous adenocarcinoma;Normal Breast-Like Subtype of Breast Carcinoma;Rhabdoid Meningioma;Skin Basosquamous Cell Carcinoma;Keloid;Thymoma Type B3;Hepatocellular Carcinoma;Medulloblastoma;Major Salivary Gland Carcinoma ex Pleomorphic Adenoma;Kidney Oncocytoma;Ileal Neuroendocrine Tumor G1;blastic plasmacytoid dendritic cell neoplasm;Atypical Meningioma;folliculitis;Parotid Gland Squamous Cell Carcinoma;Lymphomatoid papulosis;colon adenocarcinoma;Essential thrombocythemia;Rhabdomyosarcoma;central neurocytoma;pulmonary blastoma;Colorectal Neuroendocrine Tumor G1;Biphasic Mesothelioma;Colorectal Hamartoma;cecum adenocarcinoma;Non-Functioning Adrenal Cortex Adenoma;Brain Stem Glioblastoma;Secretory Meningioma;PEComa;Prostate Small Cell Carcinoma;bladder tumor;Oligoastrocytoma;T-cell acute lymphoblastic leukemia;undifferentiated pleomorphic sarcoma;skin carcinoma;ovarian mucinous adenocarcinoma;Essential thrombocythemia;hairy cell leukemia;breast hyperplasia;lobular breast carcinoma;cervical adenocarcinoma;Uveal melanoma;Chromophobe renal cell carcinoma;Angiomatous Meningioma;Alveolar rhabdomyosarcoma;uterine corpus undifferentiated sarcoma;Salivary Gland Carcinoma ex Pleomorphic Adenoma;Splenic Diffuse Large B-Cell Lymphoma;Kidney Medullary Carcinoma;gastric adenocarcinoma;Basaloid Carcinoma;smooth muscle tumor;Pancreatic Large Cell Neuroendocrine Carcinoma;Fallopian Tube Carcinoma;OSTEOGENIC SARCOMA;angiosarcoma;ureter urothelial carcinoma;Malignant Mixed Neoplasm;Pancreatic Cancer;Hydatidiform mole;Parotid Gland Adenoid Cystic Carcinoma;Small Intestinal Diffuse Large B-Cell Lymphoma;Undifferentiated Pancreatic Carcinoma with Osteoclast-Like Giant Cells;breast adenosis;Choroid plexus papilloma;Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation;Therapy-Related Myeloid Neoplasm;Chronic myelogenous leukemia;Atypical endometrial hyperplasia;Parotid Gland Carcinoma;Salivary Gland Large Cell Carcinoma;Gallbladder Adenocarcinoma;bile duct carcinoma;bladder transitional cell carcinoma;Undifferentiated Pancreatic Carcinoma;brain neoplasm;Ovarian Carcinosarcoma;gastric carcinoma;Bladder Squamous Cell Carcinoma;Small Intestinal Tubulovillous Adenoma;Pituitary Gland Adenoma;Parotid Gland Carcinoma ex Pleomorphic Adenoma;Dedifferentiated liposarcoma;Hereditary breast and/or ovarian cancer syndrome;Hepatobiliary Neoplasm;Histiocytic and Dendritic Cell Neoplasm;gastric adenosquamous carcinoma;Synovial sarcoma;Adenoid Cystic Breast Carcinoma;Melanoma;Meningothelial Meningioma;Anaplastic astrocytoma;follicular thyroid carcinoma;diffuse gastric adenocarcinoma;Breast carcinoma;Testicular Yolk Sac Tumor;Sarcomatoid Mesothelioma;OSTEOSARCOMA;B-cell chronic lymphocytic leukemia;Extramammary Paget Disease;BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 7;Giant cell glioblastoma;rectal adenocarcinoma;Fallopian Tube Carcinosarcoma;stomach neoplasm;Conjunctival Squamous Cell Carcinoma;Testicular Teratoma;Eccrine porocarcinoma;Gallbladder Small Cell Neuroendocrine Carcinoma;clear cell sarcoma;Fallopian Tube Serous Adenocarcinoma;Cortisol-Producing Adrenal Cortex Adenoma;breast ductal carcinoma in situ;leukoplakia of tongue;BONE MARROW FAILURE SYNDROME 5;Breast Cancer;ADRENOCORTICAL CARCINOMA, HEREDITARY;OSTEOGENIC SARCOMA;Li-Fraumeni syndrome;Colorectal Cancer;BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 7;NASOPHARYNGEAL CARCINOMA;GLIOMA SUSCEPTIBILITY 1;PAPILLOMA OF CHOROID PLEXUS;Hepatocellular Carcinoma;Pancreatic Cancer"
TP53_aug3,TP53,"Liver Diffuse Large B-Cell Lymphoma;Choroid plexus carcinoma;ovarian serous adenocarcinoma;Myelodysplastic/Myeloproliferative Neoplasm;Poorly Differentiated Thyroid Gland Carcinoma;Adenocarcinoma;Ovarian Transitional Cell Carcinoma;Thyroid Gland Diffuse Large B-Cell Lymphoma;ovarian teratoma;Colorectal Cancer;Sarcomatoid Carcinoma;Adrenal Gland Neuroblastoma;Lung Sclerosing Hemangioma;Pleural Mesothelioma;large cell medulloblastoma;Ovarian Endometrioid Adenocarcinoma;B-cell acute lymphoblastic leukemia;Gastric Adenoma;Thymic Small Cell Carcinoma;pancreatic neuroendocrine tumor;prostate adenocarcinoma;Granulocytic Sarcoma;Gastric Metaplasia;Small cell lung carcinoma;Spindle Cell Melanoma;Breast Carcinoma by Gene Expression Profile;NASOPHARYNGEAL CARCINOMA;Ovarian Yolk Sac Tumor;Unclassified Renal Cell Carcinoma;Neoplasm;Thymic Sarcomatoid Carcinoma;Glioma;Carcinoma;lymphoid neoplasm;Rectal Tubular Adenoma;Acute lymphoblastic leukemia;PAPILLOMA OF CHOROID PLEXUS;Intimal Sarcoma;ganglioglioma;Acute basophilic leukemia;marginal zone B-cell lymphoma;dysplastic nevus;Bladder Small Cell Neuroendocrine Carcinoma;Cervical Endometrioid Adenocarcinoma;Ocular Sebaceous Carcinoma;Adenoid cystic carcinoma;Meningeal Melanocytoma;Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant;Colorectal adenoma;Invasive Breast Carcinoma;Ampulla of Vater Carcinoma;Merkel cell skin cancer;nasopharyngeal squamous cell carcinoma;cutaneous melanoma;Olfactory Neuroblastoma;primary central chondrosarcoma;metaplastic breast carcinoma;Dedifferentiated Solitary Fibrous Tumor;colorectal adenocarcinoma;Ependymoma;Conjunctival Melanoma;gastric intestinal type adenocarcinoma;vascular sarcoma;OSTEOSARCOMA;endodermal sinus tumor;Pleural Epithelioid Mesothelioma;Mucinous Gastric Adenocarcinoma;CHONDROSARCOMA;large cell neuroendocrine carcinoma;Conjunctival Disorder;Esophageal adenocarcinoma;Papillary thyroid carcinoma;Medullomyoblastoma with Myogenic Differentiation;tonsil cancer;Endometrial Endometrioid Adenocarcinoma;testicular mixed germ cell tumor;Actinic keratosis;Dysplasia in Ulcerative Colitis;soft tissue sarcoma;medullary breast carcinoma;Papillary renal cell carcinoma;Mixed Lobular and Ductal Breast Carcinoma;Vaginal Melanoma;BONE MARROW FAILURE SYNDROME 5;Gastric Papillary Adenocarcinoma;bronchoalveolar adenocarcinoma;Cervical Clear Cell Adenocarcinoma;Hidradenocarcinoma;Bladder Adenocarcinoma;Aldosterone producing adenoma;Duodenal Adenocarcinoma;Basal cell carcinoma;thyroid neoplasm;Breast Cancer;cervical squamous cell carcinoma;Submandibular Gland Adenoid Cystic Carcinoma;Extraskeletal Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor;diffuse large B-cell lymphoma;Alveolar rhabdomyosarcoma;kidney neoplasm;Li-Fraumeni syndrome;Barrett's esophagus;Ethmoid Sinus Adenoid Cystic Carcinoma;Jejunal Neuroendocrine Tumor G1;non-functioning pituitary adenoma;Pleural Sarcomatoid Mesothelioma;Primary Peritoneal Serous Adenocarcinoma;ossifying fibroma;Penile Carcinoma;plasmacytoma;Cervical Small Cell Carcinoma;Malignant Urinary System Neoplasm;Poroma;endometrial serous adenocarcinoma;Fibroadenoma;Chordoid Meningioma;Benign Ovarian Mucinous Tumor;Endometrial stromal sarcoma;Anal Squamous Cell Carcinoma;Sinonasal Undifferentiated Carcinoma;myeloid neoplasm;Primary Pulmonary Diffuse Large B-Cell Lymphoma;Placental Choriocarcinoma;radiologic finding;Benign Ovarian Neoplasm;Ovarian Mixed Epithelial Tumor;Mediastinal Malignant Germ Cell Tumor;neoplasm of mature B-cells;Thyroid Gland Undifferentiated (Anaplastic) Carcinoma;Ovarian Serous Adenocarcinofibroma;Oligodendroglioma;Well-differentiated liposarcoma;Squamous cell carcinoma;brain glioblastoma;Chronic Eosinophilic Leukemia, Not Otherwise Specified;Cushing disease;Malignant Laryngeal Neoplasm;Testicular Sertoli Cell Tumor;Anaplastic oligodendroglioma;Pleomorphic rhabdomyosarcoma;Malignant Pancreatic Neoplasm;Maxillary Sinus Adenoid Cystic Carcinoma;ACTH-Producing Pituitary Gland Adenoma;urothelial carcinoma;Gliosarcoma;Esophageal Squamous Cell Carcinoma;Thymic Carcinoma;Borderline Ovarian Mucinous Tumor;Acute myeloid leukemia;Intestinal Type Adenocarcinoma;embryonal rhabdomyosarcoma;T-cell prolymphocytic leukemia;Central Nervous System Neoplasm;Benign Salivary Gland Myoepithelioma;Chronic lymphocytic leukemia;MYELODYSPLASTIC SYNDROME;Tracheal Adenoid Cystic Carcinoma;Signet Ring Cell Gastric Adenocarcinoma;Dysplasia of Larynx;Lung Giant Cell Carcinoma;Transitional Meningioma;Gastric Squamous Cell Carcinoma;Parathyroid Gland Carcinoma;Malignant Ovarian Brenner Tumor;Endometrial Clear Cell Adenocarcinoma;skin appendage carcinoma;Small cell lung cancer;Lung adenocarcinoma;Salivary Gland Acinic Cell Carcinoma;Colon Dysplasia;pancreatic neoplasm;carcinoid tumor;Tracheal Squamous Cell Carcinoma;Tonsillar Squamous Cell Carcinoma;Gliosarcoma;Pancreatic Acinar Cell Carcinoma;endometrium adenocarcinoma;squamous cell lung carcinoma;Vulvar Squamous Cell Carcinoma;ND;non-small cell lung carcinoma;Crohn's disease;Middle Ear Squamous Cell Carcinoma;Cervical Adenosquamous Carcinoma;collecting duct carcinoma;adrenal cortex carcinoma;malignant epithelioid mesothelioma;Epithelioid Malignant Peripheral Nerve Sheath Tumor;dedifferentiated chondrosarcoma;renal carcinoma;Kaposi's sarcoma;Adrenocortical carcinoma;benign prostatic hyperplasia;Clear cell renal carcinoma;Renal cell carcinoma;pseudomyxoma peritonei;Malignant peripheral nerve sheath tumor;POLYCYTHEMIA VERA;Hepatocellular Carcinoma;Benign Ovarian Brenner Tumor;Burkitts lymphoma;Endometrial Mucinous Adenocarcinoma;mucinous carcinoma;Splenic Mantle Cell Lymphoma;anaplastic large cell lymphoma;small cell carcinoma;Chronic neutrophilic leukemia;Pleomorphic salivary gland adenoma;Li-Fraumeni syndrome;Gonadal Teratoma;thyroid carcinoma;Appendix Neuroendocrine Tumor G1;Malignant Ovarian Mixed Epithelial Tumor;Pancreatic Small Cell Neuroendocrine Carcinoma;Ovarian Small Cell Carcinoma;Pleural Biphasic Mesothelioma;breast neoplasm;Parotid Gland Acinic Cell Carcinoma;Kidney Angiomyolipoma;Undifferentiated Gallbladder Carcinoma;Fibrous Meningioma;Benign Conjunctival Neoplasm;epithelial neoplasm;Solid Pseudopapillary Neoplasm of the Pancreas;Angioimmunoblastic T-cell lymphoma;Langerhans cell histiocytosis;Colorectal Diffuse Large B-Cell Lymphoma;Digestive System Carcinoma;Central Nervous System Lymphoma;GLIOMA SUSCEPTIBILITY 1;Appendix Goblet Cell Carcinoid;Rectal Traditional Serrated Adenoma;Benign Thyroid Gland Neoplasm;adrenocortical adenoma;leiomyosarcoma;Hodgkins lymphoma;Appendix Villous Adenoma;Major Salivary Gland Mucoepidermoid Carcinoma;Thymic Undifferentiated Carcinoma;gallbladder carcinoma;gastric tubular adenocarcinoma;B-Cell Prolymphocytic Leukemia;hepatocellular adenoma;Familial pancreatic carcinoma;Li-Fraumeni syndrome;Lymphoepithelioma-Like Lung Carcinoma;hyperplasia;Gastric Diffuse Large B-Cell Lymphoma;Major Salivary Gland Carcinoma;Chronic myelomonocytic leukemia;B-lymphoblastic leukemia/lymphoma with t9;22q34.1;q11.2;Thymic Squamous Cell Carcinoma;Anaplastic oligoastrocytoma;Testicular Leydig Cell Tumor;ALVEOLAR SOFT PART SARCOMA;colon carcinoma;follicular dendritic cell sarcoma;prostate carcinoma;Atypical teratoid rhabdoid tumor;ovarian clear cell adenocarcinoma;testicular seminoma;salivary gland squamous cell carcinoma;vulvar carcinoma;Appendix Adenocarcinoma;Minor Salivary Gland Adenocarcinoma;liposarcoma;Gallbladder Squamous Cell Carcinoma;HEPATOBLASTOMA;malignant rhabdoid tumour;Esophageal carcinoma;Lung carcinoid tumor;Malignancy in Giant Cell Tumor of Bone;Adult hepatocellular carcinoma;Cecum Villous Adenoma;Gallbladder Adenosquamous Carcinoma;Peritoneal Mesothelioma;transitional cell carcinoma of kidney;Anal Melanoma;ADRENOCORTICAL CARCINOMA, HEREDITARY;Testicular Choriocarcinoma;Anaplastic Malignant Meningioma;Ovarian Granulosa Cell Tumor;Sex Hormone-Producing Adrenal Cortex Adenoma;Undifferentiated Ovarian Carcinoma;Thyroid Gland Oncocytic Follicular Carcinoma;Malignant Adrenal Gland Pheochromocytoma;Endometrial Undifferentiated Carcinoma;Non-Functional Pancreatic Neuroendocrine Tumor;ovarian adenocarcinoma;Spinal Cord Astrocytoma;Multiple myeloma;Uterine Carcinosarcoma;pharyngeal squamous cell carcinoma;Borderline Ovarian Serous Tumor;embryonal rhabdomyosarcoma;HER2 positive breast carcinoma;oral squamous cell carcinoma;head and neck squamous cell carcinoma;Myeloproliferative disorder;Astrocytoma;small intestinal adenocarcinoma;cervical carcinoma;Ovarian neoplasm;Endometrial carcinoma;Parotid Gland Pleomorphic Adenoma;Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive;pleomorphic liposarcoma;Lung sarcomatoid carcinoma;Malignant Mesothelioma;Laryngeal squamous cell carcinoma;Grade III Prostatic Intraepithelial Neoplasia;Testicular Embryonal Carcinoma;pancreatic carcinoma;adenosquamous lung carcinoma;unspecified peripheral T-cell lymphoma;Digestive System Adenoma;Gastric Neuroendocrine Tumor G1;nodular melanoma;adrenal gland pheochromocytoma;Thymoma;ovarian carcinoma;MANTLE CELL LYMPHOMA;large cell lung carcinoma;breast ductal adenocarcinoma;Lung carcinoma;colonic neoplasm;PAPILLOMA OF CHOROID PLEXUS;Teratoma with Malignant Transformation;Rectal Villous Adenoma;mesenchymal chondrosarcoma;Ulcerative colitis;sebaceous adenocarcinoma;Normal Breast-Like Subtype of Breast Carcinoma;Rhabdoid Meningioma;Skin Basosquamous Cell Carcinoma;Keloid;Thymoma Type B3;Hepatocellular Carcinoma;Medulloblastoma;Major Salivary Gland Carcinoma ex Pleomorphic Adenoma;Kidney Oncocytoma;Ileal Neuroendocrine Tumor G1;blastic plasmacytoid dendritic cell neoplasm;Atypical Meningioma;folliculitis;Parotid Gland Squamous Cell Carcinoma;Lymphomatoid papulosis;colon adenocarcinoma;Essential thrombocythemia;Rhabdomyosarcoma;central neurocytoma;pulmonary blastoma;Colorectal Neuroendocrine Tumor G1;Biphasic Mesothelioma;Colorectal Hamartoma;cecum adenocarcinoma;Non-Functioning Adrenal Cortex Adenoma;Brain Stem Glioblastoma;Secretory Meningioma;PEComa;Prostate Small Cell Carcinoma;bladder tumor;Oligoastrocytoma;T-cell acute lymphoblastic leukemia;undifferentiated pleomorphic sarcoma;skin carcinoma;ovarian mucinous adenocarcinoma;Essential thrombocythemia;hairy cell leukemia;breast hyperplasia;lobular breast carcinoma;cervical adenocarcinoma;Uveal melanoma;Chromophobe renal cell carcinoma;Angiomatous Meningioma;Alveolar rhabdomyosarcoma;uterine corpus undifferentiated sarcoma;Salivary Gland Carcinoma ex Pleomorphic Adenoma;Splenic Diffuse Large B-Cell Lymphoma;Kidney Medullary Carcinoma;gastric adenocarcinoma;Basaloid Carcinoma;smooth muscle tumor;Pancreatic Large Cell Neuroendocrine Carcinoma;Fallopian Tube Carcinoma;OSTEOGENIC SARCOMA;angiosarcoma;ureter urothelial carcinoma;Malignant Mixed Neoplasm;Pancreatic Cancer;Hydatidiform mole;Parotid Gland Adenoid Cystic Carcinoma;Small Intestinal Diffuse Large B-Cell Lymphoma;Undifferentiated Pancreatic Carcinoma with Osteoclast-Like Giant Cells;breast adenosis;Choroid plexus papilloma;Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation;Therapy-Related Myeloid Neoplasm;Chronic myelogenous leukemia;Atypical endometrial hyperplasia;Parotid Gland Carcinoma;Salivary Gland Large Cell Carcinoma;Gallbladder Adenocarcinoma;bile duct carcinoma;bladder transitional cell carcinoma;Undifferentiated Pancreatic Carcinoma;brain neoplasm;Ovarian Carcinosarcoma;gastric carcinoma;Bladder Squamous Cell Carcinoma;Small Intestinal Tubulovillous Adenoma;Pituitary Gland Adenoma;Parotid Gland Carcinoma ex Pleomorphic Adenoma;Dedifferentiated liposarcoma;Hereditary breast and/or ovarian cancer syndrome;Hepatobiliary Neoplasm;Histiocytic and Dendritic Cell Neoplasm;gastric adenosquamous carcinoma;Synovial sarcoma;Adenoid Cystic Breast Carcinoma;Melanoma;Meningothelial Meningioma;Anaplastic astrocytoma;follicular thyroid carcinoma;diffuse gastric adenocarcinoma;Breast carcinoma;Testicular Yolk Sac Tumor;Sarcomatoid Mesothelioma;OSTEOSARCOMA;B-cell chronic lymphocytic leukemia;Extramammary Paget Disease;BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 7;Giant cell glioblastoma;rectal adenocarcinoma;Fallopian Tube Carcinosarcoma;stomach neoplasm;Conjunctival Squamous Cell Carcinoma;Testicular Teratoma;Eccrine porocarcinoma;Gallbladder Small Cell Neuroendocrine Carcinoma;clear cell sarcoma;Fallopian Tube Serous Adenocarcinoma;Cortisol-Producing Adrenal Cortex Adenoma;breast ductal carcinoma in situ;leukoplakia of tongue;BONE MARROW FAILURE SYNDROME 5;Breast Cancer;ADRENOCORTICAL CARCINOMA, HEREDITARY;OSTEOGENIC SARCOMA;Li-Fraumeni syndrome;Colorectal Cancer;BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 7;NASOPHARYNGEAL CARCINOMA;GLIOMA SUSCEPTIBILITY 1;PAPILLOMA OF CHOROID PLEXUS;Hepatocellular Carcinoma;Pancreatic Cancer"
TP53_aug4,TP53,"Liver Diffuse Large B-Cell Lymphoma;Choroid plexus carcinoma;ovarian serous adenocarcinoma;Myelodysplastic/Myeloproliferative Neoplasm;Poorly Differentiated Thyroid Gland Carcinoma;Adenocarcinoma;Ovarian Transitional Cell Carcinoma;Thyroid Gland Diffuse Large B-Cell Lymphoma;ovarian teratoma;Colorectal Cancer;Sarcomatoid Carcinoma;Adrenal Gland Neuroblastoma;Lung Sclerosing Hemangioma;Pleural Mesothelioma;large cell medulloblastoma;Ovarian Endometrioid Adenocarcinoma;B-cell acute lymphoblastic leukemia;Gastric Adenoma;Thymic Small Cell Carcinoma;pancreatic neuroendocrine tumor;prostate adenocarcinoma;Granulocytic Sarcoma;Gastric Metaplasia;Small cell lung carcinoma;Spindle Cell Melanoma;Breast Carcinoma by Gene Expression Profile;NASOPHARYNGEAL CARCINOMA;Ovarian Yolk Sac Tumor;Unclassified Renal Cell Carcinoma;Neoplasm;Thymic Sarcomatoid Carcinoma;Glioma;Carcinoma;lymphoid neoplasm;Rectal Tubular Adenoma;Acute lymphoblastic leukemia;PAPILLOMA OF CHOROID PLEXUS;Intimal Sarcoma;ganglioglioma;Acute basophilic leukemia;marginal zone B-cell lymphoma;dysplastic nevus;Bladder Small Cell Neuroendocrine Carcinoma;Cervical Endometrioid Adenocarcinoma;Ocular Sebaceous Carcinoma;Adenoid cystic carcinoma;Meningeal Melanocytoma;Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant;Colorectal adenoma;Invasive Breast Carcinoma;Ampulla of Vater Carcinoma;Merkel cell skin cancer;nasopharyngeal squamous cell carcinoma;cutaneous melanoma;Olfactory Neuroblastoma;primary central chondrosarcoma;metaplastic breast carcinoma;Dedifferentiated Solitary Fibrous Tumor;colorectal adenocarcinoma;Ependymoma;Conjunctival Melanoma;gastric intestinal type adenocarcinoma;vascular sarcoma;OSTEOSARCOMA;endodermal sinus tumor;Pleural Epithelioid Mesothelioma;Mucinous Gastric Adenocarcinoma;CHONDROSARCOMA;large cell neuroendocrine carcinoma;Conjunctival Disorder;Esophageal adenocarcinoma;Papillary thyroid carcinoma;Medullomyoblastoma with Myogenic Differentiation;tonsil cancer;Endometrial Endometrioid Adenocarcinoma;testicular mixed germ cell tumor;Actinic keratosis;Dysplasia in Ulcerative Colitis;soft tissue sarcoma;medullary breast carcinoma;Papillary renal cell carcinoma;Mixed Lobular and Ductal Breast Carcinoma;Vaginal Melanoma;BONE MARROW FAILURE SYNDROME 5;Gastric Papillary Adenocarcinoma;bronchoalveolar adenocarcinoma;Cervical Clear Cell Adenocarcinoma;Hidradenocarcinoma;Bladder Adenocarcinoma;Aldosterone producing adenoma;Duodenal Adenocarcinoma;Basal cell carcinoma;thyroid neoplasm;Breast Cancer;cervical squamous cell carcinoma;Submandibular Gland Adenoid Cystic Carcinoma;Extraskeletal Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor;diffuse large B-cell lymphoma;Alveolar rhabdomyosarcoma;kidney neoplasm;Li-Fraumeni syndrome;Barrett's esophagus;Ethmoid Sinus Adenoid Cystic Carcinoma;Jejunal Neuroendocrine Tumor G1;non-functioning pituitary adenoma;Pleural Sarcomatoid Mesothelioma;Primary Peritoneal Serous Adenocarcinoma;ossifying fibroma;Penile Carcinoma;plasmacytoma;Cervical Small Cell Carcinoma;Malignant Urinary System Neoplasm;Poroma;endometrial serous adenocarcinoma;Fibroadenoma;Chordoid Meningioma;Benign Ovarian Mucinous Tumor;Endometrial stromal sarcoma;Anal Squamous Cell Carcinoma;Sinonasal Undifferentiated Carcinoma;myeloid neoplasm;Primary Pulmonary Diffuse Large B-Cell Lymphoma;Placental Choriocarcinoma;radiologic finding;Benign Ovarian Neoplasm;Ovarian Mixed Epithelial Tumor;Mediastinal Malignant Germ Cell Tumor;neoplasm of mature B-cells;Thyroid Gland Undifferentiated (Anaplastic) Carcinoma;Ovarian Serous Adenocarcinofibroma;Oligodendroglioma;Well-differentiated liposarcoma;Squamous cell carcinoma;brain glioblastoma;Chronic Eosinophilic Leukemia, Not Otherwise Specified;Cushing disease;Malignant Laryngeal Neoplasm;Testicular Sertoli Cell Tumor;Anaplastic oligodendroglioma;Pleomorphic rhabdomyosarcoma;Malignant Pancreatic Neoplasm;Maxillary Sinus Adenoid Cystic Carcinoma;ACTH-Producing Pituitary Gland Adenoma;urothelial carcinoma;Gliosarcoma;Esophageal Squamous Cell Carcinoma;Thymic Carcinoma;Borderline Ovarian Mucinous Tumor;Acute myeloid leukemia;Intestinal Type Adenocarcinoma;embryonal rhabdomyosarcoma;T-cell prolymphocytic leukemia;Central Nervous System Neoplasm;Benign Salivary Gland Myoepithelioma;Chronic lymphocytic leukemia;MYELODYSPLASTIC SYNDROME;Tracheal Adenoid Cystic Carcinoma;Signet Ring Cell Gastric Adenocarcinoma;Dysplasia of Larynx;Lung Giant Cell Carcinoma;Transitional Meningioma;Gastric Squamous Cell Carcinoma;Parathyroid Gland Carcinoma;Malignant Ovarian Brenner Tumor;Endometrial Clear Cell Adenocarcinoma;skin appendage carcinoma;Small cell lung cancer;Lung adenocarcinoma;Salivary Gland Acinic Cell Carcinoma;Colon Dysplasia;pancreatic neoplasm;carcinoid tumor;Tracheal Squamous Cell Carcinoma;Tonsillar Squamous Cell Carcinoma;Gliosarcoma;Pancreatic Acinar Cell Carcinoma;endometrium adenocarcinoma;squamous cell lung carcinoma;Vulvar Squamous Cell Carcinoma;ND;non-small cell lung carcinoma;Crohn's disease;Middle Ear Squamous Cell Carcinoma;Cervical Adenosquamous Carcinoma;collecting duct carcinoma;adrenal cortex carcinoma;malignant epithelioid mesothelioma;Epithelioid Malignant Peripheral Nerve Sheath Tumor;dedifferentiated chondrosarcoma;renal carcinoma;Kaposi's sarcoma;Adrenocortical carcinoma;benign prostatic hyperplasia;Clear cell renal carcinoma;Renal cell carcinoma;pseudomyxoma peritonei;Malignant peripheral nerve sheath tumor;POLYCYTHEMIA VERA;Hepatocellular Carcinoma;Benign Ovarian Brenner Tumor;Burkitts lymphoma;Endometrial Mucinous Adenocarcinoma;mucinous carcinoma;Splenic Mantle Cell Lymphoma;anaplastic large cell lymphoma;small cell carcinoma;Chronic neutrophilic leukemia;Pleomorphic salivary gland adenoma;Li-Fraumeni syndrome;Gonadal Teratoma;thyroid carcinoma;Appendix Neuroendocrine Tumor G1;Malignant Ovarian Mixed Epithelial Tumor;Pancreatic Small Cell Neuroendocrine Carcinoma;Ovarian Small Cell Carcinoma;Pleural Biphasic Mesothelioma;breast neoplasm;Parotid Gland Acinic Cell Carcinoma;Kidney Angiomyolipoma;Undifferentiated Gallbladder Carcinoma;Fibrous Meningioma;Benign Conjunctival Neoplasm;epithelial neoplasm;Solid Pseudopapillary Neoplasm of the Pancreas;Angioimmunoblastic T-cell lymphoma;Langerhans cell histiocytosis;Colorectal Diffuse Large B-Cell Lymphoma;Digestive System Carcinoma;Central Nervous System Lymphoma;GLIOMA SUSCEPTIBILITY 1;Appendix Goblet Cell Carcinoid;Rectal Traditional Serrated Adenoma;Benign Thyroid Gland Neoplasm;adrenocortical adenoma;leiomyosarcoma;Hodgkins lymphoma;Appendix Villous Adenoma;Major Salivary Gland Mucoepidermoid Carcinoma;Thymic Undifferentiated Carcinoma;gallbladder carcinoma;gastric tubular adenocarcinoma;B-Cell Prolymphocytic Leukemia;hepatocellular adenoma;Familial pancreatic carcinoma;Li-Fraumeni syndrome;Lymphoepithelioma-Like Lung Carcinoma;hyperplasia;Gastric Diffuse Large B-Cell Lymphoma;Major Salivary Gland Carcinoma;Chronic myelomonocytic leukemia;B-lymphoblastic leukemia/lymphoma with t9;22q34.1;q11.2;Thymic Squamous Cell Carcinoma;Anaplastic oligoastrocytoma;Testicular Leydig Cell Tumor;ALVEOLAR SOFT PART SARCOMA;colon carcinoma;follicular dendritic cell sarcoma;prostate carcinoma;Atypical teratoid rhabdoid tumor;ovarian clear cell adenocarcinoma;testicular seminoma;salivary gland squamous cell carcinoma;vulvar carcinoma;Appendix Adenocarcinoma;Minor Salivary Gland Adenocarcinoma;liposarcoma;Gallbladder Squamous Cell Carcinoma;HEPATOBLASTOMA;malignant rhabdoid tumour;Esophageal carcinoma;Lung carcinoid tumor;Malignancy in Giant Cell Tumor of Bone;Adult hepatocellular carcinoma;Cecum Villous Adenoma;Gallbladder Adenosquamous Carcinoma;Peritoneal Mesothelioma;transitional cell carcinoma of kidney;Anal Melanoma;ADRENOCORTICAL CARCINOMA, HEREDITARY;Testicular Choriocarcinoma;Anaplastic Malignant Meningioma;Ovarian Granulosa Cell Tumor;Sex Hormone-Producing Adrenal Cortex Adenoma;Undifferentiated Ovarian Carcinoma;Thyroid Gland Oncocytic Follicular Carcinoma;Malignant Adrenal Gland Pheochromocytoma;Endometrial Undifferentiated Carcinoma;Non-Functional Pancreatic Neuroendocrine Tumor;ovarian adenocarcinoma;Spinal Cord Astrocytoma;Multiple myeloma;Uterine Carcinosarcoma;pharyngeal squamous cell carcinoma;Borderline Ovarian Serous Tumor;embryonal rhabdomyosarcoma;HER2 positive breast carcinoma;oral squamous cell carcinoma;head and neck squamous cell carcinoma;Myeloproliferative disorder;Astrocytoma;small intestinal adenocarcinoma;cervical carcinoma;Ovarian neoplasm;Endometrial carcinoma;Parotid Gland Pleomorphic Adenoma;Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive;pleomorphic liposarcoma;Lung sarcomatoid carcinoma;Malignant Mesothelioma;Laryngeal squamous cell carcinoma;Grade III Prostatic Intraepithelial Neoplasia;Testicular Embryonal Carcinoma;pancreatic carcinoma;adenosquamous lung carcinoma;unspecified peripheral T-cell lymphoma;Digestive System Adenoma;Gastric Neuroendocrine Tumor G1;nodular melanoma;adrenal gland pheochromocytoma;Thymoma;ovarian carcinoma;MANTLE CELL LYMPHOMA;large cell lung carcinoma;breast ductal adenocarcinoma;Lung carcinoma;colonic neoplasm;PAPILLOMA OF CHOROID PLEXUS;Teratoma with Malignant Transformation;Rectal Villous Adenoma;mesenchymal chondrosarcoma;Ulcerative colitis;sebaceous adenocarcinoma;Normal Breast-Like Subtype of Breast Carcinoma;Rhabdoid Meningioma;Skin Basosquamous Cell Carcinoma;Keloid;Thymoma Type B3;Hepatocellular Carcinoma;Medulloblastoma;Major Salivary Gland Carcinoma ex Pleomorphic Adenoma;Kidney Oncocytoma;Ileal Neuroendocrine Tumor G1;blastic plasmacytoid dendritic cell neoplasm;Atypical Meningioma;folliculitis;Parotid Gland Squamous Cell Carcinoma;Lymphomatoid papulosis;colon adenocarcinoma;Essential thrombocythemia;Rhabdomyosarcoma;central neurocytoma;pulmonary blastoma;Colorectal Neuroendocrine Tumor G1;Biphasic Mesothelioma;Colorectal Hamartoma;cecum adenocarcinoma;Non-Functioning Adrenal Cortex Adenoma;Brain Stem Glioblastoma;Secretory Meningioma;PEComa;Prostate Small Cell Carcinoma;bladder tumor;Oligoastrocytoma;T-cell acute lymphoblastic leukemia;undifferentiated pleomorphic sarcoma;skin carcinoma;ovarian mucinous adenocarcinoma;Essential thrombocythemia;hairy cell leukemia;breast hyperplasia;lobular breast carcinoma;cervical adenocarcinoma;Uveal melanoma;Chromophobe renal cell carcinoma;Angiomatous Meningioma;Alveolar rhabdomyosarcoma;uterine corpus undifferentiated sarcoma;Salivary Gland Carcinoma ex Pleomorphic Adenoma;Splenic Diffuse Large B-Cell Lymphoma;Kidney Medullary Carcinoma;gastric adenocarcinoma;Basaloid Carcinoma;smooth muscle tumor;Pancreatic Large Cell Neuroendocrine Carcinoma;Fallopian Tube Carcinoma;OSTEOGENIC SARCOMA;angiosarcoma;ureter urothelial carcinoma;Malignant Mixed Neoplasm;Pancreatic Cancer;Hydatidiform mole;Parotid Gland Adenoid Cystic Carcinoma;Small Intestinal Diffuse Large B-Cell Lymphoma;Undifferentiated Pancreatic Carcinoma with Osteoclast-Like Giant Cells;breast adenosis;Choroid plexus papilloma;Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation;Therapy-Related Myeloid Neoplasm;Chronic myelogenous leukemia;Atypical endometrial hyperplasia;Parotid Gland Carcinoma;Salivary Gland Large Cell Carcinoma;Gallbladder Adenocarcinoma;bile duct carcinoma;bladder transitional cell carcinoma;Undifferentiated Pancreatic Carcinoma;brain neoplasm;Ovarian Carcinosarcoma;gastric carcinoma;Bladder Squamous Cell Carcinoma;Small Intestinal Tubulovillous Adenoma;Pituitary Gland Adenoma;Parotid Gland Carcinoma ex Pleomorphic Adenoma;Dedifferentiated liposarcoma;Hereditary breast and/or ovarian cancer syndrome;Hepatobiliary Neoplasm;Histiocytic and Dendritic Cell Neoplasm;gastric adenosquamous carcinoma;Synovial sarcoma;Adenoid Cystic Breast Carcinoma;Melanoma;Meningothelial Meningioma;Anaplastic astrocytoma;follicular thyroid carcinoma;diffuse gastric adenocarcinoma;Breast carcinoma;Testicular Yolk Sac Tumor;Sarcomatoid Mesothelioma;OSTEOSARCOMA;B-cell chronic lymphocytic leukemia;Extramammary Paget Disease;BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 7;Giant cell glioblastoma;rectal adenocarcinoma;Fallopian Tube Carcinosarcoma;stomach neoplasm;Conjunctival Squamous Cell Carcinoma;Testicular Teratoma;Eccrine porocarcinoma;Gallbladder Small Cell Neuroendocrine Carcinoma;clear cell sarcoma;Fallopian Tube Serous Adenocarcinoma;Cortisol-Producing Adrenal Cortex Adenoma;breast ductal carcinoma in situ;leukoplakia of tongue;BONE MARROW FAILURE SYNDROME 5;Breast Cancer;ADRENOCORTICAL CARCINOMA, HEREDITARY;OSTEOGENIC SARCOMA;Li-Fraumeni syndrome;Colorectal Cancer;BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 7;NASOPHARYNGEAL CARCINOMA;GLIOMA SUSCEPTIBILITY 1;PAPILLOMA OF CHOROID PLEXUS;Hepatocellular Carcinoma;Pancreatic Cancer"
TP53_aug5,TP53,"Liver Diffuse Large B-Cell Lymphoma;Choroid plexus carcinoma;ovarian serous adenocarcinoma;Myelodysplastic/Myeloproliferative Neoplasm;Poorly Differentiated Thyroid Gland Carcinoma;Adenocarcinoma;Ovarian Transitional Cell Carcinoma;Thyroid Gland Diffuse Large B-Cell Lymphoma;ovarian teratoma;Colorectal Cancer;Sarcomatoid Carcinoma;Adrenal Gland Neuroblastoma;Lung Sclerosing Hemangioma;Pleural Mesothelioma;large cell medulloblastoma;Ovarian Endometrioid Adenocarcinoma;B-cell acute lymphoblastic leukemia;Gastric Adenoma;Thymic Small Cell Carcinoma;pancreatic neuroendocrine tumor;prostate adenocarcinoma;Granulocytic Sarcoma;Gastric Metaplasia;Small cell lung carcinoma;Spindle Cell Melanoma;Breast Carcinoma by Gene Expression Profile;NASOPHARYNGEAL CARCINOMA;Ovarian Yolk Sac Tumor;Unclassified Renal Cell Carcinoma;Neoplasm;Thymic Sarcomatoid Carcinoma;Glioma;Carcinoma;lymphoid neoplasm;Rectal Tubular Adenoma;Acute lymphoblastic leukemia;PAPILLOMA OF CHOROID PLEXUS;Intimal Sarcoma;ganglioglioma;Acute basophilic leukemia;marginal zone B-cell lymphoma;dysplastic nevus;Bladder Small Cell Neuroendocrine Carcinoma;Cervical Endometrioid Adenocarcinoma;Ocular Sebaceous Carcinoma;Adenoid cystic carcinoma;Meningeal Melanocytoma;Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant;Colorectal adenoma;Invasive Breast Carcinoma;Ampulla of Vater Carcinoma;Merkel cell skin cancer;nasopharyngeal squamous cell carcinoma;cutaneous melanoma;Olfactory Neuroblastoma;primary central chondrosarcoma;metaplastic breast carcinoma;Dedifferentiated Solitary Fibrous Tumor;colorectal adenocarcinoma;Ependymoma;Conjunctival Melanoma;gastric intestinal type adenocarcinoma;vascular sarcoma;OSTEOSARCOMA;endodermal sinus tumor;Pleural Epithelioid Mesothelioma;Mucinous Gastric Adenocarcinoma;CHONDROSARCOMA;large cell neuroendocrine carcinoma;Conjunctival Disorder;Esophageal adenocarcinoma;Papillary thyroid carcinoma;Medullomyoblastoma with Myogenic Differentiation;tonsil cancer;Endometrial Endometrioid Adenocarcinoma;testicular mixed germ cell tumor;Actinic keratosis;Dysplasia in Ulcerative Colitis;soft tissue sarcoma;medullary breast carcinoma;Papillary renal cell carcinoma;Mixed Lobular and Ductal Breast Carcinoma;Vaginal Melanoma;BONE MARROW FAILURE SYNDROME 5;Gastric Papillary Adenocarcinoma;bronchoalveolar adenocarcinoma;Cervical Clear Cell Adenocarcinoma;Hidradenocarcinoma;Bladder Adenocarcinoma;Aldosterone producing adenoma;Duodenal Adenocarcinoma;Basal cell carcinoma;thyroid neoplasm;Breast Cancer;cervical squamous cell carcinoma;Submandibular Gland Adenoid Cystic Carcinoma;Extraskeletal Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor;diffuse large B-cell lymphoma;Alveolar rhabdomyosarcoma;kidney neoplasm;Li-Fraumeni syndrome;Barrett's esophagus;Ethmoid Sinus Adenoid Cystic Carcinoma;Jejunal Neuroendocrine Tumor G1;non-functioning pituitary adenoma;Pleural Sarcomatoid Mesothelioma;Primary Peritoneal Serous Adenocarcinoma;ossifying fibroma;Penile Carcinoma;plasmacytoma;Cervical Small Cell Carcinoma;Malignant Urinary System Neoplasm;Poroma;endometrial serous adenocarcinoma;Fibroadenoma;Chordoid Meningioma;Benign Ovarian Mucinous Tumor;Endometrial stromal sarcoma;Anal Squamous Cell Carcinoma;Sinonasal Undifferentiated Carcinoma;myeloid neoplasm;Primary Pulmonary Diffuse Large B-Cell Lymphoma;Placental Choriocarcinoma;radiologic finding;Benign Ovarian Neoplasm;Ovarian Mixed Epithelial Tumor;Mediastinal Malignant Germ Cell Tumor;neoplasm of mature B-cells;Thyroid Gland Undifferentiated (Anaplastic) Carcinoma;Ovarian Serous Adenocarcinofibroma;Oligodendroglioma;Well-differentiated liposarcoma;Squamous cell carcinoma;brain glioblastoma;Chronic Eosinophilic Leukemia, Not Otherwise Specified;Cushing disease;Malignant Laryngeal Neoplasm;Testicular Sertoli Cell Tumor;Anaplastic oligodendroglioma;Pleomorphic rhabdomyosarcoma;Malignant Pancreatic Neoplasm;Maxillary Sinus Adenoid Cystic Carcinoma;ACTH-Producing Pituitary Gland Adenoma;urothelial carcinoma;Gliosarcoma;Esophageal Squamous Cell Carcinoma;Thymic Carcinoma;Borderline Ovarian Mucinous Tumor;Acute myeloid leukemia;Intestinal Type Adenocarcinoma;embryonal rhabdomyosarcoma;T-cell prolymphocytic leukemia;Central Nervous System Neoplasm;Benign Salivary Gland Myoepithelioma;Chronic lymphocytic leukemia;MYELODYSPLASTIC SYNDROME;Tracheal Adenoid Cystic Carcinoma;Signet Ring Cell Gastric Adenocarcinoma;Dysplasia of Larynx;Lung Giant Cell Carcinoma;Transitional Meningioma;Gastric Squamous Cell Carcinoma;Parathyroid Gland Carcinoma;Malignant Ovarian Brenner Tumor;Endometrial Clear Cell Adenocarcinoma;skin appendage carcinoma;Small cell lung cancer;Lung adenocarcinoma;Salivary Gland Acinic Cell Carcinoma;Colon Dysplasia;pancreatic neoplasm;carcinoid tumor;Tracheal Squamous Cell Carcinoma;Tonsillar Squamous Cell Carcinoma;Gliosarcoma;Pancreatic Acinar Cell Carcinoma;endometrium adenocarcinoma;squamous cell lung carcinoma;Vulvar Squamous Cell Carcinoma;ND;non-small cell lung carcinoma;Crohn's disease;Middle Ear Squamous Cell Carcinoma;Cervical Adenosquamous Carcinoma;collecting duct carcinoma;adrenal cortex carcinoma;malignant epithelioid mesothelioma;Epithelioid Malignant Peripheral Nerve Sheath Tumor;dedifferentiated chondrosarcoma;renal carcinoma;Kaposi's sarcoma;Adrenocortical carcinoma;benign prostatic hyperplasia;Clear cell renal carcinoma;Renal cell carcinoma;pseudomyxoma peritonei;Malignant peripheral nerve sheath tumor;POLYCYTHEMIA VERA;Hepatocellular Carcinoma;Benign Ovarian Brenner Tumor;Burkitts lymphoma;Endometrial Mucinous Adenocarcinoma;mucinous carcinoma;Splenic Mantle Cell Lymphoma;anaplastic large cell lymphoma;small cell carcinoma;Chronic neutrophilic leukemia;Pleomorphic salivary gland adenoma;Li-Fraumeni syndrome;Gonadal Teratoma;thyroid carcinoma;Appendix Neuroendocrine Tumor G1;Malignant Ovarian Mixed Epithelial Tumor;Pancreatic Small Cell Neuroendocrine Carcinoma;Ovarian Small Cell Carcinoma;Pleural Biphasic Mesothelioma;breast neoplasm;Parotid Gland Acinic Cell Carcinoma;Kidney Angiomyolipoma;Undifferentiated Gallbladder Carcinoma;Fibrous Meningioma;Benign Conjunctival Neoplasm;epithelial neoplasm;Solid Pseudopapillary Neoplasm of the Pancreas;Angioimmunoblastic T-cell lymphoma;Langerhans cell histiocytosis;Colorectal Diffuse Large B-Cell Lymphoma;Digestive System Carcinoma;Central Nervous System Lymphoma;GLIOMA SUSCEPTIBILITY 1;Appendix Goblet Cell Carcinoid;Rectal Traditional Serrated Adenoma;Benign Thyroid Gland Neoplasm;adrenocortical adenoma;leiomyosarcoma;Hodgkins lymphoma;Appendix Villous Adenoma;Major Salivary Gland Mucoepidermoid Carcinoma;Thymic Undifferentiated Carcinoma;gallbladder carcinoma;gastric tubular adenocarcinoma;B-Cell Prolymphocytic Leukemia;hepatocellular adenoma;Familial pancreatic carcinoma;Li-Fraumeni syndrome;Lymphoepithelioma-Like Lung Carcinoma;hyperplasia;Gastric Diffuse Large B-Cell Lymphoma;Major Salivary Gland Carcinoma;Chronic myelomonocytic leukemia;B-lymphoblastic leukemia/lymphoma with t9;22q34.1;q11.2;Thymic Squamous Cell Carcinoma;Anaplastic oligoastrocytoma;Testicular Leydig Cell Tumor;ALVEOLAR SOFT PART SARCOMA;colon carcinoma;follicular dendritic cell sarcoma;prostate carcinoma;Atypical teratoid rhabdoid tumor;ovarian clear cell adenocarcinoma;testicular seminoma;salivary gland squamous cell carcinoma;vulvar carcinoma;Appendix Adenocarcinoma;Minor Salivary Gland Adenocarcinoma;liposarcoma;Gallbladder Squamous Cell Carcinoma;HEPATOBLASTOMA;malignant rhabdoid tumour;Esophageal carcinoma;Lung carcinoid tumor;Malignancy in Giant Cell Tumor of Bone;Adult hepatocellular carcinoma;Cecum Villous Adenoma;Gallbladder Adenosquamous Carcinoma;Peritoneal Mesothelioma;transitional cell carcinoma of kidney;Anal Melanoma;ADRENOCORTICAL CARCINOMA, HEREDITARY;Testicular Choriocarcinoma;Anaplastic Malignant Meningioma;Ovarian Granulosa Cell Tumor;Sex Hormone-Producing Adrenal Cortex Adenoma;Undifferentiated Ovarian Carcinoma;Thyroid Gland Oncocytic Follicular Carcinoma;Malignant Adrenal Gland Pheochromocytoma;Endometrial Undifferentiated Carcinoma;Non-Functional Pancreatic Neuroendocrine Tumor;ovarian adenocarcinoma;Spinal Cord Astrocytoma;Multiple myeloma;Uterine Carcinosarcoma;pharyngeal squamous cell carcinoma;Borderline Ovarian Serous Tumor;embryonal rhabdomyosarcoma;HER2 positive breast carcinoma;oral squamous cell carcinoma;head and neck squamous cell carcinoma;Myeloproliferative disorder;Astrocytoma;small intestinal adenocarcinoma;cervical carcinoma;Ovarian neoplasm;Endometrial carcinoma;Parotid Gland Pleomorphic Adenoma;Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive;pleomorphic liposarcoma;Lung sarcomatoid carcinoma;Malignant Mesothelioma;Laryngeal squamous cell carcinoma;Grade III Prostatic Intraepithelial Neoplasia;Testicular Embryonal Carcinoma;pancreatic carcinoma;adenosquamous lung carcinoma;unspecified peripheral T-cell lymphoma;Digestive System Adenoma;Gastric Neuroendocrine Tumor G1;nodular melanoma;adrenal gland pheochromocytoma;Thymoma;ovarian carcinoma;MANTLE CELL LYMPHOMA;large cell lung carcinoma;breast ductal adenocarcinoma;Lung carcinoma;colonic neoplasm;PAPILLOMA OF CHOROID PLEXUS;Teratoma with Malignant Transformation;Rectal Villous Adenoma;mesenchymal chondrosarcoma;Ulcerative colitis;sebaceous adenocarcinoma;Normal Breast-Like Subtype of Breast Carcinoma;Rhabdoid Meningioma;Skin Basosquamous Cell Carcinoma;Keloid;Thymoma Type B3;Hepatocellular Carcinoma;Medulloblastoma;Major Salivary Gland Carcinoma ex Pleomorphic Adenoma;Kidney Oncocytoma;Ileal Neuroendocrine Tumor G1;blastic plasmacytoid dendritic cell neoplasm;Atypical Meningioma;folliculitis;Parotid Gland Squamous Cell Carcinoma;Lymphomatoid papulosis;colon adenocarcinoma;Essential thrombocythemia;Rhabdomyosarcoma;central neurocytoma;pulmonary blastoma;Colorectal Neuroendocrine Tumor G1;Biphasic Mesothelioma;Colorectal Hamartoma;cecum adenocarcinoma;Non-Functioning Adrenal Cortex Adenoma;Brain Stem Glioblastoma;Secretory Meningioma;PEComa;Prostate Small Cell Carcinoma;bladder tumor;Oligoastrocytoma;T-cell acute lymphoblastic leukemia;undifferentiated pleomorphic sarcoma;skin carcinoma;ovarian mucinous adenocarcinoma;Essential thrombocythemia;hairy cell leukemia;breast hyperplasia;lobular breast carcinoma;cervical adenocarcinoma;Uveal melanoma;Chromophobe renal cell carcinoma;Angiomatous Meningioma;Alveolar rhabdomyosarcoma;uterine corpus undifferentiated sarcoma;Salivary Gland Carcinoma ex Pleomorphic Adenoma;Splenic Diffuse Large B-Cell Lymphoma;Kidney Medullary Carcinoma;gastric adenocarcinoma;Basaloid Carcinoma;smooth muscle tumor;Pancreatic Large Cell Neuroendocrine Carcinoma;Fallopian Tube Carcinoma;OSTEOGENIC SARCOMA;angiosarcoma;ureter urothelial carcinoma;Malignant Mixed Neoplasm;Pancreatic Cancer;Hydatidiform mole;Parotid Gland Adenoid Cystic Carcinoma;Small Intestinal Diffuse Large B-Cell Lymphoma;Undifferentiated Pancreatic Carcinoma with Osteoclast-Like Giant Cells;breast adenosis;Choroid plexus papilloma;Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation;Therapy-Related Myeloid Neoplasm;Chronic myelogenous leukemia;Atypical endometrial hyperplasia;Parotid Gland Carcinoma;Salivary Gland Large Cell Carcinoma;Gallbladder Adenocarcinoma;bile duct carcinoma;bladder transitional cell carcinoma;Undifferentiated Pancreatic Carcinoma;brain neoplasm;Ovarian Carcinosarcoma;gastric carcinoma;Bladder Squamous Cell Carcinoma;Small Intestinal Tubulovillous Adenoma;Pituitary Gland Adenoma;Parotid Gland Carcinoma ex Pleomorphic Adenoma;Dedifferentiated liposarcoma;Hereditary breast and/or ovarian cancer syndrome;Hepatobiliary Neoplasm;Histiocytic and Dendritic Cell Neoplasm;gastric adenosquamous carcinoma;Synovial sarcoma;Adenoid Cystic Breast Carcinoma;Melanoma;Meningothelial Meningioma;Anaplastic astrocytoma;follicular thyroid carcinoma;diffuse gastric adenocarcinoma;Breast carcinoma;Testicular Yolk Sac Tumor;Sarcomatoid Mesothelioma;OSTEOSARCOMA;B-cell chronic lymphocytic leukemia;Extramammary Paget Disease;BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 7;Giant cell glioblastoma;rectal adenocarcinoma;Fallopian Tube Carcinosarcoma;stomach neoplasm;Conjunctival Squamous Cell Carcinoma;Testicular Teratoma;Eccrine porocarcinoma;Gallbladder Small Cell Neuroendocrine Carcinoma;clear cell sarcoma;Fallopian Tube Serous Adenocarcinoma;Cortisol-Producing Adrenal Cortex Adenoma;breast ductal carcinoma in situ;leukoplakia of tongue;BONE MARROW FAILURE SYNDROME 5;Breast Cancer;ADRENOCORTICAL CARCINOMA, HEREDITARY;OSTEOGENIC SARCOMA;Li-Fraumeni syndrome;Colorectal Cancer;BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 7;NASOPHARYNGEAL CARCINOMA;GLIOMA SUSCEPTIBILITY 1;PAPILLOMA OF CHOROID PLEXUS;Hepatocellular Carcinoma;Pancreatic Cancer"
TP53_aug6,TP53,"Liver Diffuse Large B-Cell Lymphoma;Choroid plexus carcinoma;ovarian serous adenocarcinoma;Myelodysplastic/Myeloproliferative Neoplasm;Poorly Differentiated Thyroid Gland Carcinoma;Adenocarcinoma;Ovarian Transitional Cell Carcinoma;Thyroid Gland Diffuse Large B-Cell Lymphoma;ovarian teratoma;Colorectal Cancer;Sarcomatoid Carcinoma;Adrenal Gland Neuroblastoma;Lung Sclerosing Hemangioma;Pleural Mesothelioma;large cell medulloblastoma;Ovarian Endometrioid Adenocarcinoma;B-cell acute lymphoblastic leukemia;Gastric Adenoma;Thymic Small Cell Carcinoma;pancreatic neuroendocrine tumor;prostate adenocarcinoma;Granulocytic Sarcoma;Gastric Metaplasia;Small cell lung carcinoma;Spindle Cell Melanoma;Breast Carcinoma by Gene Expression Profile;NASOPHARYNGEAL CARCINOMA;Ovarian Yolk Sac Tumor;Unclassified Renal Cell Carcinoma;Neoplasm;Thymic Sarcomatoid Carcinoma;Glioma;Carcinoma;lymphoid neoplasm;Rectal Tubular Adenoma;Acute lymphoblastic leukemia;PAPILLOMA OF CHOROID PLEXUS;Intimal Sarcoma;ganglioglioma;Acute basophilic leukemia;marginal zone B-cell lymphoma;dysplastic nevus;Bladder Small Cell Neuroendocrine Carcinoma;Cervical Endometrioid Adenocarcinoma;Ocular Sebaceous Carcinoma;Adenoid cystic carcinoma;Meningeal Melanocytoma;Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant;Colorectal adenoma;Invasive Breast Carcinoma;Ampulla of Vater Carcinoma;Merkel cell skin cancer;nasopharyngeal squamous cell carcinoma;cutaneous melanoma;Olfactory Neuroblastoma;primary central chondrosarcoma;metaplastic breast carcinoma;Dedifferentiated Solitary Fibrous Tumor;colorectal adenocarcinoma;Ependymoma;Conjunctival Melanoma;gastric intestinal type adenocarcinoma;vascular sarcoma;OSTEOSARCOMA;endodermal sinus tumor;Pleural Epithelioid Mesothelioma;Mucinous Gastric Adenocarcinoma;CHONDROSARCOMA;large cell neuroendocrine carcinoma;Conjunctival Disorder;Esophageal adenocarcinoma;Papillary thyroid carcinoma;Medullomyoblastoma with Myogenic Differentiation;tonsil cancer;Endometrial Endometrioid Adenocarcinoma;testicular mixed germ cell tumor;Actinic keratosis;Dysplasia in Ulcerative Colitis;soft tissue sarcoma;medullary breast carcinoma;Papillary renal cell carcinoma;Mixed Lobular and Ductal Breast Carcinoma;Vaginal Melanoma;BONE MARROW FAILURE SYNDROME 5;Gastric Papillary Adenocarcinoma;bronchoalveolar adenocarcinoma;Cervical Clear Cell Adenocarcinoma;Hidradenocarcinoma;Bladder Adenocarcinoma;Aldosterone producing adenoma;Duodenal Adenocarcinoma;Basal cell carcinoma;thyroid neoplasm;Breast Cancer;cervical squamous cell carcinoma;Submandibular Gland Adenoid Cystic Carcinoma;Extraskeletal Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor;diffuse large B-cell lymphoma;Alveolar rhabdomyosarcoma;kidney neoplasm;Li-Fraumeni syndrome;Barrett's esophagus;Ethmoid Sinus Adenoid Cystic Carcinoma;Jejunal Neuroendocrine Tumor G1;non-functioning pituitary adenoma;Pleural Sarcomatoid Mesothelioma;Primary Peritoneal Serous Adenocarcinoma;ossifying fibroma;Penile Carcinoma;plasmacytoma;Cervical Small Cell Carcinoma;Malignant Urinary System Neoplasm;Poroma;endometrial serous adenocarcinoma;Fibroadenoma;Chordoid Meningioma;Benign Ovarian Mucinous Tumor;Endometrial stromal sarcoma;Anal Squamous Cell Carcinoma;Sinonasal Undifferentiated Carcinoma;myeloid neoplasm;Primary Pulmonary Diffuse Large B-Cell Lymphoma;Placental Choriocarcinoma;radiologic finding;Benign Ovarian Neoplasm;Ovarian Mixed Epithelial Tumor;Mediastinal Malignant Germ Cell Tumor;neoplasm of mature B-cells;Thyroid Gland Undifferentiated (Anaplastic) Carcinoma;Ovarian Serous Adenocarcinofibroma;Oligodendroglioma;Well-differentiated liposarcoma;Squamous cell carcinoma;brain glioblastoma;Chronic Eosinophilic Leukemia, Not Otherwise Specified;Cushing disease;Malignant Laryngeal Neoplasm;Testicular Sertoli Cell Tumor;Anaplastic oligodendroglioma;Pleomorphic rhabdomyosarcoma;Malignant Pancreatic Neoplasm;Maxillary Sinus Adenoid Cystic Carcinoma;ACTH-Producing Pituitary Gland Adenoma;urothelial carcinoma;Gliosarcoma;Esophageal Squamous Cell Carcinoma;Thymic Carcinoma;Borderline Ovarian Mucinous Tumor;Acute myeloid leukemia;Intestinal Type Adenocarcinoma;embryonal rhabdomyosarcoma;T-cell prolymphocytic leukemia;Central Nervous System Neoplasm;Benign Salivary Gland Myoepithelioma;Chronic lymphocytic leukemia;MYELODYSPLASTIC SYNDROME;Tracheal Adenoid Cystic Carcinoma;Signet Ring Cell Gastric Adenocarcinoma;Dysplasia of Larynx;Lung Giant Cell Carcinoma;Transitional Meningioma;Gastric Squamous Cell Carcinoma;Parathyroid Gland Carcinoma;Malignant Ovarian Brenner Tumor;Endometrial Clear Cell Adenocarcinoma;skin appendage carcinoma;Small cell lung cancer;Lung adenocarcinoma;Salivary Gland Acinic Cell Carcinoma;Colon Dysplasia;pancreatic neoplasm;carcinoid tumor;Tracheal Squamous Cell Carcinoma;Tonsillar Squamous Cell Carcinoma;Gliosarcoma;Pancreatic Acinar Cell Carcinoma;endometrium adenocarcinoma;squamous cell lung carcinoma;Vulvar Squamous Cell Carcinoma;ND;non-small cell lung carcinoma;Crohn's disease;Middle Ear Squamous Cell Carcinoma;Cervical Adenosquamous Carcinoma;collecting duct carcinoma;adrenal cortex carcinoma;malignant epithelioid mesothelioma;Epithelioid Malignant Peripheral Nerve Sheath Tumor;dedifferentiated chondrosarcoma;renal carcinoma;Kaposi's sarcoma;Adrenocortical carcinoma;benign prostatic hyperplasia;Clear cell renal carcinoma;Renal cell carcinoma;pseudomyxoma peritonei;Malignant peripheral nerve sheath tumor;POLYCYTHEMIA VERA;Hepatocellular Carcinoma;Benign Ovarian Brenner Tumor;Burkitts lymphoma;Endometrial Mucinous Adenocarcinoma;mucinous carcinoma;Splenic Mantle Cell Lymphoma;anaplastic large cell lymphoma;small cell carcinoma;Chronic neutrophilic leukemia;Pleomorphic salivary gland adenoma;Li-Fraumeni syndrome;Gonadal Teratoma;thyroid carcinoma;Appendix Neuroendocrine Tumor G1;Malignant Ovarian Mixed Epithelial Tumor;Pancreatic Small Cell Neuroendocrine Carcinoma;Ovarian Small Cell Carcinoma;Pleural Biphasic Mesothelioma;breast neoplasm;Parotid Gland Acinic Cell Carcinoma;Kidney Angiomyolipoma;Undifferentiated Gallbladder Carcinoma;Fibrous Meningioma;Benign Conjunctival Neoplasm;epithelial neoplasm;Solid Pseudopapillary Neoplasm of the Pancreas;Angioimmunoblastic T-cell lymphoma;Langerhans cell histiocytosis;Colorectal Diffuse Large B-Cell Lymphoma;Digestive System Carcinoma;Central Nervous System Lymphoma;GLIOMA SUSCEPTIBILITY 1;Appendix Goblet Cell Carcinoid;Rectal Traditional Serrated Adenoma;Benign Thyroid Gland Neoplasm;adrenocortical adenoma;leiomyosarcoma;Hodgkins lymphoma;Appendix Villous Adenoma;Major Salivary Gland Mucoepidermoid Carcinoma;Thymic Undifferentiated Carcinoma;gallbladder carcinoma;gastric tubular adenocarcinoma;B-Cell Prolymphocytic Leukemia;hepatocellular adenoma;Familial pancreatic carcinoma;Li-Fraumeni syndrome;Lymphoepithelioma-Like Lung Carcinoma;hyperplasia;Gastric Diffuse Large B-Cell Lymphoma;Major Salivary Gland Carcinoma;Chronic myelomonocytic leukemia;B-lymphoblastic leukemia/lymphoma with t9;22q34.1;q11.2;Thymic Squamous Cell Carcinoma;Anaplastic oligoastrocytoma;Testicular Leydig Cell Tumor;ALVEOLAR SOFT PART SARCOMA;colon carcinoma;follicular dendritic cell sarcoma;prostate carcinoma;Atypical teratoid rhabdoid tumor;ovarian clear cell adenocarcinoma;testicular seminoma;salivary gland squamous cell carcinoma;vulvar carcinoma;Appendix Adenocarcinoma;Minor Salivary Gland Adenocarcinoma;liposarcoma;Gallbladder Squamous Cell Carcinoma;HEPATOBLASTOMA;malignant rhabdoid tumour;Esophageal carcinoma;Lung carcinoid tumor;Malignancy in Giant Cell Tumor of Bone;Adult hepatocellular carcinoma;Cecum Villous Adenoma;Gallbladder Adenosquamous Carcinoma;Peritoneal Mesothelioma;transitional cell carcinoma of kidney;Anal Melanoma;ADRENOCORTICAL CARCINOMA, HEREDITARY;Testicular Choriocarcinoma;Anaplastic Malignant Meningioma;Ovarian Granulosa Cell Tumor;Sex Hormone-Producing Adrenal Cortex Adenoma;Undifferentiated Ovarian Carcinoma;Thyroid Gland Oncocytic Follicular Carcinoma;Malignant Adrenal Gland Pheochromocytoma;Endometrial Undifferentiated Carcinoma;Non-Functional Pancreatic Neuroendocrine Tumor;ovarian adenocarcinoma;Spinal Cord Astrocytoma;Multiple myeloma;Uterine Carcinosarcoma;pharyngeal squamous cell carcinoma;Borderline Ovarian Serous Tumor;embryonal rhabdomyosarcoma;HER2 positive breast carcinoma;oral squamous cell carcinoma;head and neck squamous cell carcinoma;Myeloproliferative disorder;Astrocytoma;small intestinal adenocarcinoma;cervical carcinoma;Ovarian neoplasm;Endometrial carcinoma;Parotid Gland Pleomorphic Adenoma;Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive;pleomorphic liposarcoma;Lung sarcomatoid carcinoma;Malignant Mesothelioma;Laryngeal squamous cell carcinoma;Grade III Prostatic Intraepithelial Neoplasia;Testicular Embryonal Carcinoma;pancreatic carcinoma;adenosquamous lung carcinoma;unspecified peripheral T-cell lymphoma;Digestive System Adenoma;Gastric Neuroendocrine Tumor G1;nodular melanoma;adrenal gland pheochromocytoma;Thymoma;ovarian carcinoma;MANTLE CELL LYMPHOMA;large cell lung carcinoma;breast ductal adenocarcinoma;Lung carcinoma;colonic neoplasm;PAPILLOMA OF CHOROID PLEXUS;Teratoma with Malignant Transformation;Rectal Villous Adenoma;mesenchymal chondrosarcoma;Ulcerative colitis;sebaceous adenocarcinoma;Normal Breast-Like Subtype of Breast Carcinoma;Rhabdoid Meningioma;Skin Basosquamous Cell Carcinoma;Keloid;Thymoma Type B3;Hepatocellular Carcinoma;Medulloblastoma;Major Salivary Gland Carcinoma ex Pleomorphic Adenoma;Kidney Oncocytoma;Ileal Neuroendocrine Tumor G1;blastic plasmacytoid dendritic cell neoplasm;Atypical Meningioma;folliculitis;Parotid Gland Squamous Cell Carcinoma;Lymphomatoid papulosis;colon adenocarcinoma;Essential thrombocythemia;Rhabdomyosarcoma;central neurocytoma;pulmonary blastoma;Colorectal Neuroendocrine Tumor G1;Biphasic Mesothelioma;Colorectal Hamartoma;cecum adenocarcinoma;Non-Functioning Adrenal Cortex Adenoma;Brain Stem Glioblastoma;Secretory Meningioma;PEComa;Prostate Small Cell Carcinoma;bladder tumor;Oligoastrocytoma;T-cell acute lymphoblastic leukemia;undifferentiated pleomorphic sarcoma;skin carcinoma;ovarian mucinous adenocarcinoma;Essential thrombocythemia;hairy cell leukemia;breast hyperplasia;lobular breast carcinoma;cervical adenocarcinoma;Uveal melanoma;Chromophobe renal cell carcinoma;Angiomatous Meningioma;Alveolar rhabdomyosarcoma;uterine corpus undifferentiated sarcoma;Salivary Gland Carcinoma ex Pleomorphic Adenoma;Splenic Diffuse Large B-Cell Lymphoma;Kidney Medullary Carcinoma;gastric adenocarcinoma;Basaloid Carcinoma;smooth muscle tumor;Pancreatic Large Cell Neuroendocrine Carcinoma;Fallopian Tube Carcinoma;OSTEOGENIC SARCOMA;angiosarcoma;ureter urothelial carcinoma;Malignant Mixed Neoplasm;Pancreatic Cancer;Hydatidiform mole;Parotid Gland Adenoid Cystic Carcinoma;Small Intestinal Diffuse Large B-Cell Lymphoma;Undifferentiated Pancreatic Carcinoma with Osteoclast-Like Giant Cells;breast adenosis;Choroid plexus papilloma;Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation;Therapy-Related Myeloid Neoplasm;Chronic myelogenous leukemia;Atypical endometrial hyperplasia;Parotid Gland Carcinoma;Salivary Gland Large Cell Carcinoma;Gallbladder Adenocarcinoma;bile duct carcinoma;bladder transitional cell carcinoma;Undifferentiated Pancreatic Carcinoma;brain neoplasm;Ovarian Carcinosarcoma;gastric carcinoma;Bladder Squamous Cell Carcinoma;Small Intestinal Tubulovillous Adenoma;Pituitary Gland Adenoma;Parotid Gland Carcinoma ex Pleomorphic Adenoma;Dedifferentiated liposarcoma;Hereditary breast and/or ovarian cancer syndrome;Hepatobiliary Neoplasm;Histiocytic and Dendritic Cell Neoplasm;gastric adenosquamous carcinoma;Synovial sarcoma;Adenoid Cystic Breast Carcinoma;Melanoma;Meningothelial Meningioma;Anaplastic astrocytoma;follicular thyroid carcinoma;diffuse gastric adenocarcinoma;Breast carcinoma;Testicular Yolk Sac Tumor;Sarcomatoid Mesothelioma;OSTEOSARCOMA;B-cell chronic lymphocytic leukemia;Extramammary Paget Disease;BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 7;Giant cell glioblastoma;rectal adenocarcinoma;Fallopian Tube Carcinosarcoma;stomach neoplasm;Conjunctival Squamous Cell Carcinoma;Testicular Teratoma;Eccrine porocarcinoma;Gallbladder Small Cell Neuroendocrine Carcinoma;clear cell sarcoma;Fallopian Tube Serous Adenocarcinoma;Cortisol-Producing Adrenal Cortex Adenoma;breast ductal carcinoma in situ;leukoplakia of tongue;BONE MARROW FAILURE SYNDROME 5;Breast Cancer;ADRENOCORTICAL CARCINOMA, HEREDITARY;OSTEOGENIC SARCOMA;Li-Fraumeni syndrome;Colorectal Cancer;BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 7;NASOPHARYNGEAL CARCINOMA;GLIOMA SUSCEPTIBILITY 1;PAPILLOMA OF CHOROID PLEXUS;Hepatocellular Carcinoma;Pancreatic Cancer"
TP53_aug7,TP53,"Liver Diffuse Large B-Cell Lymphoma;Choroid plexus carcinoma;ovarian serous adenocarcinoma;Myelodysplastic/Myeloproliferative Neoplasm;Poorly Differentiated Thyroid Gland Carcinoma;Adenocarcinoma;Ovarian Transitional Cell Carcinoma;Thyroid Gland Diffuse Large B-Cell Lymphoma;ovarian teratoma;Colorectal Cancer;Sarcomatoid Carcinoma;Adrenal Gland Neuroblastoma;Lung Sclerosing Hemangioma;Pleural Mesothelioma;large cell medulloblastoma;Ovarian Endometrioid Adenocarcinoma;B-cell acute lymphoblastic leukemia;Gastric Adenoma;Thymic Small Cell Carcinoma;pancreatic neuroendocrine tumor;prostate adenocarcinoma;Granulocytic Sarcoma;Gastric Metaplasia;Small cell lung carcinoma;Spindle Cell Melanoma;Breast Carcinoma by Gene Expression Profile;NASOPHARYNGEAL CARCINOMA;Ovarian Yolk Sac Tumor;Unclassified Renal Cell Carcinoma;Neoplasm;Thymic Sarcomatoid Carcinoma;Glioma;Carcinoma;lymphoid neoplasm;Rectal Tubular Adenoma;Acute lymphoblastic leukemia;PAPILLOMA OF CHOROID PLEXUS;Intimal Sarcoma;ganglioglioma;Acute basophilic leukemia;marginal zone B-cell lymphoma;dysplastic nevus;Bladder Small Cell Neuroendocrine Carcinoma;Cervical Endometrioid Adenocarcinoma;Ocular Sebaceous Carcinoma;Adenoid cystic carcinoma;Meningeal Melanocytoma;Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant;Colorectal adenoma;Invasive Breast Carcinoma;Ampulla of Vater Carcinoma;Merkel cell skin cancer;nasopharyngeal squamous cell carcinoma;cutaneous melanoma;Olfactory Neuroblastoma;primary central chondrosarcoma;metaplastic breast carcinoma;Dedifferentiated Solitary Fibrous Tumor;colorectal adenocarcinoma;Ependymoma;Conjunctival Melanoma;gastric intestinal type adenocarcinoma;vascular sarcoma;OSTEOSARCOMA;endodermal sinus tumor;Pleural Epithelioid Mesothelioma;Mucinous Gastric Adenocarcinoma;CHONDROSARCOMA;large cell neuroendocrine carcinoma;Conjunctival Disorder;Esophageal adenocarcinoma;Papillary thyroid carcinoma;Medullomyoblastoma with Myogenic Differentiation;tonsil cancer;Endometrial Endometrioid Adenocarcinoma;testicular mixed germ cell tumor;Actinic keratosis;Dysplasia in Ulcerative Colitis;soft tissue sarcoma;medullary breast carcinoma;Papillary renal cell carcinoma;Mixed Lobular and Ductal Breast Carcinoma;Vaginal Melanoma;BONE MARROW FAILURE SYNDROME 5;Gastric Papillary Adenocarcinoma;bronchoalveolar adenocarcinoma;Cervical Clear Cell Adenocarcinoma;Hidradenocarcinoma;Bladder Adenocarcinoma;Aldosterone producing adenoma;Duodenal Adenocarcinoma;Basal cell carcinoma;thyroid neoplasm;Breast Cancer;cervical squamous cell carcinoma;Submandibular Gland Adenoid Cystic Carcinoma;Extraskeletal Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor;diffuse large B-cell lymphoma;Alveolar rhabdomyosarcoma;kidney neoplasm;Li-Fraumeni syndrome;Barrett's esophagus;Ethmoid Sinus Adenoid Cystic Carcinoma;Jejunal Neuroendocrine Tumor G1;non-functioning pituitary adenoma;Pleural Sarcomatoid Mesothelioma;Primary Peritoneal Serous Adenocarcinoma;ossifying fibroma;Penile Carcinoma;plasmacytoma;Cervical Small Cell Carcinoma;Malignant Urinary System Neoplasm;Poroma;endometrial serous adenocarcinoma;Fibroadenoma;Chordoid Meningioma;Benign Ovarian Mucinous Tumor;Endometrial stromal sarcoma;Anal Squamous Cell Carcinoma;Sinonasal Undifferentiated Carcinoma;myeloid neoplasm;Primary Pulmonary Diffuse Large B-Cell Lymphoma;Placental Choriocarcinoma;radiologic finding;Benign Ovarian Neoplasm;Ovarian Mixed Epithelial Tumor;Mediastinal Malignant Germ Cell Tumor;neoplasm of mature B-cells;Thyroid Gland Undifferentiated (Anaplastic) Carcinoma;Ovarian Serous Adenocarcinofibroma;Oligodendroglioma;Well-differentiated liposarcoma;Squamous cell carcinoma;brain glioblastoma;Chronic Eosinophilic Leukemia, Not Otherwise Specified;Cushing disease;Malignant Laryngeal Neoplasm;Testicular Sertoli Cell Tumor;Anaplastic oligodendroglioma;Pleomorphic rhabdomyosarcoma;Malignant Pancreatic Neoplasm;Maxillary Sinus Adenoid Cystic Carcinoma;ACTH-Producing Pituitary Gland Adenoma;urothelial carcinoma;Gliosarcoma;Esophageal Squamous Cell Carcinoma;Thymic Carcinoma;Borderline Ovarian Mucinous Tumor;Acute myeloid leukemia;Intestinal Type Adenocarcinoma;embryonal rhabdomyosarcoma;T-cell prolymphocytic leukemia;Central Nervous System Neoplasm;Benign Salivary Gland Myoepithelioma;Chronic lymphocytic leukemia;MYELODYSPLASTIC SYNDROME;Tracheal Adenoid Cystic Carcinoma;Signet Ring Cell Gastric Adenocarcinoma;Dysplasia of Larynx;Lung Giant Cell Carcinoma;Transitional Meningioma;Gastric Squamous Cell Carcinoma;Parathyroid Gland Carcinoma;Malignant Ovarian Brenner Tumor;Endometrial Clear Cell Adenocarcinoma;skin appendage carcinoma;Small cell lung cancer;Lung adenocarcinoma;Salivary Gland Acinic Cell Carcinoma;Colon Dysplasia;pancreatic neoplasm;carcinoid tumor;Tracheal Squamous Cell Carcinoma;Tonsillar Squamous Cell Carcinoma;Gliosarcoma;Pancreatic Acinar Cell Carcinoma;endometrium adenocarcinoma;squamous cell lung carcinoma;Vulvar Squamous Cell Carcinoma;ND;non-small cell lung carcinoma;Crohn's disease;Middle Ear Squamous Cell Carcinoma;Cervical Adenosquamous Carcinoma;collecting duct carcinoma;adrenal cortex carcinoma;malignant epithelioid mesothelioma;Epithelioid Malignant Peripheral Nerve Sheath Tumor;dedifferentiated chondrosarcoma;renal carcinoma;Kaposi's sarcoma;Adrenocortical carcinoma;benign prostatic hyperplasia;Clear cell renal carcinoma;Renal cell carcinoma;pseudomyxoma peritonei;Malignant peripheral nerve sheath tumor;POLYCYTHEMIA VERA;Hepatocellular Carcinoma;Benign Ovarian Brenner Tumor;Burkitts lymphoma;Endometrial Mucinous Adenocarcinoma;mucinous carcinoma;Splenic Mantle Cell Lymphoma;anaplastic large cell lymphoma;small cell carcinoma;Chronic neutrophilic leukemia;Pleomorphic salivary gland adenoma;Li-Fraumeni syndrome;Gonadal Teratoma;thyroid carcinoma;Appendix Neuroendocrine Tumor G1;Malignant Ovarian Mixed Epithelial Tumor;Pancreatic Small Cell Neuroendocrine Carcinoma;Ovarian Small Cell Carcinoma;Pleural Biphasic Mesothelioma;breast neoplasm;Parotid Gland Acinic Cell Carcinoma;Kidney Angiomyolipoma;Undifferentiated Gallbladder Carcinoma;Fibrous Meningioma;Benign Conjunctival Neoplasm;epithelial neoplasm;Solid Pseudopapillary Neoplasm of the Pancreas;Angioimmunoblastic T-cell lymphoma;Langerhans cell histiocytosis;Colorectal Diffuse Large B-Cell Lymphoma;Digestive System Carcinoma;Central Nervous System Lymphoma;GLIOMA SUSCEPTIBILITY 1;Appendix Goblet Cell Carcinoid;Rectal Traditional Serrated Adenoma;Benign Thyroid Gland Neoplasm;adrenocortical adenoma;leiomyosarcoma;Hodgkins lymphoma;Appendix Villous Adenoma;Major Salivary Gland Mucoepidermoid Carcinoma;Thymic Undifferentiated Carcinoma;gallbladder carcinoma;gastric tubular adenocarcinoma;B-Cell Prolymphocytic Leukemia;hepatocellular adenoma;Familial pancreatic carcinoma;Li-Fraumeni syndrome;Lymphoepithelioma-Like Lung Carcinoma;hyperplasia;Gastric Diffuse Large B-Cell Lymphoma;Major Salivary Gland Carcinoma;Chronic myelomonocytic leukemia;B-lymphoblastic leukemia/lymphoma with t9;22q34.1;q11.2;Thymic Squamous Cell Carcinoma;Anaplastic oligoastrocytoma;Testicular Leydig Cell Tumor;ALVEOLAR SOFT PART SARCOMA;colon carcinoma;follicular dendritic cell sarcoma;prostate carcinoma;Atypical teratoid rhabdoid tumor;ovarian clear cell adenocarcinoma;testicular seminoma;salivary gland squamous cell carcinoma;vulvar carcinoma;Appendix Adenocarcinoma;Minor Salivary Gland Adenocarcinoma;liposarcoma;Gallbladder Squamous Cell Carcinoma;HEPATOBLASTOMA;malignant rhabdoid tumour;Esophageal carcinoma;Lung carcinoid tumor;Malignancy in Giant Cell Tumor of Bone;Adult hepatocellular carcinoma;Cecum Villous Adenoma;Gallbladder Adenosquamous Carcinoma;Peritoneal Mesothelioma;transitional cell carcinoma of kidney;Anal Melanoma;ADRENOCORTICAL CARCINOMA, HEREDITARY;Testicular Choriocarcinoma;Anaplastic Malignant Meningioma;Ovarian Granulosa Cell Tumor;Sex Hormone-Producing Adrenal Cortex Adenoma;Undifferentiated Ovarian Carcinoma;Thyroid Gland Oncocytic Follicular Carcinoma;Malignant Adrenal Gland Pheochromocytoma;Endometrial Undifferentiated Carcinoma;Non-Functional Pancreatic Neuroendocrine Tumor;ovarian adenocarcinoma;Spinal Cord Astrocytoma;Multiple myeloma;Uterine Carcinosarcoma;pharyngeal squamous cell carcinoma;Borderline Ovarian Serous Tumor;embryonal rhabdomyosarcoma;HER2 positive breast carcinoma;oral squamous cell carcinoma;head and neck squamous cell carcinoma;Myeloproliferative disorder;Astrocytoma;small intestinal adenocarcinoma;cervical carcinoma;Ovarian neoplasm;Endometrial carcinoma;Parotid Gland Pleomorphic Adenoma;Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive;pleomorphic liposarcoma;Lung sarcomatoid carcinoma;Malignant Mesothelioma;Laryngeal squamous cell carcinoma;Grade III Prostatic Intraepithelial Neoplasia;Testicular Embryonal Carcinoma;pancreatic carcinoma;adenosquamous lung carcinoma;unspecified peripheral T-cell lymphoma;Digestive System Adenoma;Gastric Neuroendocrine Tumor G1;nodular melanoma;adrenal gland pheochromocytoma;Thymoma;ovarian carcinoma;MANTLE CELL LYMPHOMA;large cell lung carcinoma;breast ductal adenocarcinoma;Lung carcinoma;colonic neoplasm;PAPILLOMA OF CHOROID PLEXUS;Teratoma with Malignant Transformation;Rectal Villous Adenoma;mesenchymal chondrosarcoma;Ulcerative colitis;sebaceous adenocarcinoma;Normal Breast-Like Subtype of Breast Carcinoma;Rhabdoid Meningioma;Skin Basosquamous Cell Carcinoma;Keloid;Thymoma Type B3;Hepatocellular Carcinoma;Medulloblastoma;Major Salivary Gland Carcinoma ex Pleomorphic Adenoma;Kidney Oncocytoma;Ileal Neuroendocrine Tumor G1;blastic plasmacytoid dendritic cell neoplasm;Atypical Meningioma;folliculitis;Parotid Gland Squamous Cell Carcinoma;Lymphomatoid papulosis;colon adenocarcinoma;Essential thrombocythemia;Rhabdomyosarcoma;central neurocytoma;pulmonary blastoma;Colorectal Neuroendocrine Tumor G1;Biphasic Mesothelioma;Colorectal Hamartoma;cecum adenocarcinoma;Non-Functioning Adrenal Cortex Adenoma;Brain Stem Glioblastoma;Secretory Meningioma;PEComa;Prostate Small Cell Carcinoma;bladder tumor;Oligoastrocytoma;T-cell acute lymphoblastic leukemia;undifferentiated pleomorphic sarcoma;skin carcinoma;ovarian mucinous adenocarcinoma;Essential thrombocythemia;hairy cell leukemia;breast hyperplasia;lobular breast carcinoma;cervical adenocarcinoma;Uveal melanoma;Chromophobe renal cell carcinoma;Angiomatous Meningioma;Alveolar rhabdomyosarcoma;uterine corpus undifferentiated sarcoma;Salivary Gland Carcinoma ex Pleomorphic Adenoma;Splenic Diffuse Large B-Cell Lymphoma;Kidney Medullary Carcinoma;gastric adenocarcinoma;Basaloid Carcinoma;smooth muscle tumor;Pancreatic Large Cell Neuroendocrine Carcinoma;Fallopian Tube Carcinoma;OSTEOGENIC SARCOMA;angiosarcoma;ureter urothelial carcinoma;Malignant Mixed Neoplasm;Pancreatic Cancer;Hydatidiform mole;Parotid Gland Adenoid Cystic Carcinoma;Small Intestinal Diffuse Large B-Cell Lymphoma;Undifferentiated Pancreatic Carcinoma with Osteoclast-Like Giant Cells;breast adenosis;Choroid plexus papilloma;Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation;Therapy-Related Myeloid Neoplasm;Chronic myelogenous leukemia;Atypical endometrial hyperplasia;Parotid Gland Carcinoma;Salivary Gland Large Cell Carcinoma;Gallbladder Adenocarcinoma;bile duct carcinoma;bladder transitional cell carcinoma;Undifferentiated Pancreatic Carcinoma;brain neoplasm;Ovarian Carcinosarcoma;gastric carcinoma;Bladder Squamous Cell Carcinoma;Small Intestinal Tubulovillous Adenoma;Pituitary Gland Adenoma;Parotid Gland Carcinoma ex Pleomorphic Adenoma;Dedifferentiated liposarcoma;Hereditary breast and/or ovarian cancer syndrome;Hepatobiliary Neoplasm;Histiocytic and Dendritic Cell Neoplasm;gastric adenosquamous carcinoma;Synovial sarcoma;Adenoid Cystic Breast Carcinoma;Melanoma;Meningothelial Meningioma;Anaplastic astrocytoma;follicular thyroid carcinoma;diffuse gastric adenocarcinoma;Breast carcinoma;Testicular Yolk Sac Tumor;Sarcomatoid Mesothelioma;OSTEOSARCOMA;B-cell chronic lymphocytic leukemia;Extramammary Paget Disease;BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 7;Giant cell glioblastoma;rectal adenocarcinoma;Fallopian Tube Carcinosarcoma;stomach neoplasm;Conjunctival Squamous Cell Carcinoma;Testicular Teratoma;Eccrine porocarcinoma;Gallbladder Small Cell Neuroendocrine Carcinoma;clear cell sarcoma;Fallopian Tube Serous Adenocarcinoma;Cortisol-Producing Adrenal Cortex Adenoma;breast ductal carcinoma in situ;leukoplakia of tongue;BONE MARROW FAILURE SYNDROME 5;Breast Cancer;ADRENOCORTICAL CARCINOMA, HEREDITARY;OSTEOGENIC SARCOMA;Li-Fraumeni syndrome;Colorectal Cancer;BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 7;NASOPHARYNGEAL CARCINOMA;GLIOMA SUSCEPTIBILITY 1;PAPILLOMA OF CHOROID PLEXUS;Hepatocellular Carcinoma;Pancreatic Cancer"
TP53_aug8,TP53,"Liver Diffuse Large B-Cell Lymphoma;Choroid plexus carcinoma;ovarian serous adenocarcinoma;Myelodysplastic/Myeloproliferative Neoplasm;Poorly Differentiated Thyroid Gland Carcinoma;Adenocarcinoma;Ovarian Transitional Cell Carcinoma;Thyroid Gland Diffuse Large B-Cell Lymphoma;ovarian teratoma;Colorectal Cancer;Sarcomatoid Carcinoma;Adrenal Gland Neuroblastoma;Lung Sclerosing Hemangioma;Pleural Mesothelioma;large cell medulloblastoma;Ovarian Endometrioid Adenocarcinoma;B-cell acute lymphoblastic leukemia;Gastric Adenoma;Thymic Small Cell Carcinoma;pancreatic neuroendocrine tumor;prostate adenocarcinoma;Granulocytic Sarcoma;Gastric Metaplasia;Small cell lung carcinoma;Spindle Cell Melanoma;Breast Carcinoma by Gene Expression Profile;NASOPHARYNGEAL CARCINOMA;Ovarian Yolk Sac Tumor;Unclassified Renal Cell Carcinoma;Neoplasm;Thymic Sarcomatoid Carcinoma;Glioma;Carcinoma;lymphoid neoplasm;Rectal Tubular Adenoma;Acute lymphoblastic leukemia;PAPILLOMA OF CHOROID PLEXUS;Intimal Sarcoma;ganglioglioma;Acute basophilic leukemia;marginal zone B-cell lymphoma;dysplastic nevus;Bladder Small Cell Neuroendocrine Carcinoma;Cervical Endometrioid Adenocarcinoma;Ocular Sebaceous Carcinoma;Adenoid cystic carcinoma;Meningeal Melanocytoma;Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant;Colorectal adenoma;Invasive Breast Carcinoma;Ampulla of Vater Carcinoma;Merkel cell skin cancer;nasopharyngeal squamous cell carcinoma;cutaneous melanoma;Olfactory Neuroblastoma;primary central chondrosarcoma;metaplastic breast carcinoma;Dedifferentiated Solitary Fibrous Tumor;colorectal adenocarcinoma;Ependymoma;Conjunctival Melanoma;gastric intestinal type adenocarcinoma;vascular sarcoma;OSTEOSARCOMA;endodermal sinus tumor;Pleural Epithelioid Mesothelioma;Mucinous Gastric Adenocarcinoma;CHONDROSARCOMA;large cell neuroendocrine carcinoma;Conjunctival Disorder;Esophageal adenocarcinoma;Papillary thyroid carcinoma;Medullomyoblastoma with Myogenic Differentiation;tonsil cancer;Endometrial Endometrioid Adenocarcinoma;testicular mixed germ cell tumor;Actinic keratosis;Dysplasia in Ulcerative Colitis;soft tissue sarcoma;medullary breast carcinoma;Papillary renal cell carcinoma;Mixed Lobular and Ductal Breast Carcinoma;Vaginal Melanoma;BONE MARROW FAILURE SYNDROME 5;Gastric Papillary Adenocarcinoma;bronchoalveolar adenocarcinoma;Cervical Clear Cell Adenocarcinoma;Hidradenocarcinoma;Bladder Adenocarcinoma;Aldosterone producing adenoma;Duodenal Adenocarcinoma;Basal cell carcinoma;thyroid neoplasm;Breast Cancer;cervical squamous cell carcinoma;Submandibular Gland Adenoid Cystic Carcinoma;Extraskeletal Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor;diffuse large B-cell lymphoma;Alveolar rhabdomyosarcoma;kidney neoplasm;Li-Fraumeni syndrome;Barrett's esophagus;Ethmoid Sinus Adenoid Cystic Carcinoma;Jejunal Neuroendocrine Tumor G1;non-functioning pituitary adenoma;Pleural Sarcomatoid Mesothelioma;Primary Peritoneal Serous Adenocarcinoma;ossifying fibroma;Penile Carcinoma;plasmacytoma;Cervical Small Cell Carcinoma;Malignant Urinary System Neoplasm;Poroma;endometrial serous adenocarcinoma;Fibroadenoma;Chordoid Meningioma;Benign Ovarian Mucinous Tumor;Endometrial stromal sarcoma;Anal Squamous Cell Carcinoma;Sinonasal Undifferentiated Carcinoma;myeloid neoplasm;Primary Pulmonary Diffuse Large B-Cell Lymphoma;Placental Choriocarcinoma;radiologic finding;Benign Ovarian Neoplasm;Ovarian Mixed Epithelial Tumor;Mediastinal Malignant Germ Cell Tumor;neoplasm of mature B-cells;Thyroid Gland Undifferentiated (Anaplastic) Carcinoma;Ovarian Serous Adenocarcinofibroma;Oligodendroglioma;Well-differentiated liposarcoma;Squamous cell carcinoma;brain glioblastoma;Chronic Eosinophilic Leukemia, Not Otherwise Specified;Cushing disease;Malignant Laryngeal Neoplasm;Testicular Sertoli Cell Tumor;Anaplastic oligodendroglioma;Pleomorphic rhabdomyosarcoma;Malignant Pancreatic Neoplasm;Maxillary Sinus Adenoid Cystic Carcinoma;ACTH-Producing Pituitary Gland Adenoma;urothelial carcinoma;Gliosarcoma;Esophageal Squamous Cell Carcinoma;Thymic Carcinoma;Borderline Ovarian Mucinous Tumor;Acute myeloid leukemia;Intestinal Type Adenocarcinoma;embryonal rhabdomyosarcoma;T-cell prolymphocytic leukemia;Central Nervous System Neoplasm;Benign Salivary Gland Myoepithelioma;Chronic lymphocytic leukemia;MYELODYSPLASTIC SYNDROME;Tracheal Adenoid Cystic Carcinoma;Signet Ring Cell Gastric Adenocarcinoma;Dysplasia of Larynx;Lung Giant Cell Carcinoma;Transitional Meningioma;Gastric Squamous Cell Carcinoma;Parathyroid Gland Carcinoma;Malignant Ovarian Brenner Tumor;Endometrial Clear Cell Adenocarcinoma;skin appendage carcinoma;Small cell lung cancer;Lung adenocarcinoma;Salivary Gland Acinic Cell Carcinoma;Colon Dysplasia;pancreatic neoplasm;carcinoid tumor;Tracheal Squamous Cell Carcinoma;Tonsillar Squamous Cell Carcinoma;Gliosarcoma;Pancreatic Acinar Cell Carcinoma;endometrium adenocarcinoma;squamous cell lung carcinoma;Vulvar Squamous Cell Carcinoma;ND;non-small cell lung carcinoma;Crohn's disease;Middle Ear Squamous Cell Carcinoma;Cervical Adenosquamous Carcinoma;collecting duct carcinoma;adrenal cortex carcinoma;malignant epithelioid mesothelioma;Epithelioid Malignant Peripheral Nerve Sheath Tumor;dedifferentiated chondrosarcoma;renal carcinoma;Kaposi's sarcoma;Adrenocortical carcinoma;benign prostatic hyperplasia;Clear cell renal carcinoma;Renal cell carcinoma;pseudomyxoma peritonei;Malignant peripheral nerve sheath tumor;POLYCYTHEMIA VERA;Hepatocellular Carcinoma;Benign Ovarian Brenner Tumor;Burkitts lymphoma;Endometrial Mucinous Adenocarcinoma;mucinous carcinoma;Splenic Mantle Cell Lymphoma;anaplastic large cell lymphoma;small cell carcinoma;Chronic neutrophilic leukemia;Pleomorphic salivary gland adenoma;Li-Fraumeni syndrome;Gonadal Teratoma;thyroid carcinoma;Appendix Neuroendocrine Tumor G1;Malignant Ovarian Mixed Epithelial Tumor;Pancreatic Small Cell Neuroendocrine Carcinoma;Ovarian Small Cell Carcinoma;Pleural Biphasic Mesothelioma;breast neoplasm;Parotid Gland Acinic Cell Carcinoma;Kidney Angiomyolipoma;Undifferentiated Gallbladder Carcinoma;Fibrous Meningioma;Benign Conjunctival Neoplasm;epithelial neoplasm;Solid Pseudopapillary Neoplasm of the Pancreas;Angioimmunoblastic T-cell lymphoma;Langerhans cell histiocytosis;Colorectal Diffuse Large B-Cell Lymphoma;Digestive System Carcinoma;Central Nervous System Lymphoma;GLIOMA SUSCEPTIBILITY 1;Appendix Goblet Cell Carcinoid;Rectal Traditional Serrated Adenoma;Benign Thyroid Gland Neoplasm;adrenocortical adenoma;leiomyosarcoma;Hodgkins lymphoma;Appendix Villous Adenoma;Major Salivary Gland Mucoepidermoid Carcinoma;Thymic Undifferentiated Carcinoma;gallbladder carcinoma;gastric tubular adenocarcinoma;B-Cell Prolymphocytic Leukemia;hepatocellular adenoma;Familial pancreatic carcinoma;Li-Fraumeni syndrome;Lymphoepithelioma-Like Lung Carcinoma;hyperplasia;Gastric Diffuse Large B-Cell Lymphoma;Major Salivary Gland Carcinoma;Chronic myelomonocytic leukemia;B-lymphoblastic leukemia/lymphoma with t9;22q34.1;q11.2;Thymic Squamous Cell Carcinoma;Anaplastic oligoastrocytoma;Testicular Leydig Cell Tumor;ALVEOLAR SOFT PART SARCOMA;colon carcinoma;follicular dendritic cell sarcoma;prostate carcinoma;Atypical teratoid rhabdoid tumor;ovarian clear cell adenocarcinoma;testicular seminoma;salivary gland squamous cell carcinoma;vulvar carcinoma;Appendix Adenocarcinoma;Minor Salivary Gland Adenocarcinoma;liposarcoma;Gallbladder Squamous Cell Carcinoma;HEPATOBLASTOMA;malignant rhabdoid tumour;Esophageal carcinoma;Lung carcinoid tumor;Malignancy in Giant Cell Tumor of Bone;Adult hepatocellular carcinoma;Cecum Villous Adenoma;Gallbladder Adenosquamous Carcinoma;Peritoneal Mesothelioma;transitional cell carcinoma of kidney;Anal Melanoma;ADRENOCORTICAL CARCINOMA, HEREDITARY;Testicular Choriocarcinoma;Anaplastic Malignant Meningioma;Ovarian Granulosa Cell Tumor;Sex Hormone-Producing Adrenal Cortex Adenoma;Undifferentiated Ovarian Carcinoma;Thyroid Gland Oncocytic Follicular Carcinoma;Malignant Adrenal Gland Pheochromocytoma;Endometrial Undifferentiated Carcinoma;Non-Functional Pancreatic Neuroendocrine Tumor;ovarian adenocarcinoma;Spinal Cord Astrocytoma;Multiple myeloma;Uterine Carcinosarcoma;pharyngeal squamous cell carcinoma;Borderline Ovarian Serous Tumor;embryonal rhabdomyosarcoma;HER2 positive breast carcinoma;oral squamous cell carcinoma;head and neck squamous cell carcinoma;Myeloproliferative disorder;Astrocytoma;small intestinal adenocarcinoma;cervical carcinoma;Ovarian neoplasm;Endometrial carcinoma;Parotid Gland Pleomorphic Adenoma;Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive;pleomorphic liposarcoma;Lung sarcomatoid carcinoma;Malignant Mesothelioma;Laryngeal squamous cell carcinoma;Grade III Prostatic Intraepithelial Neoplasia;Testicular Embryonal Carcinoma;pancreatic carcinoma;adenosquamous lung carcinoma;unspecified peripheral T-cell lymphoma;Digestive System Adenoma;Gastric Neuroendocrine Tumor G1;nodular melanoma;adrenal gland pheochromocytoma;Thymoma;ovarian carcinoma;MANTLE CELL LYMPHOMA;large cell lung carcinoma;breast ductal adenocarcinoma;Lung carcinoma;colonic neoplasm;PAPILLOMA OF CHOROID PLEXUS;Teratoma with Malignant Transformation;Rectal Villous Adenoma;mesenchymal chondrosarcoma;Ulcerative colitis;sebaceous adenocarcinoma;Normal Breast-Like Subtype of Breast Carcinoma;Rhabdoid Meningioma;Skin Basosquamous Cell Carcinoma;Keloid;Thymoma Type B3;Hepatocellular Carcinoma;Medulloblastoma;Major Salivary Gland Carcinoma ex Pleomorphic Adenoma;Kidney Oncocytoma;Ileal Neuroendocrine Tumor G1;blastic plasmacytoid dendritic cell neoplasm;Atypical Meningioma;folliculitis;Parotid Gland Squamous Cell Carcinoma;Lymphomatoid papulosis;colon adenocarcinoma;Essential thrombocythemia;Rhabdomyosarcoma;central neurocytoma;pulmonary blastoma;Colorectal Neuroendocrine Tumor G1;Biphasic Mesothelioma;Colorectal Hamartoma;cecum adenocarcinoma;Non-Functioning Adrenal Cortex Adenoma;Brain Stem Glioblastoma;Secretory Meningioma;PEComa;Prostate Small Cell Carcinoma;bladder tumor;Oligoastrocytoma;T-cell acute lymphoblastic leukemia;undifferentiated pleomorphic sarcoma;skin carcinoma;ovarian mucinous adenocarcinoma;Essential thrombocythemia;hairy cell leukemia;breast hyperplasia;lobular breast carcinoma;cervical adenocarcinoma;Uveal melanoma;Chromophobe renal cell carcinoma;Angiomatous Meningioma;Alveolar rhabdomyosarcoma;uterine corpus undifferentiated sarcoma;Salivary Gland Carcinoma ex Pleomorphic Adenoma;Splenic Diffuse Large B-Cell Lymphoma;Kidney Medullary Carcinoma;gastric adenocarcinoma;Basaloid Carcinoma;smooth muscle tumor;Pancreatic Large Cell Neuroendocrine Carcinoma;Fallopian Tube Carcinoma;OSTEOGENIC SARCOMA;angiosarcoma;ureter urothelial carcinoma;Malignant Mixed Neoplasm;Pancreatic Cancer;Hydatidiform mole;Parotid Gland Adenoid Cystic Carcinoma;Small Intestinal Diffuse Large B-Cell Lymphoma;Undifferentiated Pancreatic Carcinoma with Osteoclast-Like Giant Cells;breast adenosis;Choroid plexus papilloma;Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation;Therapy-Related Myeloid Neoplasm;Chronic myelogenous leukemia;Atypical endometrial hyperplasia;Parotid Gland Carcinoma;Salivary Gland Large Cell Carcinoma;Gallbladder Adenocarcinoma;bile duct carcinoma;bladder transitional cell carcinoma;Undifferentiated Pancreatic Carcinoma;brain neoplasm;Ovarian Carcinosarcoma;gastric carcinoma;Bladder Squamous Cell Carcinoma;Small Intestinal Tubulovillous Adenoma;Pituitary Gland Adenoma;Parotid Gland Carcinoma ex Pleomorphic Adenoma;Dedifferentiated liposarcoma;Hereditary breast and/or ovarian cancer syndrome;Hepatobiliary Neoplasm;Histiocytic and Dendritic Cell Neoplasm;gastric adenosquamous carcinoma;Synovial sarcoma;Adenoid Cystic Breast Carcinoma;Melanoma;Meningothelial Meningioma;Anaplastic astrocytoma;follicular thyroid carcinoma;diffuse gastric adenocarcinoma;Breast carcinoma;Testicular Yolk Sac Tumor;Sarcomatoid Mesothelioma;OSTEOSARCOMA;B-cell chronic lymphocytic leukemia;Extramammary Paget Disease;BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 7;Giant cell glioblastoma;rectal adenocarcinoma;Fallopian Tube Carcinosarcoma;stomach neoplasm;Conjunctival Squamous Cell Carcinoma;Testicular Teratoma;Eccrine porocarcinoma;Gallbladder Small Cell Neuroendocrine Carcinoma;clear cell sarcoma;Fallopian Tube Serous Adenocarcinoma;Cortisol-Producing Adrenal Cortex Adenoma;breast ductal carcinoma in situ;leukoplakia of tongue;BONE MARROW FAILURE SYNDROME 5;Breast Cancer;ADRENOCORTICAL CARCINOMA, HEREDITARY;OSTEOGENIC SARCOMA;Li-Fraumeni syndrome;Colorectal Cancer;BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 7;NASOPHARYNGEAL CARCINOMA;GLIOMA SUSCEPTIBILITY 1;PAPILLOMA OF CHOROID PLEXUS;Hepatocellular Carcinoma;Pancreatic Cancer"
TP53_aug9,TP53,"Liver Diffuse Large B-Cell Lymphoma;Choroid plexus carcinoma;ovarian serous adenocarcinoma;Myelodysplastic/Myeloproliferative Neoplasm;Poorly Differentiated Thyroid Gland Carcinoma;Adenocarcinoma;Ovarian Transitional Cell Carcinoma;Thyroid Gland Diffuse Large B-Cell Lymphoma;ovarian teratoma;Colorectal Cancer;Sarcomatoid Carcinoma;Adrenal Gland Neuroblastoma;Lung Sclerosing Hemangioma;Pleural Mesothelioma;large cell medulloblastoma;Ovarian Endometrioid Adenocarcinoma;B-cell acute lymphoblastic leukemia;Gastric Adenoma;Thymic Small Cell Carcinoma;pancreatic neuroendocrine tumor;prostate adenocarcinoma;Granulocytic Sarcoma;Gastric Metaplasia;Small cell lung carcinoma;Spindle Cell Melanoma;Breast Carcinoma by Gene Expression Profile;NASOPHARYNGEAL CARCINOMA;Ovarian Yolk Sac Tumor;Unclassified Renal Cell Carcinoma;Neoplasm;Thymic Sarcomatoid Carcinoma;Glioma;Carcinoma;lymphoid neoplasm;Rectal Tubular Adenoma;Acute lymphoblastic leukemia;PAPILLOMA OF CHOROID PLEXUS;Intimal Sarcoma;ganglioglioma;Acute basophilic leukemia;marginal zone B-cell lymphoma;dysplastic nevus;Bladder Small Cell Neuroendocrine Carcinoma;Cervical Endometrioid Adenocarcinoma;Ocular Sebaceous Carcinoma;Adenoid cystic carcinoma;Meningeal Melanocytoma;Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant;Colorectal adenoma;Invasive Breast Carcinoma;Ampulla of Vater Carcinoma;Merkel cell skin cancer;nasopharyngeal squamous cell carcinoma;cutaneous melanoma;Olfactory Neuroblastoma;primary central chondrosarcoma;metaplastic breast carcinoma;Dedifferentiated Solitary Fibrous Tumor;colorectal adenocarcinoma;Ependymoma;Conjunctival Melanoma;gastric intestinal type adenocarcinoma;vascular sarcoma;OSTEOSARCOMA;endodermal sinus tumor;Pleural Epithelioid Mesothelioma;Mucinous Gastric Adenocarcinoma;CHONDROSARCOMA;large cell neuroendocrine carcinoma;Conjunctival Disorder;Esophageal adenocarcinoma;Papillary thyroid carcinoma;Medullomyoblastoma with Myogenic Differentiation;tonsil cancer;Endometrial Endometrioid Adenocarcinoma;testicular mixed germ cell tumor;Actinic keratosis;Dysplasia in Ulcerative Colitis;soft tissue sarcoma;medullary breast carcinoma;Papillary renal cell carcinoma;Mixed Lobular and Ductal Breast Carcinoma;Vaginal Melanoma;BONE MARROW FAILURE SYNDROME 5;Gastric Papillary Adenocarcinoma;bronchoalveolar adenocarcinoma;Cervical Clear Cell Adenocarcinoma;Hidradenocarcinoma;Bladder Adenocarcinoma;Aldosterone producing adenoma;Duodenal Adenocarcinoma;Basal cell carcinoma;thyroid neoplasm;Breast Cancer;cervical squamous cell carcinoma;Submandibular Gland Adenoid Cystic Carcinoma;Extraskeletal Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor;diffuse large B-cell lymphoma;Alveolar rhabdomyosarcoma;kidney neoplasm;Li-Fraumeni syndrome;Barrett's esophagus;Ethmoid Sinus Adenoid Cystic Carcinoma;Jejunal Neuroendocrine Tumor G1;non-functioning pituitary adenoma;Pleural Sarcomatoid Mesothelioma;Primary Peritoneal Serous Adenocarcinoma;ossifying fibroma;Penile Carcinoma;plasmacytoma;Cervical Small Cell Carcinoma;Malignant Urinary System Neoplasm;Poroma;endometrial serous adenocarcinoma;Fibroadenoma;Chordoid Meningioma;Benign Ovarian Mucinous Tumor;Endometrial stromal sarcoma;Anal Squamous Cell Carcinoma;Sinonasal Undifferentiated Carcinoma;myeloid neoplasm;Primary Pulmonary Diffuse Large B-Cell Lymphoma;Placental Choriocarcinoma;radiologic finding;Benign Ovarian Neoplasm;Ovarian Mixed Epithelial Tumor;Mediastinal Malignant Germ Cell Tumor;neoplasm of mature B-cells;Thyroid Gland Undifferentiated (Anaplastic) Carcinoma;Ovarian Serous Adenocarcinofibroma;Oligodendroglioma;Well-differentiated liposarcoma;Squamous cell carcinoma;brain glioblastoma;Chronic Eosinophilic Leukemia, Not Otherwise Specified;Cushing disease;Malignant Laryngeal Neoplasm;Testicular Sertoli Cell Tumor;Anaplastic oligodendroglioma;Pleomorphic rhabdomyosarcoma;Malignant Pancreatic Neoplasm;Maxillary Sinus Adenoid Cystic Carcinoma;ACTH-Producing Pituitary Gland Adenoma;urothelial carcinoma;Gliosarcoma;Esophageal Squamous Cell Carcinoma;Thymic Carcinoma;Borderline Ovarian Mucinous Tumor;Acute myeloid leukemia;Intestinal Type Adenocarcinoma;embryonal rhabdomyosarcoma;T-cell prolymphocytic leukemia;Central Nervous System Neoplasm;Benign Salivary Gland Myoepithelioma;Chronic lymphocytic leukemia;MYELODYSPLASTIC SYNDROME;Tracheal Adenoid Cystic Carcinoma;Signet Ring Cell Gastric Adenocarcinoma;Dysplasia of Larynx;Lung Giant Cell Carcinoma;Transitional Meningioma;Gastric Squamous Cell Carcinoma;Parathyroid Gland Carcinoma;Malignant Ovarian Brenner Tumor;Endometrial Clear Cell Adenocarcinoma;skin appendage carcinoma;Small cell lung cancer;Lung adenocarcinoma;Salivary Gland Acinic Cell Carcinoma;Colon Dysplasia;pancreatic neoplasm;carcinoid tumor;Tracheal Squamous Cell Carcinoma;Tonsillar Squamous Cell Carcinoma;Gliosarcoma;Pancreatic Acinar Cell Carcinoma;endometrium adenocarcinoma;squamous cell lung carcinoma;Vulvar Squamous Cell Carcinoma;ND;non-small cell lung carcinoma;Crohn's disease;Middle Ear Squamous Cell Carcinoma;Cervical Adenosquamous Carcinoma;collecting duct carcinoma;adrenal cortex carcinoma;malignant epithelioid mesothelioma;Epithelioid Malignant Peripheral Nerve Sheath Tumor;dedifferentiated chondrosarcoma;renal carcinoma;Kaposi's sarcoma;Adrenocortical carcinoma;benign prostatic hyperplasia;Clear cell renal carcinoma;Renal cell carcinoma;pseudomyxoma peritonei;Malignant peripheral nerve sheath tumor;POLYCYTHEMIA VERA;Hepatocellular Carcinoma;Benign Ovarian Brenner Tumor;Burkitts lymphoma;Endometrial Mucinous Adenocarcinoma;mucinous carcinoma;Splenic Mantle Cell Lymphoma;anaplastic large cell lymphoma;small cell carcinoma;Chronic neutrophilic leukemia;Pleomorphic salivary gland adenoma;Li-Fraumeni syndrome;Gonadal Teratoma;thyroid carcinoma;Appendix Neuroendocrine Tumor G1;Malignant Ovarian Mixed Epithelial Tumor;Pancreatic Small Cell Neuroendocrine Carcinoma;Ovarian Small Cell Carcinoma;Pleural Biphasic Mesothelioma;breast neoplasm;Parotid Gland Acinic Cell Carcinoma;Kidney Angiomyolipoma;Undifferentiated Gallbladder Carcinoma;Fibrous Meningioma;Benign Conjunctival Neoplasm;epithelial neoplasm;Solid Pseudopapillary Neoplasm of the Pancreas;Angioimmunoblastic T-cell lymphoma;Langerhans cell histiocytosis;Colorectal Diffuse Large B-Cell Lymphoma;Digestive System Carcinoma;Central Nervous System Lymphoma;GLIOMA SUSCEPTIBILITY 1;Appendix Goblet Cell Carcinoid;Rectal Traditional Serrated Adenoma;Benign Thyroid Gland Neoplasm;adrenocortical adenoma;leiomyosarcoma;Hodgkins lymphoma;Appendix Villous Adenoma;Major Salivary Gland Mucoepidermoid Carcinoma;Thymic Undifferentiated Carcinoma;gallbladder carcinoma;gastric tubular adenocarcinoma;B-Cell Prolymphocytic Leukemia;hepatocellular adenoma;Familial pancreatic carcinoma;Li-Fraumeni syndrome;Lymphoepithelioma-Like Lung Carcinoma;hyperplasia;Gastric Diffuse Large B-Cell Lymphoma;Major Salivary Gland Carcinoma;Chronic myelomonocytic leukemia;B-lymphoblastic leukemia/lymphoma with t9;22q34.1;q11.2;Thymic Squamous Cell Carcinoma;Anaplastic oligoastrocytoma;Testicular Leydig Cell Tumor;ALVEOLAR SOFT PART SARCOMA;colon carcinoma;follicular dendritic cell sarcoma;prostate carcinoma;Atypical teratoid rhabdoid tumor;ovarian clear cell adenocarcinoma;testicular seminoma;salivary gland squamous cell carcinoma;vulvar carcinoma;Appendix Adenocarcinoma;Minor Salivary Gland Adenocarcinoma;liposarcoma;Gallbladder Squamous Cell Carcinoma;HEPATOBLASTOMA;malignant rhabdoid tumour;Esophageal carcinoma;Lung carcinoid tumor;Malignancy in Giant Cell Tumor of Bone;Adult hepatocellular carcinoma;Cecum Villous Adenoma;Gallbladder Adenosquamous Carcinoma;Peritoneal Mesothelioma;transitional cell carcinoma of kidney;Anal Melanoma;ADRENOCORTICAL CARCINOMA, HEREDITARY;Testicular Choriocarcinoma;Anaplastic Malignant Meningioma;Ovarian Granulosa Cell Tumor;Sex Hormone-Producing Adrenal Cortex Adenoma;Undifferentiated Ovarian Carcinoma;Thyroid Gland Oncocytic Follicular Carcinoma;Malignant Adrenal Gland Pheochromocytoma;Endometrial Undifferentiated Carcinoma;Non-Functional Pancreatic Neuroendocrine Tumor;ovarian adenocarcinoma;Spinal Cord Astrocytoma;Multiple myeloma;Uterine Carcinosarcoma;pharyngeal squamous cell carcinoma;Borderline Ovarian Serous Tumor;embryonal rhabdomyosarcoma;HER2 positive breast carcinoma;oral squamous cell carcinoma;head and neck squamous cell carcinoma;Myeloproliferative disorder;Astrocytoma;small intestinal adenocarcinoma;cervical carcinoma;Ovarian neoplasm;Endometrial carcinoma;Parotid Gland Pleomorphic Adenoma;Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive;pleomorphic liposarcoma;Lung sarcomatoid carcinoma;Malignant Mesothelioma;Laryngeal squamous cell carcinoma;Grade III Prostatic Intraepithelial Neoplasia;Testicular Embryonal Carcinoma;pancreatic carcinoma;adenosquamous lung carcinoma;unspecified peripheral T-cell lymphoma;Digestive System Adenoma;Gastric Neuroendocrine Tumor G1;nodular melanoma;adrenal gland pheochromocytoma;Thymoma;ovarian carcinoma;MANTLE CELL LYMPHOMA;large cell lung carcinoma;breast ductal adenocarcinoma;Lung carcinoma;colonic neoplasm;PAPILLOMA OF CHOROID PLEXUS;Teratoma with Malignant Transformation;Rectal Villous Adenoma;mesenchymal chondrosarcoma;Ulcerative colitis;sebaceous adenocarcinoma;Normal Breast-Like Subtype of Breast Carcinoma;Rhabdoid Meningioma;Skin Basosquamous Cell Carcinoma;Keloid;Thymoma Type B3;Hepatocellular Carcinoma;Medulloblastoma;Major Salivary Gland Carcinoma ex Pleomorphic Adenoma;Kidney Oncocytoma;Ileal Neuroendocrine Tumor G1;blastic plasmacytoid dendritic cell neoplasm;Atypical Meningioma;folliculitis;Parotid Gland Squamous Cell Carcinoma;Lymphomatoid papulosis;colon adenocarcinoma;Essential thrombocythemia;Rhabdomyosarcoma;central neurocytoma;pulmonary blastoma;Colorectal Neuroendocrine Tumor G1;Biphasic Mesothelioma;Colorectal Hamartoma;cecum adenocarcinoma;Non-Functioning Adrenal Cortex Adenoma;Brain Stem Glioblastoma;Secretory Meningioma;PEComa;Prostate Small Cell Carcinoma;bladder tumor;Oligoastrocytoma;T-cell acute lymphoblastic leukemia;undifferentiated pleomorphic sarcoma;skin carcinoma;ovarian mucinous adenocarcinoma;Essential thrombocythemia;hairy cell leukemia;breast hyperplasia;lobular breast carcinoma;cervical adenocarcinoma;Uveal melanoma;Chromophobe renal cell carcinoma;Angiomatous Meningioma;Alveolar rhabdomyosarcoma;uterine corpus undifferentiated sarcoma;Salivary Gland Carcinoma ex Pleomorphic Adenoma;Splenic Diffuse Large B-Cell Lymphoma;Kidney Medullary Carcinoma;gastric adenocarcinoma;Basaloid Carcinoma;smooth muscle tumor;Pancreatic Large Cell Neuroendocrine Carcinoma;Fallopian Tube Carcinoma;OSTEOGENIC SARCOMA;angiosarcoma;ureter urothelial carcinoma;Malignant Mixed Neoplasm;Pancreatic Cancer;Hydatidiform mole;Parotid Gland Adenoid Cystic Carcinoma;Small Intestinal Diffuse Large B-Cell Lymphoma;Undifferentiated Pancreatic Carcinoma with Osteoclast-Like Giant Cells;breast adenosis;Choroid plexus papilloma;Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation;Therapy-Related Myeloid Neoplasm;Chronic myelogenous leukemia;Atypical endometrial hyperplasia;Parotid Gland Carcinoma;Salivary Gland Large Cell Carcinoma;Gallbladder Adenocarcinoma;bile duct carcinoma;bladder transitional cell carcinoma;Undifferentiated Pancreatic Carcinoma;brain neoplasm;Ovarian Carcinosarcoma;gastric carcinoma;Bladder Squamous Cell Carcinoma;Small Intestinal Tubulovillous Adenoma;Pituitary Gland Adenoma;Parotid Gland Carcinoma ex Pleomorphic Adenoma;Dedifferentiated liposarcoma;Hereditary breast and/or ovarian cancer syndrome;Hepatobiliary Neoplasm;Histiocytic and Dendritic Cell Neoplasm;gastric adenosquamous carcinoma;Synovial sarcoma;Adenoid Cystic Breast Carcinoma;Melanoma;Meningothelial Meningioma;Anaplastic astrocytoma;follicular thyroid carcinoma;diffuse gastric adenocarcinoma;Breast carcinoma;Testicular Yolk Sac Tumor;Sarcomatoid Mesothelioma;OSTEOSARCOMA;B-cell chronic lymphocytic leukemia;Extramammary Paget Disease;BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 7;Giant cell glioblastoma;rectal adenocarcinoma;Fallopian Tube Carcinosarcoma;stomach neoplasm;Conjunctival Squamous Cell Carcinoma;Testicular Teratoma;Eccrine porocarcinoma;Gallbladder Small Cell Neuroendocrine Carcinoma;clear cell sarcoma;Fallopian Tube Serous Adenocarcinoma;Cortisol-Producing Adrenal Cortex Adenoma;breast ductal carcinoma in situ;leukoplakia of tongue;BONE MARROW FAILURE SYNDROME 5;Breast Cancer;ADRENOCORTICAL CARCINOMA, HEREDITARY;OSTEOGENIC SARCOMA;Li-Fraumeni syndrome;Colorectal Cancer;BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 7;NASOPHARYNGEAL CARCINOMA;GLIOMA SUSCEPTIBILITY 1;PAPILLOMA OF CHOROID PLEXUS;Hepatocellular Carcinoma;Pancreatic Cancer"
XRCC4,XRCC4,"LIG4 SYNDROME;Microcephalic primordial dwarfism-insulin resistance syndrome;Primordial Dwarfism;SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION"
XRCC4_aug1,XRCC4,"LIG4 SYNDROME;Microcephalic primordial dwarfism-insulin resistance syndrome;Primordial Dwarfism;SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION"
XRCC4_aug2,XRCC4,"LIG4 SYNDROME;Microcephalic primordial dwarfism-insulin resistance syndrome;Primordial Dwarfism;SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION"
XRCC4_aug3,XRCC4,"LIG4 SYNDROME;Microcephalic primordial dwarfism-insulin resistance syndrome;Primordial Dwarfism;SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION"
XRCC4_aug4,XRCC4,"LIG4 SYNDROME;Microcephalic primordial dwarfism-insulin resistance syndrome;Primordial Dwarfism;SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION"
XRCC4_aug5,XRCC4,"LIG4 SYNDROME;Microcephalic primordial dwarfism-insulin resistance syndrome;Primordial Dwarfism;SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION"
XRCC4_aug6,XRCC4,"LIG4 SYNDROME;Microcephalic primordial dwarfism-insulin resistance syndrome;Primordial Dwarfism;SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION"
XRCC4_aug7,XRCC4,"LIG4 SYNDROME;Microcephalic primordial dwarfism-insulin resistance syndrome;Primordial Dwarfism;SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION"
XRCC4_aug8,XRCC4,"LIG4 SYNDROME;Microcephalic primordial dwarfism-insulin resistance syndrome;Primordial Dwarfism;SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION"
XRCC4_aug9,XRCC4,"LIG4 SYNDROME;Microcephalic primordial dwarfism-insulin resistance syndrome;Primordial Dwarfism;SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION"
B2M,B2M,"Burkitts lymphoma;Alveolar rhabdomyosarcoma;Colorectal Diffuse Large B-Cell Lymphoma;Primary Pulmonary Diffuse Large B-Cell Lymphoma;Uterine Carcinosarcoma;Laryngeal squamous cell carcinoma;pancreatic neuroendocrine tumor;adrenocortical adenoma;leiomyosarcoma;Hepatocellular Carcinoma;Spindle Cell Melanoma;pharyngeal squamous cell carcinoma;Atypical endometrial hyperplasia;soft tissue sarcoma;Ampulla of Vater Carcinoma;ovarian serous adenocarcinoma;Dedifferentiated liposarcoma;Merkel cell skin cancer;Anal Squamous Cell Carcinoma;Breast carcinoma;kidney neoplasm;colon carcinoma;cervical carcinoma;squamous cell lung carcinoma;Esophageal Squamous Cell Carcinoma;Hepatobiliary Neoplasm;urothelial carcinoma;Small Intestinal Tubulovillous Adenoma;small cell carcinoma;Melanoma;gastric adenocarcinoma;Thyroid Gland Undifferentiated (Anaplastic) Carcinoma;gastric intestinal type adenocarcinoma;cervical squamous cell carcinoma;colon adenocarcinoma;bladder transitional cell carcinoma;Clear cell renal carcinoma;Lung adenocarcinoma;T-cell acute lymphoblastic leukemia;Gastric Diffuse Large B-Cell Lymphoma;prostate adenocarcinoma;cutaneous melanoma;gastric carcinoma;Angioimmunoblastic T-cell lymphoma;Immunodeficiency by defective expression of MHC class I;Bladder Small Cell Neuroendocrine Carcinoma;Renal cell carcinoma;IMMUNODEFICIENCY 43;Central Nervous System Lymphoma;nasopharyngeal squamous cell carcinoma;HER2 positive breast carcinoma;Lung carcinoma;ND;Endometrial Endometrioid Adenocarcinoma;bile duct carcinoma;Hodgkins lymphoma;B-cell acute lymphoblastic leukemia;unspecified peripheral T-cell lymphoma;neoplasm of mature B-cells;Endometrial Clear Cell Adenocarcinoma;Papillary renal cell carcinoma;breast ductal adenocarcinoma;cecum adenocarcinoma;Small cell lung carcinoma;head and neck squamous cell carcinoma;Variant ABeta2M amyloidosis;vulvar intraepithelial neoplasia;Atypical Meningioma;nodular melanoma;Small Intestinal Diffuse Large B-Cell Lymphoma;Digestive System Carcinoma;MANTLE CELL LYMPHOMA;Duodenal Adenocarcinoma;prostate carcinoma;follicular dendritic cell sarcoma;small intestinal adenocarcinoma;colonic neoplasm;diffuse large B-cell lymphoma;lymphoid neoplasm;brain glioblastoma;rectal adenocarcinoma;non-small cell lung carcinoma;Esophageal adenocarcinoma;colorectal adenocarcinoma;Splenic Diffuse Large B-Cell Lymphoma;AMYLOIDOSIS, FAMILIAL VISCERAL;IMMUNODEFICIENCY 43;AMYLOIDOSIS, FAMILIAL VISCERAL;IMMUNODEFICIENCY 43;AMYLOIDOSIS, FAMILIAL VISCERAL"
B2M_aug1,B2M,"Burkitts lymphoma;Alveolar rhabdomyosarcoma;Colorectal Diffuse Large B-Cell Lymphoma;Primary Pulmonary Diffuse Large B-Cell Lymphoma;Uterine Carcinosarcoma;Laryngeal squamous cell carcinoma;pancreatic neuroendocrine tumor;adrenocortical adenoma;leiomyosarcoma;Hepatocellular Carcinoma;Spindle Cell Melanoma;pharyngeal squamous cell carcinoma;Atypical endometrial hyperplasia;soft tissue sarcoma;Ampulla of Vater Carcinoma;ovarian serous adenocarcinoma;Dedifferentiated liposarcoma;Merkel cell skin cancer;Anal Squamous Cell Carcinoma;Breast carcinoma;kidney neoplasm;colon carcinoma;cervical carcinoma;squamous cell lung carcinoma;Esophageal Squamous Cell Carcinoma;Hepatobiliary Neoplasm;urothelial carcinoma;Small Intestinal Tubulovillous Adenoma;small cell carcinoma;Melanoma;gastric adenocarcinoma;Thyroid Gland Undifferentiated (Anaplastic) Carcinoma;gastric intestinal type adenocarcinoma;cervical squamous cell carcinoma;colon adenocarcinoma;bladder transitional cell carcinoma;Clear cell renal carcinoma;Lung adenocarcinoma;T-cell acute lymphoblastic leukemia;Gastric Diffuse Large B-Cell Lymphoma;prostate adenocarcinoma;cutaneous melanoma;gastric carcinoma;Angioimmunoblastic T-cell lymphoma;Immunodeficiency by defective expression of MHC class I;Bladder Small Cell Neuroendocrine Carcinoma;Renal cell carcinoma;IMMUNODEFICIENCY 43;Central Nervous System Lymphoma;nasopharyngeal squamous cell carcinoma;HER2 positive breast carcinoma;Lung carcinoma;ND;Endometrial Endometrioid Adenocarcinoma;bile duct carcinoma;Hodgkins lymphoma;B-cell acute lymphoblastic leukemia;unspecified peripheral T-cell lymphoma;neoplasm of mature B-cells;Endometrial Clear Cell Adenocarcinoma;Papillary renal cell carcinoma;breast ductal adenocarcinoma;cecum adenocarcinoma;Small cell lung carcinoma;head and neck squamous cell carcinoma;Variant ABeta2M amyloidosis;vulvar intraepithelial neoplasia;Atypical Meningioma;nodular melanoma;Small Intestinal Diffuse Large B-Cell Lymphoma;Digestive System Carcinoma;MANTLE CELL LYMPHOMA;Duodenal Adenocarcinoma;prostate carcinoma;follicular dendritic cell sarcoma;small intestinal adenocarcinoma;colonic neoplasm;diffuse large B-cell lymphoma;lymphoid neoplasm;brain glioblastoma;rectal adenocarcinoma;non-small cell lung carcinoma;Esophageal adenocarcinoma;colorectal adenocarcinoma;Splenic Diffuse Large B-Cell Lymphoma;AMYLOIDOSIS, FAMILIAL VISCERAL;IMMUNODEFICIENCY 43;AMYLOIDOSIS, FAMILIAL VISCERAL;IMMUNODEFICIENCY 43;AMYLOIDOSIS, FAMILIAL VISCERAL"
B2M_aug2,B2M,"Burkitts lymphoma;Alveolar rhabdomyosarcoma;Colorectal Diffuse Large B-Cell Lymphoma;Primary Pulmonary Diffuse Large B-Cell Lymphoma;Uterine Carcinosarcoma;Laryngeal squamous cell carcinoma;pancreatic neuroendocrine tumor;adrenocortical adenoma;leiomyosarcoma;Hepatocellular Carcinoma;Spindle Cell Melanoma;pharyngeal squamous cell carcinoma;Atypical endometrial hyperplasia;soft tissue sarcoma;Ampulla of Vater Carcinoma;ovarian serous adenocarcinoma;Dedifferentiated liposarcoma;Merkel cell skin cancer;Anal Squamous Cell Carcinoma;Breast carcinoma;kidney neoplasm;colon carcinoma;cervical carcinoma;squamous cell lung carcinoma;Esophageal Squamous Cell Carcinoma;Hepatobiliary Neoplasm;urothelial carcinoma;Small Intestinal Tubulovillous Adenoma;small cell carcinoma;Melanoma;gastric adenocarcinoma;Thyroid Gland Undifferentiated (Anaplastic) Carcinoma;gastric intestinal type adenocarcinoma;cervical squamous cell carcinoma;colon adenocarcinoma;bladder transitional cell carcinoma;Clear cell renal carcinoma;Lung adenocarcinoma;T-cell acute lymphoblastic leukemia;Gastric Diffuse Large B-Cell Lymphoma;prostate adenocarcinoma;cutaneous melanoma;gastric carcinoma;Angioimmunoblastic T-cell lymphoma;Immunodeficiency by defective expression of MHC class I;Bladder Small Cell Neuroendocrine Carcinoma;Renal cell carcinoma;IMMUNODEFICIENCY 43;Central Nervous System Lymphoma;nasopharyngeal squamous cell carcinoma;HER2 positive breast carcinoma;Lung carcinoma;ND;Endometrial Endometrioid Adenocarcinoma;bile duct carcinoma;Hodgkins lymphoma;B-cell acute lymphoblastic leukemia;unspecified peripheral T-cell lymphoma;neoplasm of mature B-cells;Endometrial Clear Cell Adenocarcinoma;Papillary renal cell carcinoma;breast ductal adenocarcinoma;cecum adenocarcinoma;Small cell lung carcinoma;head and neck squamous cell carcinoma;Variant ABeta2M amyloidosis;vulvar intraepithelial neoplasia;Atypical Meningioma;nodular melanoma;Small Intestinal Diffuse Large B-Cell Lymphoma;Digestive System Carcinoma;MANTLE CELL LYMPHOMA;Duodenal Adenocarcinoma;prostate carcinoma;follicular dendritic cell sarcoma;small intestinal adenocarcinoma;colonic neoplasm;diffuse large B-cell lymphoma;lymphoid neoplasm;brain glioblastoma;rectal adenocarcinoma;non-small cell lung carcinoma;Esophageal adenocarcinoma;colorectal adenocarcinoma;Splenic Diffuse Large B-Cell Lymphoma;AMYLOIDOSIS, FAMILIAL VISCERAL;IMMUNODEFICIENCY 43;AMYLOIDOSIS, FAMILIAL VISCERAL;IMMUNODEFICIENCY 43;AMYLOIDOSIS, FAMILIAL VISCERAL"
B2M_aug3,B2M,"Burkitts lymphoma;Alveolar rhabdomyosarcoma;Colorectal Diffuse Large B-Cell Lymphoma;Primary Pulmonary Diffuse Large B-Cell Lymphoma;Uterine Carcinosarcoma;Laryngeal squamous cell carcinoma;pancreatic neuroendocrine tumor;adrenocortical adenoma;leiomyosarcoma;Hepatocellular Carcinoma;Spindle Cell Melanoma;pharyngeal squamous cell carcinoma;Atypical endometrial hyperplasia;soft tissue sarcoma;Ampulla of Vater Carcinoma;ovarian serous adenocarcinoma;Dedifferentiated liposarcoma;Merkel cell skin cancer;Anal Squamous Cell Carcinoma;Breast carcinoma;kidney neoplasm;colon carcinoma;cervical carcinoma;squamous cell lung carcinoma;Esophageal Squamous Cell Carcinoma;Hepatobiliary Neoplasm;urothelial carcinoma;Small Intestinal Tubulovillous Adenoma;small cell carcinoma;Melanoma;gastric adenocarcinoma;Thyroid Gland Undifferentiated (Anaplastic) Carcinoma;gastric intestinal type adenocarcinoma;cervical squamous cell carcinoma;colon adenocarcinoma;bladder transitional cell carcinoma;Clear cell renal carcinoma;Lung adenocarcinoma;T-cell acute lymphoblastic leukemia;Gastric Diffuse Large B-Cell Lymphoma;prostate adenocarcinoma;cutaneous melanoma;gastric carcinoma;Angioimmunoblastic T-cell lymphoma;Immunodeficiency by defective expression of MHC class I;Bladder Small Cell Neuroendocrine Carcinoma;Renal cell carcinoma;IMMUNODEFICIENCY 43;Central Nervous System Lymphoma;nasopharyngeal squamous cell carcinoma;HER2 positive breast carcinoma;Lung carcinoma;ND;Endometrial Endometrioid Adenocarcinoma;bile duct carcinoma;Hodgkins lymphoma;B-cell acute lymphoblastic leukemia;unspecified peripheral T-cell lymphoma;neoplasm of mature B-cells;Endometrial Clear Cell Adenocarcinoma;Papillary renal cell carcinoma;breast ductal adenocarcinoma;cecum adenocarcinoma;Small cell lung carcinoma;head and neck squamous cell carcinoma;Variant ABeta2M amyloidosis;vulvar intraepithelial neoplasia;Atypical Meningioma;nodular melanoma;Small Intestinal Diffuse Large B-Cell Lymphoma;Digestive System Carcinoma;MANTLE CELL LYMPHOMA;Duodenal Adenocarcinoma;prostate carcinoma;follicular dendritic cell sarcoma;small intestinal adenocarcinoma;colonic neoplasm;diffuse large B-cell lymphoma;lymphoid neoplasm;brain glioblastoma;rectal adenocarcinoma;non-small cell lung carcinoma;Esophageal adenocarcinoma;colorectal adenocarcinoma;Splenic Diffuse Large B-Cell Lymphoma;AMYLOIDOSIS, FAMILIAL VISCERAL;IMMUNODEFICIENCY 43;AMYLOIDOSIS, FAMILIAL VISCERAL;IMMUNODEFICIENCY 43;AMYLOIDOSIS, FAMILIAL VISCERAL"
B2M_aug4,B2M,"Burkitts lymphoma;Alveolar rhabdomyosarcoma;Colorectal Diffuse Large B-Cell Lymphoma;Primary Pulmonary Diffuse Large B-Cell Lymphoma;Uterine Carcinosarcoma;Laryngeal squamous cell carcinoma;pancreatic neuroendocrine tumor;adrenocortical adenoma;leiomyosarcoma;Hepatocellular Carcinoma;Spindle Cell Melanoma;pharyngeal squamous cell carcinoma;Atypical endometrial hyperplasia;soft tissue sarcoma;Ampulla of Vater Carcinoma;ovarian serous adenocarcinoma;Dedifferentiated liposarcoma;Merkel cell skin cancer;Anal Squamous Cell Carcinoma;Breast carcinoma;kidney neoplasm;colon carcinoma;cervical carcinoma;squamous cell lung carcinoma;Esophageal Squamous Cell Carcinoma;Hepatobiliary Neoplasm;urothelial carcinoma;Small Intestinal Tubulovillous Adenoma;small cell carcinoma;Melanoma;gastric adenocarcinoma;Thyroid Gland Undifferentiated (Anaplastic) Carcinoma;gastric intestinal type adenocarcinoma;cervical squamous cell carcinoma;colon adenocarcinoma;bladder transitional cell carcinoma;Clear cell renal carcinoma;Lung adenocarcinoma;T-cell acute lymphoblastic leukemia;Gastric Diffuse Large B-Cell Lymphoma;prostate adenocarcinoma;cutaneous melanoma;gastric carcinoma;Angioimmunoblastic T-cell lymphoma;Immunodeficiency by defective expression of MHC class I;Bladder Small Cell Neuroendocrine Carcinoma;Renal cell carcinoma;IMMUNODEFICIENCY 43;Central Nervous System Lymphoma;nasopharyngeal squamous cell carcinoma;HER2 positive breast carcinoma;Lung carcinoma;ND;Endometrial Endometrioid Adenocarcinoma;bile duct carcinoma;Hodgkins lymphoma;B-cell acute lymphoblastic leukemia;unspecified peripheral T-cell lymphoma;neoplasm of mature B-cells;Endometrial Clear Cell Adenocarcinoma;Papillary renal cell carcinoma;breast ductal adenocarcinoma;cecum adenocarcinoma;Small cell lung carcinoma;head and neck squamous cell carcinoma;Variant ABeta2M amyloidosis;vulvar intraepithelial neoplasia;Atypical Meningioma;nodular melanoma;Small Intestinal Diffuse Large B-Cell Lymphoma;Digestive System Carcinoma;MANTLE CELL LYMPHOMA;Duodenal Adenocarcinoma;prostate carcinoma;follicular dendritic cell sarcoma;small intestinal adenocarcinoma;colonic neoplasm;diffuse large B-cell lymphoma;lymphoid neoplasm;brain glioblastoma;rectal adenocarcinoma;non-small cell lung carcinoma;Esophageal adenocarcinoma;colorectal adenocarcinoma;Splenic Diffuse Large B-Cell Lymphoma;AMYLOIDOSIS, FAMILIAL VISCERAL;IMMUNODEFICIENCY 43;AMYLOIDOSIS, FAMILIAL VISCERAL;IMMUNODEFICIENCY 43;AMYLOIDOSIS, FAMILIAL VISCERAL"
B2M_aug5,B2M,"Burkitts lymphoma;Alveolar rhabdomyosarcoma;Colorectal Diffuse Large B-Cell Lymphoma;Primary Pulmonary Diffuse Large B-Cell Lymphoma;Uterine Carcinosarcoma;Laryngeal squamous cell carcinoma;pancreatic neuroendocrine tumor;adrenocortical adenoma;leiomyosarcoma;Hepatocellular Carcinoma;Spindle Cell Melanoma;pharyngeal squamous cell carcinoma;Atypical endometrial hyperplasia;soft tissue sarcoma;Ampulla of Vater Carcinoma;ovarian serous adenocarcinoma;Dedifferentiated liposarcoma;Merkel cell skin cancer;Anal Squamous Cell Carcinoma;Breast carcinoma;kidney neoplasm;colon carcinoma;cervical carcinoma;squamous cell lung carcinoma;Esophageal Squamous Cell Carcinoma;Hepatobiliary Neoplasm;urothelial carcinoma;Small Intestinal Tubulovillous Adenoma;small cell carcinoma;Melanoma;gastric adenocarcinoma;Thyroid Gland Undifferentiated (Anaplastic) Carcinoma;gastric intestinal type adenocarcinoma;cervical squamous cell carcinoma;colon adenocarcinoma;bladder transitional cell carcinoma;Clear cell renal carcinoma;Lung adenocarcinoma;T-cell acute lymphoblastic leukemia;Gastric Diffuse Large B-Cell Lymphoma;prostate adenocarcinoma;cutaneous melanoma;gastric carcinoma;Angioimmunoblastic T-cell lymphoma;Immunodeficiency by defective expression of MHC class I;Bladder Small Cell Neuroendocrine Carcinoma;Renal cell carcinoma;IMMUNODEFICIENCY 43;Central Nervous System Lymphoma;nasopharyngeal squamous cell carcinoma;HER2 positive breast carcinoma;Lung carcinoma;ND;Endometrial Endometrioid Adenocarcinoma;bile duct carcinoma;Hodgkins lymphoma;B-cell acute lymphoblastic leukemia;unspecified peripheral T-cell lymphoma;neoplasm of mature B-cells;Endometrial Clear Cell Adenocarcinoma;Papillary renal cell carcinoma;breast ductal adenocarcinoma;cecum adenocarcinoma;Small cell lung carcinoma;head and neck squamous cell carcinoma;Variant ABeta2M amyloidosis;vulvar intraepithelial neoplasia;Atypical Meningioma;nodular melanoma;Small Intestinal Diffuse Large B-Cell Lymphoma;Digestive System Carcinoma;MANTLE CELL LYMPHOMA;Duodenal Adenocarcinoma;prostate carcinoma;follicular dendritic cell sarcoma;small intestinal adenocarcinoma;colonic neoplasm;diffuse large B-cell lymphoma;lymphoid neoplasm;brain glioblastoma;rectal adenocarcinoma;non-small cell lung carcinoma;Esophageal adenocarcinoma;colorectal adenocarcinoma;Splenic Diffuse Large B-Cell Lymphoma;AMYLOIDOSIS, FAMILIAL VISCERAL;IMMUNODEFICIENCY 43;AMYLOIDOSIS, FAMILIAL VISCERAL;IMMUNODEFICIENCY 43;AMYLOIDOSIS, FAMILIAL VISCERAL"
B2M_aug6,B2M,"Burkitts lymphoma;Alveolar rhabdomyosarcoma;Colorectal Diffuse Large B-Cell Lymphoma;Primary Pulmonary Diffuse Large B-Cell Lymphoma;Uterine Carcinosarcoma;Laryngeal squamous cell carcinoma;pancreatic neuroendocrine tumor;adrenocortical adenoma;leiomyosarcoma;Hepatocellular Carcinoma;Spindle Cell Melanoma;pharyngeal squamous cell carcinoma;Atypical endometrial hyperplasia;soft tissue sarcoma;Ampulla of Vater Carcinoma;ovarian serous adenocarcinoma;Dedifferentiated liposarcoma;Merkel cell skin cancer;Anal Squamous Cell Carcinoma;Breast carcinoma;kidney neoplasm;colon carcinoma;cervical carcinoma;squamous cell lung carcinoma;Esophageal Squamous Cell Carcinoma;Hepatobiliary Neoplasm;urothelial carcinoma;Small Intestinal Tubulovillous Adenoma;small cell carcinoma;Melanoma;gastric adenocarcinoma;Thyroid Gland Undifferentiated (Anaplastic) Carcinoma;gastric intestinal type adenocarcinoma;cervical squamous cell carcinoma;colon adenocarcinoma;bladder transitional cell carcinoma;Clear cell renal carcinoma;Lung adenocarcinoma;T-cell acute lymphoblastic leukemia;Gastric Diffuse Large B-Cell Lymphoma;prostate adenocarcinoma;cutaneous melanoma;gastric carcinoma;Angioimmunoblastic T-cell lymphoma;Immunodeficiency by defective expression of MHC class I;Bladder Small Cell Neuroendocrine Carcinoma;Renal cell carcinoma;IMMUNODEFICIENCY 43;Central Nervous System Lymphoma;nasopharyngeal squamous cell carcinoma;HER2 positive breast carcinoma;Lung carcinoma;ND;Endometrial Endometrioid Adenocarcinoma;bile duct carcinoma;Hodgkins lymphoma;B-cell acute lymphoblastic leukemia;unspecified peripheral T-cell lymphoma;neoplasm of mature B-cells;Endometrial Clear Cell Adenocarcinoma;Papillary renal cell carcinoma;breast ductal adenocarcinoma;cecum adenocarcinoma;Small cell lung carcinoma;head and neck squamous cell carcinoma;Variant ABeta2M amyloidosis;vulvar intraepithelial neoplasia;Atypical Meningioma;nodular melanoma;Small Intestinal Diffuse Large B-Cell Lymphoma;Digestive System Carcinoma;MANTLE CELL LYMPHOMA;Duodenal Adenocarcinoma;prostate carcinoma;follicular dendritic cell sarcoma;small intestinal adenocarcinoma;colonic neoplasm;diffuse large B-cell lymphoma;lymphoid neoplasm;brain glioblastoma;rectal adenocarcinoma;non-small cell lung carcinoma;Esophageal adenocarcinoma;colorectal adenocarcinoma;Splenic Diffuse Large B-Cell Lymphoma;AMYLOIDOSIS, FAMILIAL VISCERAL;IMMUNODEFICIENCY 43;AMYLOIDOSIS, FAMILIAL VISCERAL;IMMUNODEFICIENCY 43;AMYLOIDOSIS, FAMILIAL VISCERAL"
B2M_aug7,B2M,"Burkitts lymphoma;Alveolar rhabdomyosarcoma;Colorectal Diffuse Large B-Cell Lymphoma;Primary Pulmonary Diffuse Large B-Cell Lymphoma;Uterine Carcinosarcoma;Laryngeal squamous cell carcinoma;pancreatic neuroendocrine tumor;adrenocortical adenoma;leiomyosarcoma;Hepatocellular Carcinoma;Spindle Cell Melanoma;pharyngeal squamous cell carcinoma;Atypical endometrial hyperplasia;soft tissue sarcoma;Ampulla of Vater Carcinoma;ovarian serous adenocarcinoma;Dedifferentiated liposarcoma;Merkel cell skin cancer;Anal Squamous Cell Carcinoma;Breast carcinoma;kidney neoplasm;colon carcinoma;cervical carcinoma;squamous cell lung carcinoma;Esophageal Squamous Cell Carcinoma;Hepatobiliary Neoplasm;urothelial carcinoma;Small Intestinal Tubulovillous Adenoma;small cell carcinoma;Melanoma;gastric adenocarcinoma;Thyroid Gland Undifferentiated (Anaplastic) Carcinoma;gastric intestinal type adenocarcinoma;cervical squamous cell carcinoma;colon adenocarcinoma;bladder transitional cell carcinoma;Clear cell renal carcinoma;Lung adenocarcinoma;T-cell acute lymphoblastic leukemia;Gastric Diffuse Large B-Cell Lymphoma;prostate adenocarcinoma;cutaneous melanoma;gastric carcinoma;Angioimmunoblastic T-cell lymphoma;Immunodeficiency by defective expression of MHC class I;Bladder Small Cell Neuroendocrine Carcinoma;Renal cell carcinoma;IMMUNODEFICIENCY 43;Central Nervous System Lymphoma;nasopharyngeal squamous cell carcinoma;HER2 positive breast carcinoma;Lung carcinoma;ND;Endometrial Endometrioid Adenocarcinoma;bile duct carcinoma;Hodgkins lymphoma;B-cell acute lymphoblastic leukemia;unspecified peripheral T-cell lymphoma;neoplasm of mature B-cells;Endometrial Clear Cell Adenocarcinoma;Papillary renal cell carcinoma;breast ductal adenocarcinoma;cecum adenocarcinoma;Small cell lung carcinoma;head and neck squamous cell carcinoma;Variant ABeta2M amyloidosis;vulvar intraepithelial neoplasia;Atypical Meningioma;nodular melanoma;Small Intestinal Diffuse Large B-Cell Lymphoma;Digestive System Carcinoma;MANTLE CELL LYMPHOMA;Duodenal Adenocarcinoma;prostate carcinoma;follicular dendritic cell sarcoma;small intestinal adenocarcinoma;colonic neoplasm;diffuse large B-cell lymphoma;lymphoid neoplasm;brain glioblastoma;rectal adenocarcinoma;non-small cell lung carcinoma;Esophageal adenocarcinoma;colorectal adenocarcinoma;Splenic Diffuse Large B-Cell Lymphoma;AMYLOIDOSIS, FAMILIAL VISCERAL;IMMUNODEFICIENCY 43;AMYLOIDOSIS, FAMILIAL VISCERAL;IMMUNODEFICIENCY 43;AMYLOIDOSIS, FAMILIAL VISCERAL"
B2M_aug8,B2M,"Burkitts lymphoma;Alveolar rhabdomyosarcoma;Colorectal Diffuse Large B-Cell Lymphoma;Primary Pulmonary Diffuse Large B-Cell Lymphoma;Uterine Carcinosarcoma;Laryngeal squamous cell carcinoma;pancreatic neuroendocrine tumor;adrenocortical adenoma;leiomyosarcoma;Hepatocellular Carcinoma;Spindle Cell Melanoma;pharyngeal squamous cell carcinoma;Atypical endometrial hyperplasia;soft tissue sarcoma;Ampulla of Vater Carcinoma;ovarian serous adenocarcinoma;Dedifferentiated liposarcoma;Merkel cell skin cancer;Anal Squamous Cell Carcinoma;Breast carcinoma;kidney neoplasm;colon carcinoma;cervical carcinoma;squamous cell lung carcinoma;Esophageal Squamous Cell Carcinoma;Hepatobiliary Neoplasm;urothelial carcinoma;Small Intestinal Tubulovillous Adenoma;small cell carcinoma;Melanoma;gastric adenocarcinoma;Thyroid Gland Undifferentiated (Anaplastic) Carcinoma;gastric intestinal type adenocarcinoma;cervical squamous cell carcinoma;colon adenocarcinoma;bladder transitional cell carcinoma;Clear cell renal carcinoma;Lung adenocarcinoma;T-cell acute lymphoblastic leukemia;Gastric Diffuse Large B-Cell Lymphoma;prostate adenocarcinoma;cutaneous melanoma;gastric carcinoma;Angioimmunoblastic T-cell lymphoma;Immunodeficiency by defective expression of MHC class I;Bladder Small Cell Neuroendocrine Carcinoma;Renal cell carcinoma;IMMUNODEFICIENCY 43;Central Nervous System Lymphoma;nasopharyngeal squamous cell carcinoma;HER2 positive breast carcinoma;Lung carcinoma;ND;Endometrial Endometrioid Adenocarcinoma;bile duct carcinoma;Hodgkins lymphoma;B-cell acute lymphoblastic leukemia;unspecified peripheral T-cell lymphoma;neoplasm of mature B-cells;Endometrial Clear Cell Adenocarcinoma;Papillary renal cell carcinoma;breast ductal adenocarcinoma;cecum adenocarcinoma;Small cell lung carcinoma;head and neck squamous cell carcinoma;Variant ABeta2M amyloidosis;vulvar intraepithelial neoplasia;Atypical Meningioma;nodular melanoma;Small Intestinal Diffuse Large B-Cell Lymphoma;Digestive System Carcinoma;MANTLE CELL LYMPHOMA;Duodenal Adenocarcinoma;prostate carcinoma;follicular dendritic cell sarcoma;small intestinal adenocarcinoma;colonic neoplasm;diffuse large B-cell lymphoma;lymphoid neoplasm;brain glioblastoma;rectal adenocarcinoma;non-small cell lung carcinoma;Esophageal adenocarcinoma;colorectal adenocarcinoma;Splenic Diffuse Large B-Cell Lymphoma;AMYLOIDOSIS, FAMILIAL VISCERAL;IMMUNODEFICIENCY 43;AMYLOIDOSIS, FAMILIAL VISCERAL;IMMUNODEFICIENCY 43;AMYLOIDOSIS, FAMILIAL VISCERAL"
B2M_aug9,B2M,"Burkitts lymphoma;Alveolar rhabdomyosarcoma;Colorectal Diffuse Large B-Cell Lymphoma;Primary Pulmonary Diffuse Large B-Cell Lymphoma;Uterine Carcinosarcoma;Laryngeal squamous cell carcinoma;pancreatic neuroendocrine tumor;adrenocortical adenoma;leiomyosarcoma;Hepatocellular Carcinoma;Spindle Cell Melanoma;pharyngeal squamous cell carcinoma;Atypical endometrial hyperplasia;soft tissue sarcoma;Ampulla of Vater Carcinoma;ovarian serous adenocarcinoma;Dedifferentiated liposarcoma;Merkel cell skin cancer;Anal Squamous Cell Carcinoma;Breast carcinoma;kidney neoplasm;colon carcinoma;cervical carcinoma;squamous cell lung carcinoma;Esophageal Squamous Cell Carcinoma;Hepatobiliary Neoplasm;urothelial carcinoma;Small Intestinal Tubulovillous Adenoma;small cell carcinoma;Melanoma;gastric adenocarcinoma;Thyroid Gland Undifferentiated (Anaplastic) Carcinoma;gastric intestinal type adenocarcinoma;cervical squamous cell carcinoma;colon adenocarcinoma;bladder transitional cell carcinoma;Clear cell renal carcinoma;Lung adenocarcinoma;T-cell acute lymphoblastic leukemia;Gastric Diffuse Large B-Cell Lymphoma;prostate adenocarcinoma;cutaneous melanoma;gastric carcinoma;Angioimmunoblastic T-cell lymphoma;Immunodeficiency by defective expression of MHC class I;Bladder Small Cell Neuroendocrine Carcinoma;Renal cell carcinoma;IMMUNODEFICIENCY 43;Central Nervous System Lymphoma;nasopharyngeal squamous cell carcinoma;HER2 positive breast carcinoma;Lung carcinoma;ND;Endometrial Endometrioid Adenocarcinoma;bile duct carcinoma;Hodgkins lymphoma;B-cell acute lymphoblastic leukemia;unspecified peripheral T-cell lymphoma;neoplasm of mature B-cells;Endometrial Clear Cell Adenocarcinoma;Papillary renal cell carcinoma;breast ductal adenocarcinoma;cecum adenocarcinoma;Small cell lung carcinoma;head and neck squamous cell carcinoma;Variant ABeta2M amyloidosis;vulvar intraepithelial neoplasia;Atypical Meningioma;nodular melanoma;Small Intestinal Diffuse Large B-Cell Lymphoma;Digestive System Carcinoma;MANTLE CELL LYMPHOMA;Duodenal Adenocarcinoma;prostate carcinoma;follicular dendritic cell sarcoma;small intestinal adenocarcinoma;colonic neoplasm;diffuse large B-cell lymphoma;lymphoid neoplasm;brain glioblastoma;rectal adenocarcinoma;non-small cell lung carcinoma;Esophageal adenocarcinoma;colorectal adenocarcinoma;Splenic Diffuse Large B-Cell Lymphoma;AMYLOIDOSIS, FAMILIAL VISCERAL;IMMUNODEFICIENCY 43;AMYLOIDOSIS, FAMILIAL VISCERAL;IMMUNODEFICIENCY 43;AMYLOIDOSIS, FAMILIAL VISCERAL"
ACTB,ACTB,"BARAITSER-WINTER SYNDROME 1;Thrombocytopenia 8, with dysmorphic features and developmental delay;DYSTONIA-DEAFNESS SYNDROME 1;BARAITSER-WINTER SYNDROME 1;ACTB Haploinsufficiency syndrome;Developmental malformations-deafness-dystonia syndrome;Baraitser-Winter syndrome;Baraitser-Winter cerebrofrontofacial syndrome;Becker nevus syndrome;Becker nevus syndrome;Becker nevus syndrome;Thrombocytopenia 8, with dysmorphic features and developmental delay;BARAITSER-WINTER SYNDROME 1;DYSTONIA-DEAFNESS SYNDROME 1"
ACTB_aug1,ACTB,"BARAITSER-WINTER SYNDROME 1;Thrombocytopenia 8, with dysmorphic features and developmental delay;DYSTONIA-DEAFNESS SYNDROME 1;BARAITSER-WINTER SYNDROME 1;ACTB Haploinsufficiency syndrome;Developmental malformations-deafness-dystonia syndrome;Baraitser-Winter syndrome;Baraitser-Winter cerebrofrontofacial syndrome;Becker nevus syndrome;Becker nevus syndrome;Becker nevus syndrome;Thrombocytopenia 8, with dysmorphic features and developmental delay;BARAITSER-WINTER SYNDROME 1;DYSTONIA-DEAFNESS SYNDROME 1"
ACTB_aug2,ACTB,"BARAITSER-WINTER SYNDROME 1;Thrombocytopenia 8, with dysmorphic features and developmental delay;DYSTONIA-DEAFNESS SYNDROME 1;BARAITSER-WINTER SYNDROME 1;ACTB Haploinsufficiency syndrome;Developmental malformations-deafness-dystonia syndrome;Baraitser-Winter syndrome;Baraitser-Winter cerebrofrontofacial syndrome;Becker nevus syndrome;Becker nevus syndrome;Becker nevus syndrome;Thrombocytopenia 8, with dysmorphic features and developmental delay;BARAITSER-WINTER SYNDROME 1;DYSTONIA-DEAFNESS SYNDROME 1"
ACTB_aug3,ACTB,"BARAITSER-WINTER SYNDROME 1;Thrombocytopenia 8, with dysmorphic features and developmental delay;DYSTONIA-DEAFNESS SYNDROME 1;BARAITSER-WINTER SYNDROME 1;ACTB Haploinsufficiency syndrome;Developmental malformations-deafness-dystonia syndrome;Baraitser-Winter syndrome;Baraitser-Winter cerebrofrontofacial syndrome;Becker nevus syndrome;Becker nevus syndrome;Becker nevus syndrome;Thrombocytopenia 8, with dysmorphic features and developmental delay;BARAITSER-WINTER SYNDROME 1;DYSTONIA-DEAFNESS SYNDROME 1"
ACTB_aug4,ACTB,"BARAITSER-WINTER SYNDROME 1;Thrombocytopenia 8, with dysmorphic features and developmental delay;DYSTONIA-DEAFNESS SYNDROME 1;BARAITSER-WINTER SYNDROME 1;ACTB Haploinsufficiency syndrome;Developmental malformations-deafness-dystonia syndrome;Baraitser-Winter syndrome;Baraitser-Winter cerebrofrontofacial syndrome;Becker nevus syndrome;Becker nevus syndrome;Becker nevus syndrome;Thrombocytopenia 8, with dysmorphic features and developmental delay;BARAITSER-WINTER SYNDROME 1;DYSTONIA-DEAFNESS SYNDROME 1"
ACTB_aug5,ACTB,"BARAITSER-WINTER SYNDROME 1;Thrombocytopenia 8, with dysmorphic features and developmental delay;DYSTONIA-DEAFNESS SYNDROME 1;BARAITSER-WINTER SYNDROME 1;ACTB Haploinsufficiency syndrome;Developmental malformations-deafness-dystonia syndrome;Baraitser-Winter syndrome;Baraitser-Winter cerebrofrontofacial syndrome;Becker nevus syndrome;Becker nevus syndrome;Becker nevus syndrome;Thrombocytopenia 8, with dysmorphic features and developmental delay;BARAITSER-WINTER SYNDROME 1;DYSTONIA-DEAFNESS SYNDROME 1"
ACTB_aug6,ACTB,"BARAITSER-WINTER SYNDROME 1;Thrombocytopenia 8, with dysmorphic features and developmental delay;DYSTONIA-DEAFNESS SYNDROME 1;BARAITSER-WINTER SYNDROME 1;ACTB Haploinsufficiency syndrome;Developmental malformations-deafness-dystonia syndrome;Baraitser-Winter syndrome;Baraitser-Winter cerebrofrontofacial syndrome;Becker nevus syndrome;Becker nevus syndrome;Becker nevus syndrome;Thrombocytopenia 8, with dysmorphic features and developmental delay;BARAITSER-WINTER SYNDROME 1;DYSTONIA-DEAFNESS SYNDROME 1"
ACTB_aug7,ACTB,"BARAITSER-WINTER SYNDROME 1;Thrombocytopenia 8, with dysmorphic features and developmental delay;DYSTONIA-DEAFNESS SYNDROME 1;BARAITSER-WINTER SYNDROME 1;ACTB Haploinsufficiency syndrome;Developmental malformations-deafness-dystonia syndrome;Baraitser-Winter syndrome;Baraitser-Winter cerebrofrontofacial syndrome;Becker nevus syndrome;Becker nevus syndrome;Becker nevus syndrome;Thrombocytopenia 8, with dysmorphic features and developmental delay;BARAITSER-WINTER SYNDROME 1;DYSTONIA-DEAFNESS SYNDROME 1"
ACTB_aug8,ACTB,"BARAITSER-WINTER SYNDROME 1;Thrombocytopenia 8, with dysmorphic features and developmental delay;DYSTONIA-DEAFNESS SYNDROME 1;BARAITSER-WINTER SYNDROME 1;ACTB Haploinsufficiency syndrome;Developmental malformations-deafness-dystonia syndrome;Baraitser-Winter syndrome;Baraitser-Winter cerebrofrontofacial syndrome;Becker nevus syndrome;Becker nevus syndrome;Becker nevus syndrome;Thrombocytopenia 8, with dysmorphic features and developmental delay;BARAITSER-WINTER SYNDROME 1;DYSTONIA-DEAFNESS SYNDROME 1"
ACTB_aug9,ACTB,"BARAITSER-WINTER SYNDROME 1;Thrombocytopenia 8, with dysmorphic features and developmental delay;DYSTONIA-DEAFNESS SYNDROME 1;BARAITSER-WINTER SYNDROME 1;ACTB Haploinsufficiency syndrome;Developmental malformations-deafness-dystonia syndrome;Baraitser-Winter syndrome;Baraitser-Winter cerebrofrontofacial syndrome;Becker nevus syndrome;Becker nevus syndrome;Becker nevus syndrome;Thrombocytopenia 8, with dysmorphic features and developmental delay;BARAITSER-WINTER SYNDROME 1;DYSTONIA-DEAFNESS SYNDROME 1"
TBP,TBP,"Spinocerebellar ataxia type 17;Parkinson disease, late-onset;SPINOCEREBELLAR ATAXIA 17"
TBP_aug1,TBP,"Spinocerebellar ataxia type 17;Parkinson disease, late-onset;SPINOCEREBELLAR ATAXIA 17"
TBP_aug2,TBP,"Spinocerebellar ataxia type 17;Parkinson disease, late-onset;SPINOCEREBELLAR ATAXIA 17"
TBP_aug3,TBP,"Spinocerebellar ataxia type 17;Parkinson disease, late-onset;SPINOCEREBELLAR ATAXIA 17"
TBP_aug4,TBP,"Spinocerebellar ataxia type 17;Parkinson disease, late-onset;SPINOCEREBELLAR ATAXIA 17"
TBP_aug5,TBP,"Spinocerebellar ataxia type 17;Parkinson disease, late-onset;SPINOCEREBELLAR ATAXIA 17"
TBP_aug6,TBP,"Spinocerebellar ataxia type 17;Parkinson disease, late-onset;SPINOCEREBELLAR ATAXIA 17"
TBP_aug7,TBP,"Spinocerebellar ataxia type 17;Parkinson disease, late-onset;SPINOCEREBELLAR ATAXIA 17"
TBP_aug8,TBP,"Spinocerebellar ataxia type 17;Parkinson disease, late-onset;SPINOCEREBELLAR ATAXIA 17"
TBP_aug9,TBP,"Spinocerebellar ataxia type 17;Parkinson disease, late-onset;SPINOCEREBELLAR ATAXIA 17"
TUBB,TUBB,"Cortical dysplasia, complex, with other brain malformations 5;Cortical dysplasia, complex, with other brain malformations 5;SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1;Circumferential Skin Creases Kunze Type;Cortical dysplasia, complex, with other brain malformations 6;Cortical dysplasia, complex, with other brain malformations 6;Multiple benign circumferential skin creases on limbs;Cortical dysplasia, complex, with other brain malformations 6;Circumferential Skin Creases Kunze Type;Cortical dysplasia, complex, with other brain malformations 6;SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1;SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1;Cortical dysplasia, complex, with other brain malformations 6;Circumferential Skin Creases Kunze Type;Cortical dysplasia, complex, with other brain malformations 6;Cortical dysplasia, complex, with other brain malformations 6;Circumferential Skin Creases Kunze Type;Cortical dysplasia, complex, with other brain malformations 6;SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1;Cortical dysplasia, complex, with other brain malformations 6;Circumferential Skin Creases Kunze Type;Cortical dysplasia, complex, with other brain malformations 6;SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1;Cortical dysplasia, complex, with other brain malformations 6;Cortical dysplasia, complex, with other brain malformations 6;Circumferential Skin Creases Kunze Type;SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1;Cortical dysplasia, complex, with other brain malformations 6;Cortical dysplasia, complex, with other brain malformations 6;Circumferential Skin Creases Kunze Type;SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1;SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1;Cortical dysplasia, complex, with other brain malformations 6;Cortical dysplasia, complex, with other brain malformations 6;Circumferential Skin Creases Kunze Type"
TUBB_aug1,TUBB,"Cortical dysplasia, complex, with other brain malformations 5;Cortical dysplasia, complex, with other brain malformations 5;SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1;Circumferential Skin Creases Kunze Type;Cortical dysplasia, complex, with other brain malformations 6;Cortical dysplasia, complex, with other brain malformations 6;Multiple benign circumferential skin creases on limbs;Cortical dysplasia, complex, with other brain malformations 6;Circumferential Skin Creases Kunze Type;Cortical dysplasia, complex, with other brain malformations 6;SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1;SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1;Cortical dysplasia, complex, with other brain malformations 6;Circumferential Skin Creases Kunze Type;Cortical dysplasia, complex, with other brain malformations 6;Cortical dysplasia, complex, with other brain malformations 6;Circumferential Skin Creases Kunze Type;Cortical dysplasia, complex, with other brain malformations 6;SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1;Cortical dysplasia, complex, with other brain malformations 6;Circumferential Skin Creases Kunze Type;Cortical dysplasia, complex, with other brain malformations 6;SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1;Cortical dysplasia, complex, with other brain malformations 6;Cortical dysplasia, complex, with other brain malformations 6;Circumferential Skin Creases Kunze Type;SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1;Cortical dysplasia, complex, with other brain malformations 6;Cortical dysplasia, complex, with other brain malformations 6;Circumferential Skin Creases Kunze Type;SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1;SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1;Cortical dysplasia, complex, with other brain malformations 6;Cortical dysplasia, complex, with other brain malformations 6;Circumferential Skin Creases Kunze Type"
TUBB_aug2,TUBB,"Cortical dysplasia, complex, with other brain malformations 5;Cortical dysplasia, complex, with other brain malformations 5;SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1;Circumferential Skin Creases Kunze Type;Cortical dysplasia, complex, with other brain malformations 6;Cortical dysplasia, complex, with other brain malformations 6;Multiple benign circumferential skin creases on limbs;Cortical dysplasia, complex, with other brain malformations 6;Circumferential Skin Creases Kunze Type;Cortical dysplasia, complex, with other brain malformations 6;SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1;SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1;Cortical dysplasia, complex, with other brain malformations 6;Circumferential Skin Creases Kunze Type;Cortical dysplasia, complex, with other brain malformations 6;Cortical dysplasia, complex, with other brain malformations 6;Circumferential Skin Creases Kunze Type;Cortical dysplasia, complex, with other brain malformations 6;SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1;Cortical dysplasia, complex, with other brain malformations 6;Circumferential Skin Creases Kunze Type;Cortical dysplasia, complex, with other brain malformations 6;SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1;Cortical dysplasia, complex, with other brain malformations 6;Cortical dysplasia, complex, with other brain malformations 6;Circumferential Skin Creases Kunze Type;SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1;Cortical dysplasia, complex, with other brain malformations 6;Cortical dysplasia, complex, with other brain malformations 6;Circumferential Skin Creases Kunze Type;SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1;SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1;Cortical dysplasia, complex, with other brain malformations 6;Cortical dysplasia, complex, with other brain malformations 6;Circumferential Skin Creases Kunze Type"
TUBB_aug3,TUBB,"Cortical dysplasia, complex, with other brain malformations 5;Cortical dysplasia, complex, with other brain malformations 5;SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1;Circumferential Skin Creases Kunze Type;Cortical dysplasia, complex, with other brain malformations 6;Cortical dysplasia, complex, with other brain malformations 6;Multiple benign circumferential skin creases on limbs;Cortical dysplasia, complex, with other brain malformations 6;Circumferential Skin Creases Kunze Type;Cortical dysplasia, complex, with other brain malformations 6;SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1;SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1;Cortical dysplasia, complex, with other brain malformations 6;Circumferential Skin Creases Kunze Type;Cortical dysplasia, complex, with other brain malformations 6;Cortical dysplasia, complex, with other brain malformations 6;Circumferential Skin Creases Kunze Type;Cortical dysplasia, complex, with other brain malformations 6;SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1;Cortical dysplasia, complex, with other brain malformations 6;Circumferential Skin Creases Kunze Type;Cortical dysplasia, complex, with other brain malformations 6;SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1;Cortical dysplasia, complex, with other brain malformations 6;Cortical dysplasia, complex, with other brain malformations 6;Circumferential Skin Creases Kunze Type;SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1;Cortical dysplasia, complex, with other brain malformations 6;Cortical dysplasia, complex, with other brain malformations 6;Circumferential Skin Creases Kunze Type;SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1;SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1;Cortical dysplasia, complex, with other brain malformations 6;Cortical dysplasia, complex, with other brain malformations 6;Circumferential Skin Creases Kunze Type"
TUBB_aug4,TUBB,"Cortical dysplasia, complex, with other brain malformations 5;Cortical dysplasia, complex, with other brain malformations 5;SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1;Circumferential Skin Creases Kunze Type;Cortical dysplasia, complex, with other brain malformations 6;Cortical dysplasia, complex, with other brain malformations 6;Multiple benign circumferential skin creases on limbs;Cortical dysplasia, complex, with other brain malformations 6;Circumferential Skin Creases Kunze Type;Cortical dysplasia, complex, with other brain malformations 6;SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1;SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1;Cortical dysplasia, complex, with other brain malformations 6;Circumferential Skin Creases Kunze Type;Cortical dysplasia, complex, with other brain malformations 6;Cortical dysplasia, complex, with other brain malformations 6;Circumferential Skin Creases Kunze Type;Cortical dysplasia, complex, with other brain malformations 6;SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1;Cortical dysplasia, complex, with other brain malformations 6;Circumferential Skin Creases Kunze Type;Cortical dysplasia, complex, with other brain malformations 6;SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1;Cortical dysplasia, complex, with other brain malformations 6;Cortical dysplasia, complex, with other brain malformations 6;Circumferential Skin Creases Kunze Type;SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1;Cortical dysplasia, complex, with other brain malformations 6;Cortical dysplasia, complex, with other brain malformations 6;Circumferential Skin Creases Kunze Type;SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1;SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1;Cortical dysplasia, complex, with other brain malformations 6;Cortical dysplasia, complex, with other brain malformations 6;Circumferential Skin Creases Kunze Type"
TUBB_aug5,TUBB,"Cortical dysplasia, complex, with other brain malformations 5;Cortical dysplasia, complex, with other brain malformations 5;SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1;Circumferential Skin Creases Kunze Type;Cortical dysplasia, complex, with other brain malformations 6;Cortical dysplasia, complex, with other brain malformations 6;Multiple benign circumferential skin creases on limbs;Cortical dysplasia, complex, with other brain malformations 6;Circumferential Skin Creases Kunze Type;Cortical dysplasia, complex, with other brain malformations 6;SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1;SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1;Cortical dysplasia, complex, with other brain malformations 6;Circumferential Skin Creases Kunze Type;Cortical dysplasia, complex, with other brain malformations 6;Cortical dysplasia, complex, with other brain malformations 6;Circumferential Skin Creases Kunze Type;Cortical dysplasia, complex, with other brain malformations 6;SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1;Cortical dysplasia, complex, with other brain malformations 6;Circumferential Skin Creases Kunze Type;Cortical dysplasia, complex, with other brain malformations 6;SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1;Cortical dysplasia, complex, with other brain malformations 6;Cortical dysplasia, complex, with other brain malformations 6;Circumferential Skin Creases Kunze Type;SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1;Cortical dysplasia, complex, with other brain malformations 6;Cortical dysplasia, complex, with other brain malformations 6;Circumferential Skin Creases Kunze Type;SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1;SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1;Cortical dysplasia, complex, with other brain malformations 6;Cortical dysplasia, complex, with other brain malformations 6;Circumferential Skin Creases Kunze Type"
TUBB_aug6,TUBB,"Cortical dysplasia, complex, with other brain malformations 5;Cortical dysplasia, complex, with other brain malformations 5;SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1;Circumferential Skin Creases Kunze Type;Cortical dysplasia, complex, with other brain malformations 6;Cortical dysplasia, complex, with other brain malformations 6;Multiple benign circumferential skin creases on limbs;Cortical dysplasia, complex, with other brain malformations 6;Circumferential Skin Creases Kunze Type;Cortical dysplasia, complex, with other brain malformations 6;SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1;SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1;Cortical dysplasia, complex, with other brain malformations 6;Circumferential Skin Creases Kunze Type;Cortical dysplasia, complex, with other brain malformations 6;Cortical dysplasia, complex, with other brain malformations 6;Circumferential Skin Creases Kunze Type;Cortical dysplasia, complex, with other brain malformations 6;SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1;Cortical dysplasia, complex, with other brain malformations 6;Circumferential Skin Creases Kunze Type;Cortical dysplasia, complex, with other brain malformations 6;SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1;Cortical dysplasia, complex, with other brain malformations 6;Cortical dysplasia, complex, with other brain malformations 6;Circumferential Skin Creases Kunze Type;SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1;Cortical dysplasia, complex, with other brain malformations 6;Cortical dysplasia, complex, with other brain malformations 6;Circumferential Skin Creases Kunze Type;SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1;SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1;Cortical dysplasia, complex, with other brain malformations 6;Cortical dysplasia, complex, with other brain malformations 6;Circumferential Skin Creases Kunze Type"
TUBB_aug7,TUBB,"Cortical dysplasia, complex, with other brain malformations 5;Cortical dysplasia, complex, with other brain malformations 5;SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1;Circumferential Skin Creases Kunze Type;Cortical dysplasia, complex, with other brain malformations 6;Cortical dysplasia, complex, with other brain malformations 6;Multiple benign circumferential skin creases on limbs;Cortical dysplasia, complex, with other brain malformations 6;Circumferential Skin Creases Kunze Type;Cortical dysplasia, complex, with other brain malformations 6;SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1;SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1;Cortical dysplasia, complex, with other brain malformations 6;Circumferential Skin Creases Kunze Type;Cortical dysplasia, complex, with other brain malformations 6;Cortical dysplasia, complex, with other brain malformations 6;Circumferential Skin Creases Kunze Type;Cortical dysplasia, complex, with other brain malformations 6;SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1;Cortical dysplasia, complex, with other brain malformations 6;Circumferential Skin Creases Kunze Type;Cortical dysplasia, complex, with other brain malformations 6;SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1;Cortical dysplasia, complex, with other brain malformations 6;Cortical dysplasia, complex, with other brain malformations 6;Circumferential Skin Creases Kunze Type;SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1;Cortical dysplasia, complex, with other brain malformations 6;Cortical dysplasia, complex, with other brain malformations 6;Circumferential Skin Creases Kunze Type;SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1;SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1;Cortical dysplasia, complex, with other brain malformations 6;Cortical dysplasia, complex, with other brain malformations 6;Circumferential Skin Creases Kunze Type"
TUBB_aug8,TUBB,"Cortical dysplasia, complex, with other brain malformations 5;Cortical dysplasia, complex, with other brain malformations 5;SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1;Circumferential Skin Creases Kunze Type;Cortical dysplasia, complex, with other brain malformations 6;Cortical dysplasia, complex, with other brain malformations 6;Multiple benign circumferential skin creases on limbs;Cortical dysplasia, complex, with other brain malformations 6;Circumferential Skin Creases Kunze Type;Cortical dysplasia, complex, with other brain malformations 6;SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1;SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1;Cortical dysplasia, complex, with other brain malformations 6;Circumferential Skin Creases Kunze Type;Cortical dysplasia, complex, with other brain malformations 6;Cortical dysplasia, complex, with other brain malformations 6;Circumferential Skin Creases Kunze Type;Cortical dysplasia, complex, with other brain malformations 6;SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1;Cortical dysplasia, complex, with other brain malformations 6;Circumferential Skin Creases Kunze Type;Cortical dysplasia, complex, with other brain malformations 6;SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1;Cortical dysplasia, complex, with other brain malformations 6;Cortical dysplasia, complex, with other brain malformations 6;Circumferential Skin Creases Kunze Type;SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1;Cortical dysplasia, complex, with other brain malformations 6;Cortical dysplasia, complex, with other brain malformations 6;Circumferential Skin Creases Kunze Type;SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1;SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1;Cortical dysplasia, complex, with other brain malformations 6;Cortical dysplasia, complex, with other brain malformations 6;Circumferential Skin Creases Kunze Type"
TUBB_aug9,TUBB,"Cortical dysplasia, complex, with other brain malformations 5;Cortical dysplasia, complex, with other brain malformations 5;SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1;Circumferential Skin Creases Kunze Type;Cortical dysplasia, complex, with other brain malformations 6;Cortical dysplasia, complex, with other brain malformations 6;Multiple benign circumferential skin creases on limbs;Cortical dysplasia, complex, with other brain malformations 6;Circumferential Skin Creases Kunze Type;Cortical dysplasia, complex, with other brain malformations 6;SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1;SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1;Cortical dysplasia, complex, with other brain malformations 6;Circumferential Skin Creases Kunze Type;Cortical dysplasia, complex, with other brain malformations 6;Cortical dysplasia, complex, with other brain malformations 6;Circumferential Skin Creases Kunze Type;Cortical dysplasia, complex, with other brain malformations 6;SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1;Cortical dysplasia, complex, with other brain malformations 6;Circumferential Skin Creases Kunze Type;Cortical dysplasia, complex, with other brain malformations 6;SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1;Cortical dysplasia, complex, with other brain malformations 6;Cortical dysplasia, complex, with other brain malformations 6;Circumferential Skin Creases Kunze Type;SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1;Cortical dysplasia, complex, with other brain malformations 6;Cortical dysplasia, complex, with other brain malformations 6;Circumferential Skin Creases Kunze Type;SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1;SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1;Cortical dysplasia, complex, with other brain malformations 6;Cortical dysplasia, complex, with other brain malformations 6;Circumferential Skin Creases Kunze Type"
HPRT1,HPRT1,"LESCH-NYHAN SYNDROME;LESCH-NYHAN SYNDROME;LESCH-NYHAN SYNDROME;Hypoxanthine guanine phosphoribosyltransferase partial deficiency;HYPERURICEMIA, HPRT-RELATED"
HPRT1_aug1,HPRT1,"LESCH-NYHAN SYNDROME;LESCH-NYHAN SYNDROME;LESCH-NYHAN SYNDROME;Hypoxanthine guanine phosphoribosyltransferase partial deficiency;HYPERURICEMIA, HPRT-RELATED"
HPRT1_aug2,HPRT1,"LESCH-NYHAN SYNDROME;LESCH-NYHAN SYNDROME;LESCH-NYHAN SYNDROME;Hypoxanthine guanine phosphoribosyltransferase partial deficiency;HYPERURICEMIA, HPRT-RELATED"
HPRT1_aug3,HPRT1,"LESCH-NYHAN SYNDROME;LESCH-NYHAN SYNDROME;LESCH-NYHAN SYNDROME;Hypoxanthine guanine phosphoribosyltransferase partial deficiency;HYPERURICEMIA, HPRT-RELATED"
HPRT1_aug4,HPRT1,"LESCH-NYHAN SYNDROME;LESCH-NYHAN SYNDROME;LESCH-NYHAN SYNDROME;Hypoxanthine guanine phosphoribosyltransferase partial deficiency;HYPERURICEMIA, HPRT-RELATED"
HPRT1_aug5,HPRT1,"LESCH-NYHAN SYNDROME;LESCH-NYHAN SYNDROME;LESCH-NYHAN SYNDROME;Hypoxanthine guanine phosphoribosyltransferase partial deficiency;HYPERURICEMIA, HPRT-RELATED"
HPRT1_aug6,HPRT1,"LESCH-NYHAN SYNDROME;LESCH-NYHAN SYNDROME;LESCH-NYHAN SYNDROME;Hypoxanthine guanine phosphoribosyltransferase partial deficiency;HYPERURICEMIA, HPRT-RELATED"
HPRT1_aug7,HPRT1,"LESCH-NYHAN SYNDROME;LESCH-NYHAN SYNDROME;LESCH-NYHAN SYNDROME;Hypoxanthine guanine phosphoribosyltransferase partial deficiency;HYPERURICEMIA, HPRT-RELATED"
HPRT1_aug8,HPRT1,"LESCH-NYHAN SYNDROME;LESCH-NYHAN SYNDROME;LESCH-NYHAN SYNDROME;Hypoxanthine guanine phosphoribosyltransferase partial deficiency;HYPERURICEMIA, HPRT-RELATED"
HPRT1_aug9,HPRT1,"LESCH-NYHAN SYNDROME;LESCH-NYHAN SYNDROME;LESCH-NYHAN SYNDROME;Hypoxanthine guanine phosphoribosyltransferase partial deficiency;HYPERURICEMIA, HPRT-RELATED"
GAPDH,GAPDH,None
GAPDH_aug1,GAPDH,None
GAPDH_aug2,GAPDH,None
GAPDH_aug3,GAPDH,None
GAPDH_aug4,GAPDH,None
GAPDH_aug5,GAPDH,None
GAPDH_aug6,GAPDH,None
GAPDH_aug7,GAPDH,None
GAPDH_aug8,GAPDH,None
GAPDH_aug9,GAPDH,None
LDHA,LDHA,GLYCOGEN STORAGE DISEASE XI;Glycogen storage disease due to lactate dehydrogenase M-subunit deficiency;GLYCOGEN STORAGE DISEASE XI
LDHA_aug1,LDHA,GLYCOGEN STORAGE DISEASE XI;Glycogen storage disease due to lactate dehydrogenase M-subunit deficiency;GLYCOGEN STORAGE DISEASE XI
LDHA_aug2,LDHA,GLYCOGEN STORAGE DISEASE XI;Glycogen storage disease due to lactate dehydrogenase M-subunit deficiency;GLYCOGEN STORAGE DISEASE XI
LDHA_aug3,LDHA,GLYCOGEN STORAGE DISEASE XI;Glycogen storage disease due to lactate dehydrogenase M-subunit deficiency;GLYCOGEN STORAGE DISEASE XI
LDHA_aug4,LDHA,GLYCOGEN STORAGE DISEASE XI;Glycogen storage disease due to lactate dehydrogenase M-subunit deficiency;GLYCOGEN STORAGE DISEASE XI
LDHA_aug5,LDHA,GLYCOGEN STORAGE DISEASE XI;Glycogen storage disease due to lactate dehydrogenase M-subunit deficiency;GLYCOGEN STORAGE DISEASE XI
LDHA_aug6,LDHA,GLYCOGEN STORAGE DISEASE XI;Glycogen storage disease due to lactate dehydrogenase M-subunit deficiency;GLYCOGEN STORAGE DISEASE XI
LDHA_aug7,LDHA,GLYCOGEN STORAGE DISEASE XI;Glycogen storage disease due to lactate dehydrogenase M-subunit deficiency;GLYCOGEN STORAGE DISEASE XI
LDHA_aug8,LDHA,GLYCOGEN STORAGE DISEASE XI;Glycogen storage disease due to lactate dehydrogenase M-subunit deficiency;GLYCOGEN STORAGE DISEASE XI
LDHA_aug9,LDHA,GLYCOGEN STORAGE DISEASE XI;Glycogen storage disease due to lactate dehydrogenase M-subunit deficiency;GLYCOGEN STORAGE DISEASE XI
RPL13A,RPL13A,None
RPL13A_aug1,RPL13A,None
RPL13A_aug2,RPL13A,None
RPL13A_aug3,RPL13A,None
RPL13A_aug4,RPL13A,None
RPL13A_aug5,RPL13A,None
RPL13A_aug6,RPL13A,None
RPL13A_aug7,RPL13A,None
RPL13A_aug8,RPL13A,None
RPL13A_aug9,RPL13A,None
GUSB,GUSB,"Mucopolysaccharidosis type 7;Mucopolysaccharidosis type 7;MUCOPOLYSACCHARIDOSIS, TYPE VII"
GUSB_aug1,GUSB,"Mucopolysaccharidosis type 7;Mucopolysaccharidosis type 7;MUCOPOLYSACCHARIDOSIS, TYPE VII"
GUSB_aug2,GUSB,"Mucopolysaccharidosis type 7;Mucopolysaccharidosis type 7;MUCOPOLYSACCHARIDOSIS, TYPE VII"
GUSB_aug3,GUSB,"Mucopolysaccharidosis type 7;Mucopolysaccharidosis type 7;MUCOPOLYSACCHARIDOSIS, TYPE VII"
GUSB_aug4,GUSB,"Mucopolysaccharidosis type 7;Mucopolysaccharidosis type 7;MUCOPOLYSACCHARIDOSIS, TYPE VII"
GUSB_aug5,GUSB,"Mucopolysaccharidosis type 7;Mucopolysaccharidosis type 7;MUCOPOLYSACCHARIDOSIS, TYPE VII"
GUSB_aug6,GUSB,"Mucopolysaccharidosis type 7;Mucopolysaccharidosis type 7;MUCOPOLYSACCHARIDOSIS, TYPE VII"
GUSB_aug7,GUSB,"Mucopolysaccharidosis type 7;Mucopolysaccharidosis type 7;MUCOPOLYSACCHARIDOSIS, TYPE VII"
GUSB_aug8,GUSB,"Mucopolysaccharidosis type 7;Mucopolysaccharidosis type 7;MUCOPOLYSACCHARIDOSIS, TYPE VII"
GUSB_aug9,GUSB,"Mucopolysaccharidosis type 7;Mucopolysaccharidosis type 7;MUCOPOLYSACCHARIDOSIS, TYPE VII"
PPIA,PPIA,None
PPIA_aug1,PPIA,None
PPIA_aug2,PPIA,None
PPIA_aug3,PPIA,None
PPIA_aug4,PPIA,None
PPIA_aug5,PPIA,None
PPIA_aug6,PPIA,None
PPIA_aug7,PPIA,None
PPIA_aug8,PPIA,None
PPIA_aug9,PPIA,None
